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ÖSSZEFOGLALÁS 
 
A változáshoz (stresszhez) történő alkalmazkodást egy komplex, specializált 
stresszválaszokra épülő adaptációs mechanizmus segíti. Az öregedés és számos betegség 
folyamatában az adaptáció elégtelensége figyelhető meg, azonban az egyes stresszválaszok 
kölcsönhatásai nem tisztázottak. Kutatásaink során különféle stresszadaptációs 
mechanizmusokat tanulmányoztunk izolált fehérjéktől a humán perifériás limfocitákig. 
A Hsp90 hősokkfehérje többszáz jelátviteli (kliens) fehérje szerkezetét stabilizálja. A 
Hsp90 (Ph.D. munkám során azonosított) C-terminális nukleotidkötőhelyének specificitását 
jellemeztük; megállapítottuk, hogy a C-terminális inhibitor szelektíven gátolja a 
szteroidreceptor kliensek funkcióját; rámutattunk, hogy a tumorokban túltermelődő humán 
Hsp90α a Hsp90β-nál hatékonyabban működik és Hsp90-inhibitorral szemben ellenállóbb. 
A kalóriacsökkentés a leghatékonyabb élettartamnövelő hatás, mely számos  
adaptációs mechanizmust aktivál, többek között a Sir2 szirtuin metabolikus, a HSF1 fehérje 
homeosztatikus hősokkválasz és az Nrf2 xenobiotikus stresszválasz mesterregulátorokat. 
Kimutattuk, hogy idős patkány máj citoszol chaperon kapacitása enyhén csökkent és elméleti 
és számítógépes modellt alkottunk a fehérje homeosztatikus puffer és a hősokkválasz 
öregedésben játszott szerepéről; kimutattuk, hogy humán időskori cinkszupplementáció és a 
kalóriacsökkentés mimetikus resveratrol stimulálja a hősokkválaszt, megerősítettük a HSF1 
szerepét a kalóriamegvonás-indukálta élettartamnövekedésben és megcáfoltuk a Sir2 
túltermelésének élettartamnövelő hatását Caenorhabditis elegans-ban; megfigyeltük a 
denaturált fehérjeszerkezet funkciótól független, emlős sejtek proliferációjára és stressz-
indukálta túlélésre gyakorolt negatív hatását; bizonyítottuk, hogy az oxidatív stressz emlős 
sejteken és C. elegans-ban egyaránt az RNS interferencia közvetítésével gátolja a 
hősokkadaptációt; valamint feltártuk, hogy az Nrf2 ortológ SKN-1 transzkripciós faktor 
optimális aktivációja szükséges a természetes immunitáshoz, aktivitáscsökkenése pedig részt 
vesz az immunoszeneszcenciában C. elegans-ban. 
Eredményeink összekapcsolják a fehérje homeosztázist, az oxidatív stresszt, a kalória 
csökkentést, a természetes immunitást valamint az öregedést, ezáltal elősegítik a különféle 
stresszek és stresszválaszok integratív szemléletét. Az azonosított mechanizmusok az emberi 
öregedés és a korral kapcsolódó betegségek tekintetében is megállhatják helyüket és új 
terápiás célpontokat kínálhatnak.  
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KÖSZÖNETNYILVÁNÍTÁS 
Köszönetemet szeretném kifejezni mindazoknak, akik hozzájárultak eddigi életutam és 
tudományos pályám alakulásához, és elnézést kérek mindazoktól, akiket itt név szerint nem 
említek. Számos általános- és középiskolai tanárom bizalmát éreztem. Selmeczi Lászlóval a 
Kórélettani Intézet diákköröseként dolgozhattam és részesülhettem a tudomány iránti 
lelkesedéséből és alázatából. Somogyi János az Orvosi Vegytani Intézetben laboratóriumába 
befogadott, hálás vagyok megbecsüléséért, beszélgetéseinkért. Mentoromnak, Csermely 
Péternek köszönöm barátságát, az inspirációt, a gondolat szabadságának tiszteletét, 
nagylelkűségét, hogy segítette önállósodásomat. 
Mandl József és Bánhegyi Gábor az Orvosi Vegytani Intézet Igazgatóiként a kutatói 
szabadságot és a magas szakmai színvonalat támogató közeget teremtettek, amelynek 
részesévé tettek és ahol bármilyen gondommal számíthattam segítségükre. Köszönöm 
mindkettejük, valamint az Intézet volt és jelen munkatársainak támogatását. 
Szerencsés vagyok, hogy diákköri és doktori éveimet Schnaider Tamással baráti 
közösségben és szolidarításban, egymástól tanulva tölthettem. Hálás vagyok Tóth Márton 
posztdoktor kollégámnak barátságáért, az együtt gondolkodásért és a C. elegans laboratórium 
megteremtésében vállalt alapvető szerepéért. Gilányi Bea kollégám érdeme a labor rendezett, 
olajozott működése, köszönöm megbízható munkáját. Munkatársaim és tanítványaim életük 
egy részét a közös munkának szentelték, köszönöm, hogy tanulhattam tőlük és általuk (a 
teljesség igénye nélkül): Putics Ákos posztdoktornak; Alper Arslan, Papp Diána, Nguyen 
Minh Tu, Gyurkó Dávid és Somogyvári Milán volt és jelenlegi PhD hallgatóknak (közülük 
többen korábbi diákkörösök és szakdolgozók voltak); Spiró Zoltán és Dancsó Balázs 
szakdolgozóknak; Vermes Ákos, Rácz Attila, Kovács Levente, Végh Eszter Mária, Maria 
Chikina, Láng Júlia, Pathó Zoltán, Tihanyi Benedek és Taisz István diákkörös hallgatóknak. 
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Hálás vagyok sok hazai és külföldi kollégámnak az együttműködések, kihívások és 
közös felfedezések formáló erejéért. Köszönöm az ismeretlen bíráló kollégák idejét, 
érdeklődését és jobbító szándékát. Vellai Tibor tudása és folyamatos önzetlen segítsége 
lehetővé tette a C. elegans műhely létrehozását és segíti magas színvonalú működését, melyet 
köszönök. Örömmel tölt el, hogy a C. elegans közösséghez tartozhatom, amelynek baráti és 
tudásközpontú légköre, valamint a nyílt tudás- és törzsbázis (Wormbase és Caenorhabditis 
Genetics Center) bármilyen merész elképzelés és együttműködés megvalósítását megkönnyíti. 
Munkám anyagi alapjait többek között a Semmelweis Egyetem jogviszonya, 
elismerései, a Magyar Tudományos Akadémia Bolyai Ösztöndíja két ízben, valamint számos 
tudományos pályázati forrás (OTKA, Norvég Finanszírozási Mechanizmus, az Európai  Unió 
FP6 és FP7-es keretprogramja) biztosította, melyeket köszönök. 
Hálás vagyok ismerősöknek, barátoknak, mestereknek. Külön köszönet Max 
Claytonnak. Nem tudom szóval megköszönni Szüleimnek, hogy vagyok, családomnak, 
gyermekeimnek, hogy vannak. 
 
Budapest, 2013. március 8. 
       
Sőti Csaba 
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RÖVIDÍTÉSEK JEGYZÉKE 
Δ9CAT: Chloramphenicol-acetiltranszferáz C-terminális 9 aminosavát nélkülöző mutáns 
CD3: Cluster of Differentiation 3, T-limfocita marker  
CDDP: ciszplatin, cisz-diamin-dikloroplatinum (II) 
CTL-2: peroxiszómális C. elegans kataláz-2 
DCR-1/Dicer: az érett mikroRNS-eket előállító citoszolikus endonukleáz C. elegans/humán 
ortológja 
GFP: zöld fluoreszcens fehérje 
GHKL: Giráz/Hsp90/His-kináz/MutL fehérjékben előforduló nem-konvencionális ATP-kötő 
domén 
HSF1: hősokk transzkripciós faktor-1 
Hsp70: 70 kDa molekulatömegű hősokkfehérje 
Hsp90: 90 kDa molekulatömegű hősokkfehérje 
Lck: Leukocyte C-terminal Src kinase 
NAD+: nikotinamid-adenin dinukleotid 
Nrf2: Nuclear factor (erythroid-derived 2)-Related Factor 2 transzkripciós faktor  
PASH-1/Drosha: a hajtű pre-mikroRNS-t előállító sejtmagi endonukleáz C. elegans/humán 
ortológja 
PMK-1: a p38 MAP kináz C. elegans ortológja 
PRDX-2: citoszolikus C. elegans peroxiredoxin-2 
Raf-1: Rapidly Accelerated Fibrosarcoma Ser/Thr kináz 1 
Sir2: Silent Information Regulator 2, NAD+-függő szirtuin deacetiláz család 
SIR-2.1: a Sir2 C. elegans ortológja 
SIRT1: a Sir2 egyik fő humán ortológja (humán sejtben 7 paralóg van: SIRT1-7) 
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SKN-1: SKiNhead transzkripciós faktor, az Nrf2 C. elegans ortológja 
TIR-1: Toll/Interleukin-1 Receptor domén fehérje, a SARM C. elegans ortológja 
UPR: unfolded protein response, az endoplazmatikus retikulum stresszválasza 
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BEVEZETÉS 
Az élő szervezet alapvető képessége, hogy érzékelje az egyensúlyából kilendítő 
környezeti hatásokat és azokra megfelelő módon reagáljon, melynek célja egy új, a 
megváltozott körülményekkel összhangban levő egyensúlyi állapot kialakítása. A hatásokat – 
Selye János munkája nyomán – stressznek, az ezt érzékelő és az alkalmazkodást segítő 
mechanizmusokat stresszválasznak, a folyamatot stresszadaptációnak nevezzük. Az utóbbi 
évtizedek kutatásai feltárták a stresszválasz(ok) moduláris szerveződését: beszélhetünk 
antioxidatív, xenobiotikus, genotoxikus, fehérje konformációs (hősokk-), metabolikus, stb. 
stresszválaszokról. Az enyhe stresszek által kiváltott hatékony stresszadaptáció eredménye 
azonos illetve eltérő stresszekkel szembeni (kereszt-)tolerancia, míg a túlzott stressz gyengíti 
az alkalmazkodást. Ezek a kereszthatások komplex, hálózatos szerveződést sejtetnek, melyek 
működésének molekuláris mechanizmusai és kölcsönhatásai nagyrészt feltáratlanok.  
Doktori értekezésem két részből áll: először a Hsp90 molekuláris chaperon biokémiai 
és funkcionális jellemzésével, majd a hősokkválasz és más stresszek illetve stresszválaszok 
kölcsönhatásaival és öregedésben játszott szerepével kapcsolatos munkánkat foglalom össze. 
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A HSP90 BIOKÉMIAI ÉS FUNKCIONÁLIS JELLEMZÉSE 
A 90 kDa molekulatömegű hősokkfehérje (Hsp90) egy konzervált, esszenciális 
citoszolikus molekuláris chaperon. A sejt összfehérje tartalmának mintegy 2-5%-át alkotja. 
Két izoformája van, a konstitutívan expresszálódó β és a stresszindukálható α, melyek 
nagyfokú szekvencia identitást mutatnak, azonban szabályozásuk eltérő. Perifériás sejtekben 
elsősorban a β izoforma fordul elő, míg intenzíven osztódó, illetve a stresszelt tumorsejtekben 
az α expressziója erősen indukálódik, így mennyisége a β izoformával összemérhető vagy azt 
meghaladja. Az eltérő szabályozás és szöveti expresszió funkcionális különbségeket sejtet. 
A Hsp90 N-terminális nukleotidkötő, ezt követő flexibilis linker, középső 
szubsztrátkötő és C-terminális dimerizációs/fehérje interakciós doménekből áll. A Hsp90 
specifikus chaperon: többszáz termodinamikailag instabil, jelátviteli kulcsmolekula, ún. 
‘kliens’ fehérje (pl. kinázok, transzkripciós faktorok, polimerázok) szerkezetét stabilizálja, 
melyek szerteágazó biológiai funkcióikat látnak el, és kiemelt szerepet játszanak a 
sejtproliferációban és túlélésben. Ehhez az N-terminális, GHKL-típusú ATP-kötőhelyének 
ATPáz aktivitása szükséges. Az N-terminális ATP-antagonista Hsp90-inhibitorok (vezető 
molekula: geldanamycin) ígéretes specifikus tumor kemoterápiás szerek, azonban a Hsp90 
gátlásával a hősokk transzkripciós faktor-1 (HSF1) aktivációja révén rezisztenciához 
vezetnek. PhD munkám során jellemeztük a Hsp90 chaperon ciklusát moduláló 
kismolekulákkal illetve ATP-vel való kölcsönhatását. Utóbbi során felfedeztünk egy C-
terminális doménen elhelyezkedő nukleotidkötőhelyet, mely az N-terminális kötőhellyel 
allosztérikus kapcsolatban áll, azonban geldanamycinnel nem, hanem novobiocinnal és 
ciszplatinnal (CDDP) gátolható. 
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Célkitűzés 
Hsp90-nel kapcsolatos kísérleteink során az alábbi kérdésekre kerestünk választ: 
1. Milyen nukleotidspecificitással rendelkezik a Hsp90 C-terminális nukleotidkötőhelye? 
2. Milyen hatást fejt ki a C-terminális nukleotidkötőhelyet gátló ciszplatin a Hsp90 
kliensfehérje komplexekre? 
3. Milyen funkcionális jelentőséggel bír a Hsp90 α és β izoformája? 
Eredmények és megbeszélésük 
1. A Hsp90 C-terminális nukleotidkötőhelyének jellemzése 
A Hsp90 N- és C-terminális nukleotidkötőhelyének jellemzésére a korábban beállított 
nukleotid-affinitáshasítási módszert és a szilárd fázisú gyantán immobilizált nukleotidokkal 
történő affinitáskromatográfiás módszert, illetve  a kettő kombinációját alkalmaztuk. Timothy 
Haysteaddel együttműködve megállapítottuk, hogy az N-terminális kötőhely adenin-
nukleotidokra (ezek között dinukleotidokra, pl. NAD+-ra, illetve alarmonokra) specifikus, míg 
a C-terminális domén széles specificitású, mind purin-, mind pirimidin-nukleotidok kötésére 
képes (Sőti és mtsai, 2003b). 
Munkánk azt sugallja, hogy a C-terminális kötőhelynek in vivo egyéb kismolekulájú 
ligandok kötésében is szerepe lehet, és lehetőséget nyújt a C-terminális kötőhelyre specifikus 
inhibitorok előállítására, melyek az N-terminális domént nélkülöző izoformákra (pl. Hsp90N) 
is hatékonyak (Sreedhar és mtsai, 2004, Sőti és mtsai, 2005b). 
2. Ciszplatin hatása a Hsp90-kliens kapcsolatra   
A C-terminális kötőhelyet gátló ciszplatinnak a Hsp90 kliensekre gyakorolt hatását 
tanulmányozva Theo Rein csoportjával együttműködésben kimutattuk, hogy a ciszplatin 
koncentrációfüggően gátolja a Hsp90 kliens glukokortikoid és androgén receptor 
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stabilizációját és funkcióját. Ezt a hatást a Hsp90 közvetíti. Ciszplatin nem hatott más Hsp90 
kliensekre, így a Ser/Thr-kináz Raf-1-re, a Tyr-kináz Lck-ra. Fontos, hogy ciszplatin nem 
befolyásolja a hősokk választ és a Hsp90α expresszióját reguláló hősokk transzkripciós 
faktor-1 (HSF1) transzaktivációját (Rosenhagen és mtsai, 2003). 
Eredményeink arra utalnak, hogy a C-terminális kötőhely szelektív gátlása a Hsp90 
bizonyos klienseivel kialakított kölcsönhatását gátolja. Mindez illusztrálja a C-terminális 
kötőhely specifikus funkcióját, továbbá első bizonyítékát adja a annak, hogy a Hsp90-nek 
bizonyos klienseivel kialakított kölcsönhatása – a hősokkválasz aktiválódásának elkerülésével 
–  terápiásan megcélozható.  
3. A Hsp90 α  és β  izoformájának funkcionális eltérései 
Az élesztő egyszerűségét, kiváló genetikai manipulálhatóságát és a Hsp90 funkció 
nagyfokú konzerváltságát kihasználva Peter Piper csoportjával együttműködve kimutattuk, 
hogy Hsp90-deficiens élesztő modellrendszerben egyedüli Hsp90-ként kifejezett humán 
Hsp90α és Hsp90β egyaránt képes az életképességet helyreállítani és kliensekkel 
komplexeket kialakítani. Azonban a két izoforma funkcionálisan eltér: a Hsp90α alacsonyabb 
affinitású (azaz tranziensebb, hatékonyabb) komplexeket alakít ki, jelenléte jóval 
hatékonyabban aktiválja a hősokkválaszt, segíti elő a v-src Tyr-kináz kliens aktivációját, és 
nagyságrendekkel ellenállóbb a Hsp90 N-terminális inhibitor radicicollal szemben (Millson és 
mtsai, 2007). 
Eredményeink a humán Hsp90 izoformák eltérő celluláris funkcióira az elsők között 
adtak bizonyítékot. Mivel a Hsp90α a tumorokban szelektíven indukálódik és a tumor 
agresszivitás és rezisztencia számos molekuláris mechanizmusát közvetíti, ezért 
megfigyeléseink rávilágítanak a tumorok nagyfokú ellenállóképességére, így a Hsp90α 
specifikus megcélzása, vagy indukciójának megelőzése fontos kemoterápiás stratégia lehet.  
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STRESSZEK ÉS STRESSZVÁLASZOK KÖLCSÖNHATÁSAINAK VIZSGÁLATA 
A fehérje konformációs homeosztázist, így a sejt fehérjehálózatát a fehérje 
homeosztatikus puffer tartja karban, mely a hősokkválasz köré szerveződik. Hősokkfehérjék 
(Hsp-k, vagy molekuláris chaperonok) segítik a fehérjék feltekeredését, a komplexek 
összeszerelődését, transzportját, és ismerik fel a nem-natív szerkezetű fehérjéket, melyeket 
helyreállítanak vagy a proteaszómális illetve autofág lebontás útjára, illetve az aggregáció felé 
segítenek. A Hsp90-központú chaperon komplex többszáz instabil szerkezetű jelátviteli 
kulcsmolekula szerkezetét stabilizálja, a sejt legtöbb kapcsolattal rendelkező fehérjéi közé 
tartozik, így a celluláris jelátviteli folyamatok zavartalan működését teszi lehetővé (ld. 
később). A proteotoxikus stressz következtében felszaporodó denaturált fehérjéket megkötik a 
fő citoszolikus Hsp90 és Hsp70 chaperonok, és gátló komplexükből elengedik a hősokk 
transzkripciós faktort-1- (HSF1)-et. Az aktiválódó HSF1 indukálja a hősokk-gének, illetve 
szabályozza a sejt önfenntartását és növekedésében érintett gének (a genom mintegy 3-4%-a) 
expresszióját, mely erősíti az ellenállóképességet és az immunitást. Ezáltal a hősokkválasz az 
akut túlélés és betegségekkel szembeni ellenállóképesség egyik fontos általános tényezője. 
Az öregedés az élő szervezet funkcióinak progresszív csökkenése. Az 
öregedéselméletek genetikai programot (celluláris szeneszcencia: Hayflick-szabály, 
gerontogének), a hibák random, ill. oxidatív stressz-okozta halmozódását (mutáció-
akkumuláció és hibakatasztrófa elmélet, szabadgyök-teória) helyezték előtérbe. Öregedés 
során megfigyelhető az oxidatív stressz és károsodások (pl. sérült fehérjék) mennyiségének 
növekedése. A sérült fehérjék a posztmitotikus sejtekben öregedés-szerű sorvadást okoznak 
(pl. mutáns fehérjék okozta neurodegeneratív betegség). Azonban az öregedés a változáshoz 
történő alkalmazkodás csökkenéseként is értelmezhető, melyre az előző elméleteket magába 
ölelő kísérleti bizonyítékot a stresszválaszok (hősokkválasz, immunválasz, egyéb önfenntartó 
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mechanizmusok) válaszkészségének korral járó csökkenése, illetve a stressztolerancia és az 
élettartam közötti optimumkorreláció szolgáltat. Ez felveti annak lehetőségét, hogy a 
stresszválaszok, pl. a hősokkválasz farmakológiás aktivációja célpont lehet az egészséges 
élettartam megnyújtásában és a degeneratív civilizációs betegségek (elhízás, diabétesz, 
kardiovaszkuláris és neurodegeneratív betegségek, immunproblémák) megelőzésében és 
kezelésében. 
A kalóriacsökkentés, a kalóriabevitel mérsékelt (30-40%-os) csökkentése az eddig 
ismert leghatékonyabb, emlős modelleken is igazolt élettartamnövelő környezeti hatás. Az 
inzulin szignálon túl a kalóriacsökkentés sejtszintű közvetítőjeként a 2000-es évek elején a 
metabolikus szenzor szirtuin (Sir2) NAD+-függő deacetilázt azonosították. Szirtuin túltermelő 
élesztő, fonálféreg és ecetmuslica törzsek élettartama megnövekedett, így a szirtuin aktiváció 
ígéretes humán élethossznövelő farmakológiás célponttá vált. Ezzel egyidőben az eredetileg 
rákellenes hatásáról ismert polifenol resveratrolban az első élettartamnövelő kismolekulát 
fedezték fel, mely hatékonynak bizonyult az élesztőtől a túltáplált egerekig. A resveratrolról 
bizonyították, hogy a Sir2 deacetiláz aktivitását serkenti és a kalóriacsökkentéshez hasonló 
anyagcsere- és génexpressziós hatásokat hoz létre. Ezen túl a kalóriacsökkentés aktivál egyéb 
stressz-reszponzív pályákat, pl. indukálja az antioxidáns választ, a hősokkfehérjéket, és a 
xenobiotikus regulátor Nrf2 transzkripciós faktort. Az erőteljes és koordinált változások azt 
sugallják, hogy a kalóriacsökkentés egy enyhe metabolikus stresszhatás által egy szervezeti 
szinten összehangolt önfenntartó program aktivációja az erőforrások szűkössé válásakor, így 
megértésével, egyéb stresszválaszokkal történő kapcsolatainak feltárásával közelebb 
juthatunk az egészséges élettartam meghosszabbításához. 
A megfelelő immunitás szükséges az akut túléléshez és hozzájárul az egészséges 
élettartam kialakításához. Az öregedés egyik legmarkánsabb velejárója a gyengülő hatékony 
immunválasz és erősődő gyulladásos tendencia kombinációjaként jellemezhető 
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immunszeneszcencia. A kalóriacsökkentés serkenti az immunműködést és késlelteti az 
immmunszeneszcenciát. Az immunválasz is felfogható egy szervezeti veszélyt érzékelő 
komplex stresszválaszként (Matzinger-hipotézis), azonban a szervezet önfenntartó 
stresszválaszaival való kapcsolata nem teljesen tisztázott.  
 
Célkitűzés 
Stresszválaszokkal kapcsolatos kutatásaink során az alábbi kérdésekre kerestünk választ: 
1. Hogyan változik a chaperon kapacitás előrehaladott korban? Mi a hősokkválasz és fehérje 
homeosztázis szerepe az öregedés során?  
2. Hogyan hat a humán időskori cinkszupplementáció a perifériás limfociták 
hősokkválaszára? 
3. Milyen kapcsolat van a metabolikus szignálutak aktivációja (kalória megvonás, 
resveratrol, genetikai szirtuin aktiváció) és a hősokkválasz valamint az élettartam között? 
4. Milyen hatást fejtenek ki a denaturált (instabil szerkezetű) fehérjék, funkciójuktól 
függetlenül a fehérje homeosztázisra és a sejtfunkcióra?  
5. Hogyan és milyen mechanizmussal hat az oxidatív stressz a hősokkadaptációra? 
6. Mi a szerepe az enyhe stresszeknek és a xenobiotikus stresszválasz regulátor Nrf2 ortológ 
SKN-1-nek a természetes immunitásban és az immunoszeneszcenciában? 
 
Eredmények és megbeszélésük 
1. A chaperon kapacitás és a hősokkválasz változása és szerepe az öregedés során 
A hősokkválasz indukálhatósága az öregedés során csökken, azonban a chaperonok 
fehérje denaturációtól védő hatékonysága munkánk kezdetekor ismeretlen volt. Hőérzékeny 
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luciferáz modellfehérjét felhasználva elsőként vizsgálva a citoszolikus teljes chaperon 
kapacitást kimutattuk, hogy globális fehérje denaturációt nem okozó körülmények között 
(39ºC) idős (26 hónapos) patkány máj citoszol preparátumok passzív chaperon (fehérje 
denaturációt és aggregációt gátló) kapacitása fiatal (10 hetes) állatokhoz képest enyhén 
csökkent. A két fő citoszolikus chaperon közül a Hsp70 mennyisége nem változott, a Hsp90 
mennyisége csökkent (Nardai és mtsai, 2002). A csökkenés hátterében akár a luciferázt 
stabilizáló Hsp90 szint csökkenése, esetleg oxidált-denaturált fehérjék (köztük a módosult 
chaperonok) korral járó mérsékelt növekedése állhat.  
A sejt és szervezeti öregedés egyik tényezője az aminosavakat módosító, így a fehérje 
konformációt károsító proteotoxikus stresszek és a fehérje homeosztázis karbantartásában 
fontos szerepet játszó chaperonok kapacitásának egyensúlytalansága. Ennek modellezésére 
megalkottuk a „Chaperon túlterhelés” modellt (Sőti és Csermely, 2003), majd ezt kibővítve a 
az „Öregedés fehérje homeosztázis hipotézisét” (Sőti és mtsai, 2003a; Arslan és mtsai, 2006; 
Sőti és Csermely 2007b). Ezeknek az információknak a felhasználásával Tom Kirkwood 
csoportjával együttműködésben egy számítógépes szimulációs modellt fejlesztettünk ki 
(Proctor és mtsai, 2005). Ezeken túl rámutattunk a chaperonok sejt hálózatában betöltött 
szervező szerepére, farmakológiai jelentőségére és az öregedés hálózatos modelljében 
elfoglalt helyére (Sőti és mtsai, 2005a és b; Csermely és Sőti 2006; Sőti és Csermely 2007a). 
2.  Humán cinkszupplementáció hatása limfociták Hsp70 fehérje expressziójára 
A cink, mint nyomelem számos fehérje és enzim integritásához nélkülözhetetlen, így 
fontos szerepet játszik a sejtproliferációban, a genetikai stabilitásban és az antioxidatív 
védelemben és az immunválaszban. Idős emberek cinkstátusza és immunfunkciója romlik. 
Tanulmányunkban, Eugenio Mocchegiani csoportjával együttműködve, idős (64-85 év 
közötti) emberek középtávú cink (10 mg/nap, 48 napig) táplálékkiegészítésének hatását 
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vizsgáltuk áramlási citometriával a humán perifériás vérsejtek fő hősokkválasz markerének, a 
Hsp70 fehérjének mind alap, mind hőindukált expressziójára. Megállapítottuk, hogy a Hsp70 
alap és hőindukált szintje – a kiegészítés előtti állapothoz, illetve a nem szupplementált 
kontroll csoporthoz képest – szignifikánsan növekedett mind az össz-, a CD3+ (T-sejt) és 
CD3- populációkban. A Hsp70 szintek szignifikánsan magasabbak voltak a magas cink 
elérhetőséggel rendelkező csoportban (Putics és mtsai, 2008a). Eredményeink felvetik a 
hősokkválasz szerepét a cinkdeficiencia és cinkpótlás immunrendszerre és 
immunszeneszcenciára kifejtett hatásaiban. 
3.  A metabolikus szignálok, szirtuin aktiváció és a hősokkválasz kapcsolata 
A növényi stresszhatásra termelődő fitoalexin resveratrol hősokk adaptációra kifejtett 
hatását vizsgálva emlős sejtkultúrán és humán limfocitákon beláttuk, hogy aktiválja a HSF1-
függő transzaktivációt és Hsp70 fehérje expressziót. Ez az aktiváció a citoszolikus 
hősokkválaszra specifikus, az endoplazmatikus retikulum stresszválaszt (UPR) nem érinti és a 
hatást nem antioxidáns hatása közvetíti. Resveratrol előkezelés letális hőstressz elleni fokozott 
védelmet biztosít (Putics és mtsai, 2008b). Mindez felveti, hogy a hősokkválasz a resveratrol, 
és talán a kalóriacsökkentés élettartamnövelő hatásának egyik közvetítője. Ezeket a 
hipotéziseinket az ezidőtájt létrehozott Caenorhabiditis elegans laboratóriumunkban kezdtük 
el tanulmányozni.  
A hősokkválasz, metabolikus stressz és kalória csökkentés kapcsolatának áttekintése 
mellett közöltük azon eredményeinket, melyek egy amerikai kutatócsoporttól függetlenül 
megerősítik, hogy a teljes kalóriamegvonás a HSF1 jelenlététől függő élettartam növelő 
hatással rendelkezik C. elegans-on. Megállapítottuk, hogy a kalóriamegvonás nem igényli a 
klasszikus metabolikus szenzor AMP-függő fehérje kináz és Sir2 ortológokat. A HSF1-függő 
élettartam növekedés a 20 fokos neutrális hőmérséklet alatt és felett egyaránt megfigyelhető 
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volt (Dancsó és mtsai, 2010). Ez felveti a kalóriamegvonás és a HSF1 klasszikus metabolikus 
jelátviteltől és fehérje homeosztázistól független szerepét az élettartam növekedésben. 
További eredményeink igazolni látszottak, hogy a resveratrol és a szirtuin magas 
kópiaszámban történő túltermelésének élettartamnövelő hatását C. elegans-ban a HSF1 
közvetíti (Tóth és mtsai, 2008, 2009 konferencia absztraktok; Dancsó és mtsai, 2010). Ezzel 
egyidőben anekdotikus hírekre hivatkozva és saját kísérletek kapcsán David Gems kételyeit 
fejezte ki a szirtuin túltermelés élettartamnövelő hatásával kapcsolatban, ezért a kérdés 
megnyugtató tisztázására együttműködésbe kezdtünk. Mindkét, az irodalomban szereplő, egy 
magas és egy alacsony kópiaszámú sir-2.1 (Sir2 ortológ) transzgén fonálféreg törzset 
egymástól függetlenül a megfelelő genetikai háttérrel visszakereszteztünk. A téma kiemelt 
fontosságára tekintettel kölcsönös látogatások során mindkét laboratóriumban mindkét fél 
által végrehajtott kettősvak kísérleteket végeztünk. A C. elegans SIR-2.1 túltermelés 
élettartamnövelő hatása a visszakeresztezés után eltűnt, melyet nemzetközi együttműködő 
partnereink is megerősítettek. Egyúttal kimutattuk, hogy az eredeti kísérletekben tapasztalt 
élettartam növekedés háttér mutációval kapcsolódott, míg Linda Partridge csoportja 
ecetmuslicában bizonyította, hogy a Sir2 transzgén élettartamnövelő hatása a transzgén 
konstrukciónak tulajdonítható (Burnett és mtsai, 2011). 
Eredményeink a korábbi tanulmányokkal szemben megkérdőjelezik a Sir2 túltermelés 
élettartamnövelő hatását két gerinctelen modell organizmuson, egyúttal felhívják a figyelmet 
a genetikai háttér és a potenciális mutációk megfelelő ellenőrzésére.  
4.  Inert denaturált modellfehérjék celluláris hatásainak viszgálata 
A rosszul feltekeredő („misfolded”) fehérje szerkezet alapvető szerepet játszik a 
konformációs betegségekben és az öregedésben, azonban hogy ennek oka mennyiben a 
kitekert szerkezetű fehérje funkcióvesztése és a keletkező kóros szerkezetű toxikus molekulák 
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funkciónyerése, nem tisztázott. Ennek vizsgálatára létrehoztunk két független, az eukarióta 
sejtben funkcióval nem rendelkező ’inert’ fehérjemolekula destabilizált konformációs 
mutánsának GFP-fúziós változatát, hogy izoláltan megvizsgáljuk a funkciónyerés hatásait. A 
GFP-degron és a GFP-Δ9CAT egyaránt kitekert fehérjeként viselkedett: jó részüket a sejt 
proteaszomális degradációval eliminálta, az erre nem képes sejtekben perinukleáris 
aggregátumokat képeztek, ahol kolokalizáltak a chaperon Hsp70-nel és indukálták 
expresszióját. Egyik fehérje sem okozott számottevő sejtpusztulást stresszmentes 
körülmények között, azonban mindkét fehérje sejtproliferáció gátlást okozott és fokozta a 
proteotoxikus stressz- (hősokk és proteaszóma inhibitor MG132) indukálta sejthalált. A 
sejthalált akár a HSF1 és Hsp70, illetve a vad és deacetiláz deficiens H363Y pontmutáns 
SIRT1 szirtuin túltermelése egyaránt képes volt, míg a SIRT6 paralóg nem volt képes 
megelőzni. Eredményeink a szirtuinok differenciációját és a SIRT1 nem-katalitikus 
hatásmechanizmusát sugallják, így az enzimaktivitást (és az anyagcserét) nem befolyásoló 
terápiás célpontot nyújthat (Arslan és mtsai, 2012; 1. ábra).  
 
 
 
1. ábra   A denaturált fehérje konformáció celluláris hatásai 
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Megfigyeléseink igazolják, hogy egyetlen, az összfehérjék 1-2%-át kitevő, inert 
denaturált fehérje expressziója a sejtre nem toxikus, azonban az azt lebontani képtelen 
sejtekben elegendő, hogy gátolja a sejtproliferációt (növekedést) és a stresszadaptációt, azaz 
az öregedő/szeneszcens sejtekre jellemző viselkedést vált ki (ld. Sőti és mtsai, 2003a). A 
SIRT1 protektív hatása a metabolikus a fehérje homeosztatikus válaszok keresztkapcsolatára 
utal. Vizsgálataink létrehoztak egy új emlős modellt és rávilágítanak a denaturált 
fehérjeszerkezet funkciótól független hatásaira. 
5.  Az oxidatív stressz hatása a hősokkadaptációra 
A fokozott oxidatív stressz kóroki szerepet játszik számos betegségben és az 
öregedésben, és hatásaiért elsősorban az általa okozott molekuláris károsodást teszik 
felelőssé. Emlős sejteken és C. elegans fonálférgen végzett kísérleteinkben az oxidatív hatású 
H2O2 hősokkadaptációra kifejtett hatását Bart Braeckmannal együttműködve tanulmányoztuk. 
H2O2 előkezelés egyaránt gátolta a Hsp70 expressziót és a hőindukált termotoleranciát emlős 
sejtekben illetve a hőindukált termotoleranciát C. elegans fonálféregben. Ezt a hatást a 
mikroRNS kötésben szerepet játszó Hsp70 3’UTR riporter konstrukt aktivációjával és a 
mikroRNS metabolizmusban kulcsszerepet játszó DCR-1/Dicer csendesítésével kapott 
eredmények szerint az RNS-interferencia közvetíti. Fonálférgekben mind dcr-1, mind másik 
kulcsenzim PASH-1/Drosha csendesítés visszaállítja az endogén peroxid-turnoverben 
deficiens ctl-2 kataláz és prdx-2 peroxiredoxin mutáns fonálférgek termotoleranciáját, illetve 
késlelteti az öregedő fonálférgek termotolerancia csökkenését (Spiró és mtsai, 2012; 2. ábra).  
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2. ábra   Az oxidatív stressz hatása a hősokkadaptációra 
 
 
 
Eredményeink feltárnak egy szabályozott, az RNS interferencia révén megvalósuló 
keresztkapcsolatot, mely hozzájárulhat az oxidatív stressz potenciális hatásaihoz 
betegségekben és az öregedés során. A keresztgátlás jelentősége egyelőre ismeretlen, de egy 
adaptációt segítő stresszválasz független stressz általi gyengítése példát ad a komplex 
rendszerek működése kapcsán fellépő túlzott kooperáció öregítő hatására (Kiss és mtsai, 
2009). Az RNS interferencia, illetve a résztvevő, azonosítandó mikroRNS-ek új terápiás 
célpontokat kínálhatnak.  
6.  Az SKN-1/Nrf2 szerepe a természetes immunitásban és az 
immunszeneszcenciában 
A természetes immunitás kiváló modellje a C. elegans fonálféreg, egyszerű 
immunrendszerén túl azért is, mert számos humán fakultatív patogénnel való kölcsönhatását 
és az ellenük kialakított rezisztenciát és immunválaszt tudjuk rajta tanulmányozni. Az utóbbi 
időben derült fény arra, hogy a megfelelő természetes immunitás az antimikrobiális 
effektorokon túl a gazdaszervezet épségét megőrző-helyreállító mechanizmusokra is 
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támaszkodik. Ilyen mechanizmus a xenobiotikus stresszválasz, mely a szervezetre 
potenciálisan káros anyagokat, pl. oxidatív vagy elektrofil ágenseket közömbösít. Ennek  
mesterregulátora az SKN-1/Nrf2 transzkripciós faktor. Kísérleteink során kimutattuk, hogy 
enyhe oxidatív (H2O2) és metabolikus (csökkent inzulin jelátvitel) stresszek fokozzák a 
humán opportunista patogén Pseudomonas aeruginosa elleni patogén rezisztenciát, 
melyekhez az SKN-1 jelenléte szükséges. SKN-1 hiányos fonálférgek csökkent túlélést 
mutatnak mind a Gram-negatív P. aeruginosa, mind Gram-pozitív Enterococcus faecalis 
baktériumokon. P. aeruginosa hatására az intesztinális SKN-1 nukleáris transzlokációja és 
transzaktivációja következik be, melyhez szükség van a TIR-1 adapter és PMK-1/p38 MAP 
kináz fehérjékre és egy eleddig ismeretlen tényezőre. Az SKN-1 transzkripciós aktivitása az 
életkor előrehaladtával már a reproduktív időszak alatt drasztikusan csökken, és a korral 
csökkenő expressziót mutató SKN-1-függő gének között túlreprezentáltak a P. aeruginosa 
fertőzés által regulált gének. Az SKN-1 turnoverének gátlásával létrehozott excesszív 
aktivációja azonban – ugyan fokozza az oxidatív rezisztenciát – de csökkenti a patogén 
rezisztenciát (Papp és mtsai, 2012; 3. ábra). 
 
 
 
 
3. ábra   Az SKN-1 szerepe a patogén rezisztenciában 
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Eredményeink feltárják a xenobiotikus stresszválasz regulátor SKN-1 fehérje 
természetes immunitásban és immunoszeneszcenciában játszott szerepét, melynek a humán 
immunitásban és immun-öregedésben is szerepe lehet. Az SKN-1 túlaktivációjának patogén 
rezisztenciára kifejtett antagonisztikus hatása illusztrálja az erőforrások optimális 
allokációjával fellépő konfliktust, ami az oxidatív stressz öregedés-okozó hatásának kivédése 
révén gyengítheti a patogén rezisztenciát (Kiss és mtsai, 2009). Az SKN-1/Nrf2 új terápiás 
stratégia illetve screen célpontja lehet. 
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AZ ÚJ TUDOMÁNYOS EREDMÉNYEK ÖSSZEFOGLALÁSA 
Tudományos munkám legfontosabb kutatási eredményeit az alábbi tézisekben foglalom össze: 
Hsp90-nel kapcsolatos eredmények 
1. Jellemeztük a Hsp90 C-terminális nukleotidkötőhelyét és megállapítottuk, hogy széles 
nukleotid-specificitással rendelkezik. 
2. Kimutattuk, hogy a Hsp90 C-terminális kötőhelyét gátló ciszplatin szelektíven gátolja a 
szteroid receptor kliensek stabilizációját, és nem érinti a Hsp90 kinázokkal és HSF1-gyel 
alkotott komplexeit. 
3. A humán Hsp90α és β funkcionális jellemzése során rávilágítottunk a Hsp90α 
hatékonyabb chaperon működésére és fokozott Hsp90-antagonista radicicollal szembeni 
rezisztenciájára. 
Stresszválaszokkal kapcsolatos eredmények 
4. Kimutattuk, hogy idős patkány májból izolált citoszol chaperon kapacitása enyhén 
csökkent. 
5. A fehérje homeosztatikus puffer, a hősokkválasz és az öregedés kapcsolatáról elméleti és 
számítógépes szimulációs modelleket alkottunk. 
6. Megállapítottuk, hogy az időskori humán cinkszupplementáció stimulálja a perifériás 
limfociták alap és hőindukált Hsp70 expresszióját. 
7. Kimutattuk, hogy a kalória csökkentés-mimetikum resveratrol emlős sejtekben aktiválja a 
hősokkválaszt.  
8. Rámutattunk, hogy a kalória megvonás C. elegans-ban hőmérsékletfüggetlenül és HSF1-
függő módon hosszabbítja meg az élettartamot. 
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9. Két szirtuin túltermelő transzgén C. elegans törzsben igazoltuk, hogy nem a szirtuin 
túltermelés növeli meg az élettartamot, hanem a genetikai háttérben taláható mutáció.  
10. Létrehoztunk két emlős modellt az inert denaturált fehérjék funkciótól független 
hatásainak vizsgálatára és kimutattuk, hogy a denaturált szerkezet gátolja a sejtproliferációt és 
a stresszadaptációt, melyet a hősokkválasz és a SIRT1 szirtuin túltermelése kivéd. 
11. Felderítettük, hogy az oxidatív stressz emlős sejtekben és C. elegans-ban az RNS 
interferencia közvetítésével gátolja a hősokkadaptációt. 
12. Feltártuk, hogy a xenobiotikus regulátor SKN-1/Nrf2 transzkripciós faktor optimális 
aktivációja szükséges a természetes immunitáshoz, aktivitáscsökkenése pedig részt vesz az 
immunoszeneszcenciában C. elegans-ban 
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Abstract
Chaperones have an important role in the repair of proteotoxic damage, which is greatly increased in aged subjects.
Chaperone levels and expression were subject of numerous studies in aged organisms. However, there were only very few
attempts to measure chaperone activity in aged animals. Here, we report our initial studies showing a decreased chaperone
capacity of liver cytosol from aged rats compared to those of young counterparts. The amount of Hsc70/Hsp70 was not
significantly different in livers of young and aged rats. On the contrary, old animals showed a significant decrease in their
hepatic Hsp90 content, which may explain their decreased chaperone activity. The observed decrease in chaperone capacity
may also reflect a direct proteotoxic damage of chaperones, or an increase in chaperone occupancy, i.e. a ‘chaperone overload’
due to the increased amount of damaged hepatic proteins in aged rats. Experiments are in progress to elucidate the mechanism
of the observed age-induced changes in chaperone function. q 2002 Elsevier Science Inc. All rights reserved.
Keywords: Molecular chaperones; Heat shock proteins; Stress proteins; Hsc70; Hsp70; Hsp90; Luciferase; Protein aggregation; Protein
denaturation; Chaperone overload
1. Introduction
Chaperones are ubiquitous, highly conserved
proteins, which either assist in folding of newly
synthesized or damaged proteins in an ATP-depen-
dent, active process or work in an ATP-independent,
passive mode sequestering damaged proteins for
future refolding or digestion (Bukau and Horwich,
1998; Hartl, 1996). Chaperones are especially needed
and their synthesis is induced after an environmental
stress leading to proteotoxic damage.
Aging is characterized by an increased rate of
protein modification such as oxidation, glycation,
deamidation of asparaginyl and glutaminyl residues
and the subsequent formation of isopeptide bonds, etc.
(Stadtman and Berlett, 1998; Wright, 1991). Suscep-
tibility to various proteotoxic damages is further
increased due to transcriptional and translational
errors and the resulting folding defects (Dukan et al.,
2000).
Due to the decrease in proteasome function during
aging (Conconi et al., 1996; Bulteau et al., 2001) as
well as the impaired lysosomal protein degradation in
aged rats (Cuervo and Dice, 2000), damaged proteins
accumulate in cells of aged and may cause a
chaperone overload. Here, the competition of
0531-5565/02/$ - see front matter q 2002 Elsevier Science Inc. All rights reserved.
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damaged proteins may disrupt the folding assistance
of other chaperone targets, such as: (1) newly
synthesized proteins; (2) ‘constantly damaged’
(mutant) proteins; and (3) constituents of the
cytoarchitecture (Csermely, 2001a,b).
Despite of the large number of studies on
chaperone levels and induction in aged organisms
(reviewed by So¨ti and Csermely (2002) and Verbeke
et al. (2001)) direct studies on chaperone function in
aged organisms are largely restricted to the eye lens
chaperone, a-crystallin. Chaperone activity of a-
crystallin is decreased in senile human lenses
(Cherian and Abraham, 1995). As another of the
sporadic examples of chaperone function in aged
animals, Hsp90 fails to protect the proteasome in aged
animals (Conconi et al., 1996).
In our present studies we have pursued an initial
test of passive chaperone function by an indirect
method, by measuring the attenuation of heat-induced
luciferase denaturation by liver cytosolic preparations
from young and aged rats. Our data show a decreased
chaperone capacity of liver cytosol from aged rats
compared to those of young counterparts, which is the
first data on total chaperone function of cytosolic
chaperones in aging.
2. Materials and methods
2.1. Materials
Anti-Hsc/Hsp701 antibody (rabbit, polyclonal) was
a kind gift of Zolta´n Pe´nzes (Biorex R&D Co.,
Veszpre´m, Hungary) (Kurucz et al., 1999). Anti-
Hsp90a/b antibody (goat, polyclonal, sc-1055) was a
Santa Cruz (Santa Cruz, CA, USA) product. Anti-
luciferase antibody (goat, polyclonal) was purchased
from Promega (Madison, WI, USA). Secondary anti-
rabbit, and anti-goat antibodies were DAKO A/S
products (Glostrup, Denmark). Chemicals used for
polyacrylamide gel electrophoresis and protein deter-
mination were from Bio-Rad (Richmond, CA, USA).
All other chemicals (including luciferase) used were
from Sigma Chemicals Co. (St Louis, MO, USA).
2.2. Animals
Young (10 weeks ^ 3 days old) and aged (26
months ^ 2 weeks old) Wistar rats were from Charles
River Inc. (Hungary). Animals were kept and
sacrificed according to the Guidelines of the Hungar-
ian Council of Health Sciences (permission no.
39/1999).
2.3. Isolation of rat liver cytosol
Livers were removed and homogenized by a
Potter–Elvehjem homogenizer in two volumes of an
ice-cold buffer consisting of 20 mM Hepes, pH 7.4
and a complete protease inhibitor cocktail (Roche,
Mannheim, Germany). Liver homogenates were
filtered through a cheesecloth and centrifuged at
4 8C for 10 min at 700 £ g. Supernatants were
centrifuged in a Beckman J2-HS centrifuge at 4 8C
for 10 min at 12,000 £ g. Postmitochondrial super-
natants were cleared from microsomes in a Beckman
Optima TL ultracentrifuge using a TLA 100.4 rotor at
4 8C for 60 min at 100,000 £ g. The supernatant
cytosol was immediately aliquoted, frozen in liquid
nitrogen and stored at 280 8C. Extreme care was
exercised to use the thawed aliquots immediately and
never re-freeze them. Protein content of the obtained
cytosolic samples was measured using the Bradford
(1976) method with bovine serum albumin as
standard.
2.4. Protection of luciferase from heat denaturation
by cytosolic chaperones
Cytosolic proteins at a final concentration of
40 mg/ml were mixed with 400 nM of firefly lucifer-
ase in a final volume of 200 ml of a buffer consisting
of 20 mM Hepes, pH 7.5 and 50 mM potassium
acetate and incubated at 39 8C. At time points
indicated 2 ml aliquots were removed from the
incubation mixture, and their luciferase activity was
measured by adding them to 36 ml of the reaction
mixture containing 25 mM Tricin (pH 7.8), 10 mM
MgSO4, 0.2 mM EDTA, 20 mM DTT, 0.26 mM
Coenzyme A, 1 mM ATP and 30 mg/ml luciferin.
Luciferase activity was measured in a BioOrbit
Galaxy 1258 luminometer (Turku, Finland) with an
integration time of 10 s, at a normal gain setting.
1 Abbreviations used: Hsc70, the constitutive form of the 70 kDa
heat shock protein; Hsp70, inducible form of the 70 kDa heat shock
protein; Hsp90, 90 kDa heat shock protein.
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2.5. Protection of luciferase from aggregation by
cytosolic chaperones
Cytosolic proteins at a final concentration of
40 mg/ml were mixed with 400 nM of firefly lucifer-
ase in a final volume of 200 ml of a buffer consisting
of 20 mM Hepes, pH 7.5 and 50 mM potassium
acetate and incubated at temperatures indicated. At
time points indicated all the 200 ml samples were
removed from the thermostatized tubes, and centri-
fuged in a Beckman Optima TL ultracentrifuge using
a TLA 100.1 rotor at 4 8C for 10 min at 350,000 £ g.
Supernatants were carefully removed. Luciferase
content of the supernatants and ice-cold control
samples without incubation/centrifugation procedures
were assessed by subjecting the samples of SDS
PAGE and consecutive Western blotting. Blots were
visualized by anti-luciferase antibody using the ECL
chemiluminescence kit.
2.6. Assessment of chaperone levels
80 mg of cytosolic proteins were subjected to SDS
PAGE on a 10.5% gel using a BioRad MiniProtean B
system. Gels were blotted with a home-made semidry
blotting apparatus to Protran nitrocellulose membrane
(Schleicher & Schuell Co., Keene, NH, USA). Blots
were blocked by 2% bovine serum albumin and
visualized by anti-Hsc/Hsp70 and anti-Hsp90a/b
antibodies using the ECL chemiluminescence kit.
Loading efficiency was controlled by assessing the
identical amount of the externally added luciferase to
the samples. Photographic images were quantitated by
densitometry using an LKB Ultroscan XL laser
densitometer (Bramma, Sweden).
2.7. Statistical evaluation
Statistical evaluation of luciferase heat denatura-
tion data was performed by the Student’s t-test.
3. Results
Parallel with our ongoing experiments to measure
the active (ATP-dependent) chaperone activity of
cytosolic preparations, we also assessed the passive
(ATP-independent) chaperone activity of liver
cytosols using an indirect method. Here, we report
our initial results of these, latter experiments. For this
we had to find a test protein, which is much more
susceptible to denaturation than most of the cytosolic
proteins, including molecular chaperones. Luciferase,
a commonly used firefly enzyme was suitable for this
purpose, since it rapidly loses its activity when
incubated at 39 8C, where most of cellular proteins
(potential other targets and chaperones) still remain
intact (Freeman et al., 2000).
The effect of cytosol from young and old rats on
the heat-induced luciferase denaturation is shown in
Fig. 1. Luciferase denaturation is complete in 30 min
irrespective of the presence of protecting cytosolic
chaperones. At all other time points measured cytosol
from livers of young (10 weeks old) rats shows a
better protection than that of old (26 months old)
animals. The difference between the protected
luciferase activity is significant after 5 min of
incubation reaching a level of significance of
p , 0.03.
Another important consequence of ATP-indepen-
dent chaperone function is the prevention of protein
aggregation. Therefore, a different test of passive
Fig. 1. Protection of luciferase activity against heat denaturation by
cytosol of young (10 weeks) and old (26 months) Wistar rats.
Isolation of rat liver cytosol, incubation of luciferase and
measurement of luciferase activity were performed as described
in Section 2. Squares: luciferase activity in the presence of cytosol
from young (10 weeks) rats. Triangles: luciferase activity in the
presence of cytosol from old (26 months) rats. Data were obtained
from duplicate measurements from three rats per group. There is a
significant difference between luciferase activity in the presence of
cytosol from young and old rats at 5 min of incubation with a level
of significance p , 0.03.
G. Nardai et al. / Experimental Gerontology 37 (2002) 1257–1262 1259
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chaperone function giving complementary results to
the experiments shown in Fig. 1, is the assessment of
the heat-induced aggregation of luciferase. In initial
experiments, we obtained a measurable aggregation
of the enzyme (i.e. partition to the pellet after ultra-
centrifugation at 350,000 £ g for 10 min) both at 39
and 42 8C, but not at 0 8C, where no aggregation was
detected neither in the presence of young nor in the
presence of aged cytosols (data not shown). Measure-
ment of luciferase aggregation in the presence of
cytosolic proteins from livers of young and old rats at
42 8C showed a larger amount of non-aggregated
luciferase in the presence of cytosols from young rats
(Fig. 2; 0.21 ^ 0.04 and 0.15 ^ 0.04 for young and
old animals, respectively). However, the difference
was not significant ( p , 0.104). Examination of
luciferase aggregation at less stringent conditions
(39 8C) did not give conclusive results (data not
shown).
As an obvious reason for the weaker luciferase
protection of liver cytosol from aged rats, a decreased
chaperone content comes to mind. To analyze this
possibility we have measured the levels of the two
most abundant cytosolic chaperones, Hsc/Hsp70 and
Hsp90a/b (Bukau and Horwich, 1998; Hartl, 1996).
As it is shown in Fig. 3A, there were no significant
differences in the level of Hsc/Hsp70 in cytosol from
young and old rats (the antibody we used recognizes
both the constitutive and inducible forms of the rat
70 kDa heat shock protein). On the contrary, old
animals contained a significantly lower amount of
Hsp90a/b than their young counterparts (the antibody
we used recognizes both the alpha and beta isoforms
of the rat 90 kDa heat shock protein; Fig. 3B;
0.60 ^ 0.09 and 0.26 ^ 0.10; for young and old
animals, respectively, p , 0.011).
4. Discussion
The most important finding of the present paper is a
decreased chaperone capacity of liver cytosol from
aged rats compared to those of young animals, which
is the first data on total chaperone function of
cytosolic chaperones in aging.
The attenuated chaperone function in aged rats
might have at least three independent reasons: (1) the
amount of chaperones was diminished; (2) chaperones
were damaged; (3) chaperones became occupied by
an increased amount of damaged proteins or peptides.
Analyzing the first possibility, we measured the levels
of the two most important cytosolic chaperones,
Hsc/Hsp70 and Hsp90. The significant decrease in
Hsp90 content may explain the diminished hepatic
chaperone capacity of aged rats. Existing data on
chaperone levels in livers of aged rats are rather
contradictory: Wu et al. (1993) measured an
unchanged Hsc70 level, while Cuervo and Dice
Fig. 2. Prevention of luciferase aggregation by cytosol samples from livers of young (10 weeks) and old (26 months) Wistar rats. Isolation of rat
liver cytosol, incubation of luciferase at 42 8C, and measurement of luciferase aggregation were performed as described in Section 2. Bars show
the amount of non-aggregated luciferase in the presence of cytosolic proteins of each examined animal in artificial densitometric units.
G. Nardai et al. / Experimental Gerontology 37 (2002) 1257–12621260
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(2000) and Hall et al. (2001) showed an increased
Hsc70 (and Hsp70) content of old rats, while to our
best knowledge no report assessed hepatic Hsp90
levels of old rats. Higher chaperone levels may reflect
an adaptation mechanism to the growing number of
unfolded polypeptide chains, which titrate out the
chaperones from the heat shock factor complex, and
induce a constitutive stress response. This rather
permanent stress probably ‘wears out’ the mechanism
to mobilize the stress response, which may explain
why the induction of various chaperones is impaired
in aging (So¨ti and Csermely, 2002). The intrinsic
variability of the experienced stress and the various
ages and strains used in different studies may explain
the observed variability of chaperone levels in aged
rats.
The observed decrease in chaperone capacity may
also reflect a direct proteotoxic damage of chaperones,
or an increase in chaperone occupancy, i.e. a
‘chaperone overload’ due to the increased amount of
Fig. 3. Level of major cytosolic chaperones from livers of young (10 weeks) and old (26 months) Wistar rats. Isolation of rat liver cytosol, and
measurement of Hsc/Hsp70 and Hsp90a/b levels were performed as described in Section 2. Bars show the amount of the respective cytosolic
heat shock protein of each rat in artificial densitometric units. Panel A: Hsc/Hsp70 levels. Panel B: Hsp90a/b levels.
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damaged hepatic proteins in aged rats. Macario and
Conway de Macario (2002) raised the idea of ‘sick
chaperones’ in aged organisms in a recent review.
Indeed: chaperones are interacting with a plethora of
other proteins (Csermely, 2001a), which requires
rather extensive binding surfaces. These exposed
areas may make chaperones a preferential target for
proteotoxic damage: chaperones may behave as
‘suicide proteins’ during aging. On the other hand,
the dramatic increase of potential targets, the
‘chaperone overload’ (Csermely, 2001b), saturates
the remaining chaperone capacity and worsens the
situation probably further. Experiments are in pro-
gress to elucidate the mechanism of the observed age-
induced changes in chaperone function by analyzing
the amount of damaged proteins, and the structure/
function relationships of chaperones.
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The Heat Shock Protein 90-Targeting Drug Cisplatin
Selectively Inhibits Steroid Receptor Activation
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Cisplatin is an antineoplastic drug that binds to
DNA, thereby inhibiting cell division and tumor
growth. Cisplatin may also disrupt the function of
some proteins, including heat shock protein 90
(Hsp90). We report that cisplatin dose-dependently
inhibited transcriptional activity of the androgen
receptor and the glucocorticoid receptor (GR) in
transient reporter assays. A truncated, hormone-
independent GR was only partially inhibited at sig-
nificantly higher doses of cisplatin. Cisplatin treat-
ment of neuroblastoma cells led to an immediate
inhibition of hormone binding by GR, followed by
proteasome-dependent degradation of the recep-
tor. Other Hsp90-regulated proteins, i.e. the phos-
phokinases raf-1, lck, and c-src, were not affected,
indicating a specific functional interference of cis-
platin with the steroid receptors GR and androgen
receptor. Cisplatin did not elicit a stress response,
in contrast to geldanamycin. Immunoprecipitation
revealed that cisplatin disrupts binding of GR to
Hsp90. Moreover, cisplatin-treated Hsp90 was un-
able to associate with untreated ligand binding do-
main of GR. Reticulocyte lysate was able to restore
hormone binding of GR in vitro, but not when the
lysate was pretreated with geldanamycin. Our data
reveal that cisplatin influences steroid receptors
also independently of its DNA-mediated effects
and, thus, suggest a novel modes of action for this
cytostatic drug. (Molecular Endocrinology 17:
1991–2001, 2003)
TOGETHER WITH ITS various derivatives, cisplatin[cis-diamminedichloroplatinum (II), CDDP] is one
of the most commonly applied antineoplastic drugs
today. It is a long-standing paradigm that the cytotoxic
effect of cisplatin is primarily due to its well-described
formation of adducts with DNA (1–3) that cause G2
arrest in the cell cycle, usually leading to apoptosis
and inhibition of tumor growth (4, 5). It has been spec-
ulated that protein targets (6) may also be important
for the observed effects of CDDP (5), an idea strongly
supported by a recent report (7). CDDP has also been
reported recently to bind to heat shock protein 90
(Hsp90) (8), thereby reducing its chaperoning activity.
The CDDP-binding region has been localized near the
C terminus of Hsp90, distant from the N-terminal bind-
ing site of geldanamycin (GA) (9), another antineoplas-
tic agent that also reduces Hsp90 chaperoning activity
(10). These results suggest that CDDP and GA may
inhibit the chaperoning activity of Hsp90 by different
mechanisms.
Hsp90 is one of the most abundant molecular chap-
erones in the eukaryotic cytosol and is known to reg-
ulate the stability and function of a wide spectrum of
intracellular proteins. Hsp90 client proteins are in-
volved in a variety of biological processes including
development, cell cycle control and steroid hormone
signaling (11–13). The two best-characterized classes
in the steadily growing list of Hsp90-regulated proteins
are transcription factors, e.g. steroid receptors such
as the glucocorticoid (GR) and androgen receptor
(AR), and protein kinases including raf1, src, and lck
(11, 12). GR is an essential factor in many develop-
mental and physiological processes (14) and has been
used in numerous studies to elucidate the contribution
of chaperones to proper folding and function of signal
transduction molecules (15). In the absence of its li-
gand, the glucocorticoids, GR is part of a multiprotein
complex comprising the receptor, Hsp90, and several
other chaperones and cochaperones (16). This com-
plex keeps the receptor protein in an inactive, yet
ligand-activable state (17). Upon binding to hormone,
GR is translocated to the nucleus and both positively
and negatively regulates transcription of a variety of
genes (18, 19). Similar Hsp90 heterocomplexes have
been found to be important for other factors, e.g. heat
shock factor 1 (HSF1) and protein kinases like raf1, lck,
and c-src (20–23).
There is evidence that some physiological effects of
CDDP may result from its targeting of Hsp90. For
example, CDDP is commonly used as antineoplastic
agent for a variety of prostate cancer types which in
turn are often associated with hyperactivity of the
Hsp90-dependent androgen receptor (AR). Moreover,
Abbreviations: AR, Androgen receptor; CDDP, cisplatin
cis-diamminedichloroplatinum (II); FCS, fetal calf serum; GA,
geldanamycin; GR, glucocorticoid receptor; HA, herbimycin
A; HSF1, heat shock factor 1; Hsp90, heat shock protein;
PMSF, phenylmethylsulfonyl fluoride; RAD, radicicol; RL, re-
ticulocyte lysate.
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CDDP-resistance in cells transfected with the Hsp90-
dependent protein kinase v-src can be overcome by
the Hsp90-targeting drugs radicicol (RAD) or herbimy-
cin A (HA) (24). Interestingly, RAD, HA, and its homolog
GA originally were identified as naturally occurring an-
titumor antibiotics (25–27) and characterized later as
tyrosine kinase inhibitors (28–30). Subsequently, it has
become clear that they actually act through binding to
Hsp90 (9, 31–35). Moreover, it is a long-standing, al-
though unexplained, observation that glucocorticoids
like dexamethasone decrease CDDP-induced emesis
if added to an antiemetic pharmacological regimen
(36). Thus, one can hypothesize that dexamethasone,
as a potent ligand of GR, fights CDDP-induced emesis
by counteracting CDDP-induced defects in GR
function.
To evaluate whether important aspects of CDDP
function involve Hsp90-dependent proteins, we inves-
tigated the effects of CDDP on the steroid receptors
GR and AR. We demonstrate that CDDP inhibits GR-
as well as AR-mediated transcriptional activation in
neuroblastoma cells. Hormone binding of GR is re-
duced by CDDP due to perturbation of the chaperone
heterocomplex and followed by proteasomal degra-
dation of GR. However, HSF1 is not activated by
CDDP and the protein levels and activation of the
kinases raf1, c-src, and lck are not changed by CDDP,
in contrast to GA. Impairment of GR binding to hor-
mone by CDDP can be reversed in vitro with untreated
reticulocyte lysate, but only if its Hsp90 is intact. Our
results provide new insights into the molecular mech-
anisms of Hsp90 inhibition by CDDP, which may lead
to an improvement of CDDP pharmacotherapy in the
future.
RESULTS
Dose-Dependent Inhibition of the Glucocorticoid
and Androgen Receptors by Cisplatin
To test the hypothesis that cisplatin (CDDP) inhibits
the activity of Hsp90-dependent steroid hormone re-
ceptors such as the glucocorticoid receptor (GR) or
the androgen receptor (AR), we used a reporter gene
assay in transient transfections of cultivated cells (37).
Neuroblastoma SK-N-MC cells were transfected with
a plasmid expressing the receptor (either GR or AR), a
reporter plasmid with the mouse mammary tumor vi-
rus promoter controlling the firefly luciferase structural
gene, and a -galactosidase encoding plasmid to
monitor transfection efficiency and general transcrip-
tional activity. Cells were incubated in medium with 10
nM cortisol for stimulation of GR or 10 nM dihydrotes-
tosterone for stimulation of AR together with increas-
ing concentrations of CDDP. The stimulation of the
reporter gene activity in the presence of CDDP was
related to the stimulation in the absence of CDDP,
which was set to 100% for each titration. Both GR-
and AR-dependent transcription were severely im-
paired (Fig. 1, A and B, respectively). About half-
maximal activity of the receptors was observed at a
concentration of CDDP of 0.1–1 M (GR) or 1 M (AR),
and virtually complete inhibition was reached at con-
centrations of 100 M CDDP. CDDP did not affect the
enzymatic activity of the luciferase reporter (control
not shown).
To evaluate the specificity of the inhibitory effect on
GR and AR, we tested two other reagents, the CDDP
structural isomer transplatin and cyclophosphamide,
which is another DNA-targeting antineoplastic drug.
Transplatin and cyclophosphamide failed to affect
GR-dependent activity up to a concentration of 100
M (Fig. 1, C and D). We also tested whether CDDP
reduced the viability of the SK-N-MC cells under our
assay conditions and found no effect on the MTT
assay up to 100 M CDDP (data not shown).
The inability of other DNA targeting drugs, such as
cyclophosphamide, to inhibit GR-dependent tran-
scription from the mouse mammary tumor virus pro-
moter does not completely rule out the possibility that
the effect of CDDP is due to its interaction with DNA
(38). To begin to characterize the inhibitory effect of
CDDP on GR we used a truncated GR that is devoid of
the ligand binding domain. This receptor is not regu-
lated by Hsp90, does not bind to hormone, and dis-
plays constitutive transcriptional activity to a moderate
extent (39). CDDP also dose-dependently inhibited
this receptor (Fig. 1E). However, in contrast to the
full-length GR (Fig. 1A), higher doses were needed and
the effect was not as strong. We conclude that, what-
ever the mechanism for the inhibitory effect of CDDP
on the truncated GR is, it cannot fully account for the
effect on full-length GR.
A likely target for the additional effect of CDDP on
full-length GR is the ability to bind to hormone, either
by binding to the ligand binding domain or by binding
to proteins regulating hormone binding. Hormone
binding of GR was determined as a measure of GR
folding. SK-N-MC cells were transfected with a GR
expression vector and binding of radioactive cortisol
was determined in whole cells 24 h after transfection in
the presence of increasing concentrations of CDDP
during a 1-h incubation. Nonspecific binding was
monitored by adding 1000-fold excess of unlabeled
cortisol, and specific binding was determined by sub-
tracting the low nonspecific binding from the binding
measured in the absence of unlabeled competitor. As
shown in Fig. 2, hormone binding by GR was dose-
dependently reduced by CDDP. Virtually complete in-
hibition was reached at 100 M CDDP. Furthermore,
the level of GR protein extracted from the cells re-
mained unchanged throughout the titration, indicating
that GR is not degraded after the 1-h incubation, but
merely rendered nonfunctional. These results strongly
suggest that CDDP inhibits the chaperone-dependent
folding of GR, an effect independent of its interaction
with DNA.
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The Effect of CDDP Is Specific for Steroid
Receptors and Leads to Proteasome-Dependent
Depletion of Cellular GR
A possible target to mediate these DNA-independent
effects of CDDP is Hsp90. Other Hsp90-targeting
drugs like geldanamycin (GA) and radicicol bind to the
N-terminal ATP site and reduce the activity and protein
levels of not only steroid receptors, but also several
kinases (10, 23, 40–43). Therefore, we addressed two
important questions: does prolonged treatment with
CDDP affect protein levels of GR and are other Hsp90-
dependent proteins also affected?
Figure 3 shows that treatment of GR-transfected
SK-N-MC cells with CDDP or GA led to a dose-
dependent decrease in the protein level of GR. The
degradation observed here after 16 h of incubation
with CDDP was clearly preceded by the inactivation of
hormone binding by GR, which was observed after 1 h
in the absence of degradation (Fig. 2). However, pro-
tein levels of the serine/threonine kinase raf-1 (Fig. 3C)
and the tyrosine kinase c-src (Fig. 3D), as well as of
Hsp90 itself (Fig. 3E), were not affected by CDDP, in
contrast to GA. These data support the hypothesis
that CDDP interaction with Hsp90 has specific conse-
quences in that it impairs correct folding of GR, which
leads to its degradation, but not of the protein kinases
raf-1 and c-src.
We also tested whether degradation of GR is pro-
teasome dependent, similar to the GA-induced deg-
radation of other Hsp90 substrate proteins (32, 44, 45).
GR-transfected SK-N-MC-cells were treated with
Fig. 1. Inhibition of GR- and AR-Dependent Transactivation by CDDP
Human neuroblastoma SK-N-MC cells were transfected with a GR-dependent reporter plasmid (MTV-Luc) a control plasmid
expressing -galactosidase and either a plasmid expressing full-length GR (A, C, D), AR (B) or GR lacking the ligand binding
domain (E, “GRLBD”). After transfection, cells were cultivated with either 10 nM cortisol (A, C, D) or 10 nM dihydrotestosterone
(B), together with increasing amounts of cisplatin (CDDP) (A, B, E), transplatin (TDDP) (C), or cyclophosphamide (CYPH) (D).
Luciferase activities were normalized to the -galactosidase activities and are presented as percent activity with hormone-
stimulated cells set as 100%. Results represent mean values  SEM of three independent experiments performed in duplicate.
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CDDP in combination with the highly specific protea-
some inhibitors lactacystin (46) or MG132 (47). As a
control, cell cultures were treated with GA instead of
CDDP (43). After 16 h incubation in the presence of
these drugs, GR levels were assessed by Western
blotting of cell extracts. Treatment with lactacystin or
MG132 alone had no apparent effect (Fig. 3, A and B),
but both efficiently inhibited degradation of GR by GA,
in full agreement with a previous report (32). Lactacys-
tin and MG132 also blocked GR degradation induced
by CDDP (Fig. 3, A and B), indicating that the same
proteolytic pathway is induced.
To corroborate our conclusion that the Hsp90-
targeting drug CDDP specifically affects steroid recep-
tors, we analyzed the functions of several Hsp90-
dependent proteins. GA and radicicol are known to
elicit a cellular stress response by releasing HSF1 from
Hsp90, and this response can be monitored by tran-
scription from HSF1-dependent promoters (22). We
therefore tested the activity of an HSF1-dependent
promoter transfected into SK-N-MC cells with and
without exposure to CDDP or GA. Whereas GA clearly
showed induction of this promoter, CDDP had no ef-
fect (Fig. 4A).
Activation of the Hsp90-regulated kinases lck,
which is a member of the src kinase family, and raf-1
is accompanied by their phosphorylation (48). To an-
alyze whether CDDP may influence the activation of
these kinases, we pretreated Jurkat cells with 1.8 M
GA or with 100 M CDDP, followed by stimulation with
an anti-CD3 antibody (OKT3). Levels and phosphory-
lation of lck and raf-1 were detected after cell lysis and
Western blotting. As shown in Fig. 4B, GA efficiently
reduced the basal protein levels and prevented the
activation of both, lck and raf-1. In contrast to GA,
CDDP had only a marginal affect on the basal protein
levels and phosphorylation of raf-1 and activated lck.
It should be noted that GR is efficiently inhibited by
CDDP also in Jurkat cells under these conditions (data
not shown).
We finally compared the effect of GA and CDDP on
ATP-hydrolysis of Hsp90 purified from Saccharomy-
ces cerevisiae (Hsp82), which has previously been
used to characterize the ATPase activity of Hsp90 (49,
50). CDDP did not inhibit the ATPase activity of the
yeast Hsp82 up to a concentration of 1 mM (data not
shown), in contrast to GA (51).
From these data, we conclude that the effect of
CDDP on Hsp90-dependent processes differs from
that of GA in that the effect of CDDP is much more
specific, i.e. is confined to steroid receptors.
CDDP Disrupts Hsp90-GR Interaction and
Prevents Hsp90-GR Complex Formation in Vitro
To shed light on the mechanism of CDDP action on
Hsp90-GR interaction, we supplemented cell lysates
of GR-transfected SK-N-MC cells with 10 M CDDP.
After incubation for 1 h on ice, Hsp90 was immuno-
precipitated and blots were probed for Hsp90 and for
co-precipitated GR. Whereas GR was readily coimmu-
Fig. 2. CDDP Inhibits Hormone Binding of GR in Vivo
SK-N-MC cells were transfected with a plasmid express-
ing GR and binding of radiolabeled cortisol was determined
after 24 h in whole cells. Cortisol and CDDP (at the concen-
trations indicated) were added for 1 h. Hormone binding with
cortisol alone was set to 100%. Results represent mean
values  SEM of three independent experiments performed in
duplicate. GR levels were assessed by Western blotting.
Fig. 3. CDDP Induces Proteasome-Dependent Degradation
of GR, But Not of Hsp90-Dependent Kinases
SK-N-MC cells were transfected with a plasmid express-
ing GR (pRK7GR, 0.75 g per plate) and treated for 16 h at 37
C with either 1 M GA or 10 M CDDP and the proteasome
inhibitors lactacystin (100 M, A) or MG132 (50 M, B) where
indicated. Nontransfected cells were used in C–E and treated
with 1 M GA or 10 M CDDP (or the concentrations indicated
in C and D) and lactacystin. Total cellular protein (100 g) was
fractionated by SDS-PAGE, probed with -GR- (H-300) (A
and B), -Raf1- (C), -c-Src- (mAB327) (D), or -Hsp90
(H114) (E) antibody followed by chemiluminescent detection.
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noprecipitated with Hsp90 from untreated cell lysates,
preincubation with CDDP or GA caused a marked
decrease in the amounts of co-precipitated GR
(Fig. 5A).
To further elucidate the molecular mechanism of
CDDP action, we investigated the effect of CDDP
treatment of Hsp90 on complex formation with GR.
Chaperone complexes with GR can be reconstituted
in reticulocyte lysate with the GR ligand binding do-
main alone, and immune-isolated similarly to the full-
length receptor (52). We therefore analyzed complex
formation between CDDP-treated Hsp90 and the li-
gand binding domain of GR in reticulocyte lysate.
Hsp90 was radioactively labeled by in vitro translation
in reticulocyte lysate, -mercaptoethanol was re-
moved and the protein mixture was incubated with
different concentrations of CDDP. It was important to
then remove unreacted CDDP to ensure that it does
not modify the ligand binding domain of GR in the
following binding reaction. Labeled, CDDP-reacted
Hsp90 was incubated with the myc-tagged ligand
binding domain of GR, bound to myc antibodies on
Sepharose beads for 10 min. As seen in Fig. 5B, CDDP
dose-dependently interfered with complex formation
between Hsp90 and GR. Thus, CDDP appears to act
by both disrupting preformed Hsp90/GR complexes
Fig. 4. CDDP Is Permissive for Activation of lck and raf
Kinase and Does Not Activate HSF1-Dependent Promoters
A, SK-N-MC cells were transfected with an HSF1-depen-
dent luciferase reporter and a -galactosidase control plas-
mid. After transfection, cells were cultivated with or without
DMSO as well as with increasing amounts of CDDP or GA as
indicated. Luciferase activities were normalized to the -
galactosidase activities and are presented as fold induction
with untreated cells as reference. Results represent mean
values  SEM of three independent experiments. B, After
pretreatment with 1.8 M GA or 100 M CDDP for 16 h, Jurkat
cells were stimulated with 5 g/ml OKT3 antibody, and Raf-1
and Lck proteins were detected by immunoblotting. Shown
are representative Western blots and the quantification of
three independent experiments.
Fig. 5. CDDP Interferes with Association of Hsp90 with GR
A, SK-N-MC cells were transfected with a GR expressing
plasmid (pRK7GR). Cell lysates were incubated with or with-
out 10 M CDDP or 1 M GA for 2 h at 4 C and then
immunoprecipitated with an Hsp90-directed antibody. After
SDS-PAGE and transfer to nitrocellulose, blots were probed
for Hsp90 and GR. B, Hsp90 was radiolabeled using an in
vitro transcription/translation system, -mercaptoethanol re-
moved by gel filtration, treated with CDDP and unreacted
CDDP removed by gel filtration. Association with myc-tagged
GR ligand binding domain, bound to Sepharose beads via a
myc antibody, was allowed for 10 min in the presence of
reticulocyte lysate and bound proteins were eluted with high
salt buffer. The relative amounts of bound labeled Hsp90
were assessed after gel electrophoresis (lower panel). Re-
sults represent mean values  SEM of three independent
experiments.
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(Fig. 5A) and preventing these complexes from form-
ing (Fig. 5B).
CDDP Inhibition of GR Hormone Binding Can Be
Rescued in Vitro by Reticulocyte Lysates with
Intact Hsp90
Whereas our data provide strong evidence that the
effect of CDDP on GR involves interaction with Hsp90,
the possibility remained that CDDP actually targets GR
directly, which also may cause its inactivation and
subsequent degradation. Moreover, CDDP is reactive
toward sulfhydryl groups, and it has been previously
demonstrated that sulfhydryl-targeting agents can in-
activate GR (53–55). We asked whether targeting of
GR or targeting of an associated chaperone like Hsp90
underlies CDDP-induced inactivation of GR. We
treated cells expressing GR with CDDP as in the ex-
periment for Fig. 2. After CDDP treatment, cells were
lysed, unreacted CDDP was removed by gel filtration
and dose-dependent inhibition of hormone binding by
CDDP was confirmed (data not shown). However,
when we supplemented the hormone binding reaction
with reticulocyte lysate (RL) supplemented with ATP,
binding was restored (Fig. 6A). No hormone binding
was observed with RL alone. This demonstrates that
the CDDP impairment of hormone binding by GR can-
not be due to an interaction of CDDP with GR. More-
over, hormone binding of CDDP-treated GR was not
restored, when we pretreated RL with GA before gel
filtration (Fig. 6B). GA is established as specific inhib-
itor of Hsp90 used in numerous studies (56). There-
fore, this result strongly suggests that it must be the
intact Hsp90 from RL that restores hormone binding
activity to GR by replacing the CDDP-impaired Hsp90
activity from the cell extract.
DISCUSSION
Our results establish that CDDP specifically inhibits a
subset of Hsp90-dependent processes, in particular
the maturation of steroid hormone receptors repre-
sented by GR and AR. CDDP apparently interferes
with the formation of the Hsp90 complexes required
for the folding of these proteins. This discovery has a
significant impact on our understanding of both the
function of Hsp90 and the physiological conse-
quences of CDDP application.
The most interesting aspect of our results with re-
gard to Hsp90 function is that, unlike GA, CDDP dis-
rupts some functions of Hsp90 but not others.
Whereas the activity of the steroid hormone receptors
GR and AR was drastically reduced by CDDP, HSF1-
dependent transcription was not elicited. In contrast,
GA, which targets the N-terminal ATP binding site of
Hsp90, inhibits steroid receptors and activates HSF1-
dependent promoters (this study and Refs. 22 and 32).
Moreover, treatment of cells with CDDP leads to pro-
teasome-dependent degradation of GR, whereas
protein level and activation of the Hsp90-dependent
protein kinases lck, c-src, and raf-1 were essentially
unchanged. Inhibition of Hsp90 by GA, however, re-
sults in inactivation and degradation of not only GR,
but also lck, c-src, and raf-1 (this study and Refs. 31,
48, and 57).
The inhibitory effect of CDDP on GR-dependent
transcription has previously been ascribed to the well-
documented interaction of CDDP with DNA (38).
Moreover, in the case of the mineralocorticoid recep-
tor induction of oxidative stress by CDDP has been
suggested to cause diminished receptor activity (59).
At a molecular level, oxidative stress would affect the
sulfhydryl groups of proteins and sulfhydryl-targeting
drugs have been shown to decrease GR function (53–
55). Our observation that a truncated GR lacking the
ligand binding domain is also inhibited by CDDP, albeit
only at higher concentrations, can be explained by an
effect on protein-DNA interactions, either by targeting
the DNA or by targeting the cysteines of the zinc
fingers in the DNA binding domain of GR. Modification
of these cysteines has been shown before to inhibit
DNA binding activity of GR (60). We assume that what-
ever mechanism applies to the inhibition of the trun-
cated GR also contributes to the inhibition of full-
Fig. 6. Hormone Binding of GR Can Be Restored in Vitro by
Reticulocyte Lysate with Intact Hsp90
Binding of GR expressed in SK-N-MC cells and treated
with CDDP (as in Fig. 2) to cortisol was measured. Hormone
binding in the absence of CDDP was set to 100%. A, 5%
reticulocyte lysate, ATP and Mg2 was added to the extracts
from cells treated with1 M and 100 M CDDP. B, RL was
pretreated with the specific Hsp90-inhibitor geldanamycin (1
M) before it was added to the CDDP-treated cell extracts.
Results represent three independent experiments.
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length GR. However, our data with full-length GR
strongly suggest that an additional, and possibly the
major effect of CDDP on steroid receptors is due to its
interaction with Hsp90. Inhibition of hormone binding
of GR cannot be explained by interference of CDDP
with protein-DNA interactions. Moreover, disruption of
the Hsp90 heterocomplex by CDDP, as detected by
immunoprecipitation, clearly shows a DNA-indepen-
dent effect of CDDP. Because we are able to rescue
hormone binding of GR after removal of excess CDDP
and supplementing with untreated reticulocyte lysate,
but not with GA-treated lysate, modification of GR
resulting from oxidative stress is most likely not re-
sponsible for the effect of CDDP. Furthermore, CDDP
not only disrupted existing GR-Hsp90 interactions but
also prevented formation of new interactions when
reacted only with Hsp90.
The differential effects of the two Hsp90-targeting
agents CDDP and GA could be explained by their
different interaction site with Hsp90. Crystallographic
analysis revealed the ATP-binding pocket of Hsp90 as
the binding site of GA (9), whereas CDDP has been
reported to bind to the middle to C-terminal part of
Hsp90 (8). An additional binding site for ATP in the
C-terminal part of Hsp90 has been postulated (61),
and CDDP has been proposed to act as a selective
nucleotide competitor for this site (62). The signifi-
cance of this cryptic ATP binding site remains to be
elucidated. The other postulated C-terminal ATP com-
petitor novobiocin apparently binds in this region (61)
and leads to depletion of Hsp90-dependent proteins
including raf1 and v-src (63). This effect is similar to
that of GA but different from the effect of CDDP, as we
observed no degradation of raf-1 and c-src. Also in
contrast to CDDP, novobiocin has been described to
inhibit allosterically the N-terminal ATP binding site
(62). Thus, we suggest that CDDP and novobiocin
interact with the C-terminal region of Hsp90 at differ-
ent sites and/or in different manners.
With regard to the exact binding site of CDDP on
Hsp90, we speculate that it reacts with cysteine resi-
dues, most likely to cysteine 596 of the human protein.
The corresponding cysteine of rat Hsp90 has been
reported to be particularly reactive (64). Although we
have not detected significant amounts of covalent
Hsp90 dimers in our assays, it is interesting to note
that others did so under their experimental conditions
(65). These covalent dimers could arise from subse-
quent reactions of platinated Hsp90.
It should be noted that inhibition of Hsp70 by the
SH-targeting drug N-ethylmaleimide has been re-
ported (66). Because Hsp70 participates in folding the
GR, it is possible that it is another chaperone target for
CDDP, in addition to Hsp90. Reticulocyte lysate
treated with GA was unable to restore cortisol binding
of GR. Because GA is established as specific inhibitor
of Hsp90 (56), Hsp70 was most likely functional in this
extract, arguing in favor of Hsp90 being an important,
and possibly the major chaperone target of CDDP.
Considering the possible physiological relevance of
our findings, we note that CDDP is typically adminis-
tered at doses of 80–100 mg/m2 body surface (67, 68).
As a rough estimate, the initial concentration in the
blood (assuming even distribution throughout the
blood) would be 140–180 M, and about 10–12 M
assuming even distribution throughout the entire body
liquid. Depending on the pharmacokinetics (distribu-
tion, uptake, degradation) there will be locally and
temporally higher and lower concentrations. In any
case, at least the initial concentrations are well within
those needed to inhibit steroid receptors.
The effect of CDDP on steroid receptors may ex-
plain some of its clinical side effects. Delayed nausea
and vomiting after application of CDDP remain a sig-
nificant cause of treatment-related morbidity, because
they are inadequately controlled by current therapies.
Also newer therapeutics like 5-HT3 receptor antago-
nists are of insufficient efficacy (69). Corticosteroids
make a considerable contribution toward the control
of CDDP-induced acute and delayed emesis (70). Two
randomized studies demonstrated that the combina-
tion of dexamethasone and ondansetron is more effi-
cacious than ondansetron alone (71, 72); ondansetron
plus dexamethasone is now considered a standard
antiemetic therapy for CCDP-treated patients (67).
Also, ACTH has been shown to be effective in the
prevention of acute CDDP-induced vomiting (73). The
mechanism by which ACTH exerts its effect against
emesis are not fully understood. It stimulates the pro-
duction of corticosteroids, which are known to be
active against emesis, but it also acts directly on the
brain and modulates behavior.
Another severe side-effect of CDDP treatment is
renal failure or renal electrolyte wasting (74, 75). Be-
cause this is usually controlled by administration of
mineralocorticoid and sodium, it has been suggested
that renal responsiveness to mineralocorticoid may be
impaired in CDDP-treated patients (59). Although we
did not test the mineralocorticoid receptor, in light of
our findings we would explain these clinical observa-
tions by an effect of CDDP on Hsp90, which leads to
reduced function of the mineralocorticoid receptor.
Further insight into the molecular mechanisms of
CDDP will allow improvements in its important clinical
usage.
MATERIALS AND METHODS
Cell Culture and Transfection
Human neuroblastoma SK-N-MC cells (American Type Cul-
ture Collection, Manassas, VA; no. HTB-10) were kindly pro-
vided by the laboratory of C. Behl (Max Planck Institute of
Psychiatry, Munich, Germany). They were cultured in DMEM
supplemented with 10% fetal calf serum (FCS), 36 mg/liter
sodium pyruvate, 100 U/ml penicillin, 100 g/ml streptomy-
cin sulfate, 0.25 g/ml amphotericin (all from Life Technolo-
gies, Inc.), and 4.5 g/liter glucose at 37 C and 10% CO2.
Two days before transfection, cells were seeded into me-
dium containing 10% charcoal-stripped, steroid-free FCS.
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Dextran T-70 (Pharmacia, Uppsala, Sweden) was used for
charcoal-stripping of FCS (76). Jurkat (J32) cells were cul-
tured in RPMI 1640 medium supplemented with 10% FCS, 2
mM L-glutamine, 100 U/ml penicillin, and 100 g/ml
streptomycin.
SK-N-MC cells were harvested at about 60–80% conflu-
ency and about 0.5 to 1 107 cells were resuspended in 400
l of electroporation buffer [50 mM K2HPO4, 20 mM KAc (pH
7.35)]. A 1.5-g steroid-responsive luciferase reporter plas-
mid MTV-Luc (77), 2.5 g simian virus 40 promoter-driven
-galactosidase expression vector pCH110 (Pharmacia LKB,
Freiburg, Germany), and 0.75 g pRK7GR that expresses
human GR (78) from the cytomegalovirus promoter of the
vector pRK7 (79) were added and transfection was per-
formed using an electroporation system (Biotechnologies &
Experimental Research, San Diego, CA) after determination
of the optimal electrical field strength (80). Electroporated
cells were replated and cultured for 16 h in fresh medium
(containing 10% steroid-free FCS), supplemented with cor-
tisol, dihydrotestosterone, cisplatin, transplatin, geldanamy-
cin, and cyclophosphamide (purchased from Sigma Chemi-
cal Co., Deisenhofen, Germany) in the combinations and
concentrations indicated in the text and figure legends. Cells
without drug were supplemented with the solvent of the
respective drug, reference cells without cortisol and drug
were supplemented with the solvents of cortisol (i.e. ethanol)
and the drug.
Luciferase and -Galactosidase Assay
Luciferase and -galactosidase assays were as described
before (37). Briefly, cells were scraped from the plate in 1 ml
of lysis buffer [0.1 M KHPO4 (pH 7.8) and 1 mM dithiothreitol]
and cytosolic extracts were made by three freeze and thaw
cycles and subsequent centrifugation. Fifty microliters of
each supernatant (corresponding to 1–2  105 cells) were
transferred to a 96-well plate. One hundred fifty microliters of
33 mM KHPO4 (pH 7.8), 1.7 mM ATP, 3.3 mM MgCl2, and 13
mM Luciferin (Roche Biochemicals, Mannheim, Germany)
were added to each sample by the injector of an automatic
luminometer (Luminat LB 96, Wallac GmbH, Freiburg, Ger-
many) and light emission was measured for 10 sec. To cor-
rect for variations in transfection efficiencies, values of the
luciferase assay were normalized using -galactosidase ac-
tivities that were measured as follows: 50 l of cell extract
were added to 100 l galactosidase buffer (60 mM Na2HPO4,
40 mM NaH2PO4, 10 mM KCl, 1 mM MgCl2, and 50 mM
-mercaptoethanol) on a 96-well plate. 20 l of 2 mg/ml
ONPG was added and the reaction was incubated at 37 C.
After 10–30 min, absorption was measured at 405 nm in a
multiphotometer (Dynatech MR5000, Billingshurst, West
Sussex, UK). Correcting the luciferase activities by the -
galactosidase activities was important, because a moderate
reduction of the general transcription was observed in some
experiments at the highest concentrations of cyclophospha-
mide and CDDP. We also found that fewer cells were at-
tached at the highest concentrations of CDDP and cyclo-
phosphamide. In another control experiment, we found that
CDDP did not change the luciferase activity when added to
cell extracts before measurement (not shown).
HSF1 Response
For analysis of HSF1-dependent transcription, SK-N-MC
cells were cotransfected with 3 g of an HSF1-driven lucif-
erase reporter plasmid (HSE-Luc) and 3 g of the -galac-
tosidase control plasmid. Cells were incubated with or with-
out the indicated amounts of CDDP or GA and harvested
after 16 h for analysis of luciferase and -galactosidase ac-
tivities as described above.
Hormone Binding of GR in Vivo and in Vitro
To determine hormone binding of GR in vivo, SK-N-MC cells
were seeded and transfected with pRK7GR as described
above. Twenty-four hours after transfection, cells were incu-
bated with fresh medium containing 10 nM [3H]-cortisol (Am-
ersham, Braunschweig, Germany; specific activity was 62
Ci/mmol) alone or with CDDP at the concentrations indicated.
To determine nonspecific hormone binding, a 1000-fold ex-
cess of unlabeled cortisol was added in parallel samples.
After 1 h, cell plates were put on ice, cells were washed three
times with ice-cold PBS, and cells were scraped from the
plate in 500 l of PBS, collected by centrifugation at 2 C and
resuspended in 100 l of PBS. Ninety microliters were used
for scintillation counting (Beckman LH 6500, Munich, Germa-
ny), the remaining was used to determine the cell number.
Counts were divided by the cell number, and nonspecific
binding was subtracted from each value.
To determine hormone binding in vitro, SK-N-MC cells
were seeded out and transfected with pRK7GR and, after
24 h, treated with CDDP for 1 h as described above. Cells
were lysed with RIPA buffer [10 mM Tris-HCl (pH 7.4), 100 mM
NaCl, 1% (vol/vol) deoxycholate, 1% (vol/vol) Triton X-100,
0.1% (wt/vol) sodium dodecyl sulfate, 0.5 mM phenylmethyl-
sulfonyl fluoride (PMSF), 0.5 mM aprotinin] at 4 C for 30 min.
After centrifugation, residual CDDP which may be present
was removed by gel filtration over biospin 6 columns (Bio-
Rad, Hercules, CA), which had been preequilibrated with
hormone binding buffer [5 mM Tris/HCl (pH 7.4), 1 mM EDTA,
10 mM Na2MoO6x2H2O]. At this time, the extracts were di-
vided into aliquots.
To test hormone binding, 10-l aliquots were either incu-
bated (1 h, 4 C) with 100 nM radiolabeled cortisol alone, or in
combination with 1000 excess (100 M) unlabeled cortisol
to determine nonspecific binding. Bound and free steroids
were separated by gel filtration by using Sephadex LH-20
(Pharmacia). Radioactivity was measured in a liquid scintilla-
tion counter (Beckman LH 6500) and protein concentration
was determined by the Lowry method (81) to normalize the
data.
To reverse the inhibition by cisplatin, rabbit reticulocyte
lysate (Green Hectares, Oregon, WI) was added (5% of the
total volume) to aliquots, along with 2 mM ATP and 6 mM
Mg2 and incubated for 10 min at room temperature. Hor-
mone binding was determined as described above. As a
control, hormone binding of reticulocyte lysate alone was
also determined. To inhibit Hsp90 in the reticulocyte lysate, 1
M of the Hsp90 inhibitor geldanamycin was added to the
lysate, excess was removed by gel filtration (biospin 6) before
adding the lysate, together with 2 mM ATP and 6 mM Mg2,
to an aliquot of extract from CDDP-treated cells. Again, hor-
mone binding was determined as described above.
Immunoprecipitation and Western analysis
For immunoprecipitation of Hsp90, SK-N-MC cells were
transfected with 0.75 g pRK7GR as described above and
solubilized in 10 mM Tris-HCl (pH 7.4), 10 mM NaCl, 1%
(vol/vol) deoxycholate, 1% (vol/vol) Triton X-100, 40 mM NaF,
1 mM Na3VO4, 0.5 mM PMSF, and 0.5 mM aprotinin. The
extract was incubated for 30 min on ice. Lysates were incu-
bated with the Hsp90-specific antibodies and protein A
Sepharose (Pharmacia) for 2 h at room temperature. Immu-
noblot detection of GR and Hsp90 in the immunoprecipitates,
as well as of proteins in total cell lysates (100 g), was
performed after SDS-PAGE and electrophoretic transfer of
proteins to 0.2-m nitrocellulose filter (Schleicher & Schuell,
Keene, NH). The filters were blocked by 5% nonfat milk in
Tris-buffered saline/Tween buffer, specific primary antibod-
ies were added and agitated for 1 h at room temperature. GR
and Hsp90 were detected with rabbit polyclonal antibodies
(H-300, H-114, Santa Cruz Biotechnology, Inc., Santa Cruz,
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CA), Src1 with Mab 327, and raf1 with H-71 (Santa Cruz
Biotechnology, Inc.). Washing was three times for 5 min in
Tris-buffered saline/Tween buffer. Detection was achieved
using appropriate peroxidase-conjugated secondary anti-
bodies and enhanced chemiluminescent (ECL) substrate
(Amersham Biosciences, Freiburg, Germany).
Activation of lck and raf
Determination of lck and raf activation was performed essen-
tially as described (48). Jurkat T-cells at a density of 2 
106/ml were treated with the indicated additions for 16 h. In
the last 4 h, serum was deprived to decrease the basal level
of growth signals. After pretreatment, T cells were stimulated
with 5 g/ml anti-CD3 antibody (OKT3, gift of Ma´rta Szamel)
for 20 min. Cells were washed twice with ice-cold PBS, then
lysed using 25 mM Tris-HCl, 100 mM NaCl,1% Brij98, 4 mM
EDTA, 1 mM dithiothreitol, 1 mM sodium-vanadate, 10 mM
sodium-fluoride, 10 mM -glycerophosphate, 1 mM PMSF, 5
g/ml leupeptin, 0.7 g/ml pepstatin A (pH 7.4), for 30 min. at
4 C. After centrifugation (14,000  g, 10 min), 30 g protein
of the supernatant were loaded per well on a 7.5% SDS-
PAGE, transferred to nitrocellulose, then blots were probed
with anti-raf-1 and anti-lck antibodies (kind gift of Attila
Steta´k).
Binding of Hsp90 to the Ligand Binding Domain of GR
in Vitro
The procedure was adapted from Young and Hartl (52).
Briefly, Hsp90 was labeled using an in vitro transcription and
translation system (Promega). Buffer was changed to buffer B
[100 mM KOAc, 20 mM HEPES-KOH (pH 7.5), 5% glycerol]
using biospin 6 columns (Bio-Rad). Incubation with or without
CDDP was for 30 min, followed by another gel filtration to
remove excess CDDP. Binding reaction was with myc-
tagged ligand binding domain of GR, which had been bound
to anti-myc antibodies on Sepharose beads (52), together
with reticulocyte lysate, ATP and Mg2 for 10 min. Unbound
material was removed, beads were washed twice with buffer
B and proteins were eluted with high salt buffer [20 mM
Tris-Cl (pH 7.5), 500 mM NaCl, and 1 mM EDTA]. After gel
electrophoresis and autoradiography, the intensity of Hsp90
bands was determined using Scion Image (Scion Corp.,
Frederick, MD).
Acknowledgments
We thank Christian Behl (University Mainz, Germany) for
kindly providing SK-N-MC cells, Constanze Winklhofer (Max
Planck Institute of Biochemistry, Martinsried, Germany) for
the HSF1 reporter plasmid [originally a kind gift from Richard
Voellmy (University of Miami, FL) (82–84)], Dietmar Spengler
(Max Planck Institute of Psychiatry, Munich, Germany) for the
GR- and AR-expressing plasmids, Ma´rta Szamel (Medical
School Hannover, Germany) for the OKT3 antibody, Attila
Steta´k (Semmelweis University Budapest, Hungary) for anti-
lck and anti-raf antibodies, Andrea Jarzabek (Max Planck
Institute of Psychiatry) and Katalin Miha´ly (Semmelweis Uni-
versity) for excellent technical assistance, Dale Milfay (Max
Planck Institute of Psychiatry) for critically reading the manu-
script, and Pe´ter Csermely and Tama´s Schnaider (both Sem-
melweis University) for helpful discussions.
Received April 16, 2003. Accepted July 10, 2003.
Address all correspondence and requests for reprints to:
Theo Rein, Max Planck Institute of Psychiatry, Kraepelin-
strasse 10, D-80804 Munich, Germany. E-mail: theorein@
mpipsykl.mpg.de.
REFERENCES
1. Kartalou M, Essigmann JM 2001 Mechanisms of resis-
tance to cisplatin. Mutat Res 478:23–43
2. Reedijk J 2003 New clues for platinum antitumor
chemistry: Kinetically controlled metal binding to DNA.
Proc Natl Acad Sci USA 100:3611–3616
3. Kartalou M, Essigmann JM 2001 Recognition of cisplatin
adducts by cellular proteins. Mutat Res 478:1–21
4. Chu G 1994 Cellular responses to cisplatin. The roles of
DNA-binding proteins and DNA repair. J Biol Chem 269:
787–790
5. Gonzalez VM, Fuertes MA, Alonso C, Perez JM 2001 Is
cisplatin-induced cell death always produced by apopto-
sis? Mol Pharmacol 59:657–663
6. Akaboshi M, Kawai K, Maki H, Akuta K, Ujeno Y, Miya-
hara T 1992 The number of platinum atoms binding to
DNA, RNA and protein molecules of HeLa cells treated
with cisplatin at its mean lethal concentration. Jpn J
Cancer Res 83:522–526
7. Mandic, A, Hansson, J, Linder, S, Shoshan, MC 2003
Cisplatin induces endoplasmic reticulum stress and nu-
cleus-independent apoptotic signaling. J Biol Chem 278:
9100–9106
8. Itoh H, Ogura M, Komatsuda A, Wakui H, Miura AB,
Tashima Y 1999 A novel chaperone-activity-reducing
mechanism of the 90-kDa molecular chaperone HSP90.
Biochem J 343:697–703
9. Stebbins CE, Russo AA, Schneider, C, Rosen, N, Hartl
FU, Pavletich NP 1997 Crystal structure of an Hsp90-
geldanamycin complex: targeting of a protein chaperone
by an antitumor agent. Cell 89:239–250
10. Whitesell L, Mimnaugh EG, De Costa B, Myers CE, Neck-
ers LM 1994 Inhibition of heat shock protein HSP90-
pp60v-src heteroprotein complex formation by benzo-
quinone ansamycins: essential role for stress proteins in
oncogenic transformation. Proc Natl Acad Sci USA 91:
8324–8328
11. Richter K, Buchner J 2001 Hsp90: chaperoning signal
transduction. J Cell Physiol 188:281–290
12. Young JC, Moarefi I, Hartl FU 2001 Hsp90: a specialized
but essential protein-folding tool. J Cell Biol 154:267–273
13. Mayer MP, Bukau B 1999 Molecular chaperones: the
busy life of Hsp90. Curr Biol 9:R322–R325
14. Evans-Storms RB, Cidlowski JA 2000 Delineation of an
antiapoptotic action of glucocorticoids in hepatoma
cells: the role of nuclear factor-B. Endocrinology 141:
1854–1862
15. Pratt WB, Gehring U, Toft DO 1996 Molecular chaper-
oning of steroid hormone receptors. EXS 77:79–95
16. Pratt WB, Toft DO 1997 Steroid receptor interactions
with heat shock protein and immunophilin chaperones.
Endocr Rev 18:306–360
17. Nathan DF, Lindquist S 1995 Mutational analysis of
Hsp90 function: interactions with a steroid receptor and
a protein kinase. Mol Cell Biol 15:3917–3925
18. Beato M, Klug J 2000 Steroid hormone receptors: an
update. Hum Reprod Update 6:225–236
19. Karin M 1998 New twists in gene regulation by glucocor-
ticoid receptor: is DNA binding dispensable? Cell 93:
487–490
20. Bijlmakers MJ, Marsh M 2000 Hsp90 is essential for the
synthesis and subsequent membrane association, but
not the maintenance, of the Src-kinase p56(lck). Mol Biol
Cell 11:1585–1595
21. Schulte TW, Blagosklonny MV, Ingui C, Neckers L 1995
Disruption of the Raf-1-Hsp90 molecular complex results
in destabilization of Raf-1 and loss of Raf-1-Ras associ-
ation. J Biol Chem 270:24585–24588
22. Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R 1998
Repression of heat shock transcription factor HSF1 ac-
Rosenhagen et al. • Cisplatin Inhibits GR Mol Endocrinol, October 2003, 17(10):1991–2001 1999
 on February 8, 2006 mend.endojournals.orgDownloaded from 
               dc_625_12
tivation by HSP90 (HSP90 complex) that forms a stress-
sensitive complex with HSF1. Cell 94:471–480
23. Xu Y, Singer MA, Lindquist S 1999 Maturation of the
tyrosine kinase c-src as a kinase and as a substrate
depends on the molecular chaperone Hsp90. Proc Natl
Acad Sci USA 96:109–114
24. Masumoto N, Nakano S, Fujishima H, Kohno K, Niho Y
1999 v-src induces cisplatin resistance by increasing the
repair of cisplatin-DNA interstrand cross-links in human
gallbladder adenocarcinoma cells. Int J Cancer 80:
731–737
25. DeBoer C, Meulman PA, Wnuk RJ, Peterson DH 1970
Geldanamycin, a new antibiotic. J Antibiot (Tokyo) 23:
442–447
26. Omura S, Iwai Y, Takahashi Y, Sadakane N, Nakagawa
A, Oiwa H, Hasegawa Y, Ikai T 1979 Herbimycin, a new
antibiotic produced by a strain of Streptomyces. J Anti-
biot (Tokyo) 32:255–261
27. Kwon HJ, Yoshida M, Abe K, Horinouchi S, Beppu T
1992 Radicicol, an agent inducing the reversal of trans-
formed phenotypes of src-transformed fibroblasts. Bio-
sci Biotechnol Biochem 56:538–539
28. Shimada Y, Ogawa T, Sato A, Kaneko I, Tsujita Y 1995
Induction of differentiation of HL-60 cells by the anti-
fungal antibiotic, radicicol. J Antibiot (Tokyo) 48:824–830
29. Zhao JF, Nakano H, Sharma S 1995 Suppression of RAS
and MOS transformation by radicicol. Oncogene 11:
161–173
30. Fukazawa H, Li PM, Yamamoto C, Murakami Y, Mizuno
S, Uehara Y 1991 Specific inhibition of cytoplasmic pro-
tein tyrosine kinases by herbimycin A in vitro. Biochem
Pharmacol 42:1661–1671
31. Stancato LF, Silverstein AM, Owens-Grillo JK, Chow YH,
Jove R, Pratt WB 1997 The hsp90-binding antibiotic
geldanamycin decreases Raf levels and epidermal
growth factor signaling without disrupting formation of
signaling complexes or reducing the specific enzymatic
activity of Raf kinase. J Biol Chem 272:4013–4020
32. Whitesell L, Cook P 1996 Stable and specific binding of
heat shock protein 90 by geldanamycin disrupts glu-
cocorticoid receptor function in intact cells. Mol Endo-
crinol 10:705–712
33. Hartson SD, Barrett D.J, Burn P, Matts RL 1996 Hsp90-
mediated folding of the lymphoid cell kinase p56lck.
Biochemistry 35:13451–13459
34. Prodromou C, Roe SM, O’Brien R, Ladbury JE, Piper PW,
Pearl LH 1997 Identification and structural characteriza-
tion of the ATP/ADP-binding site in the Hsp90 molecular
chaperone. Cell 90:65–75
35. Roe SM, Prodromou C, O’Brien R, Ladbury JE, Piper PW,
Pearl LH 1999 Structural basis for inhibition of the Hsp90
molecular chaperone by the antitumor antibiotics radici-
col and geldanamycin. J Med Chem 42:260–266
36. Hesketh PJ, Roman A, Hesketh AM, Perez EA, Edelman
M, Gandara DR 2000 Control of high-dose-cisplatin-
induced emesis with an all-oral three-drug antiemetic
regimen. Support Care Cancer 8:46–48
37. Herr A, Wochnik GM, Rosenhagen MC, Holsboer F, Rein
T 2000 Rifampicin is not an activator of the glucocorti-
coid receptor. Mol Pharmacol 57:732–737
38. Mymryk JS, Zaniewski E, Archer TK 1995 Cisplatin in-
hibits chromatin remodeling, transcription factor binding,
and transcription from the mouse mammary tumor virus
promoter in vivo. Proc Natl Acad Sci USA 92:2076–2080
39. Hollenberg SM, Giguere V, Segui P, Evans RM 1987
Colocalization of DNA-binding and transcriptional acti-
vation functions in the human glucocorticoid receptor.
Cell 49:39–46
40. Mimnaugh EG, Chavany C, Neckers L 1996 Polyubiquiti-
nation and proteasomal degradation of the p185c-
erbB-2 receptor protein-tyrosine kinase induced by
geldanamycin. J Biol Chem 271:22796–22801
41. Levitzki A 1999 Protein tyrosine kinase inhibitors as novel
therapeutic agents. Pharmacol Ther 82:231–239
42. Cissel DS, Beaven MA 2000 Disruption of Raf-1/heat
shock protein 90 complex and Raf signaling by dexa-
methasone in mast cells. J Biol Chem 275:7066–7070
43. Yorgin PD, Hartson SD, Fellah AM, Scroggins BT, Huang
W, Katsanis E, Couchman JM, Matts RL, Whitesell L
2000 Effects of geldanamycin, a heat-shock protein 90-
binding agent, on T cell function and T cell nonreceptor
protein tyrosine kinases. J Immunol 164:2915–2923
44. Schneider C, Sepp-Lorenzino L, Nimmesgern E, Ouerfelli
O, Danishefsky S, Rosen N, Hartl FU 1996 Pharmaco-
logic shifting of a balance between protein refolding and
degradation mediated by Hsp90. Proc Natl Acad Sci
USA 93:14536–14541
45. Segnitz B, Gehring U 1997 The function of steroid hor-
mone receptors is inhibited by the hsp90-specific com-
pound geldanamycin. J Biol Chem 272:18694–18701
46. Lee DH, Goldberg AL 1996 Selective inhibitors of the
proteasome-dependent and vacuolar pathways of pro-
tein degradation in Saccharomyces cerevisiae. J Biol
Chem 271:27280–27284
47. Bush KT, Goldberg AL, Nigam SK 1997 Proteasome
inhibition leads to a heat-shock response, induction of
endoplasmic reticulum chaperones, and thermotoler-
ance. J Biol Chem 272:9086–9092
48. Schnaider T, Somogyi J, Csermely P, Szamel M 2000
The Hsp90-specific inhibitor geldanamycin selectively
disrupts kinase-mediated signaling events of T-lympho-
cyte activation. Cell Stress Chaperones 5:52–61
49. Panaretou B, Prodromou C, Roe SM, O’Brien R, Ladbury
JE, Piper PW, Pearl LH 1998 ATP binding and hydrolysis
are essential to the function of the Hsp90 molecular
chaperone in vivo. EMBO J 17:4829–4836
50. Obermann WM, Sondermann H, Russo AA, Pavletich
NP, Hartl FU 1998 In vivo function of Hsp90 is dependent
on ATP binding and ATP hydrolysis. J Cell Biol 143:
901–910
51. Rosenhagen MC, Young JC, Wochnik GM, Herr A,
Schmidt U, Hartl FU, Holsboer F, Rein T 2001 Synergistic
inhibition of the glucocorticoid receptor by radicicol and
benzoquinone ansamycins. Biol Chem 382:499–504
52. Young JC, Hartl FU 2000 Polypeptide release by Hsp90
involves ATP hydrolysis and is enhanced by the co-
chaperone p23. EMBO J 19:5930–5940
53. Stancato LF, Silverstein AM, Gitler C, Groner B, Pratt WB
1996 Use of the thiol-specific derivatizing agent N-
iodoacetyl-3-[125I]iodotyrosine to demonstrate confor-
mational differences between the unbound and hsp90-
bound glucocorticoid receptor hormone binding domain.
J Biol Chem 271:8831–8836
54. Stancato LF, Hutchison KA, Chakraborti PK, Simons
SSJ, Pratt WB 1993 Differential effects of the reversible
thiol-reactive agents arsenite and methyl methanethio-
sulfonate on steroid binding by the glucocorticoid recep-
tor. Biochemistry 32:3729–3736
55. Bodwell JE, Holbrook NJ, Munck A 1984 Evidence for
distinct sulfhydryl groups associated with steroid- and
DNA-binding domains of rat thymus glucocorticoid re-
ceptors. Biochemistry 23:4237–4242
56. Neckers L 2002 Hsp90 inhibitors as novel cancer che-
motherapeutic agents. Trends Mol Med 8:S55–S61
57. An WG, Schulte TW, Neckers LM 2000 The heat shock
protein 90 antagonist geldanamycin alters chaperone as-
sociation with p210bcr-abl and v-src proteins before
their degradation by the proteasome. Cell Growth Differ
11:355–360
58. Deleted in proof
59. Iida T, Makino Y, Okamoto K, Yoshikawa N, Makino I,
Nakamura T, Tanaka H 2000 Functional modulation of
the mineralocorticoid receptor by cis-diamminedichloro-
platinum (II). Kidney Int 58:1450–1460
2000 Mol Endocrinol, October 2003, 17(10):1991–2001 Rosenhagen et al. • Cisplatin Inhibits GR
 on February 8, 2006 mend.endojournals.orgDownloaded from 
               dc_625_12
60. Hutchison KA, Matic G, Meshinchi S, Bresnick EH, Pratt
WB 1991 Redox manipulation of DNA binding activity
and BuGR epitope reactivity of the glucocorticoid recep-
tor. J Biol Chem 266:10505–10509
61. Marcu MG, Chadli A, Bouhouche I, Catelli M, Neckers LM
2000 The heat shock protein 90 antagonist novobiocin
interacts with a previously unrecognized ATP-binding
domain in the carboxyl terminus of the chaperone. J Biol
Chem 275:37181–37186
62. So˜ti C, Ra´cz A, Csermely P 2002 A Nucleotide-depen-
dent molecular switch controls ATP binding at the C-
terminal domain of Hsp90. N-terminal nucleotide binding
unmasks a C-terminal binding pocket. J Biol Chem 277:
7066–7075
63. Marcu MG, Schulte TW, Neckers L 2000 Novobiocin and
related coumarins and depletion of heat shock protein
90-dependent signaling proteins. J Natl Cancer Inst 92:
242–248
64. Nardai G, Sass B, Eber J, Orosz G, Csermely P 2000
Reactive cysteines of the 90-kDa heat shock protein,
Hsp90. Arch Biochem Biophys 384:59–67
65. Kanelakis KC, Shewach DS, Pratt WB 2002 Nucleotide
binding states of hsp70 and hsp90 during sequential
steps in the process of glucocorticoid receptor hsp90
heterocomplex assembly. J Biol Chem 277:33698–
33703
66. Liu Q, Levy EJ, Chirico WJ 1996 N-Ethylmaleimide inac-
tivates a nucleotide-free Hsp70 molecular chaperone.
J Biol Chem 271:29937–29944
67. Chawla SP, Grunberg SM, Gralla RJ, Hesketh PJ, Rit-
tenberg C, Elmer ME, Schmidt C, Taylor A, Carides AD,
Evans JK, Horgan KJ 2003 Establishing the dose of the
oral NK1 antagonist aprepitant for the prevention of che-
motherapy-induced nausea and vomiting. Cancer 97:
2290–2300
68. Forth, W, Henschler, D, Rummel W 1990 Pharmakologie
und toxikologie. 5th ed. Mannheim, Germany: Wissen-
schaftsverlag
69. Sorbe BG, Hogberg T, Glimelius B, Schmidt M, Wernst-
edt L, Hansen, O, Sorensen BT, Raisanen I, van Oost-
erom AT, de Bruijn KM 1994 A randomized, multicenter
study comparing the efficacy and tolerability of tropise-
tron, a new 5-HT3 receptor antagonist, with a metoclo-
pramide-containing antiemetic cocktail in the prevention
of cisplatin-induced emesis. Cancer 73:445–454
70. Sam TS, Chan SW, Rudd JA, Yeung JH 2001 Action of
glucocorticoids to antagonise cisplatin-induced acute
and delayed emesis in the ferret. Eur J Pharmacol 417:
231–237
71. Hesketh PJ, Harvey WH, Harker WG, Beck TM, Ryan T,
Bricker LJ, Kish JA, Murphy WK, Hainsworth JD, Haley B
1994 A randomized, double-blind comparison of intrave-
nous ondansetron alone and in combination with intra-
venous dexamethasone in the prevention of high-dose
cisplatin-induced emesis. J Clin Oncol 12:596–600
72. Roila F, Tonato M, Cognetti F, Cortesi E, Favalli G, Ma-
rangolo M, Amadori D, Bella MA, Gramazio V, Donati D
1991 Prevention of cisplatin-induced emesis: a double-
blind multicenter randomized crossover study compar-
ing ondansetron and ondansetron plus dexamethasone.
J Clin Oncol 9:675–678
73. Passalacqua R, Cocconi G, Caminiti C, Silingardi V, Bella
MA, Bichisao E, Michiara M, Malavasi V, Donati D, Di
Costanzo F, Rocca A, Di Sarra S, Scaglione F, Fraschini
F 1997 Double-blind, multicenter, randomized trial to
compare the effect of two doses of adrenocorticotropic
hormone vs. placebo in controlling delayed emesis after
high-dose cisplatin in adult patients with cancer. J Clin
Oncol 15:2467–2473
74. Blachley JD, Hill JB 1981 Renal and electrolyte distur-
bances associated with cisplatin. Ann Intern Med 95:
628–632
75. Hutchison FN, Perez EA, Gandara DR, Lawrence HJ,
Kaysen GA 1988 Renal salt wasting in patients treated
with cisplatin. Ann Intern Med 108:21–25
76. Damm K 1994 Gene transfection studies using recombi-
nant steroid receptors. In: De Kloet ER, Sutanto W, eds.
Methods in neurosciences: neurobiology of steroids. San
Diego: Academic Press; 265–276
77. Hollenberg SM, Evans RM 1988 Multiple and cooperative
trans-activation domains of the human glucocorticoid
receptor. Cell 55:899–906
78. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A,
Lebo R, Thompson EB, Rosenfeld MG, Evans RM 1985
Primary structure and expression of a functional human
glucocorticoid receptor cDNA. Nature 318:635–641
79. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bock-
aert J, Seeburg, PH, Journot L 1993 Differential signal
transduction by five splice variants of the PACAP recep-
tor. Nature 365:170–175
80. Chu G, Hayakawa H, Berg P 1987 Electroporation for the
efficient transfection of mammalian cells with DNA. Nu-
cleic Acids Res 15:1311–1326
81. Lowry OH, Rosebrough N, Farr AL, Randall NJ 1951
Protein measurements with the Folin phenol reagent.
J Biol Chem 193:265
82. Voellmy R, Ahmed A, Schiller P, Bromley P, Rungger D
1985 Isolation and functional analysis of a human
70,000-dalton heat shock protein gene segment. Proc
Natl Acad Sci USA 82:4949–4953
83. Zuo J, Rungger D, Voellmy R 1995 Multiple layers of
regulation of human heat shock transcription factor 1.
Mol Cell Biol 15:4319–4330
84. Winklhofer KF, Reintjes A, Hoener MC, Voellmy R, Tatzelt
J 2001 Geldanamycin restores a defective heat shock
response in vivo. J Biol Chem 276:45160–45167
Rosenhagen et al. • Cisplatin Inhibits GR Mol Endocrinol, October 2003, 17(10):1991–2001 2001
 on February 8, 2006 mend.endojournals.orgDownloaded from 
               dc_625_12
Mini-review
Aging and molecular chaperones
Csaba So˝ti*, Pe´ter Csermely
Department of Medical Chemistry, Semmelweis University, P.O. Box 260, H-1444 Budapest 8, Hungary
Received 19 May 2003; received in revised form 26 June 2003; accepted 30 June 2003
Abstract
Chaperone function plays a key role in sequestering damaged proteins and in repairing proteotoxic damage. Chaperones are induced by
environmental stress and are called as stress or heat shock proteins. Here, we summarize the current knowledge about protein damage in aged
organisms, about changes in proteolytic degradation, chaperone expression and function in the aging process, as well as the involvement of
chaperones in longevity and cellular senescence. The role of chaperones in aging diseases, such as in Alzheimer’s disease, Parkinson’s
disease, Huntington’s disease and in other neurodegenerative diseases as well as in atherosclerosis and in cancer is discussed. We also
describe how the balance between chaperone requirement and availability becomes disturbed in aged organisms, or in other words, how
chaperone overload develops. The consequences of chaperone overload are also outlined together with several new research strategies to
assess the functional status of chaperones in the aging process.
q 2003 Elsevier Inc. All rights reserved.
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1. Introduction: molecular chaperones
Chaperones are ubiquitous, highly conserved proteins
(Hartl, 1996), either assisting in the folding of newly
synthesized or damaged proteins in an ATP-dependent
active process or working in an ATP-independent passive
mode sequestering damaged proteins for future refolding or
digestion. Environmental stress leads to proteotoxic
damage. Damaged, misfolded proteins bind to chaperones,
and liberate the heat shock factor (HSF) from its chaperone
complexes. HSF is activated and transcription of chaperone
genes takes place (Morimoto, 2002). Most chaperones,
therefore, are also called stress or (after the archetype of
experimental stress) heat shock proteins (Hsp-s).
2. Aging proteins—proteins of aging organisms
During the life-span of a stable protein, various
posttranslational modifications occur including backbone
and side chain oxidation, glycation, etc. In aging
organisms, the disturbed cellular homeostasis leads to
an increased rate of protein modification: in an 80-year
old human, half of all proteins may become oxidized
(Stadtman and Berlett, 1998). Susceptibility to various
proteotoxic damages is mainly increased due to dysfunc-
tion of mitochondrial oxidation of starving yeast
cells (Aguilaniu et al., 2001). In prokaryotes, transla-
tional errors result in folding defects and subsequent
protein oxidation (Dukan et al., 2000), which predomi-
nantly takes place in growth arrested cells (Ballesteros
et al., 2001).
Additionally, damaged signalling networks loose their
original stringency, and irregular protein phosphorylation
occurs (e.g.: the Parkinson disease-related a-synuclein also
becomes phosphorylated, leading to misfolding and aggre-
gation; Neumann et al., 2002).
3. Aging protein degradation
Irreversibly damaged proteins are recognized by
chaperones, and targeted for degradation. Proteasome
level and function decreases with aging, and some
oxidized, aggregated proteins exert a direct inhibition on
0531-5565/$ - see front matter q 2003 Elsevier Inc. All rights reserved.
doi:10.1016/S0531-5565(03)00185-2
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proteasome activity. Chaperones also aid in lysosomal
degradation. The proteolytic changes are comprehensively
reviewed by Szweda et al. (2002). Due to the degradation
defects, damaged proteins accumulate in the cells of
aged organisms, and by aggregation may cause a variety
of protein folding diseases (reviewed by So˝ti and
Csermely, 2002a).
4. Aging chaperones I: defects in chaperone induction
Damaged proteins compete with the HSF in binding to
the Hsp90-based cytosolic chaperone complex, which may
contribute to the generally observed constitutively elevated
chaperone levels in aged organisms (Zou et al., 1998; So˝ti
and Csermely, 2002b). On the contrary, the majority of the
reports showed that stress-induced synthesis of chaperones
is impaired in aged animals. While HSF activation does not
change, DNA binding activity may be reduced during aging
(Heydari et al., 2000). A number of signalling events use an
overlapping network of chaperones not only to establish the
activation-competent state of different transcription factors
(e.g. steroid receptors), but also as important elements in the
attenuation of respective responses. HSF transcriptional
activity is also negatively influenced by higher levels of
chaperones (Morimoto, 2002). Differential changes of these
proteins in various organisms and tissues may lead to
different extents of (dys)regulation. More importantly, the
cross-talk between different signalling pathways through a
shared pool of chaperones may have severe consequences
during aging when the cellular conformational homeostasis
is deranged (see below).
5. Aging chaperones II: defects in chaperone function
Direct studies on chaperone function in aged organisms
are largely restricted to a-crystallin having a decreased
activity in aged human lenses (Cherian and Abraham, 1995;
Cherian-Shaw et al., 1999). In a recent study, an initial test
of passive chaperone function of whole cytosols was
assessed showing a decreased chaperone capacity in aged
rats compared to those of young counterparts (Nardai et al.,
2002).
What can be the mechanism behind these deleterious
changes in chaperone function? Chaperones may also be
prone to oxidative damage, as GroEL is preferentially
oxidized in growth-arrested E. coli (Dukan and Nystro¨m,
1999). Macario and Conway de Macario (2002) raised the
idea of ‘sick chaperones’ in aged organisms in a recent
review. Indeed, chaperones are interacting with a plethora of
other proteins (Csermely, 2001a), which requires rather
extensive binding surfaces. These exposed areas may make
chaperones a preferential target for proteotoxic damage:
chaperones may behave as ‘suicide proteins’ during aging,
sacrificing themselves instead of ‘normal’ proteins. The high
abundance of chaperones (which may constitute more than
5% of cellular proteins), and their increased constitutive
expression in aged organisms makes them a good candidate
for this ‘altruistic courtesy.’ It may be especially true for
mitochondrial Hsp60, the role of which would deserve
extensive studies.
6. Aging chaperones III: defects in capacity,
the chaperone overload
Another possible reason of decreased chaperone function
is chaperone overload (Csermely, 2001b). In aging organ-
isms, the balance between misfolded proteins and available
free chaperones is grossly disturbed: increased protein
damage, protein degradation defects increase the amount of
misfolded proteins, while chaperone damage, inadequate
synthesis of molecular chaperones and irreparable folding
defects (due to posttranslational changes) decrease the
amount of available free chaperones. Chaperone overload
occurs, where the need for chaperones may greatly exceed
the available chaperone capacity (Fig. 1).
Under these conditions, the competition for available
chaperones becomes fierce and the abundance of damaged
proteins may disrupt the folding assistance to other
Fig. 1. Chaperone overload: a shift in the balance between misfolded
proteins and available free chaperones in aging organisms. The accumu-
lation of chaperone substrates along with an impaired chaperone function
may exhaust the folding assistance to specific chaperone targets and leads to
deterioration in vital processes. Chaperone overload may significantly
decrease the robustness of cellular networks, and compromise the
adaptative responses. See text for details.
C. So˝ti, P. Csermely / Experimental Gerontology 38 (2003) 1037–10401038
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chaperone targets, such as: (1) newly synthesized proteins;
(2) ‘constantly damaged’ (mutant) proteins; and (3)
constituents of the cytoarchitecture (Csermely, 2001a).
This may cause defects in signal transduction, protein
transport, immune recognition, cellular organization as
well as the appearance of previously buffered, hidden
mutations in the phenotype of the cell (Csermely, 2001b).
Chaperone overload may significantly decrease the
robustness of cellular networks, as well as shift their
function towards a more stochastic behavior. As a result
of this, aging cells become more disorganized, their
adaptation is impaired.
7. Senescent cells and chaperones
The involvement of chaperones in aging at the cellular
level is recently reviewed (So˝ti et al., 2003). Non-dividing-
senescent-peripheral cells tend to have increased chaperone
levels (Verbeke et al., 2001), and cannot preserve the
induction of several chaperones (Liu et al., 1989), similarly
to cells from aged animals. Activation and binding of HSF
to the heat shock element is decreased in aged cells (Choi
et al., 1990). Interestingly, cellular senescence seems to
unmask a proteasomal activity leading to the degradation of
HSF (Bonelli et al., 2001).
Chaperone induction per se seems to counteract senes-
cence. Repeated mild heat shock (a kind of hormesis) has
been reported to delay fibroblast aging (Verbeke et al.,
2001), though it does not seem to extend replicative life-
span. A major chaperone, Hsp90 is required for the correct
function of telomerase, an important enzyme to extend the
life-span of cells (Holt et al., 1999).
Mortalin (mtHsp70/Grp75), a member of the Hsp70
family, produces opposing phenotypic effects related to its
localization. In normal cells, it is pancytoplasmically
distributed, and its expression causes senescence. Its
upregulation and perinuclear distribution, however, is
connected to transformation, probably via p53 inactivation.
Mortalin also induces life-span extension in human
fibroblasts or in C. elegans harboring extra copies of the
orthologous gene (Kaul et al., 2002).
8. Aging organisms and chaperones: age-related diseases
Unbalanced chaperone requirement and chaperone
capacity in aged organisms helps the accumulation of
aggregated proteins, which often cause folding diseases,
mostly of the nervous system, due to the very limited
proliferation potential of neurons. Over expression of
chaperones often delays the onset or diminishes the
symptoms of the disease (So˝ti and Csermely, 2002b).
Other aging diseases, such as atherosclerosis and cancer
are also related to chaperone action. Here space limitation
precludes a detailed description of these rapidly developing
fields, however, numerous recent reviews were published on
these subjects, where the interested readers may find a good
summary and several hints for further readings (Ferreira and
Carlos, 2002; Neckers, 2002; Sarto et al., 2000; Wick and
Xu, 1999).
9. Chaperones and longevity
Increased chaperone induction leads to increased long-
evity (Tatar et al., 1997). Moreover, a close correlation
exists between stress resistance and longevity in several
long-lived C. elegans and Drosophila mutants (Lithgow and
Kirkwood, 1996). As the other side of the same coin,
damaged HSF has been found as an important gene to cause
accelerated aging in C. elegans (Garigan et al., 2002).
Caloric restriction, the only effective experimental manipu-
lation known to retard aging in rodents and primates
(Ramsey et al., 2000), restores age-impaired chaperone
induction, while reversing the age-induced changes in
constitutive Hsp levels (see So˝ti and Csermely, 2002a,b).
These examples confirm the hypothesis that a better
adaptation capacity to various stresses greatly increases
the chances to reach longevity.
10. Conclusions and perspectives
Aging can be defined as a multicausal process leading to
a gradual decay of self-defensive mechanisms, and an
exponential accumulation of damage at the molecular,
cellular and organismal level. The protein oxidation,
damage, misfolding and aggregation together with the
simultaneously impaired function and induction of chaper-
ones in aged organisms disturb the balance between
chaperone requirement and availability. There are several
important aspects for future investigation of this field:
† the measurement of active chaperone function (i.e.
chaperone-assisted refolding of damaged proteins)
in cellular extracts does not have a well-established
method yet;
† we have no methods to measure free chaperone levels;
† among the consequences of chaperone overload, changes
in signal transduction, protein transport, immune recog-
nition and cellular organization have not been system-
atically measured and/or related to the protein folding
homeostasis of aging organisms and cells.
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Summary
 
Chaperone function plays a key role in repairing proteo-
toxic damage and in the maintenance of cell survival. Here
we compare the regulatory role of molecular chaperones
(heat shock proteins, stress proteins) in cellular senes-
cence, apoptosis and necrosis. We also review the current
data on chaperone level and function in aging cells, and
list some possible therapeutic interventions. Finally, we
postulate a hypothesis, that increasing chaperone occu-
pancy might be an important event which forces cells out
of the normal cell cycle towards senescence. In the case
of severe stress, this may lead to apoptosis or, following
lethal stress, to cell necrosis.
Key words: apoptosis; chaperones; heat shock proteins;
necrosis; senescence; stress proteins.
 
Introduction: molecular chaperones
 
Chaperones are ubiquitous, highly conserved proteins, and are
key elements of the maintenance of the conformational homeo-
stasis of proteins in our cells (Hartl, 1996; Bukau & Horwich, 1998).
Classes of major chaperones are listed in Table 1. Chaperones
either assist in the folding of newly synthesized or damaged
proteins in an ATP-dependent, active process, or work in an ATP-
independent, passive mode, sequestering damaged proteins
for future refolding or proteasome-mediated degradation.
Chaperones participate in signalling, protein traffic and many
more cellular functions, and therefore they are vital for our cells
during their whole lifetime. However, the demand increases after
environmental stress, leading to proteotoxic damage. In stressed
cells ATP levels drop significantly, and thus several chaperones
may become ATP-independent ‘holders’ of damaged proteins,
preventing their fatal aggregation. After the cell has been recov-
ered, and the ATP level is increased, chaperones, which have a
rather low affinity for ATP, regain their ATP-dependent mode, and
are converted to ‘folders’ helping in the refolding, transport and/
or ATP-dependent degradation of sequestered, damaged proteins.
Various targets of molecular chaperones include (1) newly
synthesized proteins, (2) ‘constantly damaged’ (mutant) proteins
and (3) newly damaged proteins. Chaperones also bind to numer-
ous other proteins, such as other chaperones, co-chaperones,
constituents of the cytoskeleton, etc. These targets and other
chaperone-associated proteins might easily compete with each
other (Csermely, 2001a,b). Chaperones may neutralize the con-
formational consequences of several mutations, and therefore
‘buffer’ their potential phenotypical changes and make them
phenotypically silent (Rutherford & Lindquist, 1998; Roberts
& Feder, 1999; Fares 
 
et al
 
., 2002; Queitsch 
 
et al
 
., 2002). An
increased amount of damaged proteins may cause the pheno-
type of these mutations to re-appear by a competition for the
chaperone-buffer. As we will discuss later, this phenomenon
may occur in aging organisms and in cultured cells (Csermely,
2001b). Chaperone occupancy emerges as an integrator of
cellular, organismal and populational responses.
 
Senescence, apoptosis and necrosis
 
Several cell types, such as human diploid fibroblasts, endothelial
cells, T lymphocytes, epidermal keratinocytes, adrenocortical cells,
smooth muscle cells, glial cells, lens epithelial cells and human
pancreatic 
 
β
 
-cells, exhibit only a limited number of replications
in cell culture. Morphological and functional properties change
until the cell reaches a non-dividing – senescent – state (Hayflick
& Moorhead, 1961; Hayflick, 1965; Smith & Pereira-Smith,
1996). Continued proliferation of human cell cultures beyond
the ‘Hayflick limit’ (e.g. by inactivation of the p53 and retino-
blastoma growth inhibitory pathways) results in critical telomere
erosion culminating in a period of massive cell death termed
‘cellular crisis’ (Wright & Shay, 1992). It was thought that the rep-
licative capacity of senescent cells decreases with the age of the
donor. However, later studies, including that of Cristofalo 
 
et al
 
.
(1998), found no significant correlation between the proliferative
potential of various cell lines and the age of donors (Rubin, 2002).
However, cellular senescence is not a general phenomenon:
certain rodent stem cells, human astrocytes, rodent glial cells
and rodent oligodendrocyte precursor cells seem to have an
indefinite lifespan in cell culture, while maintaining a normal
phenotype (Rubin, 2002). Ramirez 
 
et al
 
. (2001) reported that
inadequate cell growth conditions may also lead to premature
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growth arrest. These findings emphasized the importance of
the selection process of primary cells during biopsy and initial
culturing, and raised the possibility that the ‘stress history’ of
primary cells both in the donor organism and during biopsy/
culture may also significantly influence the replicative lifespan
of cultured primary cells. Premature senescence can be induced
by a large number of stressors, e.g. increased oxygen, hydrogen
peroxide, 
 
tert
 
-butylhydroperoxide, 
 
γ
 
-radiation, UV light, DNA
strand breaks and pro-inflammatory cytokines (e.g. TNF-
 
α
 
 or
IL-1; Toussaint 
 
et al.
 
, 2002), if the overall stress level is moderate.
As an additional example, UV-B or oxidative stress induced
replicative senescence of normal and telomerase-immortalized
human foreskin fibroblasts (DeMagalhaes 
 
et al
 
., 2002). Severe
stress, however, causes cell death.
Cells typically die either by apoptosis or necrosis. These two
forms of cell death are probably much closer to each other than
previously thought (Proskuryakov 
 
et al
 
., 2002). Both necrosis
(where the cell membrane is ruptured, and the released cell
content causes a massive inflammatory response) and apoptosis
(where the cell content remains ‘well-packed’ in the apoptotic
bodies, and inflammation does not occur) can be (1) caused by
the same pathophysiological exposures, (2) prevented by anti-
apoptotic mechanisms and (3) transformed from one form to
the other by chemical interventions.
Senescent cells can stay viable at this state for several years
with regular renewal of the medium (Bree 
 
et al
 
., 2002). Senes-
cent fibroblasts are resistant to programmed cell death (Wang,
1995), are unable to undergo p53-dependent apoptosis, and are
shifted to necrosis upon DNA damage (Seluanov 
 
et al
 
., 2001).
However, apoptosis-resistance is not a general feature of senes-
cent cells, which may also be apoptosis prone depending on the
cell type and apoptotic stimuli, e.g. porcine pulmonary artery
endothelial cells show an enhanced apoptosis when cultured
for a prolonged period of time (Zhang 
 
et al
 
., 2002). Senescent
fibroblasts promote carcinogenesis of neighbouring cells by
secreting tumorigenic factors (Krtolica 
 
et al
 
., 2001). Therefore,
the accumulation of senescent cells may contribute to the
age-dependent dramatic increase of cancer incidences. Before
elucidating the role of chaperones in cellular senescence, here
we give a brief survey of the most important aspects of their
multiple roles in apoptotic and necrotic processes.
 
Role of chaperones in apoptosis and necrosis
 
In agreement with the cytoprotective role of molecular chaperones
it has been shown that they generally inhibit apoptosis (Samali
& Orrenius, 1998). As an example, overexpression of Hsp70
in mice led to leukaemia due to a massive decrease of T-cell
apoptosis in the thymus (Seo 
 
et al
 
., 1996). Hsp70 and many other
heat shock proteins can overcome both caspase-dependent and
caspase-independent apoptotic stimuli and confer immortality
in various human cell types (Nylandsted 
 
et al
 
., 2000; Verbeke
 
et al
 
., 2001b). Hsp70 inhibits stress kinases, inducing a block
in Bid activation and in all the consecutive steps of cytochrome
c release, caspase-3 activation and poly ADP-ribose polymerase
cleavage in human cell lines (Gabai 
 
et al
 
., 1998, 2002). As a
general anti-apoptotic effect, small heat shock proteins and Hsp70
protect against oxidative stimuli and thus block an important
initiation factor of apoptotic processes (Su 
 
et al
 
., 1999; Arrigo,
2001). Besides this, small Hsp-s also prevent cytochrome c
release in Jurkat cells (Samali 
 
et al
 
., 2001) and the activation of
caspases in U937 cells (Garrido 
 
et al
 
., 1999). As an additional
mechanism, both Hsp70 and Hsp90 block the formation and
activation of the Apaf-1 complex and, consequently, the acti-
vation of caspase-9 (Bree 
 
et al
 
., 2002). Hsp90 is also a chaperone
for PDK1 and Akt, the downstream members of the PI3K–PDK–
Akt anti-apoptotic pathway (Sato 
 
et al
 
., 2000; Fujita 
 
et al
 
., 2002),
and helps in the overexpression of the anti-apoptotic protein,
Bcl-2 (Dias 
 
et al
 
., 2002) in various human cell lines.
On the other hand, there are examples for the positive
involvement of stress proteins in apoptotic signalling (Punyiczki
& Fésüs, 1998). Hsp90 and its 75-kDa homologue Hsp75
participate in the signalling of tumour necrosis factor in human
and rat cells (TNF-
 
α
 
; Song 
 
et al.
 
, 1995; Galea-Lauri 
 
et al
 
., 1996).
The capacity of stress proteins may be exhausted due to a robust
stress response resulting in protein misfolding and aggregation.
Chaperone overload initiates either cell cycle arrest or apoptosis
by two mechanisms: by proteasomal inhibition (which blocks
cyclin degradation; Bence 
 
et al
 
., 2001), and by induction of the
JNK-dependent pathway suppressing the JNK-inhibitor, Hsp70
(Gabai 
 
et al
 
., 1998, 2002) in human cell lines. Hsp90 inhibition
also results in exaggerated apoptosis of TNF
 
α
 
-treated human cells
(Lewis 
 
et al
 
., 2000). Cytoplasmic translocation of mitochondrial
Hsp60 is one of the pro-apoptotic signals, which (together with
that of cytochrome c) promotes the activation of cytoplasmic
caspases, when mitochondrial integrity becomes compromised
in Jurkat T lymphocytes (Samali 
 
et al
 
., 1999; Xanthoudakis 
 
et al
 
.,
Table 1 Major classes of molecular chaperones
 
 
Most important eukaryotic 
representativesa Recent reviews
Hsp25b, Hsp27, crystallins, 
small heat shock proteins
Arrigo (2001); VanMontfort et al. (2002)
Hsp60, chaperonins Bukau & Horwich (1998); Hartl (1996);
Thirumalai & Lorimer (2001)
Hsp70, Hsc70, Grp78 Bukau & Horwich (1998); Hartl (1996);
Mayer et al. (2002)
Hsp90, Grp94 Csermely et al. (1998); Pearl & Prodromou 
(2002); Pratt & Toft (2002); Richter & 
Buchner (2001); Young et al. (2001)
Hsp104 Porankiewicz et al. (1999)
aNeither the co-chaperones (chaperones which help the function of other 
chaperones listed), nor the so-called folding catalysts, the peptidyl-prolyl 
isomerases (immunophilins) and protein disulphide isomerases were included 
in this table, albeit almost all of these proteins also possess a ‘traditional’ 
chaperone activity in their own right. Several chaperones of the endoplasmic 
reticulum (e.g. calreticulin, calnexin, etc.), which do not belong to any of the 
major chaperone families, as well as some heat shock proteins (e.g. ubiquitin), 
which do not possess chaperone activity were also not mentioned.
bThe abbreviations ‘Hsp’ and ‘Grp’ refer to heat shock proteins, and glucose-
regulated proteins, chaperones induced by heat shock or glucose deprivation, 
respectively. Numbers refer to their molecular weight in kDa.
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1999). Several peptidyl-prolyl 
 
cis
 
-
 
trans
 
 isomerase cyclophilins,
which are also apoptosis-activated nucleases, are potential direct
elements in the apoptotic machinery in HeLa cells (Montague
 
et al
 
., 1997). One of the major endoplasmic reticulum chaperones,
calreticulin, promotes both Ca-dependent apoptosis and necrosis
pathways in several 
 
C. elegans,
 
 rat and human model systems
(Nakamura 
 
et al
 
., 2000; Xu 
 
et al
 
., 2001; Kageyama 
 
et al
 
., 2002).
However, calreticulin protects neuroblastoma and renal epithelial
cells from apoptosis upon cell differentiation as well as iodo-
acetamide treatment, respectively (Liu 
 
et al
 
., 1997; Johnson
 
et al
 
., 1998).
In contrast to the necrosis-promoting effect of calreticulin
in 
 
C. elegans
 
 (Xu 
 
et al
 
., 2001), heat shock proteins generally
protect cells against necrosis. In the absence of Hsp27 and Hsp70
the lethal stress increases ceramide generation, which induces
cell necrosis in human fibroblasts (Verbeke 
 
et al
 
., 2001b). In
addition, Hsp70 helps to convert the ATP-depletion-induced cell
necrosis to apoptosis (Vayssier & Polla, 1998).
During cell necrosis, cells release various chaperones, such as
calreticulin, Hsp10, Hsp70, Hsp90, etc., which serve as a ‘danger
signal’ (Basu 
 
et al
 
., 2000). Extracellular chaperones provoke
inflammation and induce the necrosis of nearby endangered
human cells (Proskuryakov 
 
et al
 
., 2002).
 
Involvement of chaperone function in 
cellular senescence
 
Several chaperones have a direct effect on cellular senescence
(Table 2). Overexpression of Hsp27 in bovine arterial endothelial
cells leads to an accelerated growth and senescence (Piotrowicz
 
et al
 
., 1995). Bag-1, a co-chaperone of Hsp70, slows down cell
proliferation by impaired activation of the necessary Raf kinase,
when Hsp70 levels are high enough, i.e. after stress (Song 
 
et al
 
.,
2001). When a senescence-promoting factor, mot-1, was isolated
from cytoplasmic extracts of senescing (mortal) fibroblasts, it
turned out to be a member of the Hsp70 chaperone family. Anti-
mortalin antibodies rescued cells from senescence and induced
cell proliferation. In contrast, overexpression of mot-2, another
member of the mortalin family, in human fibroblasts permitted
their escape from senescence (Wadhwa 
 
et al
 
., 2002).
The previous examples may lead to the conclusion that
chaperones promote cellular senescence. However, chaperone
induction 
 
per se
 
 may counteract senescence, since repeated
mild heat shock (a kind of hormesis) has been reported to delay
fibroblast aging (Rattan, 1998), though it does not seem to
extend replicative lifespan. Hsp90 is required for the correct
function of telomerase, a major enzyme involved in determining
the lifespan of cells (Holt 
 
et al
 
., 1999). Up-regulation of telomerase
activity in transformed prostate epithelial cells is completely due
to an increased assembly by up-regulated chaperones (Harvey
 
et al
 
., 2002). It is reasonable to assume that the proliferative
potential of telomerase-positive stem cells may correlate with
their available chaperone capacity. Besides telomerase activity,
protection of shortened/altered telomeres (Karlseder 
 
et al
 
., 2002)
might be another important element of chaperone-mediated
senescence-delay. Interestingly, in contrast to the senescence-
promoting effect of extra copies of Hsp27, when a mutant, non-
phosphorylated form of Hsp27 was expressed in bovine arterial
endothelial cells, cellular senescence was hindered (Piotrowicz
 
et al
 
., 1995). Hsp90 also chaperones cyclin-dependent kinases,
and when Hsp90 level is diminished, even a mild heat shock
induces cell cycle arrest (Nakai & Ishikawa, 2001).
Little is known about the action of chaperones in non-dividing,
senescent cells. Apolipoprotein J (clusterin), an extracellular chap-
erone, has been described as a biomarker of senescence, and
is implicated in the prevent ion/delay of apoptosis (Petropou-
lou 
 
et al
 
., 2001; Trougakos & Gonos, 2002). As another exam-
ple, impaired Hsp90 function leads to the activation of HSF-1,
restoration of the heat shock response and slower chronological
aging of non-dividing 
 
Saccharomyces cerevisiae
 
 (Harris 
 
et al
 
., 2001).
On the other hand, impaired Hsp70 induction (and probably
function) of senescent cells leads to their reduced thermotoler-
ance due to a loss of an Hsp70-mediated inhibitory control of
stress kinase signalling (Volloch 
 
et al
 
., 1998). Increased chaperone
occupancy may significantly contribute to decreased p53 stability
in senescent cells, causing an enhanced cell necrosis (Seluanov
 
et al
 
., 2001). Exhausted chaperones may thus lead to a reversal
of the general apoptosis resistance of senescent cells.
 
Changes of chaperone function in cellular 
senescence
 
Like cells from aged animals (Sõti & Csermely, 2002) senescent
cells tend to have increased chaperone levels: as one of the
Table 2 Role of molecular chaperones in cellular senescence
 
 
Chaperone Change References
Increased senescence
Hsp27 increased senescence of endothelial cells 
decreased cell proliferation by decreased
Piotrowicz et al. (1995)
Bag-1 Raf activation after stress Song et al. (2001)
cytoplasmic mortalin-1 (a Hsp70 homologue) senescent fibroblast phenotype Wadhwa et al. (2002)
Decreased senescence
non-phosphorylatable Hsp27 senescence inhibition of endothelial cells Piotrowicz et al. (1995)
mortalin-2 (a Hsp70 homologue) malignant transformation of NIH 3T3 fibroblasts Wadhwa et al. (2002)
Hsp90 (Hsp70, p23, Hsp40, Hop) telomerase activation: extended proliferative lifespan Holt et al. (1999); Harvey et al. (2002)
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examples, chondrocytes have an elevated Hsp27 level (Pfeuty
& Gueride, 2000). Senescing fibroblasts possess higher Hsp70 as
well as lower Hsp90 and Hsp27 levels. Repeated mild heat shock
partially prevented the decrease in Hsp27 level, while making
the changes in Hsp70 and Hsp90 levels more pronounced
(Verbeke 
 
et al
 
., 2001a).
Senescing fibroblasts are defective in the induction of several
chaperones, such as Hsp70 and Hsp90 as well as the collagen-
specific Hsp47 (Liu 
 
et al
 
., 1989; Miyaishi 
 
et al
 
., 1995; Bonelli 
 
et al
 
.,
1999). The exact mechanism of the defective Hsp-activation is
not known. As with aged animals (Sõti & Csermely, 2002), a
decreased activation and binding of heat shock factor-1 (HSF-
1) to the respective DNA-element, HSE was reported in senescing
cells (Choi 
 
et al
 
., 1990). Lu 
 
et al
 
. (2000) found a decreased
trimerization of HSF-1 after hypo-osmotic shock in senescent
fibroblasts. However, Bonelli 
 
et al
 
. (1999) identified mRNA
processing right before RNA translocation from the nucleus to
the cytoplasm as the defective step of Hsp70 synthesis in senes-
cent human fibroblasts. As another mechanism, the increased
amount of damaged proteins in senescent cells may occupy
Hsp70 and Hsp90, which may cause the release of HSF-1 from
the Hsp70Hsp90HSF-1 complex (Morimoto, 1998). This would
explain both the increase in the basal levels of major chaperones
(an adaptive response) and also the defect in their further induc-
tion (a partially non-responsive state).
 
Possible therapeutic applications
 
Induction of the senescent state may be an important step in
preventing malignant transformation. However, the elimination
of senescent cells might be the ultimate goal in various forms
of cancer, since senescent cells themselves play an important
role in the initiation of malignant transformation (Wang, 1995;
Krtolica 
 
et al
 
., 2001). Low doses of Hsp90-antagonists inhibit
telomerase without affecting the growth rate of tumour cells.
Based on this finding it was postulated that inhibition of Hsp90
can provoke senescence by the inhibition of telomerase (Harvey
 
et al
 
., 2002). Hence, chaperone inhibition is a promising tool
to decrease cytoprotection and to initiate apoptosis or necrosis
of senescent cells. There are several drug candidates which
inhibit chaperone function (Table 3). All these drug candidates
may be used to induce senescence and, later, to eliminate senes-
cent cells in patients.
On the other hand, either improving the function of post-
replicative cells may be useful in several other disease states,
such as in neurodegenerative diseases (Alzheimer’s, Parkinson’s,
etc.). A class of drugs known as chaperone co-inducers have a
well-established cytoprotective role (Vígh 
 
et al
 
., 1997), and may
help to preserve the functional reserve capacity of differentiated/
senescent cells.
 
The protein homeostasis hypothesis of 
senescence
 
Senescence runs in parallel with an accumulation of damage
at the molecular–cellular level. The attenuation of molecular
chaperone inducibility and the simultaneous accumulation of
damaged proteins raises the possibility that preservation of
protein homeostasis is a major determinant in the occurrence and
duration of cellular senescence. This concept leads to our ‘protein
homeostasis hypothesis of senescence’ (Fig. 1), a key element
of which is the balance between the amount of damaged
(denatured) proteins and the available capacity of molecular
chaperones to refold/repair them. When the balance is:
 
1
 
in favour of available chaperones (compensated stress):
proliferative signals are transduced and cells may be temporarily
arrested, but finally they divide normally again;
 
2
 
in favour of denatured proteins (stress, senescence): prolifer-
ative signals stop, cells become irreversibly arrested and enter
into a prolonged senescent phase;
 
3
 
strongly in favour of denatured proteins (lethal stress):
chaperones become unavailable, stress kinases are activated and
proteasome inhibition leads to apoptosis;
 
4
 
very strongly in favour of denatured proteins (supralethal
stress): complete loss of chaperone availability, ceramide accu-
mulation and ATP depletion leads to necrosis.
Two intriguing consequences arise from the above hypothesis:
 
A
 
When denatured proteins are just slightly, but permanently
higher than the level of available chaperones (case 2, remitting
in senescent state), silent mutations may be exposed, contribut-
ing to polygenic diseases, such as atherosclerosis, diabetes, cancer,
etc. (Csermely, 2001b).
 
B
 
In agreement with the assumption of Toussaint 
 
et al
 
. (2002),
the above hypothesis raises the possibility that many forms of
cellular senescence are induced by the effects of prolonged
stress on primary cells, when transferring and maintaining them
Table 3 Drug candidates influencing molecular chaperones
 
 
Drug candidate Major effect Company and web-site References
Geldanamycin analogues Hsp90 inhibition Conforma Inc. (www.conforma.com) Neckers (2002)
Geldanamycin-testosterone Specific Hsp90 inhibition in tumours Kosan Bioscience (www.kosan.com) Harvey et al. (2002)
Radicicol Hsp90 inhibition Kyowa Hakko Kogyo Ltd. (www.kyowa.co.jp) Soga et al. (1998)
Purine-scaffold Hsp90 binders, PU3 Hsp90 inhibition Chiosis et al. (2002)
? Hsp90 inhibition RiboTargets Co. (www.ribotargets.com)
Deoxyspergualine Hsp70 inhibition Nippon Kayaku Co. (www.nipponkayaku.co.jp)
Arimoclomol, Iroxanadine Chaperone co-induction Biorex R & D Co. (www.biorex.hu) Vígh et al. (1997)
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in culture. In agreement with the above hypothesis, in certain
rodent stem cells, human astrocytes, rodent glial cells and
rodent oligodendrocyte precursor cells, the use of appropriate
culture media allows the cells to escape senescence while
remaining untransformed (Rubin, 2002). In light of the above
findings (which still have to be extended to more senescence-
prone human cells), it is an exciting question to ask whether
and how senescent cells exist in vivo. Our hypothesis would
imply that a low level of persistent environmental stress is an
important factor in inducing replicative senescence in living
organisms by exhausting their capacity for chaperone-induction.
As a general conclusion, chaperones may not only constitute
the most ancient defence mechanism of our cells, but also
behave as direct sensors of their functional competence. Various
levels of chaperone overload may make an important contribu-
tion to the signals directing the cell to senescence, apoptosis
or necrosis.
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Comparative analysis of the ATP-binding sites of Hsp90 by nucleotide
affinity cleavage: a distinct nucleotide specificity of the C-terminal
ATP-binding site
Csaba So}ti1, A´kos Vermes1, Timothy A. J. Haystead2 and Pe´ter Csermely1
1Department of Medical Chemistry, Semmelweis University School of Medicine, Budapest, Hungary;
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The 90-kDa heat shock protein (Hsp90) is a molecular
chaperone that assists both in ATP-independent sequestra-
tion of damaged proteins, and in ATP-dependent folding of
numerous targets, such as nuclear hormone receptors and
protein kinases. Recent work from our lab and others has
established the existence of a second, C-terminal nucleotide
binding site besides the well characterized N-terminal, gel-
danamycin-sensitive ATP-binding site. The cryptic C-ter-
minal site becomes open only after the occupancy of the
N-terminal site. Our present work demonstrates the appli-
cability of the oxidative nucleotide aﬃnity cleavage in the
site-speciﬁc characterization of nucleotide binding proteins.
We performed a systematic analysis of the nucleotide bind-
ing speciﬁcity of the Hsp90 nucleotide binding sites.
N-terminal binding is speciﬁc to adenosine nucleotides with
an intact adenine ring. Nicotinamide adenine dinucleotides
and diadenosine polyphosphate alarmones are speciﬁc
N-terminal nucleotides. The C-terminal binding site is much
more unspeciﬁc—it interacts with both purine and pirimi-
dine nucleotides. Eﬃcient binding to the C-terminal site
requires both charged residues and a larger hydrophobic
moiety. GTP and UTP are speciﬁc C-terminal nucleotides.
2¢,3¢-O-(2,4,6-trinitrophenyl)-nucleotides (TNP-ATP, TNP-
GTP) and pyrophosphate access the C-terminal binding site
without the need for an occupied N-terminal site. Our data
provide additional evidence for the dynamic domain–
domain interactions of Hsp90, give hints for the design of
novel types of speciﬁc Hsp90 inhibitors, and raise the
possibility that besides ATP, other small molecules might
also interact with the C-terminal nucleotide binding site
in vivo.
Keywords: alarmones; Hsp90; molecular chaperone; NAD;
nucleotide analogs.
The 90-kDa heat shock protein (Hsp90) is a cytoplasmic
chaperone that helps the folding of nuclear hormone
receptors and various protein kinases [1–4]. Hsp90 is an
ATP-binding chaperone [5,6] and ATP binding induces a
conformational change in Hsp90 [7,8]. Assembly of the
Hsp90-organized chaperone machinery, the foldosome,
with target proteins requires ATP [9,10]; moreover, ATP
binding and hydrolysis are essential for the in vivo function
of Hsp90 [11,12].
Crystallization of the N-terminal domain uncovered a
Bergerat-type ATP-binding fold [13], which can also be
occupied by geldanamycin (GA) [14] and radicicol [15,16].
These natural antitumor antibiotics abolish Hsp90-depend-
ent folding of immature client proteins, and direct them to
proteolysis [17,18].
Recent communications have reported a second ATP-
binding site in the C-terminal domain of Hsp90 [19–21]. Our
studies demonstrated that the C-terminal nucleotide binding
site becomes accessible only after the occupancy of the
N-terminal site and is sensitive to cisplatin [20].
The characterization of the nucleotide binding properties
of Hsp90 has been hindered for quite a while by the low
afﬁnity interactions of nucleotides with this protein, which
required the development of new experimental techniques
and approaches.More than a decade ago it was been shown
by us that Hsp90 has a low afﬁnity ATP/GTP-binding
site(s) and is able to autophosphorylate itself using both
nucleotides [5]. Later, David Toft and coworkers analyzed
the nucleotide speciﬁcity of full-length Hsp90 by means
of c-phosphate-linked ATP–Sepharose afﬁnity chromato-
graphy. They showed a competition with soluble ADP and
ATP, but not with GTP up to 5 mM [9]. On the contrary,
recent experiments on N-terminally truncated Hsp90
constructs suggested that GTP, indeed, may bind to the
C-terminal domain [19]. Using different ﬂuorescent ATP
analogs, including N6-etheno-ATP, Scheibel et al. [6] could
not detect a high afﬁnity ATP-binding to Hsp90. However,
they could see a weak binding to an ATP-analog spin-
labeled on the ribose hydroxyls [6]. Unfortunately, the
question, whether GA inhibited this interaction was not
addressed. Another study demonstrated that CTP and
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NAD affected the tertiary–quaternary structure of the
Hsp90 homolog of Neurospora crassa [22].
Since the available data in the literature is rather sporadic,
and previous experiments obviously could not take into
account the existence of the second ATP-binding site on
Hsp90,whichhasbeenuncovered just recently [19–21], in the
present study we undertook a systematic and comparative
analysis of the nucleotide speciﬁcity of both the N-terminal
and C-terminal Hsp90 nucleotide binding sites. In this study
we demonstrate that oxidative nucleotide afﬁnity cleavage is
a useful technique to characterize the nucleotide binding sites
of Hsp90. Using this approach we show that the N-terminal
site is fairly speciﬁc for adenine nucleotides with an intact
adenine ring. On the contrary, the C-terminal site is much
more unspeciﬁc—it binds both purine and pirimidine
nucleotides. Nicotinamide adenine dinucleotides and dia-
denosine polyphosphate alarmones are speciﬁc N-terminal
nucleotides, while GTP and UTP are speciﬁc C-terminal
nucleotides. Our data provide additional evidence for
thedynamicdomain–domain interactions ofHsp90, help the
design of more site-speciﬁc Hsp90 inhibitors, and raise the
possibility thatbesidesATPother smallmoleculesmight also
interact with the C-terminal nucleotide binding site in vivo.
Materials and methods
Chemicals
The chemicals used for PAGE, protein determination,
blotting membranes, Q2 FPLC and Econo-Pac HTP
cartridges were from Bio-Rad. Butyl-Sepharose 4B and
DEAE-Sepharose Fast Flow were from Pharmacia LKB
Biotechnology Inc. GA was from Gibco-BRL. TNP-
nucleotides and etheno-ATP were from Molecular Probes.
The ECL bioluminescence kit was from New England
Nuclear. The K3725B anti-(C-terminal Hsp90) Ig [23] was a
kind gift of T. Nemoto (Department of Oral Biochemistry,
Nagasaki University, Nagasaki, Japan), H. Iwanari and
H. Yamashita (Institute of Immunology Ltd, Tokyo,
Japan). The K41218 anti-(N-terminal Hsp90) Ig [23] was
purchased Institute of Immunology Ltd. The PA3-012 anti-
(N-terminal Hsp90) Ig was from Afﬁnity Bioreagents
(Golden, CO, USA). c-Phosphate-linked ATP–Sepharose
was prepared according to [24]. All the other chemicals used
were from Sigma Chemicals Co. Fluka AG.
Purification of Hsp90
Hsp90 was puriﬁed from rat liver using consecutive
chromatography steps on ButylSepharose 4B, DEAE–
Sepharose Fast Flow, Econo-Pac HTP and mono-Q FPLC
as described previously [25]. The purity of the ﬁnal Hsp90
preparations was >95% as judged by silver staining of
SDS polyacrylamide gels [26]. Protein concentrations were
determined according to Bradford [27].
Oxidative nucleotide affinity cleavage
Afﬁnity cleavage was performed as described byAlonso and
Rubio [28], according to the details given in So}ti et al. [20].
Brieﬂy, 2 lg puriﬁed rat liverHsp90was preincubated in the
absence or presence of 36 mM GA for 1 h on ice in 20 mM
Hepes, 50 mM KCl pH 7.4. Different nucleotides or ana-
logs were added at a ﬁnal concentration of 1 mM, if not
otherwise indicated, and after an additional incubation of
15 min at 37 C afﬁnity cleavage was induced by the addi-
tion of 0.5 mM FeCl3 and 30 mM ascorbate and completed
by an additional incubation of 30 min at 37 C. Hsp90
fragmentation was assessed by sequential immunoblotting
with anti-(C-terminal) and anti-(N-terminal) Igs.
Quantification of nucleotide binding
Quantitative determinations were performed as described
earlier [20]. Blots were analyzed by densitometry of the most
prominent fragments. The N-terminally cleaved 70-kDa
fragment (C70) was taken as a representative of N-terminal
nucleotide binding, the C-terminally cleaved 46-kDa frag-
ment (N46) represented the C-terminal nucleotide binding,
respectively.
ATP–Sepharose binding
Between 3 and 5 lg rat Hsp90 was preincubated on ice for
1 h in 200 lL of a buffer consisting of 20 mMHepes, 50 mM
KCl, 6 mMMgCl2, 0.01%NP40 pH 7.5. In the case ofATP
competition, samples contained an ATP regeneration
system (10 mM creatine phosphate and 20 UÆmL)1 creatine
kinase). Finally, 25 lL ATP–Sepharose was added and
tubes were incubated at 37 C for 30 min with frequent
agitation, then the resin was pelleted, washed three or four
times with the above buffer and analyzed by SDS/PAGE.
Results
c-Phosphate-linked ATP–Sepharose binds Hsp90
via both its N- and C-terminal ATP-binding sites
In our previous experiments, we analyzed the N-, and
C-terminal nucleotide binding sites of Hsp90 using two
independent techniques. The oxidative nucleotide afﬁnity
cleavage was successfully applied to Hsp90 in our previous
work [20]. c-Phosphate-linked ATP–Sepharose binding has
been used as the ﬁrst biochemical assay for the unambig-
uous identiﬁcation of Hsp90 as an ATP-binding protein by
Grenert et al. [9]. Though C-terminal fragments of Hsp90
also bound to the resin [19], and we demonstrated that
Hsp90 was able to bind in the presence of a saturating
concentration of the N-terminal inhibitor, GA [20], others
could not detect binding under these circumstances [29]. We
were intrigued by this apparent contradiction, and made an
additional attempt to resolve the discrepancy.
Using the afﬁnity cleavage the hydroxyl radicals gener-
ated by the oxidation of iron tethered to the polyphosphate
moiety of ATP resulted in two major cleavage products
in Hsp90: a 70-kDa major Hsp90 fragment (C70) at the
N-terminal binding site, and a 46-kDa major fragment
(N46) at the C-terminal Hsp90 nucleotide binding site ([20]
and Fig. 1A, lane 3). The C-terminal site became accessible
only if theN-terminal site was occupied and not cleaved—in
our case with the N-terminal speciﬁc inhibitor GA (Fig. 1A,
lane 4) [13,19]. Performing the cleavage reaction on Hsp90
bound to the c-phosphate-linked ATP–Sepharose resin
showed that Hsp90 is bound to the ATP–Sepharose
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through both nucleotide binding domains (lane 5; C70 and
N46), and in the presence of GA, only the C-terminal site is
cleaved (lane 6; N46). Unbound Hsp90 in the supernatant
did not undergo any ATP-dependent cleavage (data not
shown). Fig. 1A also shows that the fragments character-
istic of the c-phosphate (C73 and N39-42) appear neither at
the N- nor the C-terminal site, respectively. Instead, the 39-
kDa fragment present at the C-terminal site is produced by
the diphosphate moiety of ADP [20]. The reason for this
may be that the ATP-bound resin may impose a steric
hindrance to the binding of the terminal phosphate,
therefore Hsp90 adopts an ADP-conformation [20] on
the resin. This may explain how the C-terminal binding site
could escape attention, where the afﬁnity towards ATP is
higher than to ADP [19,20].
Independent evidence for the involvement of both
ATP-binding sites in Hsp90/ATP–Sepharose interactions
comes from the application of different Hsp90 inhibitors
(Fig. 1B). While binding of Hsp90 was not prevented by
the N-terminal-speciﬁc GA (lane 3) or radicicol (data not
shown), novobiocin inhibited binding completely (lanes 5
and 6). This experiment gave further evidence that Hsp90 is
also bound to the ATP–Sepharose via its C-terminal
nucleotide binding site, and conﬁrmed our previous obser-
vation that novobiocin, which binds to the C terminus of
Hsp90 [19] allosterically inhibits the N-terminal binding site
[20]. It has tobenoted, thatusing several lotsof commercially
available ATP–Sepharose the C-terminal binding was not
always detected, especially when the assay was conducted
under more stringent conditions (e.g. three washes, data not
shown).
Comparative analysis of the nucleotide specificity
of Hsp90 nucleotide binding sites
After demonstrating that these techniques may be used to
study the biochemistry of the nucleotide binding domains,
we performed a comparative analysis of the nucleotide
speciﬁcity of Hsp90 nucleotide binding sites. Fig. 2A shows
that the N-terminal nucleotide binding site prefers adenine
nucleotides (ATP and dATP). Binding of CTP was slightly
permitted, while GTP and UTP did not bind to this site.
We observed no signiﬁcant binding of dGTP and dUTP, or
UDP-glucose to the N-terminal binding site (data not
shown). The C-terminal domain allowed binding of all
kinds of nucleotides tested. We would like to note that the
anti-(C-terminal) Ig K3725B, and the anti-(N-terminal) Ig
PA3-012 used in most of our experiments were both
Hsp90b-speciﬁc antibodies. However, analysis of silver
stained gels, as well as the repetition of few selected
experiments with the K41218 anti-(N-terminal) Ig, which
recognizes both Hsp90 isoforms, revealed no signiﬁcant
differences between the nucleotide-binding speciﬁcities of
Hsp90a and Hsp90b (data not shown).
As an additional proof, we analyzed the competition of
these nucleotides with ATP–Sepharose binding, in the
absence (N- and C-terminal binding), and in the presence
(only C-terminal binding) of GA. Fig. 2B shows that these
experiments yielded similar results. ATP andCTP competed
with both sites, while GTP and UTP exhibited a C-terminal
preference (Fig. 2B). These experiments provided evidence
for the applicability of the nucleotide afﬁnity cleavage
technique to study the speciﬁcity of the nucleotide binding
sites. Since GTP is a C-terminal-speciﬁc nucleotide, we
further analyzed the properties of Hsp90 nucleotide binding
sites using afﬁnity cleavage with different ATP- and GTP-
derivatives.
Interactions of nonhydrolyzable nucleotides with Hsp90
In agreement with the speciﬁcity proﬁle of the pre-
vious experiments, the N-terminal domain bound the
Fig. 1. c-Phosphate-linked ATP–Sepharose binds Hsp90 via both its
N- and C-terminal ATP-binding sites. (A) Aﬃnity cleavage on c-phos-
phate-linked ATP–Sepharose. Ctr, Untreated protein; ox, protein
incubated with redox system. In lanes 5 and 6 (ATPS), 25 lL c-phos-
phate-linkedATP–Sepharose was added instead of ATP. C70 andN46
denote the major N- and C-terminal ADP/ATP-fragments, respect-
ively. Similarly, C73 and N39-42 indicate the major N- and C-terminal
ATP fragments, respectively. (B) Novobiocin inhibits c-phosphate-
linkedATP–Sepharosebinding.Hsp90waspreincubated in the absence
or presence of 36 lM geldanamycin (GA) and/or 10 mM novobiocin
(NB). (C) Diﬀerent c-phosphate-linked ATP-Sepharose resins interact
diﬀerently with the C-terminal nucleotide binding domain of Hsp90.
Binding of Hsp90 to the commercially available and ‘lab-made’ ATP-
Sepharose resins was analyzed as described in Materials andMethods.
Figures are representatives of three independent experiments.
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poorly hydrolyzable ATP analog, adenosine 5¢-[c-thio]-
triphosphate (ATPcS), and the unhydrolyzable
adenyl-5¢-yl-imidodiphosphate (AMP-PNP), but not
guanyl-5¢-yl-imidodiphosphate (GMP-PNP, Fig. 3). Bind-
ing of both ATPcS and AMP-PNP could be prevented by
GA. Binding of these nucleotides to Hsp90 is in agreement
with several previous reports (reviewed in [3]). ATPcS
usually contains enough ADP to saturate the N-terminal
nucleotide binding site, which has a 10- to 20-fold lower
afﬁnity to ATP than to ADP [9,13]. ATPcS produced an
N-terminal fragmentation resembling that of ADP (see the
absence of the C73 c-phosphate binding fragment in lane 5)
[20], but the application of an ATP regeneration system
restored the usual ATP cleavage pattern (data not shown).
The C-terminal domain bound each nonhydrolyzable
nucleotides tested. GMP-PNP produced a strong fragmen-
tation at the C-terminal domain, seen in blots developed
with either anti-(N-terminal) or anti-(C-terminal) Ig (Fig. 3
and data not shown). Interestingly, GMP-PNP could
interact with the middle-C-terminal domain in the absence
of GA (Fig. 3).
Differently substituted nucleotide analogs bind better to
the C-terminal than to the N-terminal domain of Hsp90
It has been reported that Hsp90 cannot bind strongly to
adenine-modiﬁed nucleotide analogs, but interacts with
ribose-modiﬁed ATP with an afﬁnity comparable to that of
unmodiﬁed ATP [6]. Therefore we studied the interaction of
differently substituted nucleotides with Hsp90. N6-etheno-
ATP, and the 2¢,3¢-trinitrophenyl ATP derivative, TNP-
ATP displayed a much weaker binding to the Hsp90 N
terminus than ATP (Fig. 4). GA competed with the
N-terminal binding of both nucleotides. In agreement with
no binding of GTP and GMP-PNP to the N terminus
(Figs 2 and 3) N-terminal binding of TNP-GTP was not
detected (Fig. 4). The C-terminal domain bound each of
these nucleotide analogs. TNP-nucleotide binding was
possible without GA, though the characteristic N46 band
was stronger in the presence of GA. Similarly toGNP-PNP,
TNP-nucleotides produced stronger fragmentation at the
C-terminal domain, seen in blots developed with either
anti-N- or anti-C-terminal Igs (Fig. 4 and data not shown).
Fig. 3. Interactions of nonhydrolyzable nucleotides with Hsp90. Hsp90
was preincubated in the absence or presence of 36 lM GA, aﬃnity-
cleaved using 2 mM ATP, 1 mM ATPcS, adenyl-5¢-yl-imidodiphos-
phate (AMP-PNP) or guanyl-5¢-yl-imidodiphosphate (GMP-PNP)
and cleavage products were assessed. Western blots are representative
of three independent experiments.
Fig. 4. Diﬀerently substituted nucleotide analogs bind better to the
C-terminal than to the N-terminal domain of Hsp90. After a pre-
incubation in the absence or presence of 36 mM GA, Hsp90 was
aﬃnity-cleaved using 1 mM of ATP,N6-etheno-ATP (e-ATP), 2¢,3¢-O-
(2,4,6-trinitrophenyl)-ATP or 2¢,3¢-O-(2,4,6-trinitrophenyl)-GTP
(TNP-ATP and TNP-GTP, respectively) and cleavage products were
analyzed. Western blots are representative of three independent
experiments.
Fig. 2. The Hsp90 N- and C-terminal nucleotide-binding sites display
divergent nucleotide speciﬁcities. (A) Aﬃnity cleavage assay. Hsp90 was
aﬃnity-cleaved in the presence of various nucleotides at a concentra-
tion of 1 mM. Nucleotide binding was determined in the absence
(N-terminal) or in the presence (C-terminal) of 36 lM GA. Blots were
analyzed by densitometry of the N-terminally cleaved 70-kDa (C70) or
the C-terminally cleaved 46-kDa (N46) major fragments for N- and
C-terminal nucleotide binding, respectively. Data were normalized to
the cleavage-eﬃciency of ATP and GA + ATP in N- and C-terminal
nucleotide binding, respectively, and are the means of two independent
experiments. (B) ATP–Sepharose competition. Hsp90 was preincu-
bated with 20 mM nucleotides as indicated, then ATP–Sepharose
binding was tested. Note that the ATP–Sepharose has a ligand density
of 10–15 lmolÆmL)1. The ﬁgure represents one of two experiments
with similar results.
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Binding of TNP-nucleotides was also conﬁrmed by ﬂuor-
escence measurements, but the small increase in quantum
yield made detailed analysis impossible (data not shown).
Nicotinamide-adenine dinucleotides bind to the
N-terminal, but not to the C-terminal domain of Hsp90
After an earlier prediction of Callebaut et al. [30] Garnier
et al. [21] also proposed the C-terminal ATP binding site to
be a Rossmann fold. Following these suggestions we
became interested to measure if nicotinamide adenine
dinucleotides bind to Hsp90. Here we could utilize the
diphosphate structure as a good chelator of Fe2+ ions
allowing an oxidative cleavage reaction similar to that with
nucleoside triphosphates or nucleoside diphosphates. To
our surprise, it was the N-terminal domain of Hsp90, which
bound both NAD+ and NADH + H+. GA competed
with both nucleotides efﬁciently (Fig. 5). Similar to our
results with the ribose-substituted nucleotide analog, TNP-
ATP, the esteriﬁcation of ribose-2¢-OH both in NADP+
and NADPH strongly inhibited their binding (Fig. 5). On
the contrary, none of the nicotinamide adenine dinucleo-
tides displayed a signiﬁcant interaction with the C-terminal
nucleotide binding site. ATP + GA, as a positive control,
induced the appearance of the N46 in the presence of all
nucleotides (Fig. 5).
Binding of alarmones to Hsp90
Diadenosine polyphosphates and diguanosine polyphos-
phates serve as alarmones both in prokaryotic and eukary-
otic organisms [31]. Moreover, their interaction with the
Hsp70 homologue molecular chaperone, DnaK, has been
shown [32,33]. We were interested whether these alarmones
bind to Hsp90. Fig. 6 shows that indeed, all of the
diadenosine polyphosphates bound to the N-terminal site
of Hsp90 at 1 mM, and binding could be inhibited by GA.
However, none of the diadenosine polyphosphates tested
displayed a signiﬁcant binding to the C-terminal site of
Hsp90, and they did not bind to theN-terminal site at a ﬁnal
concentration of 2 lM. Half-maximal binding of diadeno-
sine polyphosphate (AP4A) to the N-terminal domain
occurred above 200 lM (which is the highest physiological
concentration; Fig. 6 and data not shown). Interestingly,
alarmones induced a stronger cleavage than ATP (Fig. 6),
which is not due to their higher binding efﬁciency to Hsp90
as the characteristic alarmone cleavage pattern could be
diminished (i.e. competed) by the addition of equimolar
ATP (compare the second vs. the last two lanes of Fig. 6).
The results show that the cleavage efﬁciency of the
b-phosphate-linked Fe2+ is weaker with ATP than with
ADP and ADP-like compounds such as alarmones. ATP
may induce a different conformation ofHsp90 thanADPor
alarmones, probably because Hsp90 should adopt a
thermodynamically less favored conformation to capture
the ATP-c-phosphate. Diguanosine polyphosphate (GP4G)
displayed a very weak binding, which was exclusive to the
C terminal domain (data not shown). Based on our data
Hsp90 does not seem to be a speciﬁc alarmone-binding
protein in vitro.
Binding of noniron-chelating nucleotide analogs
and pyrophosphate to Hsp90
Wewere interested whether a common structural element of
the many nucleotide polyphosphates tested, pyrophosphate,
is able to induce a speciﬁc cleavage pattern of Hsp90 in our
oxidative cleavage assay. Indeed, pyrophosphate bound
weakly to the N- and much stronger to the C-terminal
Fig. 6. Binding of diadenosine polyphosphates to Hsp90. After a
preincubation in the absence or presence of 36 lM GA, or 1 mM
diadenosine polyphosphates as indicated, Hsp90 was aﬃnity-cleaved
in the presence of ATP, ADP or diadenosine polyphosphates at a ﬁnal
concentration of 1 mM. Western blots are representative of three
independent experiments.
Fig. 7. Binding of noniron-chelating nucleotide analogs and pyrophos-
phate to Hsp90. After a preincubation in the absence or presence
of 36 lM GA, Hsp90 was aﬃnity-cleaved in the presence of 1 mM
ATP, and/or 0.1 mM o-methylﬂuorescein-phosphate (OMFP), 1 mM
sodium-pyrophosphate (PPi) and 1 mM ﬂuorosulfonyl-benzoyl-
adenosine (FSBA), as indicated. Western blots are representative of
two independent experiments.
Fig. 5. Nicotinamide adenine dinucleotides bind to the N-terminal, but
not to the C-terminal domain of Hsp90. After a preincubation in the
absence or presence of 36 lM GA, Hsp90 was aﬃnity-cleaved in the
presence of ATP, and/or diﬀerent nicotinamide adenine dinucleotides
at ﬁnal concentrations of 1 mM, as indicated. Western blots are rep-
resentative of two independent experiments.
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domains in the absence of GA (Fig. 7). Binding to the
N-terminal domain was inhibited by GA. Pyrophosphate
cleavage was much less speciﬁc than that of the nucleotides,
since pyrophosphate induced a strong, GA-independent
fragmentation of both the C-terminal and the middle
domain of Hsp90 (Fig. 7 and data not shown). ATP
inhibited the pyrophosphate-induced C-terminal cleavage
(Fig. 7).
o-Methylﬂuorescein phosphate (OMFP) was a good
substrate of the Hsp90-associated ATPase in our previous
experiments and competed well with ATP in the regular
assays of the Hsp90-associated ATPase [34]. Fluorosulfo-
nyl-benzoyl-adenosine (FSBA) has been used to label and
identify ATP-binding sites [35,36] and also weakly labeled
Hsp90 (data not shown). Therefore we wanted to know if
the hydrolyzable ATP-analog OMFP as well as FSBA
[35,36], interact with the oxidative afﬁnity cleavage assay
despite the fact that they do not efﬁciently chelate iron.
Nevertheless, in our experiments they displayed a weak
binding to the N-terminal domain (Fig. 7). Neither OMFP,
nor FSBA could compete with ATP at their maximal
concentration of 0.1 and 1 mM, respectively. However, they
opened the C-terminal nucleotide-binding domain in the
absence of GA, and induced ATP-binding and the appear-
ance of the speciﬁc N46 fragment (Fig. 7). Fluorescein
isothiocyanate behaved similarly toOMFP andFSBA (data
not shown).
Discussion
Nucleotide affinity cleavage as a tool to characterize
the specificity of nucleotide binding domains
Using the well characterized N-terminal nucleotide binding
site and theATP–Sepharose assaywe could demonstrate for
the ﬁrst time that nucleotide afﬁnity cleavage is a useful
technique to study the biochemical properties of nucleotide
binding domains. It may be especially important in case of:
(a) multiple nucleotide binding sites, because they can be
distinguished; (b) low afﬁnity interactions; and (c) stringent
site structure, where, e.g. ﬂuorophore or other substitution
is not well tolerated. Though it has not yet been shown, the
Fe(II)–ATP complex may display a different binding
afﬁnity, or even the orientation (therefore the cleavage) of
the iron-polyphosphate moiety might differ form that of the
biologically predominant magnesium–ATP. Furthermore,
the susceptibility of neighboring peptide bonds may differ
from protein to protein, resulting in different cleavage
efﬁciency. Further studies are needed to investigate the
general applicability of this technique in nucleotide-binding
proteins.
Nucleotide binding to the N-terminal domain of Hsp90
The N-terminal nucleotide binding site of Hsp90 is fairly
speciﬁc. It binds ATP and 2¢-deoxy-ATP with similar
efﬁciency (Fig. 8). On the contrary, it does not show a
signiﬁcant interaction with GTP, pirimidine nucleotides,
and nucleotides in which the ribose-2¢-OH position has been
substituted (TNP, ribose-attached resin; phosphate in
NADP). The integrity of the adenine ring is also important
for binding, since Hsp90 does not bind to C8-linked ATP-
resins under stringent conditions ([6,13]; Cs. S}oti and
P. Csermely, unpublished observations), and a substitution
at the 6-adenine position (e.g. etheno-ATP) disrupts binding
as well.
The Hsp90 N-terminal nucleotide binding site binds
NAD and adenosine polyphosphate alarmones. It is worth
noting thatNADbinding ofHsp90may interfere with some
ATPase measurements based on coupled assays at lowATP
concentrations [12]. However, Hsp90 does not show a
NADPH : quinone oxidoreductase activity [37], and its
alarmone binding efﬁciency is fairly low. Alarmone binding
gives another evidence that the c-phosphate should point
out of the nucleotide binding cleft, and the bulky second
adenine should protrude far from the domain reinfor-
cing the notions made by the c-phosphate-linked ATP–
Sepharose [9,20].
Nucleotide binding to the C-terminal domain of Hsp90
Nucleotide binding to the C-terminal nucleotide binding
site is fairly unspeciﬁc. This site binds both purine and
pirimidine nucleotides, when the N-terminal site is already
occupied (Fig. 8). UTP and GTP are C-terminal-speciﬁc
nucleotides. Based on the demonstration that autophos-
phorylation ofHsp90 is insensitive to high concentrations of
GA, but inhibited by novobiocin, a recent report [38]
suggested that the C-terminal ATP-binding site may be
responsible for Hsp90 autophosphorylation. In light of
these data our earlier ﬁnding that Hsp90 autophosphory-
lation can be achieved by GTP [5] gives an additional
support for the C-terminal speciﬁcity of GTP.
Our experiments showed that the C-terminal site also
interacts with ribose-modiﬁed nucleotides with afﬁnities
comparable to unsubstituted ATP, which may shed new
light on earlier ﬁndings [6]. The C-terminal site (unlike the
N-terminal site) does not interact with nicotinamide adenine
dinucleotides and alarmones. This is in contrast with the
predictions of Garnier et al. [21], who proposed the C
terminus as a NAD-binding site.
Fig. 8. Nucleotide speciﬁcity of the N- and C-terminal nucleotide bind-
ing sites of Hsp90.N-terminal domain (N) requires adenine nucleotides
with an intact adenine ring; the stick model is the structure of the
kinked ADP in the Hsp90 crystal, the phosphates pointing out of the
domain; R stands for phosphates (ATP) or other moieties as in NAD
or adenosine alarmones. c-Phosphate is anchored in the middle
domain (black). C-terminal domain (C) needs a larger hydrophobic
moiety (labeled by the aromatic ring) connected to charged residues
(phosphates, like pyrophosphate; labeled by negative charges). The
large hydrophobic domain allows the binding of a variety of purine
and pirimidine nucleotides. The charged residues bind to a region close
to the N-terminal c-phosphate binding motif.
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Binding to the C-terminal site demands both charged
groups and a large, hydrophobic moiety (e.g. ATP can
inhibit pyrophosphate binding). The negligible alarmone
binding suggests that the C-terminal site is more restricted
with respect to the phosphate positioning, since another
nucleoside weakens the afﬁnity. On the other hand, our
previous assumptions [20] indicated that the c-phosphate
binding site is beyond the C-terminal domain. It is still an
interesting open question how much the C-terminal nuc-
leotide binding site overlaps with the C-terminal dimeri-
zation domain and with the C-terminal binding sites for
substrates and for Hsp90-interacting cochaperones.
As an important ﬁnding of our present studies, some
nucleotide analogs, such as TNP-nucleotides and pyro-
phosphate bind to the C-terminal nucleotide binding site
without the requirement for previous occupancy of the
N-terminal site. The structural means by which these
nucleotide analogs release the N-terminal site-mediated
block of C-terminal binding need to be clariﬁed in further
experiments.
As another interesting outcome, experiments shown in
Fig. 7 provide additional evidence for the domain–domain
interactions of Hsp90: N-terminal ATP-binding and clea-
vage inhibit pyrophosphate-dependent cleavage of the
C-terminal domain (Fig. 7, lane 10 bottom panel). On the
other hand, noniron binding N-terminal ATP agonists
unlock the C-terminal domain and permit ATP binding and
fragmentation (Fig. 7, lanes 6 and 14, bottom panel).
In conclusion, the present studies provide the ﬁrst
systematic and detailed characterization of the nucleotide
binding speciﬁcity of the N- and C-terminal nucleotide
binding sites of the 90-kDa molecular chaperone, Hsp90.
Our data also provide additional evidence for the domain–
domain interactions of Hsp90 and help the design of new
Hsp90 inhibitors, which would be highly useful both in
uncovering the physiological function and mechanism of
Hsp90 action and also in clinical practice.
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Abstract
Many molecular chaperones are also known as heat shock proteins because they are synthesised in increased amounts after brief exposure
of cells to elevated temperatures. They have many cellular functions and are involved in the folding of nascent proteins, the re-folding of
denatured proteins, the prevention of protein aggregation, and assisting the targeting of proteins for degradation by the proteasome and
lysosomes. They also have a role in apoptosis and are involved in modulating signals for immune and inflammatory responses. Stress-induced
transcription of heat shock proteins requires the activation of heat shock factor (HSF). Under normal conditions, HSF is bound to heat shock
proteins resulting in feedback repression. During stress, cellular proteins undergo denaturation and sequester heat shock proteins bound to
HSF, which is then able to become transcriptionally active.
The induction of heat shock proteins is impaired with age and there is also a decline in chaperone function. Aberrant/damaged proteins
accumulate with age and are implicated in several important age-related conditions (e.g. Alzheimer’s disease, Parkinson’s disease, and
cataract). Therefore, the balance between damaged proteins and available free chaperones may be greatly disturbed during ageing. We have
developed a mathematical model to describe the heat shock system. The aim of the model is two-fold: to explore the heat shock system and its
implications in ageing; and to demonstrate how to build a model of a biological system using our simulation system (biology of ageing e-
science integration and simulation (BASIS)).
# 2004 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Many chaperones are also known as heat shock proteins
(Hsps), because they are synthesised in increased amounts
after brief exposure of cells to an elevated temperature.
However, they are present in cells at all times and are
upregulated by a variety of other stresses such as irradiation,
hyperoxia, viral infection and oxidative stress. They range in
molecular mass from !15 to 110 kDa and are divided into
groups based on both size and function, and include Hsp100,
Hsp90, Hsp70, Hsp60, Hsp40 and the small HSPs (Kregel,
2002). They are present in the cytosol, mitochondria, ER and
nucleus with different family members functioning in
different organelles. They have an affinity for the exposed
hydrophobic patches on incompletely folded proteins and
hydrolyse ATP, often binding and releasing their protein
with each cycle of ATP hydrolysis.
Chaperones have many cellular functions. They are
involved in the folding of nascent proteins, the refolding of
denatured proteins, the prevention of protein aggregation,
assisting the targeting of proteins for degradation by the
proteasome and lysosomes, have a role in apoptosis, and are
involved in modulating signals for immune and inflamma-
tory responses.
Many newly synthesized proteins need assistance from
chaperones in order to fold correctly. 10–20% of new
proteins associate with chaperones (Wickner et al., 1999).
For example, the Hsp70 machinery acts early in the life of
many proteins, binding to a string of about seven
www.elsevier.com/locate/mechagedev
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hydrophobic amino acids before the protein leaves the
ribosome. Once a protein has been correctly folded, it can
later become misfolded as a result of a variety of stresses.
Misfolded proteins have exposed hydrophobic surfaces
which will clump together and then precipitate out of
solution. Chaperones play a role in dissolving protein
aggregates and precipitates (Glover and Lindquist, 1998).
They can also prevent aggregation of misfolded proteins
from taking place by binding to the hydrophobic surface and
then assisting in protein refolding. Hsp60-like proteins form
a large barrel-shaped structure into which misfolded proteins
are fed, preventing their aggregation and providing them
with a favourable environment in which to attempt to refold.
If a denatured protein cannot be refolded, then chaper-
ones assist in its degradation. Chaperones and proteolytic
systems are often co-ordinately regulated (Mathew and
Morimoto, 1998). The ubiquitin–proteasome machinery is
the major route of removal of proteins. Ubiquitination is
mediated by a cascade of enzyme activities. Ubiquitin
is expressed constitutively in all cells and expression is
upregulated upon exposure to stress. The fate of proteins that
accumulate during exposure of cells to stress is dependent on
the interplay of chaperones and the ubiquitin–proteasome
system.
Chaperones generally inhibit apoptosis (Samali and
Orrenius, 1998). Hsp27, Hsp70 and Hsp90 are predomi-
nantly anti-apoptotic. For example Hsp70 and many other
Hsps can overcome both caspase-dependent and caspase-
independent apoptotic stimuli (Nylandsted et al., 2000;
Verbeke et al., 2001). On the other hand, there are examples
of positive involvement of Hsps in apoptotic signalling
(Punyiczki and Fesus, 1998).
The ‘‘protein homeostasis hypothesis of senescence’’ is
based on the balance between the amount of damaged
(denatured) proteins and the available capacity of molecular
chaperones to refold/repair them (So˝ti et al., 2003).
When the balance is
1. In favour of available chaperones (compensated stress):
cells may be arrested temporarily but divide normally
again after repair/refolding takes place.
2. In favour of damaged proteins (stress, senescence): cells
become irreversibly arrested. Strongly in favour of
damaged proteins (lethal stress): proteasome inhibition
leads to apoptosis.
3. Very strongly in favour of damaged proteins (supralethal
stress): complete loss of chaperone availability, ATP
depletion leads to necrosis (See Fig. 1 of So˝ti et al.,
2003.)
The level of chaperones in the cell increases after con-
ditions of stress. Stress-induced transcription requires act-
ivation of heat shock factor (HSF) that binds to the heat
shock promoter element (HSE) (Morimoto, 1998). There are
four known HSFs but only HSF1 is found in vertebrates.
Under normal growth conditions, HSF1 activity is repressed
and exists either in the cytosol or nucleus in an inert mo-
nomeric state. HSF1 is maintained as a non-DNA-binding
inactive complex both by internal coiled-coil interactions
and by stoichiometric binding with Hsp90, Hsp70 and other
chaperones. The synergistic interaction between these ch-
aperones modulates HSF1 activity by feedback repression.
During and after stress, the cellular proteins undergo den-
aturation and/or polyubiquitination and sequester the cha-
perones bound to HSF1. The inactive HSF1 becomes free
and translocates into the nucleus if it was previously in the
cytosol (Verbeke et al., 2001). Activation of HSF1 is acc-
ompanied by the transition from an inert monomeric state to
a transcriptionally active trimer. The active trimers bind to
the DNA heat shock element (HSE) and stimulate tran-
scription of heat shock proteins.
In this paper we describe a model of the heat shock
system and the interaction of molecular chaperones with
denatured proteins. The model is then used to explore the
cellular conditions under which protein homeostasis can be
maintained and the conditions that lead to protein
aggregation. This model is one of a number of sub-models
which are currently being developed for the virtual ageing
cell as part of the biology of ageing e-science integration and
simulation (BASIS) system (Kirkwood et al., 2003). Further
details can be found on our web-site (www.basis.ncl.ac.uk),
where this model is available for users to run their own
simulations and to change parameter values.
2. Molecular chaperones and ageing
There is an accumulation of damaged and denatured
proteins with age, especially in post-mitotic cells such as
neurons. In neurons, damaged protein may aggregate and
become resistant to degradation causing neurodegeneration.
Neuronal chaperones have been found to be localised in
neuronal plaques and fibrillary tangles and it has been
suggested that they were probably involved in an attempt to
sequester the b-amyloid and other damaged proteins (So˝ti
and Csermely, 2000; So˝ti and Csermely, 2003).
Chaperones have many exposed binding surfaces and so
are themselves very susceptible to oxidative damage which
may result in their functional decline. This is especially true
of long-lived chaperones such as crystalline. Although levels
of chaperones within cells do not decline with age, it has
been shown that the induction of heat shock protein after
stress is decreased in aged animals (So˝ti and Csermely,
2003). The level of HSF1 does not change with age but a
decrease in the activation and binding of its DNA binding
site has been observed in aged animals (Heydari et al.,
2000). However, levels of Hsp90 may also increase with age
which would suppress the activation of HSF1. There is also a
decline in proteasome activity with age which results in a
further increase in the amount of damaged proteins within
cells. The decline in Hsp induction and the increase in
denatured protein, including damage to chaperones, all
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contribute to the overall decline in chaperone capacity with
age. According to the hypothesis of So˝ti et al. (2003) this
will lead to an increase in cellular senescence, apoptosis
or necrosis, depending on the degree of damage and the
balance between damaged protein and available free func-
tional chaperones.
3. Elements of the model
We have developed a model of protein turnover and the
role of Hsp90 in guarding protein homeostasis. The main
components of the model are described below.
3.1. Hsp90 and heat shock factor-1 (HSF1)
Hsp90 is a 90 kDa molecular chaperone and is one of the
most abundant cytosolic proteins in eukaryotes, constituting
about 1–2% of total protein (Jakob and Buchner, 1994).
Hsp90 is a phosphorylated dimer containing 2–3 covalently
bound phosphates per monomer. It forms multichaperone
complexes that bind to so-called client proteins such as
steroid receptors and protein kinases, under nonstress
conditions. Clients are inherently unstable multidomain
proteins with hydrophobic interaction surfaces. In these
interactions, Hsp90 stabilises the clients in a partially folded,
functional state in an ATP-dependent active process, to
prevent their collapse and degradation. Hsp90 also interacts
with actin and tubulin, constituents of the cytoskeleton,
and stabilizes the integrity of the cellular network (Sreedhar
et al., 2003). However, during stress, it works in an
ATP-independent passive mode sequestering damaged
proteins for future refolding or proteasome-mediated
degradation.
Hsp90 is not able to refold denatured proteins by itself but
requires other chaperones to complete the task, in particular
Hsp70 (Csermely et al., 1998). In our current model, we
assume that there is always sufficient Hsp70 in the cell for
refolding to take place and do not include Hsp70 as a
separate element. The reason for this assumption is to keep
the model as simple as possible, but we have built the model
in such a way that it will be relatively straightforward to add
Hsp70 (and other chaperones) to the model at a future date.
Although the cellular concentration of Hsp90 is high, most
of this protein is bound to other proteins or complexes and so
there is a need for an increase in Hsp90 levels when there is a
rise in denatured proteins in the cell. Denatured proteins
sequester Hsp90 that is bound to heat shock factor-1 (HSF1)
and so in our model we will only consider the Hsp90–HSF1
complex as a source of Hsp90 for denatured proteins and
ignore all other complexes containing Hsp90. Even under
normal cellular conditions, a small proportion of protein
becomes denatured and is constantly being reformed with
the aid of chaperones. Sowe assume that there is enough free
Hsp90 within the cell to form complexes with this low level
of denatured protein.
Heat shock factor-1 (HSF1) contains a DNA-binding
motif in the amino terminus and adjacent hydrophobic
heptad repeats which mediates subunit trimerisation.
Hsp90 forms complexes with HSF1 in unstressed cells
(Nadeau et al., 1993). During stress, e.g. elevated
temperatures, the level of denatured proteins rises and
then competes for Hsp90, causing Hsp90 to dissociate from
HSF1. HSF1 then forms trimers, a reaction which is
favoured at increased temperature (Zou et al., 1998) and
becomes transcriptionally active. Trimerisation is a
reversible reaction in vivo but not in vitro (Zou et al.,
1998). Trimers bind to DNA at the HSE which results in
the transcription of heat shock proteins. For example,
at elevated temperatures, the concentration of Hsp90
increases several folds. These findings suggest that Hsp90
is a repressor of HSF1 activation under normal conditions
(Zou et al., 1998).
3.2. Protein
Proteins are continually being turned over in a cell:
degraded if they are damaged or when no longer needed by
the cell; and newly synthesized as required. Newly
synthesized proteins have to fold into their correct three-
dimensional conformation. Many proteins are able to fold
without any assistance but about 10–20% of newly-
synthesized proteins are found to be associated with
chaperones.
The protein that we initially chose for our model
was citrate synthase (CS), an enzyme composed of two
identical 48 kDa subunits, which catalyses the reaction of
oxaloacetic acid and acetyl-CoA to form citric acid
and CoA. It is a fairly stable protein having a half-life of
about 6–7 days in skeletal muscle (Booth and Holloszy,
1977). It is inactivated and aggregates rapidly upon
incubation at 43 8C (Jakob et al., 1995). Jakob et al.
(1995) showed that Hsp90 binds transiently to unfolding
intermediates of thermal unfolding CS and that these
intermediates are able to rapidly refold to their native state
upon release from Hsp90.
We chose a protein which is fairly stable, but we can also
use our model to examine how protein stability affects
protein homeostasis. If we know the half-life of the protein
then we can adjust the parameters that affect protein
turnover. This will be further explained in the next section.
3.3. Reactive oxygen species
Reactive oxygen species (ROS) are produced by
mitochondria as a by-product of normal metabolism. Levels
of ROS within the cell are normally kept at low levels by the
action of antioxidants. However, if a cell is stressed the
levels of ROS can increase considerably. There is also a
gradual increase in ROS levels during ageing. For example,
the number of damaged mitochondria may increase with age
and so more ROS are produced, or there may be a decrease in
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the efficiency of anti-oxidant systems. High levels of ROS
cause damage to DNA, protein and lipids. In particular, there
may be an increase in protein misfolding.
3.4. ATP
Hsp90 has an ATP/ADP binding site in its N terminal
domain. The passive, stress-induced chaperone activity of
Hsp90 does not require ATP. The stabilisation of client
proteins by Hsp90 is ATP-dependent but we do not include
this process in our model. The process of refolding damaged
proteins requires ATP (in fact, it is Hsp70 which uses ATP
for the refolding of damaged proteins but for simplicity we
omit Hsp70 from the refolding step in our model at the
present time). Degradation of proteins by the ubiquitin
system also requires ATP. If the level of damaged proteins
within a cell reaches a critical threshold, the cell may
become senescent, undergo apoptosis or undergo necrosis.
The fate of the cell is partly determined by the ATP level.
4. Description of the model
New proteins need to be synthesized in order to replace
the damaged proteins which are degraded. The rate of
synthesis depends on the half-life of the protein. Once
synthesized, they have to be folded into their native state. For
simplicity we model this as one reaction. In this model we
assume that proteins are either in their native form, i.e.
correctly folded (NatP) or are misfolded (MisP).
We assume that Hsp90 is present in its active dimeric
state. Although Hsp90 is very abundant in the cell, we only
consider the pool of Hsp90 which is available for binding
with HSF1 and for binding to a low level of misfolded
protein (5% of total protein). Initially the majority of HSF1
is bound to Hsp90 and the concentration of HSF1 is too low
to form trimers. This low level prevents further transcription
of the chaperone. Any misfolded protein may be either
refolded (with the help of a chaperone), degraded (by the
ubiquitin–proteasome system) or form aggregates (AggP).
Both refolding and degradation require ATP. There are two
ways in which a misfolded protein can form an aggregate:
either two misfolded proteins bind together or a misfolded
protein binds to a previously formed aggregate. An increase
in the number of misfolded proteins leads to Hsp90
disassociating from HSF1 and binding to MisP. HSF1 is
then free to form dimers (DiH), and then trimers (TriH), with
both reactions being reversible. A trimer can bind to HSE to
form a complex (HSETriH) which then activates the
transcription of Hsp90 leading to an increase in the level
of Hsp90 in the cell. This increases the chance of any
misfolded protein being correctly refolded.
We build our model by constructing a set of biochemical
reactions to describe the processes outlined above. The
reactions are described below in Section 4.1. The network
diagram of reactions is shown in Fig. 1. We use mass-action
kinetics for all the reactions, i.e. we assume that the
instantaneous rate of a reaction is directly proportional
to the concentration or each reactant raised to the power of
its stoichiometry. We also assume that all the reactions
take placewithin one compartment, namely the cell, and do
not consider subcellular localization in this model.
However, it is intended that we will modify the model in
the future to include different compartments within the
cell such as the nucleus, the cytosol, and the mitochondria.
We would then need to add further reactions to represent
translocation from one compartment to another. For
example, in our model we would add a reaction to
represent the translocation of HSF1-trimers from the
cytosol to the nucleus.
The model is encoded using the systems biology markup
language (SBML) (Hucka et al., 2003). SBML is a
computer-readable format for representing models of
biochemical reaction networks. Once a model has been
encoded, it can then be simulated using one of a number of
software tools. Our BASIS system provides one such tool,
where models can be simulated, results plotted and
parameters can be changed (www.basis.ncl.ac.uk).
The model described here is too complex to reason about
directly and so it is necessary to carry out simulations to see
how the system changes with time. We used stochastic
modelling rather than a deterministic analysis, since it is
important to include the inherently stochastic behaviour of
the intra-cellular processes. Also some of the species in the
model are present in small numbers, and so it would be
incorrect to use a deterministic approach.
The model was simulated using the STOCKS simulator,
developed by Andrzej Kierzek and colleagues (Puchalka and
Kierzek, 2004), which combines the Gibson and Bruck
(2000) algorithm with the t-leap method of Gillespie
(Gillespie, 2001).
4.1. Reactions in the model
The following set of reactions are shown in Fig. 1a.
New proteins are synthesized and fold into their native
state at rate k1: "!k1 NatP:
Normal proteins (NatP) become misfolded, depending on
the level of ROS in the cell, at a rate k2: NatPþ ROS
"!k2 MisPþ ROS. This also includes nascent proteins which
do not fold correctly.
Misfolded proteins (MisP) are bound by Hsp90 at rate
k3, competing with HSF1: MisPþ Hsp90"!k3 MCom; where
MCom represents the complex of misfolded protein with
Hsp90.
Misfolded proteins bound to Hsp90 dissociate at rate
k4: MCom"!k4 MisPþ Hsp90:This represents unsuccessful
refolding.
Themisfolded protein which is bound toHsp90 (MCom) is
refolded to form NatP and released at rate k5: MComþ
ATP"!k5 NatPþ Hsp90þ ADP: This reaction requires ATP.
C.J. Proctor et al. /Mechanisms of Ageing and Development 126 (2005) 119–131122
               dc_625_12
If refolding is unsuccessful, misfolded proteins are
degraded at rate k6: MisPþ ATP"!k6 ADP: This reaction
requires ATP.
Misfolded proteins which are neither refolded nor
degraded form aggregates (AggP) at rate k7:
2MisP"!k7 AggP:
The next set of reactions are shown in Fig. 1b.
Hsp90 binds to HSF1 to form a complex at rate k8:
Hsp90þ HSF1"!k8 HCom; where HCom represents the
complex of Hsp90 and HSF1.
Hsp90–HSF1 complexes dissociate at rate k9:
HCom"!k9 HSF1þ Hsp90:
HSF1 forms dimers at rate k10 : 2HSF1"!k10 DiH: HSF1
reacts with dimers to form trimers at rate k11: HSF1þ
DiHrrow
k11
TriH: These reactions are reversible with the
reverse reactions proceeding at rate k12 and k13, respectively.
The trimer (TriH) binds to HSE at rate k14: TriHþ
HSEw
k14
HSETriH; and dissociates at rate k15.
Bound HSE activates transcription of Hsp90 at rate k16:
HSETriH"!k16 HSETriHþ Hsp90:
Hsp90 degrades at rate k17: Hsp90þ ATP"!k17 ADP; a
reaction which requires ATP.
The following set of reactions are not shown in Fig. 1.
ATP is generated by the mitochondria in the cell
from ADP at rate k18: ADP"!k18 ATP:
Other cellular processes, apart from refolding, consume
ATP to form ADP at rate k19: ATP"!k19 ADP:
Reactive oxygen species (ROS) are produced by the
mitochondria at rate k20: "!k20 ROS:
ROS is scavenged by antioxidants at rate k21: ROS"!k21 ? :
4.2. Setting the parameter values and initial conditions
Table 1 lists the species and initial conditions. We
assume that there are 6 $ 106 molecules of native protein
initially. Since we assume that under normal conditions, 5%
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Fig. 1. Network diagram of the model. (a) Protein turnover. (b) Autoregulation of Hsp90.
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of native protein is misfolded and complexed to Hsp90,
we set the initial level of Hsp90 to 300,000. We assume
that there are 6000 molecules of HSF1 but that the majority
of it is initially complexed to Hsp90. The levels of ROS, ATP
and ADP are initially set at 100, 100,000 and 1000,
respectively.
Table 2 lists the default parameter values and also
some of the assumptions made in estimating the values. It
is not always possible to obtain exact parameter values
as experimental data are often qualitative rather than
quantitative. For example, it is known that Hsp90 has a
strong binding affinity for HSF1, as it is a client protein, and
a much weaker affinity for a misfolded protein. Therefore,
we set the values of k3 and k8, the rates for binding of Hsp90
to misfolded protein and HSF1, respectively, so that k8 is 10
times greater than k3.
In some cases we have quantitative data, for example the
half-life of a protein, but it is not always possible to use the
values directly. It would seem straightforward to calculate
the degradation rates and synthesis rates of protein from the
C.J. Proctor et al. /Mechanisms of Ageing and Development 126 (2005) 119–131124
Table 1
Initial conditions for the model
Species Initial value (number of molecules) Comments
Native protein 6000000 Only one type of protein is considered
Hsp90–HSF1 complex 5900 The majority of HSF1 is bound to Hsp90
Hsp90 300000 Assume that there is sufficient free Hsp90 to bind to 5% of native protein
HSF1 100 Assume ratio of bound to free HSF1 is 59:1 initially
ROS 100 This value can be varied during the simulation
ATP 10000 Assume only a small proportion of cellular ATP is available for the refolding reaction
ADP 1000 Ratio of ATP:ADP is 10:1 under normal cellular conditions
HSE 1 One inducible gene on chromosome 14 (Csermely et al., 1998)
All species not shown in Table 1 have their initial amount set to zero.
Table 2
Default parameter values of the model
Reaction Parameter Default value Units Assumptions made
Protein synthesis k1 10.0 mol s
"1 Half-life of 6–7days (Kawanaka et al., 1997)
Misfolding k2 0.00002 mol
"1 s"1 Ratio of native:misfolded proteins is 19:1 under
normal conditions (Lodish et al., 2000)
Binding of misfolded
protein by Hsp90
k3 50.0 mol
"1 s"1 The binding affinity of misfolded protein to Hsp90 is
less than that of HSF1
Dissociation of misfolded
protein complex
k4 0.00001 s
"1 The rate of unsuccessful refolding is low compared to
refolding under normal conditions
Re-folding k5 4.0 $ 10"6 mol"1 s"1 Rapid reaction when bound to Hsp90
(Jakob et al., 1995) if ATP levels are high
Protein degradation k6 6.0 $ 10"7 mol"1 s"1 Half-life of 6–7days (Kawanaka et al., 1997)
Protein aggregation k7 1.0 $ 10"7 mol"1 s"1 This is a slow reaction unless high levels of
misfolded protein
Binding of HSF1 and Hsp90 k8 500.0 mol
"1 s"1 The affinity of HSF1for Hsp90 is 10 times
stronger than that of misfolded proteins
Dissociation of HSF1 complex k9 1.0 s
"1 Under normal conditions most of HSF1 is
complexed to Hsp90
Dimerisation of HSF1 k10 0.01 mol
"1 s"1 This reaction is rapid only when levels of
unbound HSF1 are high
Trimerisation of HSF1 k11 100.0 mol
"1 s"1 This is a fast reaction once dimers are formed
Dissociation of HSF1-trimers k12 0.5 s
"1 This is a slow reaction
Dissociation of HSF1-dimers k13 0.5 s
"1 This is a slow reaction
Binding of HSE and
HSF1-trimers
k14 0.05 mol
"1s"1 This reaction only proceeds when trimers are available
Dissociation of HSE and
HSF1-trimers
k15 0.08 s
"1 If all HSF1 forms trimers, the ratio of the forward
to reverse reaction is about 1000:1
Hsp90 transcription k16 1000.0 s
"1 This is fast when HSE is bound
Hsp90 degradation k17 8.02 $ 10"9 s"1 Half-life of 1 day
ATP formation k18 12.0 s
"1 Assume that ratio of ATP:ADP is 10:1 under
normal conditions
ADP formation k19 0.02 s
"1
ROS production k20 0.1 mol s
"1 Assume constant production level of ROS
ROS removal k21 0.001 s
"1 Rate of removal depends on level of ROS
mol: number of molecules.
               dc_625_12
C.J. Proctor et al. /Mechanisms of Ageing and Development 126 (2005) 119–131 125
Fig. 2. Simulation results for a normal unstressed cell. (a) Levels of native protein (NatP), misfolded protein (MisP), misfolded protein complexed with Hsp90,
aggregated protein (AggP) and unbound Hsp90. (b) Levels of ATP, ADP and ROS (ROS was scaled $20 for clearer visualisation). Initial conditions and
parameters as in Tables 1 and 2, respectively.
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Fig. 3. Simulation results for cell undergoing period of stress. In this simulation the level of ROSwas increased two-fold for 10 min. (a) Levels of native protein
(NatP), misfolded protein (MisP), misfolded protein complexed with Hsp90, aggregated protein (AggP) and unbound Hsp90. (b) Levels of ATP, ADP and ROS
(ROS was scaled $20 for clearer visualisation). Initial conditions and parameters as in Tables 1 and 2, respectively.
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Fig. 4. Simulation results for a cell experiencing increased levels of ROS with time. (a) Levels of native protein (NatP), misfolded protein (MisP), misfolded
protein complexed with Hsp90, aggregated protein (AggP) and unbound Hsp90. Total Hsp90 increases in step with misfolded protein complexed to Hsp90,
native protein corresponding decreases, all other species are close to zero. (b) Levels of ATP, ADP and ROS. Initial conditions as in Table 1. k21 = 0.00001, all
other parameters as in Table 2.
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given half-life, if we assume that the protein level remains
constant. However, we have more than one step to
degradation which means that further information is needed.
In our model we have chosen a protein with a half-life of 6
days. Using the formula l = "ln(0.5)/t1/2, where l is the
degradation rate, gives l = 1.34 $ 10"6 s"1. Since the
native protein has to be misfolded before it can be degraded,
k6 needs to be higher than this value. If all misfolded protein
was degraded then we could simply set k6 = l $ 19 (since
the ratio of native to misfolded protein is 19:1). However,
misfolded protein can also be refolded or form aggregates.
So to find the value of k6 which results in the half-life
of native proteins being equal to 6 days, we set the
synthesis rate to zero and ran the simulation for various
values of k6 until we found a value which gave the correct
half-life. Using this procedure we obtained a value of
k6 = 6.0 $ 10"7.
In order to calculate the synthesis rate k1, we assume that
the level of protein remains constant. We set the initial value
of native protein as 6,000,000 molecules so at steady state
k1 = 6 $ 106 $ 1.34 $ 10"6 = 8.04. We can also calculate
the misfolding rate k2, using the observation that 95% of
protein is in its native form under normal conditions (Lodish
et al., 2000).
We set the parameter describing the binding affinity of
Hsp90 to HSF1 (k6), so that it is ten times greater than the
binding affinity of Hsp90 to misfolded protein (k3). In
reality, the ratio of these parameters should be in the region
of 100–1000. The reason for this discrepancy is that we have
only included a subset of protein in our model. If we had
included total cellular protein, then there would be a larger
amount of misfolded protein competing with HSF1 for
Hsp90.
The key benefit of a mathematical model is that it allows
us to explore the effects of varying any of the default
parameter values. For example, we varied the rate of ROS
removal k21, so that the level of ROS increased with time
(see Section 5.3).
5. Results
5.1. Unstressed cell
Using the initial conditions and parameter values listed in
Tables 1 and 2, we carried out a simulation for 10,000 s.
(Note: time here and in subsequent results refers to
simulation time within the biological context of the model,
not the actual run-time of the simulation on the computer.)
Fig. 2 shows a typical simulation. If we repeated the
simulations many times and averaged the results we would
obtain smoother curves. However, even from a single
simulation we can see that the species quickly reach a steady
state. About 95% of the total protein is in its native formwith
the remaining 5% being misfolded and complexed to Hsp90.
There is no aggregated protein present.
The levels of ROS, ATP and ADP remain fairly constant
throughout the simulation with values 100, 10000, and 1000,
respectively (see Fig. 2b).
5.2. Cell exposed to transient stress
We next examined the effect of increasing the ROS level
two-fold for 10 min, after the simulation had been running
for about 8 min. Fig. 3 shows the results of a simulation run
for 2000 s. We can see a sudden decrease in native protein as
it denatures and rapidly forms complexes with Hsp90. There
is also an increase in aggregated protein. When the ROS
level returns to normal, some of the denatured protein is
refolded. However, the aggregated protein persists because
we have assumed that it cannot be degraded and that
aggregation is not reversible. This results in the level of
native protein being lower than its initial level. The level of
Hsp90 remains at a higher level as it is a relatively stable
protein but we would expect it to return slowly to normal
levels.
5.3. Increase in ROS with time
In this simulation we decreased the rate of ROS removal
by changing the parameter k21 from 0.001to 0.00001. This
causes a gradual increase in ROS over time. As shown by
Fig. 4, the model predicts that the level of native protein
rapidly declines and there is a corresponding increase in the
denatured protein which forms complexes with Hsp90.
There is a corresponding decrease in the level of ATP as ATP
is needed for both the refolding and degradation of
misfolded protein. However, note that the linear increase
in ROS leads to a non-linear decrease in ATP. This is due to
the initial steep decrease in the level of native protein, which
is then followed by a more gradual decline. The level of
Hsp90 increases and is able to deal with the increase in
denatured protein so that the level of aggregated protein
remains close to zero. The decline in ATP results in the
misfolded protein remaining in complex with Hsp90 as both
the capacity for refolding and degradation is reduced. Note
that we have so far assumed that there is no decline in the
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Fig. 5. Extending the model. Hsp90 becomes misfolded and then either is
degraded or forms aggregates.
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Fig. 6. Simulation results for the extendedmodel with increasing levels of ROS. (a) Levels of native protein (NatP), misfolded protein (MisP), misfolded protein
complexed with Hsp90, aggregated protein (AggP) and unbound Hsp90. (b) Levels of ATP, ADP and ROS. Initial conditions as in Table 1. k17 = 1.52 $ 10"7,
k21 = 0.00001, k22 = 10
"6, k23 = 10
"7, all other parameters as in Table 2.
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capacity of Hsp90. In the next section we modify this
assumption.
5.4. Extensions to the model
One of the advantages of building our models using the
network approach is that it is straightforward to extend the
model as more information becomes available or new
hypotheses are formed. For example, in our basic model we
modelled the degradation of Hsp90 by one reaction (see Fig.
1b). The rate of this reaction depended on the level of Hsp90
and ATP. However, Hsp90 is also subject to damage and as it
has many hydrophobic regions, it will also form aggregates
when it is not in its correct conformation. Sowe modified the
model so that Hsp90 can become misfolded, and that once
misfolded, it can either be degraded or form aggregates. Fig.
5 shows the additional reactions. For simplicity the figure
shows the reaction of aggregation of misfolded Hsp90 by a
single arrow. However, we actually model this as three
different reactions, either two misfolded Hsp90 molecules
can aggregate, a misfolded Hsp90 can aggregate with a
misfolded protein other than Hsp90, or a misfolded Hsp90
can bind to previously formed aggregated protein. The result
of adding this detail to the model, is that the level of
aggregated proteins begins to rise with time due to the
decline in functional Hsp90 as can be seen by comparing
Fig. 6 with Fig. 4.
6. Discussion
We have developed a mathematical model of the
chaperone system, with particular focus on the role of
Hsp90 in guarding protein homeostasis. Our model shows
that when the level of denatured protein rises as a result of
increased stress, Hsp90 is upregulated and can prevent the
formation of aggregated protein, provided that the stress is
not too severe or long-lasting. As levels of oxidative stress
increase with age, we see that eventually there comes a point
when the levels of Hsp90 cannot increase enough to form
complexes with the increasing numbers of denatured
proteins, and as a consequence, aggregated protein begins
to form. If the chaperones themselves also become damaged
and the degradation machinery becomes less efficient with
time, then the formation of aggregates is further increased.
Since ATP is required for both refolding and degradation, a
decline in ATP with age makes the situation worse.
The models described here are available on our web-site
(www.basis.ncl.ac.uk) and we encourage the reader to carry
out their own simulations and to change parameter values of
interest. The levels of native protein, misfolded protein and
aggregated protein can then be compared with Fig. 2.
It is also possible to change the initial number of each
species in the model, for example the initial amount of native
protein. However, when changing initial levels of species it
may also be necessary to change parameter values that affect
the synthesis or degradation of the relevant species. For
example, if we change the initial amount of native protein it
is also be necessary to change the protein synthesis rate,
otherwise the level of native protein would steadily decline
and eventually reach the original level. An on-line
companion document explaining how to explore the
chaperone model using BASIS is available at this web-site.
The simulations were carried out under a Linux Debian
environment on a standard PC. The runtime required was
relatively short, for example, Fig. 3 was generated in under
4 min. For the interested reader, simulations can be carried
out using the BASIS system, which is accessible through a
web-browser.
Our next step in developing this model will be to include
the different cellular outcomes: temporary arrest, cellular
senescence, apoptosis and necrosis as given by the ‘‘protein
homeostasis hypothesis’’ (So˝ti et al., 2003). The outcome
will depend on the levels of denatured protein, aggregated
protein, Hsp90 and ATP. We will then be able to obtain the
distribution of cells in each state at different time points and
will also be able to compare the distributions obtained for
different sets of parameter values.
We set the levels of ROS, ATP and ADP in this model and
put in reactions to represent ROS production and scavenging
and general reactions of ATP/ADP. However, we are also
currently developing models of the mitochondria where the
ROS and ATP are produced. Future developments will link
the chaperone model to the mitochondria model by taking
out the general reactions of ROS and ATP and replacing the
initial levels of these species with the levels output from the
mitochondria model.
The model that we have described can be extended in
many ways. For example, we could include the function of
other chaperones such as the role of Hsp100 in dissolving
protein aggregates. Further detail could also be added to
many of the reactions described such as protein synthesis,
Hsp90 synthesis and the degradation steps.
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Molecular chaperones as regulatory elements of cellular
networks
Csaba So˝ti1, Csaba Pa´l2,3, Bala´zs Papp2,4 and Pe´ter Csermely1
Molecular chaperones help hundreds of signaling molecules to
keep their activation-competent state, and regulate various
signaling processes ranging from signaling at the plasma
membrane to transcription. Besides these specific regulatory
roles, recent studies have revealed that chaperones act as
genetic buffers stabilizing the phenotypes of various cells and
organisms. This may be related to their low affinity for the
proteins they interact with, which means that they represent
weak links in protein networks. Chaperones may uncouple
protein, signaling, membrane, organelle and transcriptional
networks during stress, which gives the cell additional
protection. The same networks are preferentially remodeled in
various diseases and aging, which may help us to design novel
therapeutic and anti-aging strategies.
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Introduction
The term ‘molecular chaperone’ denotes a large family of
abundant, ubiquitous proteins that form an ancient
defense system in our cells. Chaperones promote cell
survival by sequestering damaged proteins and prevent-
ing their aggregation. During stressful conditions, such as
elevated temperature, they prevent protein aggregation
by facilitating the refolding or elimination of misfolded
proteins. The stress-induced response to damaged
proteins is helped by a sophisticated regulatory system,
which shuts down most cellular functions and, in parallel,
induces the synthesis of several chaperones and other
survival-promoting proteins. Therefore, many of the cha-
perones are also called stress or ‘heat shock’ proteins in
reference to the archetype of cellular stress, heat shock.
Besides their role during stress, chaperones have multiple
roles under normal conditions. They promote the trans-
port of macromolecules (e.g. proteins or RNA) and parti-
cipate in almost every remodeling event involving larger
protein complexes, including signaling, transcription, cell
division, migration, differentiation, etc [1–3]. The multi-
ple roles of chaperones have inflated the term, which is
now used to describe almost any protein (or RNA) that
transiently accompanies other molecules and promotes
their transport or assembly to larger complexes. Thus
chaperones for RNAs, copper and lipids have also been
described. Certain chaperones are specialized to a single
protein or to a small class of proteins, like the chaperones
of catenin, collagen, the major histocompatibility com-
plex, myosin and others. The term ‘intramolecular cha-
perone’ has been coined for protein segments (usually
residing in the N terminus) that help the folding of the
rest of the protein. Moreover, small compounds can be
termed ‘chemical chaperones’, and are used in clinical
practice to cure protein folding diseases. Space limitations
restrict this review to the ‘original’ chaperones: those
protein chaperones that have multiple protein substrates.
Chaperones mostly form low-affinity, dynamic, temporary
interactions (weak links) in cellular networks. Given that
chaperones generally have a large number of partners, they
behave like hubs in protein–protein interaction networks.
Moreover, many chaperone effects (e.g. cell survival or
changes in the phenotype diversity) are typical integrative
properties, which can rarely be understood by studying the
individual chaperone–client interactions exclusively.
Thus the network approach is a promising tool to explain
some key aspects of chaperone function [3,4,5,6]. We
will highlight several potential connections between the
individual chaperone–protein contacts and cellular net-
works, and will explain how some aspects of the network
approach can be used to understand the integrative proper-
ties of chaperone-mediated regulation. Finally, we will
show how the network approach is linked to chaperone-
related therapeutic and anti-aging strategies.
Chaperones and cellular networks
Chaperones form large complexes and have a large num-
ber of co-chaperones to regulate their activity, binding
properties and function [1–3]. These chaperone com-
plexes regulate local protein networks, such as the mito-
chondrial protein transport apparatus [7] and the
assembly [8] and substrate specificity [9] of the major
cytoplasmic proteolytical system, the proteasome.
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Chaperones and the signaling, membrane and
organelle networks
The major chaperone-regulated cellular networks are
related to signaling, membrane structure and transcrip-
tion. Though the network approach has been worked out
only for segments of the whole signaling network or
‘signalome’ [10], chaperones may be important elements
in the promotion of cross-talk between various signaling
processes. The Hsp90 chaperone complex promotes the
maturation of >100 kinase substrates including several
members of the Raf-1-related signaling pathway. The
antiapoptotic protein Bag1 (Bcl-2-associated athanogene
protein 1) activates this pathway. Under stress, Bag1 is
associated with another chaperone, Hsp70 (70-kDa heat
shock protein), which leads to the attenuation of Bag1-
mediated Raf-1 activation (Figure 1). Thus, the Bag1/
Raf-1 interaction may contribute to the mechanism
underpinning how stress shuts down cell proliferation
[11].
Another well-known chaperone-mediated signaling path-
way, the activation of nitric oxide synthases, gives us an
example of chaperone effects on various membranes. The
endothelial nitric oxide synthase (eNOS) is activated if
assembled to a raft-associated complex containing Hsp90
(90-kDa heat shock protein), the Akt kinase (protein
kinase B) and calmodulin. The formation of this complex
is helped by statins, the widely used anti-atherosclerotic
drugs [12]. A co-chaperone of Hsp70 and Hsp90, CHIP
(carboxyl terminus of Hsc70-interacting protein), re-
directs the maturating eNOS, which usually follows a
Golgi-to-plasma-membrane route, into an insoluble cel-
lular compartment, leading to its inactivation [13]. Both
Hsp90 and Hsp70 are raft-associated chaperones [14].
Besides its role in eNOS trafficking, Hsp90 helps the
GTP-binding protein Ga12 to associate with membrane
rafts [15] and promotes the traffic of STAT3 (signal
transducer and activator of transcription protein 3) from
membrane rafts to the cell nucleus after interleukin-6
stimulation [16] (Figure 1). Rab3A, a key player in Ca-
dependent exocytosis, is also regulated by the Hsp90/
Hsp70/cysteine string protein chaperone complex in
synaptic membranes [17]. Finally, studies of Vı´gh et al.
showed that chaperones may have a general role in
membrane stabilization [18]. All these examples link
chaperones to the membrane network of the cell, which
integrates the plasma membrane, the endoplasmic reti-
culum (ER), various vesicles, the nuclear membrane and
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mitochondria [19–21]. Moreover, chaperones may facil-
itate cytoplasmic traffic [3,22–25]. Links between the ER,
the mitochondria and the cytoplasm have already been
shown to signal messages of cellular stress between these
compartments [26–28]. Chaperones may emerge as sta-
bilizers and regulators of the connectivity and traffic of
these important networks.
The connections between elements of the mitochondrial
network, the ER, nuclear membranes and the cytoplas-
mic meshwork may be key points of cellular integrity and
information transfer, while de-coupling of these segments
may be an efficient protection against any cellular
damage. One might expect that chaperones are needed
for an efficient coupling of these cellular networks. De-
coupling of network elements and modules is a widely
used method to stop the propagation of damage [4,6].
In case of stress, the increased occupancy of chaperones
by damaged proteins together with the stress-induced
translocation of chaperones to the nucleus [1–3,29] might
lead to an ‘automatic’ de-coupling of network elements
and modules, providing the cell periphery with an addi-
tional safety measure (Figure 2).
Chaperones and the transcriptional network
Chaperones are well known to protect the cell nucleus
after stress. As a novel version of this role, Hsp70 was
shown to drive damaged nuclear proteins to the nucleo-
lus, clearing other nuclear components of misfolded pro-
teins and decreasing the danger of their widespread
aggregation [29]. In agreement with these findings, cha-
perones promote the transport of ribosomal subunits [30]
and the mobility of steroid receptors inside the nucleus
[31]. Molecular chaperones regulate both the activation
[32–34] and the disassembly of numerous transcriptional
complexes [35,36] (Figure 1). Thus, chaperones emerge
212 Cell regulation
Figure 2
Current Opinion in Cell Biology
Stress,
disease
aging
Chaperone
complex
Cytoskeletal
network
Signaling
/transcriptional
network
Nuclear
translocation
Protein
refolding
Membrane
/organelle
network
Chaperones as regulators of cellular networks. Chaperones emerge as integrative regulators of the signaling/transcriptional, cytoskeletal and
membrane/organelle networks of the cell. Modification of chaperones as well as a change in the extent to which they are required in various
networks may affect most of the other connected cellular functions. As an example, stress (disease or aging) may induce a chaperone-mediated
de-coupling of cellular integrity, severing the connections between organelles (e.g. mitochondria, ER, the nuclear membrane and vesicles)
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fragmentation of all networks in the cell periphery. The residual or newly formed links between network members are typically weaker than
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as regulators of the transcriptional network [37]. Stress-
induced nuclear translocation of chaperones may preserve
nuclear remodeling capacity during environmental
damage, and thus protect the integrity of DNA.
Emergent properties of the chaperone-
regulated cellular networks
The previous examples showed that chaperones are
involved in the regulation of signaling, organelle,
membrane, cytoskeletal and transcriptional networks
(Figure 2). However, relatively little is known about
the chaperone-mediated, emergent properties of cellular
functions. One of the most important advances in this area
came from Susan Lindquist and her co-workers when
they discovered that Hsp90 acts as a buffer of genetic
changes in Drosophila [38] and in Arabidopsis [39]. A
recent paper suggests that this effect might originate
epigenetically from Hsp90-induced heritable changes
in the chromatin structure [40].
Chaperone overload
Chaperone-induced genetic buffering is diminished dur-
ing stress, which causes the sudden appearance of the
phenotype of previously hidden mutations, thereby pro-
moting population survival by providing a possible mole-
cular mechanism for fast evolutionary changes [38,39]. On
the other hand, the stress-induced appearance of genetic
variation at the level of the phenotype cleanses the
genome of the population by allowing the disappearance
of disadvantageous mutations by natural selection. Cha-
perones are highly conserved proteins [1–3], so similar
mechanisms might operate in humans. Moreover, the
tremendous advance of medicine in the last two hundred
years has significantly reduced the effects of natural
selection and potentially increased the accumulation of
hidden mutations in the human genome. However, cha-
perones may become occupied by the damaged proteins
in aged organisms (half of cellular proteins of 70–80 years
old humans may be already oxidized), resulting in a
chaperone overload. As a consequence the protein pro-
ducts harboring the ‘hidden mutations’ may be released
and may contribute to the development of civilization
diseases, such as cancer, atherosclerosis and diabetes [41–
43]. This effect may be negligible today, although it will
increase with each generation. Still, we probably have
many hundreds of years to think about a possible solution.
Chaperones as weak links
Recent findings [44,45] raised the idea that not only
chaperones but a large number of other proteins may also
regulate the phenotypic diversity of the population.
Though a relatively small number of other regulators
have been uncovered so far, it seems unlikely that a
common molecular mechanism, such as involvement in
signaling or in modifications to the chromatin structure,
can explain all the effects observed. If a general explana-
tion is sought, it is more likely to be related to the network
properties of the cell. In this context, chaperones are
typical weak linkers, providing low-affinity, low-probabil-
ity contacts with other proteins (Figure 2). Weak links are
known to promote system stability in a large variety of
networks from macromolecules to social networks and
ecosystems, which suggests that this may be a general
network-level phenomenon explaining many of the
genetic buffering effects of chaperones [6].
Chaperone therapies
Cellular networks are remodeled under stress [46] and in
various diseases. Effective interventions to push the
equilibrium towards the original state may not be limited
to single-target drugs with a well-designed, high affinity
interaction with one of the cellular proteins. In agreement
with this general assumption, several examples show that
multi-target therapy may be superior to the usual single-
target approach [47]. The best known examples of multi-
target drugs include Aspirin, Metformin or Gleevec as
well as combinatorial therapy and natural remedies.
Because of the multiple regulatory roles of chaperones,
chaperone modulators provide additional examples of
multi-target drugs. Indeed, chaperone substitution (in
the form of chemical chaperones [48]), the pharmacolo-
gical help of chaperone induction by stress, termed cha-
perone co-induction [49], and chaperone inhibition [50]
are all promising therapeutic strategies. Both chaperone
co-inducers and chaperone inhibitors, including geldana-
mycin analogues and other Hsp90 inhibitors, have
recently completed successful clinical trials.
Conclusions
Chaperones regulate cellular functions at two levels. In
several cases they interact with a specific target protein
and help it to fold after synthesis, or re-fold after stress.
These strong interactions make chaperones important
parts of the central scaffold of cellular networks, such
as the protein net, the signaling network, the membrane
and organelle network and the transcriptional network.
However, in most cases chaperones have only a low-
affinity, temporary, weak interaction with most of their
targets (Figure 2). Changes to these interactions do not
affect the general behavior of the whole network, the cell.
However, inhibition of these weak interactions might
lead to a rise in cellular noise and the destabilization
and disintegration of the whole network and by promot-
ing an ‘error catastrophe’ help us to combat cancer [50].
In contrast, chaperone activation might decrease cellular
noise, and consequent cell-stabilization might give an
additional, indirect help to prevent protein folding dis-
eases including various forms of neurodegeneration, such
as amyotrophic lateral sclerosis, Alzheimer’s disease,
Parkinson’s disease and Huntington’s disease [48,49].
Besides slowing or reversing the development these
diseases, chaperone-based therapies may also generally
benefit the aging organism by stabilizing its cells and
functions. Thus properly working chaperones may be key
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players to help us achieve improved life conditions at an
advanced age. The assessment of the multiple roles of
chaperones in the context of cellular networks is just
beginning.
Update
Recently a promising model was developed to integrate
various chaperone-dependent and other elements in the
signaling network leading to the activation of heat shock
factor-1 and the consequent synthesis of molecular cha-
perones [51]. Hsp90 was shown to act as a molecular
switch of the Erb-B2 oncogenic tyrosine kinase signaling
network by regulating the heterodimer formation
between Erb-B2 and various other kinases [52]. This
extends the membrane-dependent remodeling effects
of Hsp90 to a novel field. As a theoretical contribution
to chaperone therapies, the efficiency of multi-target
drugs over single target drugs has been summarized,
and a new drug-design paradigm was proposed in a recent
publication [53].
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Heat shock proteins as emerging therapeutic targets
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Chaperones (stress proteins) are essential proteins to help the formation and maintenance of the
proper conformation of other proteins and to promote cell survival after a large variety of
environmental stresses. Therefore, normal chaperone function is a key factor for endogenous stress
adaptation of several tissues. However, altered chaperone function has been associated with the
development of several diseases; therefore, modulators of chaperone activities became a new and
emerging field of drug development. Inhibition of the 90 kDa heat shock protein (Hsp)90 recently
emerged as a very promising tool to combat various forms of cancer. On the other hand, the induction
of the 70 kDa Hsp70 has been proved to be an efficient help in the recovery from a large number of
diseases, such as, for example, ischemic heart disease, diabetes and neurodegeneration. Development
of membrane-interacting drugs to modify specific membrane domains, thereby modulating heat shock
response, may be of considerable therapeutic benefit as well. In this review, we give an overview of the
therapeutic approaches and list some of the key questions of drug development in this novel and
promising therapeutic approach.
British Journal of Pharmacology advance online publication, 19 September 2005; doi:10.1038/sj.bjp.0706396
Keywords: Chaperone coinducers; chaperones; Hsp90; Hsp70, heat shock proteins; geldanamycin; stress proteins; membrane
fluidity
Abbreviations: 17AAG, 17-allylamino-17-demethoxy-geldanamycin; HSF, heat shock factor; Hsp, heat shock protein; PKC,
protein kinase C
Molecular chaperones
Molecular chaperones (1) protect other proteins against
aggregation, (2) solubilize initial, loose protein aggregates,
(3) assist in folding of nascent proteins or in refolding of
damaged proteins, (4) target severely damaged proteins to
degradation and (5) in case of excessive damage, sequester
damaged proteins to larger aggregates. Chaperones are
ubiquitous, highly conserved proteins, which utilize a cycle
of ATP-driven conformational changes to refold their targets,
and which probably played a major role in the molecular
evolution of modern enzymes (Hartl, 1996; Csermely, 1997;
1999; Thirumalai & Lorimer, 2001). Due to the significant
overlap in their functions, the major classes of molecular
chaperones are best classified by their molecular weights, thus,
for example, the abbreviation Hsp90 refers to the 90 kDa heat
shock protein (Hsp).
Cellular stress leads to the expression of Hsp’s. Stress can be
any sudden change in the cellular environment, to which the
cell is not prepared to respond, such as heat shock. However,
almost all types of cellular stress induce Hsp’s. Owing to the
generality of this phenomenon, Hsp’s are often called stress
proteins. The rationale behind this phenomenon is that after
stress there is an increased need for the chaperone function of
Hsp’s, which triggers their induction. This need is caused by
the increased amount of damaged proteins, by the inhibition of
their elimination via the proteasome as well as by the damage
of the chaperones themselves. Hsp induction might help to
renature chaperones and, therefore, Hsp induction might lead
to a ‘cascading amplification’ of available chaperone activity.
Hsp synthesis is induced by the activation of the heat shock
factor (HSF)-1. In resting cells several chaperones, most
importantly Hsp90, were shown to bind to HSF-1 and keep it
in an inactive form. During stress, these repressing chaperones
become occupied by misfolded proteins, which results in the
dissociation of the cytoplasmic chaperone/HSF-1 complex.
Dissociation of HSF-1 from Hsp90 uncovers the nuclear
localization signal of this transcription factor and allows its
translocation to the cell nucleus. During this process, the
trimerization and phosphorylation of HSF-1 occurs (Morimoto,
2002). Though the exact sequence of these events has not been
clearly established, recent studies uncovered the polo-like
kinase 1 as an important actor in the phosphorylation and
consequent nuclear translocation of HSF-1 at the Ser-419
residue (Kim et al., 2005). However, other studies (Guettouche
et al., 2005) found Ser-326 but not Ser-419 as an important site
of activation-related phosphorylation of HSF-1. Part of the
nuclear HSF-1 is assembled to heat shock granules, which may
modify the chromatin structure (Jolly et al., 2004). Binding of
HSF-1 to the heat shock elements of the heat shock-inducible
genes unlocks the RNA polymerase, which becomes arrested
(‘pauses’) in most of these genes after transcribing the initial
segment of the mRNA in the absence of HSF-1. HSF-1 is
released from the DNA by a nuclear complex of Hsp90, which
is probably followed by its retrotranslocation to the cytoplasm.
The details of the nuclear translocation of Hsp90 during stress,
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their complex formation in the nucleus and consequent
recruitment to the DNA-bound HSF-1 are not entirely known.
All elements of the HSF-1 activation and downregulation
cascade, such as additional proteins of the cytoplasmic or
nuclear HSF-1/Hsp90 complexes, for example, the Ral-
binding protein 1 and tubulin in the cytoplasmic HSF-1/
Hsp90 complex (Hu & Mivechi, 2003) or p23 in the nuclear
HSF-1/Hsp90 complex (Guo et al., 2001), are of great interest
as potential drug targets (Figure 1).
Hsp’s never work alone. They are always forming a complex
with each other and recruit various smaller proteins, called
cochaperones, which regulate their ATP-ase cycle, therefore
the speed of Hsp-assisted refolding. A central chaperone
complex of the cytoplasm is assembled around Hsp90 and is
called foldosome (Pratt & Toft, 2003).
Therapeutic potential of Hsp90 inhibition
Inhibition of Hsp90 as an efficient tool for anticancer
therapies
Hsp90 is one of the most abundant proteins of eukaryotic cells,
comprising 1–2% of total proteins under nonstress conditions.
It is evolutionarily conserved among species, and is essential
for cell survival. Hsp90 exerts its chaperone activity together
with a number of cochaperones, playing an important role in
the folding of at least 200 specific proteins of various signaling
pathways, and in the refolding of denatured proteins after
stress (Csermely et al., 1998; Buchner, 1999; Pratt & Toft,
2003).
Hsp90 is an ATP-dependent chaperone. The N-terminal
domain of Hsp90 contains a rather unique ATP-binding site,
the Bergerat-fold, characteristic of only some bacterial gyrases,
topoisomerases and histidine-kinases besides Hsp90 (Prodro-
mou et al., 1997; Stebbins et al., 1997). The unique ATP-
binding site allowed the development of specific Hsp90
inhibitors. Recently, it was shown that Hsp90 contains a
second nucleotide-binding site at its C-terminal domain, which
may open new possibilities for the inhibition of this chaperone
(Marcu et al., 2000; Garnier et al., 2002; Soti et al., 2002).
Hsp90 interacts with and stabilizes a growing list of various
kinases including several key members of malignant transfor-
mation, such as the ErbB2, Src, Abl or Met tyrosine kinases,
or the Raf, Akt and cyclin-dependent serine kinases. Besides
these, Hsp90 is necessary for the maturation of several
transcription factors, like the nuclear hormone receptors and
the hypoxia-inducible factor-1. Additionally, Hsp90 binding
has been shown to contribute to the accumulation of mutant
forms of the tumor suppressor transcription factor p53. Hsp90
is associated with nitric oxide synthases, the antiapoptotic
protein, Apaf-1, etc. (Csermely et al., 1998; Buchner, 1999;
Pratt & Toft, 2003; Zhao et al., 2005).
The above examples show that a large number of proteins
need the help of molecular chaperones to maintain their
activation-competent conformation. ‘Conventional’ inhibitors
interact with their target, directly inhibiting its function.
However, chaperone-based inhibitors do not interact with the
effector proteins, but inhibit the ability of the associated
chaperone(s) to maintain their activation-competent confor-
mation. As a result, the client proteins became degraded by the
proteasome (Schulte et al., 1997). In contrast to most direct
inhibitors, which are often fairly specific for a given protein,
chaperone-based inhibitors diminish the level of many protein
targets in parallel (Sreedhar et al., 2004b; Neckers & Neckers,
2005). Thus, chaperone inhibitors behave as typical multi-
target drugs, which were suggested to be more efficient than
highly selective single-target drugs in many applications
(Csermely et al., 2005).
The most important Hsp90 inhibitors are geldanamycin
(Whitesell et al., 1994), its less toxic analog, 17-allylamino-17-
demethoxy-geldanamycin (17AAG) (Schulte & Neckers, 1998)
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Figure 1 Elements of HSF-1 activation: potential drug targets. The figure contains the major elements of the activation of HSF-1,
the major transcription factor leading to the induction of Hsp synthesis. The potential drug targets are the following: (1) cytoplasmic
complex of HSF-1 and Hsp90; (2) HSF-1 translocation to the nucleus; (3) intranuclear distribution of HSF-1; (4) nuclear complex of
HSF-1 and Hsp90; (5) retrotranslocation of HSF-1 to the cytoplasm. RalBP-1, Ral-binding protein-1; p23, cochaperone of Hsp90.
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as well as radicicol, and its more stable oxime derivatives (Soga
et al., 1998; Agatsuma et al., 2002; Ikuina et al., 2003), which
have a higher affinity for Hsp90 than geldanamycin (Roe et al.,
1999). Recently, new geldanamycin analogs (Hargreaves et al.,
2003) as well as a third class of tumor-specific Hsp90
inhibitors, the purine-scaffold inhibitors, were developed
(Chiosis et al., 2002; Vilenchik et al., 2004), and there are
ongoing efforts to synthesize even more Hsp90-interacting
drug candidates (Banerji et al., 2003; Maloney et al., 2003;
Workman, 2004; Dymock et al., 2005; Kreusch et al., 2005)
(Table 1). Hsp90 inhibition was achieved in an unusual way,
using the antitumor agent histone deacetylase inhibitors. These
compounds, such as Trichostatin-A, induce the acetylation
and consequent inhibition of Hsp90 (Yu et al., 2002).
The tumor specificity of Hsp90 inhibitors is helped by an
unusual mechanism (Figure 2; Kamal et al., 2003). Hsp90
is largely in a latent, uncomplexed state in normal cells.
However, Hsp90 becomes activated, forming a large complex
with various cochaperones in tumor cells. 17AAG binds to the
tumor-specific, complex form of Hsp90 with a 100-fold higher
affinity than to the latent form (Kamal et al., 2003), raising the
possibility that active Hsp90 behaves as a tumor-selective
catalyst to convert geldanamycin derivatives to their active
conformation (Lee et al., 2004). The increased affinity of
Hsp90 inhibitors towards tumor-specific Hsp90 is also true for
purine-based inhibitors (Vilenchik et al., 2004).
Inhibition of Hsp90 induces apoptosis of various tumor cells
(Sreedhar & Csermely, 2004). Hsp90 inhibition also leads to a
defect in a number of proliferative signals, including the Akt-
dependent survival pathway (Munster et al., 2001; 2002; Basso
et al., 2002). Hsp90 inhibition may also sensitize tumor cells
against various attacks by helping their lysis under hypoxia,
complement attack or mild detergent treatment (Sreedhar
et al., 2003; 2004a).
Importantly, there are additional drugs which interact with
Hsp90, such as the widely used chemotherapeutic agents,
cisplatin (Itoh et al., 1999), taxol (Byrd et al., 1999), as well as
the antibactericid novobiocin (Marcu et al., 2000). Cisplatin
was recently shown to bind to a novel nucleotide-binding site
of Hsp90 at its C-terminus (Soti et al., 2002), while novobiocin
binds to several domains of Hsp90 (Marcu et al., 2000; Soti
et al., 2002). The C-terminal nucleotide-binding pocket has a
unique nucleotide-binding specificity (Soti et al., 2003), as well
as a differential effect on Hsp90 client proteins (Soti et al.,
2002), which gives hopes that selective inhibitors against this
segment of Hsp90 can be developed, showing novel properties
in various anticancer protocols. This can be an important
approach all the more, since recently a new Hsp90 isoform,
Hsp90N, has been reported, which lacks the N-terminal
domain; thus, the tumor cells which accumulate this chaperone
are resistant against any conventional Hsp90 inhibitors
(Grammatikakis et al., 2002).
Hsp90 inhibitors enter clinical trials
Though the very first Hsp90 inhibitor geldanamycin showed
clear antitumor effects, it encountered difficulties in clinical
trials due to its high hepatotoxicity in some of the human
tumor models (Supko et al., 1995). Thus, a search for new
classes of Hsp90 inhibitors with lower toxicity began, and was
successful in developing the analog 17AAG. 17AAG possesses
all the Hsp90-related characteristics of geldanamycin (Schulte
& Neckers, 1998) with lower toxicity (Brunton et al., 1998;
Chiosis et al., 2003; Workman, 2003) and completed five Phase
I clinical trials and enters to phase II trials soon (Banerji et al.,
2005; Neckers & Neckers, 2005). Both geldanamycin and
17AAG can be metabolized by NADH quinone oxidoreduc-
tase 1 (DT-diaphorase), which is known to potentiate
antitumor activity by stabilizing the tumor suppressor p53.
NADH quinone oxidoreductase 1 may be a major factor in
conferring on 17AAG as well as its parent compound the
advantage that they specifically accumulate in tumor cells
(Chiosis et al., 2003; Workman, 2003), which also contributes
to the explanation why Hsp90 inhibitors are not so generally
Table 1 Hsp modulator compounds (a few examples)
Compound Modulation Targets Potential indications References
Carbenoxonole Inducer Hsp70 Ulcer Nagayama et al. (2001)
2-Cyclopenten-1-one Inducer HSF-1 Viral infections Rossi et al. (1996)
Dexamethasone Inducer HSF-1 Ischemic heart disease,
inflammation
Sun et al. (2000)
Geranyl-geranyl acetone Inducer Hsp70 Cerebral and cardiac
ischemia
Ooie et al. (2001), Yasuda et al.
(2005)
Paeoniflorin Inducer Hsp27,
Hsp40,
Hsp70
Not identified yet Yan et al. (2004)
Proteasome inhibitors Inducer Hsp70 Neuro-degeneration Kim et al. (2004)
Stannous chloride Inducer Hsp70 Tissue transplantation House et al. (2001)
Glycyrrhizin Co-inducer HSF-1 Not identified yet Yan et al. (2004)
Bimoclomol, arimoclomol,
BRX-220
Co-inducer HSF-1,
membranes
ALS, diabetic
neurophaty,
pancreatitis, ischemic
heart disease
Vigh et al. (1997), Jednakovits et al.
(2000), Kurthy et al. (2002),
Rakonczay Jr. et al. (2002), Kieran
et al. (2004)
Geldanamycin, 17AAG Inhibitor Hsp90 Cancer Whitesell et al. (1994), Neckers &
Neckers (2005)
Radicicol, cyclo-proparadicicol Inhibitor Hsp90 Cancer Soga et al. (1998), Yang et al. (2004)
PU3, PU24F-Cl (purin-based
molecules)
Inhibitor Hsp90 Cancer Chiosis et al. (2001)
Dihydroxy-phenylpyrazole Inhibitor Hsp90 Cancer Kreusch et al. (2005)
Trichostatin-A (histone
deacetylase inhibitors)
Inhibitor Hsp90 Cancer Yu et al. (2002)
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toxic to patients as one would expect from the pleiotropic roles
of Hsp90 inhibited by them besides their higher affinity to the
tumor-specific, complexed form of Hsp90 mentioned before
(Kamal et al., 2003; Vilenchik et al., 2004).
Combination therapies, applying low doses of Hsp90
inhibitors together with conventional chemotherapeutic
agents, seem to be an effective way to target various cancers.
For example, in the case of Bcr–Abl-expressing leukemias, a
low dose of geldanamycin is sufficient to sensitize these cells to
apoptosis in the presence of ineffective concentrations of
doxorubicin (Blagosklonny et al., 2001). 17AAG in combina-
tion with taxol showed enhanced cytotoxic effects on taxol-
resistant ErbB2-overexpressing breast cancer cells (Munster
et al., 2001; Sausville, 2001). Another approach is to combine
17AAG with angiogenesis inhibitors, which was proven to be
highly successful in breast tumors (de Candia et al., 2003). As
an alternative strategy the synthesis of geldanamycin hybrids,
such as the adduct with steroids (Kuduk et al., 1999; 2000) as
well as with inhibitors of the PI-3-kinase related survival
pathway (Chiosis et al., 2001), conferred further selectivity and
efficiency for these drugs besides their tumor-specific accumu-
lation. Besides the success of 17AAG, other Hsp90 inhibitors
also entered phase I trials, which shows the high therapeutic
potential of these drugs (Neckers & Neckers, 2005).
Hsp90 inhibitors as Hsp inducers?
Hsp synthesis is induced by the activation of HSF-1. Hsp90
dissociates during HSF-1 activation due to a competitive
binding of misfolded proteins to this chaperone (Morimoto,
2002). Hsp90 inhibitors may also cause the transcriptional
activation of HSF-1 by disrupting Hsp/HSF-1 complexes.
Indeed, geldanamycin and 17AAG were shown to activate
HSF-1 (Kim et al., 1999b; Bagatell et al., 2000) and the
expression of Hsp40, Hsp70 and Hsp90 (Sittler et al., 2001).
Thus, the inhibition of Hsp90, paradoxically, leads to an
increase in their overall amount as well, which should be taken
into account as a potential disadvantage, when clinical
applications of these drugs are designed. Indeed, both
geldanamycin and 17AAG were shown to antagonize the
action of cisplatin in human colon adenocarcinoma cells
(Vasilevskaya et al., 2003).
Inhibition or activation of Hsp90 is cardioprotective?
Griffin et al. (2004) has recently demonstrated that radicicol,
which activates Hsp expression by binding to Hsp90, induces
Hsp expression in neonatal rat cardiomyocytes, and this
increase in Hsp’s confers cardioprotection to these cardio-
myocytes. However, they found that radicicol induction of the
Hsp’s and cardioprotection are dependent on the inhibition
of Hsp90 in cardiomyocytes, and concluded that inhibitors of
the function of Hsp90’s in the cell may represent potential
cardioprotective agents. In contrast, another recent study
shows that in vivo gene transfer of Hsp90 in the myocardium
leads to a protection of the ischemic myocardium in pigs via a
direct stimulation of eNOS by Hsp90 (Kupatt et al., 2004). It is
well known that NO is cardioprotective; however, increased
NO synthesis with concomitant superoxide synthesis leads to
the formation of the cytotoxic peroxynitrite in certain
cardiovascular disorders (Ferdinandy & Schulz, 2003).
Therefore, further studies are necessary to evaluate the
possible role of Hsp90 inhibitors in the therapy of ischemic
heart disease.
Therapeutic potential of upregulation of Hsp’s
While the inhibitors of Hsp90 are of potential therapeutic
interest primarily in cancer therapy, upregulation of other
Hsp’s, especially that of Hsp70, has been shown to be of great
therapeutic potential in a variety of diseases.
Hsp-based immunotherapies of cancers and infections
The ability of Hsp’s to interact with a wide range of proteins
and peptides, a property that is shared by major histocompat-
ibility complex molecules, has made the Hsp’s to be used in
new immunotherapies of cancers and infections. Increased
Hsp60, Hsp70 and Hsp72 may lead to tumor cell sensitization
for immune attacks by two mechanisms: tumor cells may
express Hsp’s on their surface, which leads to their enhanced
recognition by the natural killer cells of the native immune
system (Multhoff et al., 1997; Multhoff, 2002), as well as a
specific antitumor immunity may be induced by Hsp-related
antitumor vaccination (Chu et al., 2000; Baker-LePain et al.,
2003; Shigapova et al., 2005). Hsp induction may help these
processes and may be overcome by the limitations of aging-
(Wick & Grubeck-Loebenstein, 1997; Pawelec et al., 2002)
and chaperone overload-induced (Csermely, 2001) immuno-
suppression. As these topics have been extensively reviewed
recently (Ranford & Henderson, 2002; Srivastava, 2002;
Manjili et al., 2004; Oki & Younes, 2004), no further details
are given in our present review.
Tissue protection by induction and ‘coinduction’ of Hsp70
and other Hsp’s
From the now classical observations of Currie et al. (1988),
we know that heat-shock response has a significant role in
normal cell:
uncomplexed
Hsp90
tumor cell:
Hsp90-centered
chaperone machine
100-times
better affinity
of 17AAG
Figure 2 The tumor specificity of 17AAG, a geldanamycin analog
inhibitor of Hsp90. 17AAG has a 100-times higher affinity towards
the tumor-specific Hsp90 complexed by a large number of
cochaperones than to the Hsp90 dimer, which is the predominant
form of this chaperone in normal cells (Kamal et al., 2003; Lee et al.,
2004).
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cardioprotection. Similarly, Hsp72 induction helps the survival
of neurons after stroke (Yenari et al., 1998), as well as
improves the efficiency of tissue transplantation (Perdrizet
et al., 1993). Hsp70 induction eases the deleterious conse-
quences of chronic diseases, such as diabetes, as revealed by
the application of the Hsp coinducer compounds bimoclomol
and BRX-220 (Nanasi & Jednakovits, 2001; Kurthy et al.,
2002). Conditions like Alzheimer’s, Parkinson’s, Huntington’s
or prion disease, where the accumulation of misfolded proteins
is the major cause of neurodegeneration (Warrick et al., 1999;
Carmichael et al., 2000; Sittler et al., 2001), as well as
conditions such as trauma, where neuroregeneration becomes
necessary (Kalmar et al., 2002; 2003), also have beneficial
effects from overexpression of Hsp40 and Hsp70.
There are various approaches to induce Hsp’s using
pharmacological interventions without any traditional forms
of stress, such as heat shock. Proteasome inhibitors upregulate
Hsp synthesis by increasing the amount of misfolded proteins,
which compete for Hsp’s with HSF-1 (Kim et al., 1999a; 2004).
Some of the protein kinase inhibitors were also shown to
induce Hsp27 induction (Kawamura et al., 1999). Stannous
chloride has been shown as a nontoxic, efficient inducer of
Hsp70, improving the success rate of tissue transplantations
(House et al., 2001). Geranyl-geranyl acetone, a nontoxic
Hsp70 inducer, has been shown to protect neurons against
cerebral ischemia (Yasuda et al., 2005). Similarly, the antiulcer
drug carbenoxolone has also been shown to be an inducer of
Hsp70 (Nagayama et al., 2001) (Table 1).
Most of the above methods introduce a certain level of stress
to the cells and thus provoke Hsp synthesis. However, in most
of the diseases it seems to be more efficient if the administered
drug does not induce Hsp’s, and just helps the natural Hsp
induction provoked by the natural stimuli on the cell. This help
in Hsp induction was termed as chaperone ‘coinduction’ (Vigh
et al., 1997). Chaperone coinducers act like ‘smart drugs’ by a
selective interaction with only those cells which are in danger,
and may provide an important novel therapy in a number of
acute and chronic diseases.
The best-known chaperone coinducer is aspirin, which
enhances Hsp70 synthesis (Jurivich et al., 1992). Recently,
certain herbal extracts were also shown to possess Hsp
coinducer activity (Yan et al., 2004). Another family of drug
candidates exemplified by Bimoclomol helps the induction of
Hsp70 synthesis by both perturbing various membrane
structures and helping the release of putative lipid-signaling
molecules, as well as by the prolongation of the binding of
HSF-1 to the heat shock elements on the DNA (Vigh et al.,
1997; Hargitai et al., 2003; Torok et al., 2003; Kieran et al.,
2004). Bimoclomol binds to HSF-1 with a low affinity
(Figure 3), which may contribute to its effect to prolong
HSF-1 binding to DNA. Chaperone coinducers also stabilize
membranes, which may be of special importance to prevent
apoptotic events related to the decomposition of cardiolipin
and the consecutive instabilization of the mitochondrial
membrane (Torok et al., 2003). Recently, a successful
application of the chaperone coinducer arimoclomol has been
shown to delay the onset of amyotrophic lateral sclerosis
(Kieran et al., 2004). Another chaperone coinducer, BRX-220,
has been shown to protect against CCK-induced acute
pancreatitis (Fujiwara et al., 2004) (Table 1).
Figure 3 Bimoclomol binds to the HSF-1 with a low affinity (Hargitai et al., 2003). Fitting of /R/-bimoclomol to the 3D model of
the DNA-binding domain of human HSF-1. The SiteID, FlexX and the FlexiDock modules of the Sybyl package were used
sequentially to identify the loop domain as the active center (yellow–red amino acids) of the DNA-binding domain of human HSF-1
and dock bimoclomol (green) into this site. The calculated binding energy for the /R/-bimoclomol was 26 kcalmol1. The
backbone of the polypeptide is shown (purple).
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Diminished heat stress response in hyperlipidemia and
aging: potential use of Hsp inducers as anti-ischemic
agents?
It is well known that aging leads to a diminished heat shock
response in several tissues, thereby resulting in the deteriora-
tion of stress adaptation (Demirel et al., 2003) (for a review,
see Soti & Csermely, 2003). We have recently reported that
experimental hyperlipidemia also leads to diminished heat-
stress response, as measured by Hsp70 expression in the
ischemic heart of rats (Csont et al., 2002). It is of great interest
that both aging and hyperlipidemia have been shown to
decrease the cardioprotective effects of the ischemic precondi-
tioning, that is, the endogenous adaptive response of the heart
to ischemic stress (for reviews, see Ferdinandy et al., 1998;
Baxter & Ferdinandy, 2001; Ferdinandy, 2003). The role of
Hsp’s in the mechanism of preconditioning has been exten-
sively reviewed elsewhere (Latchman, 2001; Snoeckx et al.,
2001). It has been shown that the cardioprotective effect of
preconditioning is linked to the functions of Hsp70, Hsp27,
and alphaB-crystalline. Heat stress or Hsp70 gene transfection
into rat hearts has been shown to protect the ischemic
myocardium (Arnaud et al., 2001; Jayakumar et al., 2001).
Therefore, it is plausible to speculate that the loss of the
protective effect of preconditioning in these disease states is
related – at least in part – to diminished heat stress response.
We have recently shown using DNA-microarray assay that
hyperlipidemia alters the expression of several chaperones
in the rat myocardium, including upregulation of Hsp86,
metallothionein and glutathione-S-transferase, as well as
downregulation of proteasome component C9, ubiquitin-like
protein FUBI, Hsp105, calreticulin and chaperonin subunit 5
epsilon (Puskas et al., 2004).
The mechanisms by which hyperlipidemia and aging lead to
diminished heat stress response are not known. It is suggested,
however, that the altered membrane lipid composition and
physical state (fluidity) of membranes are decisive factors in the
processes of perception and transduction of stress into a signal
that triggers the transcriptional activation of stress protein
genes. Nevertheless, Hsp inducers and coinducers may have
great therapeutic potential in aging and hyperlipidemia to regain
the endogenous adaptation of the heart to ischemic stress.
Cellular membranes act as alternative
thermosensors to regulate Hsp expression
Elucidation of primary sensors that perceive various stress
stimuli and transducers that carry signals culminating in the
expression of a particular Hsp is of great interest for the
development of novel Hsp inducers and coinducers. According
to the classical model, the common primary signal for
induction of Hsp’s is an increase in the amount of denatured
proteins within the cell during stress and their competition
with HSF (Morimoto, 1998) (see above for more refs). Hsp’s
are present in abnormal levels in a variety of human diseases
and aging, but there is no evidence for concomitant modifica-
tion of the kinetics of accumulation of denatured proteins that
could justify the changes observed in the expression of Hsp’s
(Vigh et al., 1998; Vigh & Maresca, 2002). For example,
curcumin, a well-known dietary pigment with potent anti-
inflammatory, antioxidant and anticancer effects, causes heat
shock response in transformed cell lines such as leukemia,
breast, colon, etc.; however, it has no effect on nontransformed
cell lines (Khar et al., 2001). Since no differences in the pattern
of protein denaturation have been reported between normal
and transformed cell lines, these data imply that the protein
denaturation is not (or not only) the mechanism by which
Hsp’s are upregulated. There is also evidence for differential
expression patterns of different Hsp’s in the same cell type in
response to the same stimulus (Heads et al., 1995). For example,
herbimycin-A provokes Hsp70 synthesis and protects against a
subsequent lethal heat stress; however, it does not activate the
transcription of other Hsp genes such as hsp90, hsp60, hsp27
and grp78 in cultured neonatal cardiomyocytes (Morris et al.,
1996). Monophosphoryl lipid A, a nontoxic derivative of
endotoxin with potent anti-ischemic effect, induced a remark-
able accumulation of Hsp70, but did not change the expression
of Hsp27, Hsp32 and Hsp90 in adult rat cardiac myocytes
(Nayeem et al., 1997). Selective stimulation of small Hsp’s,
Hsp27, and alfaB-crystalline but not Hsp70 was shown by
anisomycin following heat stress in C6 glioma cells (Kato et al.,
1999), by sphingosine1-phospate in osteoblasts (Kozawa et al.,
1999), by hydroxyurea in B16 murine melanoma cells (Eskenazi
et al., 1998), by short-chain fatty acids in the rat intestinal
epithelial cells (Ren et al., 2001) or by thrombin in aortic
smooth muscle A10 cells (Hirade et al., 2002), respectively.
These observations indicate that Hsp expression in response to
various stressors is regulated by differential control mechanisms
rather than by uniform mechanisms.
On the basis of experimental evidence, it is proposed that,
besides protein denaturation, specific membrane domains may
act as alternative sensors or ‘cellular thermometers’. Stress-
induced membrane perturbations are converted into signal(s)
leading to activation of heat-shock genes (Carratu et al., 1996;
Horvath et al., 1998; Vigh et al., 1998; Vigh & Maresca, 2002;
Shigapova et al., 2005). Changes in membrane composition
and/or fluidity alter the ‘set point’ for Hsp expression, with
expression initiated at lower temperatures in cells with more
fluid membranes (Carratu et al., 1996; Horvath et al., 1998;
Chatterjee et al., 2000; Shigapova et al., 2005) (Figure 4).
Cellular membranes as potential targets for Hsp inducers
Although the Hsp coinducing effects of bimoclomol were
shown to be mediated via HSF-1 as described above,
bimoclomol does not affect protein denaturation in the cells
(Vigh et al., 1997; Hargitai et al., 2003). It has been shown
that bimoclomol and its analogs specifically interact with
and significantly increase the fluidity of negatively charged
membrane lipids. Accordingly, the Hsp coinducing activity of
bimoclomol is highly susceptible to the fatty acid composition
and fluidity of membrane of target cells. In addition,
bimoclomol is an efficient inhibitor of bilayer-to-nonbilayer
lipid-phase transitions. Consequently, while sensitizing the
cellular membranes at mild heat shock conditions, the drug
protects against irreversible membrane damage at higher
temperatures (Torok et al., 2003). Thus, even subtle alterations
of the lipid phase of membranes caused by aging or
pathophysiological conditions may influence membrane-
initiated signaling processes either through fluidity changes
or by specific interactions of membrane lipids with receptor
proteins localized in the membrane. Taken together, it is highly
conceivable that plasma membrane, which is the barrier to the
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external environment and well suited for sensing stress, acts
also as an important regulatory interface. In line of this
concept, recently it was speculated that the reduced HSF-1 and
Hsp levels in diabetes are the result of reduced membrane
fluidity (Hooper & Hooper, 2005). In fact, as a result of
glycation, oxidative stress and insulin deficiency, diabetes is
associated with less fluid membranes in human mononuclear
leucocytes and platelets (Tong et al., 1995; Srivastava, 2002).
Since heat treatment itself causes membrane hyperfluidization,
it is not surprising that the daily hot water immersions in
patents with type II diabetes improve glycemic control and
reduce neuropathic symptoms (Hooper, 1999).
Perturbation of the organization and phase state of acidic
glycerophospholipids, the major determinants of the activity
of membrane proteins (van Klompenburg et al., 1997), by
nontoxic drugs like bimoclomol may influence the structure/
activity of membrane-bound proteins without direct drug–
protein interaction. Protein function influenced by membrane
fluidity and/or microheterogeneity has been suggested for
phospholipase A2, which is stimulated by heat shock, resulting
in arachidonic acid release (Honger et al., 1996; Samples
et al., 1999). Arachidonic acid stimulates HSF–DNA binding,
increases phosphorylation of HSF-1 and upregulates tran-
scription of theHsp70 gene in HeLa cells (Jurivich et al., 1994).
Elevated activity of membrane-bound phospholipases and the
resultant release of free fatty acids and diacylglycerols could
also enhance the membrane association and activation of
protein kinase C (PKC) isoforms responsible for the phos-
phorylation of HSFs. In agreement with these data, adminis-
tration of a PKC activator phorbol ester compound in
combination with heat shock markedly enhanced Hsp70
expression in K562 cells (Holmberg et al., 1997). Several other
pharmacological modulators of kinase/phosphatase activities
can alter the different regulatory steps of the heat shock
response. Highlighting the complexity of this point, over-
expression of inducible Hsp70 downregulated the basal
activities of protein kinase A, various free and membrane-
associated PKC isoforms and the MAP kinase pathways
including c-Jun N-terminal kinase and p38 stress-activated
protein kinase (p38 SAPK) (Kiang et al., 2002). Through the
activation of the glycosylation of membrane sterols, cholester-
ol glucoside is rapidly accumulating in cells from mold to
humans by exposure to environmental stress, and cholesterol
glucoside production is followed by the activation of certain
PKCs and induction of Hsp’s (Kunimoto et al., 2002).
Cholesterol glucoside accelerated the binding of HSF-1 to
HSE and upregulated Hsp70 synthesis in human fibroblast
(Kunimoto et al., 2002). Orally administered cholesterol
glucoside apparently showed antiulcer activity in rats via
HSF activation and Hsp70 induction (Kunimoto et al., 2003).
A bimoclomol-related compound, BRX-235, was shown to
induce phosphorylation of p38 SAPK, implying that the
molecule acted upstream of p38 SAPK (Denes et al., 2002;
Kabakov et al., 2005). HSF-1 appears to have several
additional layers of regulation in the cell, including Ras/
ERK1/GSK3/14-3-3 pathway (Hamaguchi et al., 2003; Wang
et al., 2003), Akt-induced inhibition of GSK-3b (Bijur & Jope,
2000), small G-protein signalling such as Ras (Engelberg et al.,
1994; Murakoshi et al., 2004) and oxidative stress-induced
membrane translocation of Rac1 (Xu et al., 2000; Han et al.,
2001), all potential targets for Hsp modulator development.
Noteworthy that simvastatin, the known hydroxymethyl-
glutaryl-CoA reductase inhibitor antihyperlipidemic drug,
blocked the oxidative stress-induced membrane translocation
of Rac1 (Negre-Aminou et al., 2002).
It is highly conceivable that the above findings are linked to
those hypothetic signal transduction pathways which transmit
the heat stress signal from membranes to DNA to induce
expression of Hsp’s. However, a lipid-selective association of a
subpopulation of Hsp’s with membranes, leading to increased
molecular order, may in turn lead to downregulation of the
heat shock gene expression (Torok et al., 1997; 2001;
Tsvetkova et al., 2002). Such a ‘crosstalk’ between the primary
stress sensor in the membranes and Hsp’s suggests a feedback
mechanism in the regulation of heat-shock genes, explaining
the known temporality of induction of Hsp’s. These findings
show that knowledge on pathways of stress signaling will
provide several molecular targets for further development of
Hsp modulators.
Conclusions and future perspectives
Chaperones play a major role in the mechanism of endogenous
stress adaptation of several tissues. However, altered chaperone
function has been associated with the development of several
pathologies; therefore, chaperone modulators became a new
and emerging field of drug development. Inhibitors of Hsp90
recently emerged as a very promising tool to combat various
forms of cancer. On the other hand, activation of chaperone
induction proved to be an efficient tool for the recovery from a
large number of diseases, such as, for example, ischemic heart
disease, diabetes and neurodegeneration. Development of
several Hsp modulators has already reached clinical phases.
Due to the promising results, specific chaperone modulators
could be one of the future blockbuster drugs on the market for
several different therapeutic indications.
Aging and disease states
Alterations in lipid metabolism
(sphingolipid, inositol lipid, cholesterol, 
formation of lipid peroxidation products, etc.)
Specific (microdomains: rafts, caveolaes, etc.)
and global (fludity, surface charge, permeability, etc.)
changes in membranes: development of “membrane defects”
Alterations in membrane and lipid-associated stress signaling
(Ras-ERK, Akt, PKC/JNK, etc.)
Unbalanced posttranslational modifications of HSF1
(multisite phosphorylation, SUMO-ylation etc.)
Dysregulated stress protein expression
(e.g. in aging and hypercholesterolemia: diminished stress response; 
in cancer: pathologically increased level of HSPs)
Figure 4 Cascade of events from membrane defects to dysregulated
stress protein response.
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Expressed as the sole Hsp90 of yeast, the a and b isoforms
of human Hsp90 differ with regard to their capacities for
activation of certain client proteins, whereas only Hsp90b
generates sensitivity to the Hsp90 inhibitor radicicol
Stefan H. Millson1, Andrew W. Truman1, Attila Ra´cz2, Bin Hu3, Barry Panaretou3, James Nuttall1,
Mehdi Mollapour1, Csaba So¨ti2 and Peter W. Piper1
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Heat shock protein 90 (Hsp90), an essential molecular
chaperone, catalyzes the ﬁnal activation step of many
of the key regulatory proteins in eukaryotic cells (the
Hsp90 ‘clients’). The list of proteins that are Hsp90
clients is impressive and ever-expanding (reviewed in
http://www.picard.ch [1,2]). It includes several of the
important determinants of multistep carcinogenesis,
such as ERBB2, C-RAF, CDK4, AKT ⁄PKB, steroid
hormone receptors, mutant p53, HIF-1a, survivin and
telomerase (hTERT). Genomic studies in yeast have
recently addressed the breadth of the Hsp90 clientele,
revealing that up to 10% of the proteome may be sub-
ject to Hsp90 regulation [3,4].
Most simple eukaryotes have only a single form of
cytosolic Hsp90 (e.g. Drosophila [5] and Caenorhabditis
elegans [6]). Although budding yeast (Saccharomyces
cerevisiae) has two isoforms of cytosolic Hsp90, one
constitutively expressed at high level (Hsc82) and the
other strongly heat-inducible (Hsp82) [7], these
most probably arose as the result of the ancestral
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Heat shock protein 90 (Hsp90) is a molecular chaperone required for the
activity of many of the most important regulatory proteins of eukaryotic
cells (the Hsp90 ‘clients’). Vertebrates have two isoforms of cytosolic
Hsp90, Hsp90a and Hsp90b. Hsp90b is expressed constitutively to a high
level in most tissues and is generally more abundant than Hsp90a, whereas
Hsp90a is stress-inducible and overexpressed in many cancerous cells.
Expressed as the sole Hsp90 of yeast, human Hsp90a and Hsp90b are both
able to provide essential Hsp90 functions. Activations of certain Hsp90
clients (heat shock transcription factor, v-src) were more efﬁcient with
Hsp90a, rather than Hsp90b, present in the yeast. In contrast, activation
of certain other clients (glucocorticoid receptor; extracellular signal-regu-
lated kinase-5 mitogen-activated protein kinase) was less affected by the
human Hsp90 isoform present in these cells. Remarkably, whereas expres-
sion of Hsp90b as the sole Hsp90 of yeast rendered cells highly sensitive to
the Hsp90 inhibitor radicicol, comparable expression of Hsp90a did not.
This raises the distinct possibility that, also for mammalian systems, altera-
tions to the Hsp90a ⁄Hsp90b ratio (as with heat shock) might be a signiﬁ-
cant factor affecting cellular susceptibility to Hsp90 inhibitors.
Abbreviations
AD, activator domain; BD, DNA-binding domain; CT, C-terminal activator ⁄modulator; DO, complete dropout glucose medium; ERK,
extracellular signal-regulated kinase; GR, glucocorticoid receptor; HSF, heat shock transcription factor; Hsp90, heat shock protein 90;
MAP kinase, mitogen-activated protein kinase; v-src, v-src tyrosine kinase; Y2H, yeast two-hybrid.
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duplication of the S. cerevisiae genome [8], as most
yeast species have just a single Hsp90.
Vertebrates also have two major forms of cytosolic
Hsp90 (Hsp90a; Hsp90b), isoforms that are generally
around 85% identical in amino acid sequence [9,10].
Hsp90b is expressed constitutively to a higher level
than Hsp90a in most tissues and is important for long-
term cellular adaptation, differentiation, and evolution.
The other isoform, Hsp90a (in humans, a form with
86% identity and 93% similarity in sequence to
Hsp90b), is generally stress-inducible and may there-
fore be a more cytoprotective form of Hsp90 [11].
Hsp90a is also expressed to high level in many cancers
[9], as well as extracellularly, where its effects on the
activity of metalloproteinase 2 may be important in
cancer cell metastasis [12].
Although the differential patterns of expression of
Hsp90a and Hsp90b suggest that these isoforms may
not be completely equivalent in function, there is as
yet no ﬁrm genetic evidence for a functional difference
between Hsp90a and Hsp90b [11]. During the heat
shock response, many mammalian cell types display
strong heat shock transcription factor (HSF)-directed
induction of Hsp90a. This induction of Hsp90a will
increase the a ⁄b isoform ratio, an increase that might
be a signiﬁcant factor in Hsp90-dependent actions [13].
In the yeast heat shock response, HSF-directed eleva-
tion of Hsp90 level is required in order to facilitate the
activation of an Hsp90 client protein kinase needed for
high-temperature growth [14]. This kinase, in turn,
activates a transcription factor responsible for a signiﬁ-
cant fraction of the non-HSF-dependent events of gene
induction in yeast subjected to heat shock stress [14].
The human genome appears to have just two func-
tional genes for Hsp90a and one for Hsp90b [10]. So
essential is the Hsp90 function conferred by these genes
that it is possible that neither Hsp90a nor Hsp90b can
be inactivated completely in vertebrate systems, creat-
ing a situation where the remaining isoform would have
to provide all the essential functions for cytosolic
Hsp90. Hsp90b loss is known to cause embryonic
lethality in the mouse [15]. Whereas it might be feasible
to generate Hsp90a or Hsp90b gene knockouts in
particular animal tissues, it is not clear whether this is a
realistic strategy for revealing any functional differ-
ences between the isoforms. We have therefore investi-
gated yeast strains that express, to similar levels, either
human Hsp90a or human Hsp90b as their sole Hsp90.
Here we report a study of the activation of various
Hsp90 clients and Hsp90 inhibitor sensitivity in such
strains; analysis that showed that many mammalian
clients are able to be activated by both Hsp90a and
Hsp90b. Whether Hsp90a or Hsp90b is expressed in
the yeast, however, has a dramatic effect on Hsp90
inhibitor sensitivity. This raises the intriguing possibil-
ity that the a ⁄b isoform ratio may be an important
determinant of such inhibitor sensitivity in mammalian
cells. In an independent study, yeasts expressing either
Hsp90a or Hsp90b were recently used to study the
effects of some naturally occurring sequence polymor-
phisms in the human genes for Hsp90 [16].
Results
PP30[hHsp90a] and PP30[hHsp90b] ) yeast strains
that express human Hsp90a or Hsp90b as their
sole Hsp90
S. cerevisiae strains PP30[pHSC82b], PP30[pHSP82]
and PP30[hHsp90b] are hsc82D hsp82D double mutant
cells that express, from a plasmid-borne Hsp90 gene,
either the native yeast Hsc82, the native yeast Hsp82 or
human Hsp90b as their sole, essential Hsp90 [17]. For
the current study, we constructed in this genetic back-
ground an additional strain in which the Hsp90 present
is human Hsp90a (PP30[hHsp90a]; see Experimental
procedures). Western blotting using an antiserum that
recognizes, with comparable efﬁciencies, both of the
yeast and both of the human isoforms of Hsp90 indi-
cated that the levels of Hsp90 expression in strains
PP30[pHSC82b], PP30[pHSP82], PP30[hHsp90a] and
PP30[hHsp90b] were comparable, although the Hsp90b
expression of PP30[hHsp90b] appeared to be slightly
lower than that of the other three strains (Fig. 1A). These
yeasts, isogenic but for theirHsp90 gene, might therefore
be expected to exhibit similar phenotypes. Nevertheless,
as the studies below reveal, the strains expressing
human Hsp90a or Hsp90b do exhibit some differences.
These isoforms are therefore not completely identical
in their in vivo actions, at least when expressed in yeast.
Phenotypic differences between strains
PP30[hHsp90a] and PP30[hHsp90b]
Investigating the properties of the strains expressing
human Hsp90a or human Hsp90b as their sole Hsp90,
we found no defect in respiratory growth, cell wall
integrity or the ability to withstand osmostress (pro-
perties defective in certain Hsp90 mutants of yeast
[3,14,18,19]; unpublished data). Both strains were
growth-arrested when exposed to the mating phero-
mone a-factor (data not shown), and so were not defec-
tive in this Hsp90-dependent response [20]. Also, when
rendered histidine prototrophic through the introduc-
tion of an HIS3 vector, both PP30[hHsp90a] and
PP30[hHsp90b] grew well at 30 C in the presence of
Human Hsp90a and Hsp90b expressed in yeast S. H. Millson et al.
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30 mm 3-aminotriazole. They are therefore not defective
in the Hsp90-dependent activation of Gcn2p kinase [21].
In contrast, the strain expressing Hsp90b was slightly
temperature-sensitive [PP30[hHsp90a], and exhibited
growth on YPD to 39–40 C, whereas PP30[hHsp90b]
grew only to 36–37 C (not shown)]. Growth of S. cere-
visiae at high temperature requires the activity of the
C-terminal activator ⁄modulator (CT) domain of yeast
HSF (Hsf1p). Cells expressing a CT domain-deﬁcient
Hsf1p exhibit no growth above 35 C. This high-temper-
ature growth defect is rescued by Hsp90 overexpression,
revealing that this growth defect is primarily due to the
low level of (Hsf1p-directed) Hsp90 expression in these
cells [14,22].
To ﬁnd whether heat activation of the Hsf1p CT
domain is defective in our strains expressing a single
Hsp90 isoform (all strains with a wild-type Hsf1p), we
monitored a reporter gene (HSE2-lacZ [23]) that mea-
sures activity of the Hsf1p CT domain (HSE2-lacZ
heat activation is completely lost in a yeast mutant
that expresses normal Hsp90 but a CT domain-deﬁ-
cient HSF; see Fig. 1B). We found efﬁcient HSE2-lacZ
activation by heat shock in cells expressing either the
native yeast Hsp82 or Hsc82, or the human Hsp90a
(PP30[pHSC82b], PP30[pHSP82], and PP30[hHsp90a],
respectively), but only moderate HSE2-lacZ activation
in the identically stressed PP30[hHsp90b] (Fig. 1C).
The induction of CT domain activity by heat stress is
therefore less efﬁcient with Hsp90b as compared to
Hsp90a present in the yeast. As temperature sensitivity
is normally associated with compromised activity of
the Hsf1p CT domain [14,22], the compromised heat
activation of this domain with Hsp90b present in the
yeast (Fig. 1C) is a plausible explanation for the mod-
erate degree of temperature sensitivity exhibited by
strain PP30[hHsp90b].
Activation of mammalian Hsp90 clients by either
Hsp90a or Hsp90b expressed in yeast
We were interested in whether mammalian Hsp90 cli-
ents would display any differences in activation when
expressed in the PP30[hHsp90a] and PP30[hHsp90b]
yeast strains, differences that might indicate a func-
tional nonequivalence of human Hsp90a and Hsp90b.
We therefore expressed in these strains three vertebrate
Hsp90 clients whose activities are known to be Hsp90-
dependent when expressed in yeast (client proteins,
therefore, that have already been demonstrated to be
activated by the native Hsp90s of yeast): glucocorticoid
receptor (GR) [24], v-src tyrosine kinase (v-src) [25],
and extracellular signal-regulated kinase-5 (ERK5)
mitogen-activated protein (MAP) kinase [18].
GR assays indicated that human Hsp90a and
Hsp90b, as well as the native yeast Hsp90s, were all
capable of activating GR in these strains (Fig. 2).
Active v-src expression is normally lethal for yeast,
an organism with very low intrinsic levels of tyrosine
kinase activity [25]. With use of a galactose-inducible
system for v-src expression, high levels of tyrosine
phosphorylation were generated in response to v-src
induction in PP30[hHsp90a] (Fig. 3B); an induction
associated with strong growth inhibition (Fig. 3A). In
contrast, the identically treated culture of strain
PP30[hHsp90b] exhibited much lower levels of tyrosine
A
B
C
Fig. 1. (A) Measurement of the relative levels of Hsp90 expression
in strains PP30[pHSC82b], PP30[pHSP82], PP30[hHsp90a], and
PP30[hHsp90b]. Ten micrograms of total soluble protein was gel
fractionated, and then western blotted; the blot was then probed
with anti-(Achlya Hsp90) monoclonal serum. The bands indicated by
an asterisk correspond to a slightly degraded, N-terminally trun-
cated form of Hsp90 that is often present in total cell extracts of
yeast [45]. (B) Levels of HSE2-LacZ reporter gene activity in strain
PSY145* with wild-type Hsf1p [22] (hatched bars) or strain
PSY145*HSF(1–583) with a CT domain-deficient Hsf1p [22] (open
bars), showing that heat induction of HSE2-LacZ is dependent on
the Hsf1p CT domain. (C) Measurements of HSE2-LacZ expression
in strains PP30[pHSP82], PP30[pHSC82b], PP30[hHsp90a], and
PP30[hHsp90b]; cultures either in growth at 25 C (–) or heat
shocked from 25 C to 37 C for 1 h (+). Measurements in (B) and
(C) are the mean and SD of eight separate assays on each culture.
S. H. Millson et al. Human Hsp90a and Hsp90b expressed in yeast
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phosphorylation (Fig. 3B), and the cells were also rela-
tively much less sensitive to the lethal effects of the
v-src expression (Fig. 3A). Hsp90a, but not Hsp90b,
therefore facilitated the efﬁcient production of active
v-src in these strains.
Although MAP kinases are generally considered to
have non-Hsp90-dependent activities [26], we recently
found that human ERK5 MAP kinase is an Hsp90 cli-
ent, at least when expressed in active form in yeast
[18]. ERK5 is the human ortholog of the yeast Slt2p
cell integrity MAP kinase (also an Hsp90 client); heter-
ologous expression of ERK5 in yeast completely res-
cuing the effects of loss of this native Slt2p [3,18].
ERK5 activity in yeast is therefore readily monitored
as the suppression of slt2D mutant phenotypes [18]. To
determine whether ERK5 could still provide the cell
integrity MAP kinase function when, in yeast cells,
either human Hsp90a or Hsp90b replaced the native
Hsp90, we constructed slt2D mutant versions of strains
PP30[hHsp90a] and PP30[hHsp90b] (see Experimental
procedures). These strains (PP30[hHsp90a]slt2D and
PP30[hHsp90b]slt2D) were then transformed with either
a control empty vector or a vector for constitutive
ERK5 expression (pG1 and pG1-ERK5, respectively
[18]), as well as a plasmid bearing the YIL117w-LacZ
reporter gene [27], which monitors the activity of
Rlm1p, a transcription factor activated by cell integrity
MAP kinase.
Loss of cell integrity MAP kinase generates a num-
ber of characteristic phenotypes in yeast, including
temperature and caffeine sensitivity [28–30] and loss of
mating projection formation upon treatment with mat-
ing pheromones [31]. Plasmid pG1-ERK5 rescues these
phenotypes of slt2D yeast [18]. It was also able to res-
cue these phenotypes in both PP30[hHsp90a]slt2D and
PP30[hHsp90b]slt2D, the restoration of high-tempera-
ture (37 C) growth being shown in Fig. 4A. Both iso-
forms of human cytosolic Hsp90 can therefore activate
human ERK5 MAP kinase in yeast.
Rlm1p, the major trans-activator of cell wall genes
in yeast, is activated through Slt2p-catalyzed phos-
phorylation [27,32,33]. slt2D mutant cells therefore
display a pronounced Rlm1p activity defect. Hsp90 is
required for the rescue of their Rlm1p activity defect
by ERK5 expression, as such rescue is abolished by
the T22I Hsp90 mutation or by Hsp90 inhibitor treat-
ment [18]. As shown in Fig. 4B, ERK5 expression
provided an appreciable rescue of the Rlm1p activity
of PP30[hHsp90a]slt2D and PP30[hHsp90b]slt2D, acti-
vity that was increased by two stress inducers of cell
integrity pathway signaling, heat shock and caffeine.
This is yet further evidence that both Hsp90a and
Hsp90b are able to activate human ERK5 expressed
in yeast.
Fig. 2. Measurements of GR activity in 30 C cultures of strains
PP30[pHSP82], PP30[pHSC82b], PP30[hHsp90a], and PP30[hHsp90b],
3 h following addition of either 20 lM (open bars) or 50 lM (solid
bars) dexamethosone. The data shown are the mean and SD of
four separate assays on each culture. In the absence of inducer,
activity levels were consistently less than 10 mU (units are defined
as in [43,45]).
A
B
Fig. 3. (A) v-src exerts a much stronger dominant-negative effect in
Hsp90a-expressing tha in Hsp90b-expressing yeast. Serial dilution
of either PP30[hHsp90a] or PP30[hHsp90b], transformed either
with empty pRS316 vector or the vector for galactose-inducible
v-src expression, grown for 3 days at 29 C on DO minus uracil
and galactose plates. (B) Analysis of the levels of protein
tyrosine phosphorylation before (–) or 1 h after (+) transfer of these
PP30[hHsp90a] and PP30[hHsp90b] transformants from glucose to
galactose medium. Detection was with antibody to phosphotyro-
sine.
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Two MAP kinase clients show a stronger
interaction with Hsp90b as compared to Hsp90a
Slt2p and ERK5 are Hsp90 client MAP kinases that
both acquire stronger capacity for Hsp90 binding
in vivo when phosphorylated by the upstream MAP
kinase kinase, Mkk1 ⁄ 2p. Their interactions with the
native Hsp90 of yeast are therefore strengthened by
conditions of stress, such as heat shock, that activate
cell integrity pathway signaling to Mkk1 ⁄ 2p [3,14,18].
We used the yeast two-hybrid (Y2H) system to deter-
mine the relative strengths of in vivo interaction of
these two MAP kinases with the two isoforms of
human Hsp90. In the yeast Hsp90s, a C-terminal
Gal4p DNA-binding domain (BD) extension preserves
the essential Hsp90 functions in vivo, whereas position-
ing this BD at the N-terminus of Hsp90 inactivates the
chaperone [34]. We therefore constructed strains that
express Y2H ‘bait’ fusions comprising Hsp90a and
Hsp90b with C-terminal BD extensions (Hsp90a-BD,
Hsp90b-BD; see Experimental procedures). These were
then mated to cells expressing the previously described
Gal4p activator domain (AD)-Slt2p and AD-ERK5
‘prey’ fusions [3,18]. Expression of the GAL7 pro-
moter-regulated LacZ gene in the resulting diploid
strains, a gene reporter of protein–protein interaction,
was then analyzed. As shown in Fig. 5A, both the
Slt2p and ERK5 MAP kinases displayed stronger
Y2H interactions with Hsp90b than with Hsp90a.
Consistent with Slt2 and ERK5 acquiring an
enhanced capacity for Hsp90 binding in vivo in
response to Mkk1 ⁄ 2-directed phosphorylation of the
MAP kinase activation loop [3,14,18], Y2H interaction
of these MAP kinases with the two isoforms of human
Hsp90 was strengthened by heat shock (Fig. 5A). The
stronger interaction of ERK5 with Hsp90b, relative to
Hsp90a, was then conﬁrmed through an analysis of
extracts of PP30[hHsp90a]slt2D and PP30[hHsp90b]
slt2D cells expressing a functional [18] ERK5(1–407)-
His12 fusion. More Hsp90b, relative to Hsp90a, was
associated with the nickel resin-retained ERK5(1–407)-
A
B
Fig. 4. (A) Growth (3 days in YPD) at either 30 C or 37 C of
PP30[hHsp90a]slt2D and PP30[hHsp90b]slt2D cells transformed
with pG1 or pG1-ERK5. (B) Measurements of YIL117c-LacZ expres-
sion in PP30[hHsp90a]slt2D (open bars) and PP30[hHsp90b]slt2D
(black bars) transformed with pG1-ERK5, either in growth at 25 C
(unstressed), heat shocked from 25 C to 37 C for 1 h, or exposed
for 1 h to 8 mM caffeine at 25 C. In the absence of ERK5 expres-
sion, expression levels were less than 2 mU.
A
B
Fig. 5. (A) The relative strengths of Hsp90a-BD–AD-Slt2p, Hsp90b-
BD–AD-Slt2p, Hsp90a-BD–AD-ERK5 and Hsp90b-BD–AD–ERK5
Y2H interactions, both at 30 C and 1 h following a 30 C to 39 C
heat shock. These measurements of interaction-responsive LacZ
expression in strain PJ694 reveal that AD-Slt2p and AD-ERK5 bind
more strongly to Hsp90b-BD than to Hsp90a-BD in this system.
The control cells (all exhibiting less than 0.1 mU b-galactosidase
activity, not shown) were those expressing AD-Slt2p or AD-ERK5
but with empty pBDC vector, as the basal levels of LacZ expres-
sion in this system are generally due to the AD fusion [49]. (B)
Determination of Hsp90 associated with nickel resin-retained, wild-
type ERK5(1–407)-His12 in extracts from PP30[hHsp90a]slt2D and
PP30[hHsp90b]slt2D cultures, either in growth at 25 C, or heat
shocked from 25 C to 39 C for 1 h. The blots were probed with
anti-(Achlya Hsp90) and anti-tetra-His sera. Control lanes (C) are the
extracts from unstressed, non-ERK5-expressing cultures of the
same strains.
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His12 (Fig. 5B). As this, and the Y2H interactions in
Fig. 5A, essentially reﬂect the formation of a late-stage
complex of the Hsp90 chaperone cycle [3,14,18], it is
possible that MAP kinase complexes with Hsp90b in
yeast progress more slowly through this chaperone
cycle than do the equivalent complexes with Hsp90a
(see Discussion).
Expression of Hsp90a or Hsp90b markedly affects
cellular sensitivity to the Hsp90 inhibitor radicicol
We recently reported that strain PP30[hHsp90b] is
extremely sensitive to Hsp90 inhibitors [35]. This, how-
ever, is not a general effect of human Hsp90 expres-
sion in yeast, as the cells expressing Hsp90a were not
sensitized to the Hsp90-targeting antibiotic radicicol.
Instead, strain PP30[hHsp90a] was relatively radicicol-
resistant, displaying levels of sensitivity comparable to
that of isogenic strains expressing either of the two iso-
forms of the native yeast Hsp90 (PP30[pHSC82b],
PP30[pHSP82]); Fig. 6A,C,D. Remarkably, low radici-
col levels (to 4 lm) were found to increase the ﬁnal
biomass yields of PP30[pHSP82], relative to the other
strains tested (Fig. 6). In addition, at high temperature
(37 C as compared to 30 C), the presence of the
Hsp82 isoform of yeast Hsp90 in these cells rendered
cells much less susceptible to radicicol inhibition as
compared to comparable expression (Fig. 1A) of the
97% identical Hsc82 (compare Fig. 6B,C). In normal
yeast (although not these engineered strains), Hsp82 is
the strongly heat-inducible isoform of Hsp90, whereas
Hsc82 is constitutively expressed [7]. As far as we are
aware, the data in Fig. 6A–C represent the ﬁrst evi-
dence of a phenotypic difference generated by compa-
rable expression (Fig. 1A) of the different isoforms of
native Hsp90 in yeast.
With 30 C 4 lm radicicol treatment of proliferating
PP30[hHsp90b] cells, the cells continued to enlarge, but
their growth totally lacked organization (rhodamine–
phalloidin staining revealed almost instant loss of any
actin organization following Hsp90 inhibitor treatment;
data not shown). After 6 h, many of these cells displayed
an apparent arrest of DNA and vacuolar segregation
between the mother and daughter (Fig. 6D; middle
image). By 24 h, over half had adopted the terminal
phenotype of enlarged, misshapen cells, their elongated
shape being consistent with a general failure of the acto-
myosin contractile ring formation that normally leads to
cytokinesis (Fig. 6D; left-hand cell cluster in right-hand
image). With such 4 lm radicicol treatment, all of these
phenotypes were displayed by PP30[hHsp90b], but not
the more resistant PP30[hHsp90a] (Fig. 6D). At this
A
D
B C
Fig. 6. (A–C) Only Hsp90b, not Hsp90a, sensitizes yeast to radicicol. Final biomass yields, expressed as a percentage of that of cells with
no inhibitor, for cells expressing just a single isoform of either yeast Hsp90 (r, Hsp82; j, Hsc82) or human Hsp90 (e, Hsp90a; h, Hsp90b),
cultured for 42 h in the presence of (A) 0–4 lM radicicol, 30 C, (B) 0–50 lM radicicol, 30 C, or (C) 0–50 lM radicicol, 37 C. (D) Morphologic
differences between PP30[hHsp90a] and PP30[hHsp90b] cultured for 6 or 24 h at 30 C in the presence of 4 lM radicicol.
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radicicol concentration, the latter strain was not arrested
in growth (Fig. 6A,B).
Discussion
In this work, we have investigated how the presence
of Hsp90a or Hsp90b ) as the sole Hsp90 in yeast
cells ) inﬂuences both the activation of certain clients
in these cells and cellular sensitivity to the Hsp90
inhibitor radicicol. The most striking ﬁnding was that
it is only expression of Hsp90b, not comparable
expression of Hsp90a, which renders yeast highly sen-
sitive to radicicol (Fig. 6). This raises the distinct pos-
sibility that, in mammalian systems as well, alterations
to the Hsp90a ⁄Hsp90b ratio (as with heat shock) may
be a signiﬁcant factor affecting sensitivity of cells to
Hsp90 inhibitors. Up to now, the Hsp90a ⁄Hsp90b iso-
form ratio has never been considered as a possible
inﬂuence on Hsp90 drug resistance. Instead, the total
level of the drug target (Hsp90) in cells, and the
amount of this Hsp90 that becomes locked into com-
plexes with client proteins [36] have generally been
considered to be important factors in such resistance.
Nevertheless, the true picture as regards the determi-
nants of Hsp90 drug resistance is considerably more
complicated than this, as studies of yeast mutants have
revealed that altered resistance can arise with mutation
to Hsp90, with altered cochaperone function and with
the loss of plasma membrane drug efﬂux pumps [35].
The results of this study point to the two isoforms
of human cytosolic Hsp90 differing in the relative efﬁ-
ciencies with which they activate certain Hsp90 clients,
at least in yeast. Cells that express Hsp90b as their sole
Hsp90 are moderately heat-sensitive, which may be
due in part to lowered Hsf1p activity (Fig. 1C). Acti-
vations of GR and ERK5 were seemingly efﬁcient with
either Hsp90a or Hsp90b in the yeast (Figs 2 and 4).
In contrast, activation of v-src was clearly compro-
mised with Hsp90b rather than Hsp90a present in the
cells (Fig. 3). Evidently, therefore, Hsp90a engages in
a much more productive chaperone cycle leading to
v-src activation in yeast, as compared to Hsp90b.
Among src tyrosine kinases, v-src exhibits a much
higher dependence on Hsp90 relative to c-src [1,25].
The former is just one of many mutant oncogenic pro-
teins that tend to accumulate as Hsp90-containing
multiprotein complexes in cancer cells; cells that are
often found to be overexpressing Hsp90a at a high
level [36]. Future studies should therefore address
whether diverse oncogenic proteins ) with activities
that often exhibit a high dependence on Hsp90 func-
tion ) are, in general, more efﬁciently activated by
Hsp90a than by Hsp90b.
Hsp90 tends to transiently bind its client proteins, in
a chaperone cycle thought to take place over a time
scale of minutes [37,38]. In yeast, Hsp90b undergoes
stronger Y2H interaction with MAP kinase clients than
Hsp90a (Fig. 5). As detection of in vivo protein–protein
interaction by the Y2H approach requires a fairly long
association of ‘bait’ and ‘prey’ fusions in the nucleus of
the living cell, these stronger MAP kinase Y2H interac-
tions with Hsp90b as compared to Hsp90a (Fig. 5A)
are consistent with a longer residence time of these cli-
ents in the form of multiprotein complexes in vivo when
associated with Hsp90b as compared to Hsp90a ) an
indication that Hsp90b may progress rather more
slowly through the chaperone cycle than Hsp90a. Y2H
interactions with Hsp90 are generally only detected
when the chaperone cycle is slowed [3].
In mammalian cells, the fraction of the cellular
Hsp90 existing in the form of multiprotein complexes
with client proteins appears to be a major determinant
of Hsp90 drug sensitivity, the high sensitivity of certain
cancer cells to these drugs apparently being associated
with the large pool of mutant client proteins sequester-
ing much of the Hsp90 into Hsp90–client complexes
[36]. Thus, the high radicicol sensitivity of
PP30[hHsp90b] relative to the other strains tested
(Fig. 6) may, in part, be due to a higher Hsp90 frac-
tion in this strain existing as multichaperone complexes
with high afﬁnity for client proteins, rather that as the
latent uncomplexed chaperone.
The ATPase reaction of Hsp90 is thought to consti-
tute the rate-limiting step of the Hsp90 chaperone cycle
in vivo, ATP turnover rate therefore being an important
determinant of the length of time for which a client
remains Hsp90-bound [39–41]. The question therefore
arises of whether more inefﬁcient Hsp90b operation in
yeast relates to the extremely low intrinsic ATPase of
this Hsp90b [41]. Nevertheless, intrinsic ATPase activ-
ity measurements on puriﬁed vertebrate Hsp90s indi-
cate that this activity is not appreciably different for
Hsp90a as compared to Hsp90b [ATP turnover rates
for recombinant chick Hsp90a and human Hsp90b are
0.025 and 0.015 min)1 (30 C), respectively [42]; for
recombinant human Hsp90a and 90% pure rat
Hsp90b, they are 0.046 and 0.035 min)1 (37 C),
respectively (C. So¨ti, unpublished data)]. In vivo, how-
ever, a number of other factors may come into play to
affect this activity. A still unexplored factor is whether
Hsp90a differs signiﬁcantly from Hsp90b in its regula-
tion by cochaperones. For example, heat shock
increases the levels of Aha1p, a cochaperone that acti-
vates the ATPase activity of Hsp90. Aha1p levels will
therefore increase in cells under the same heat stress
conditions that generate an increased Hsp90a ⁄Hsp90b
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ratio [43]. This, in turn, may affect the operation of the
Hsp90 chaperone machine.
Experimental procedures
Yeast strains and yeast culture
Cultures were grown at 30 C or 33 C, either on complete
dropout glucose medium (DO) [44] or on YPD medium
[2% (w ⁄ v) glucose, 2% Bacto peptone, 1% yeast extract,
20 mgÆL)1 adenine). Radicicol was purchased from Sigma
(Poole, UK).
Derivatives of strain PP30 that express, as their sole
Hsp90, the native Hsc82 or Hsp82 of S. cerevisiae
(PP30[pHSC82b], PP30[pHSP82]), as well as human
Hsp90b (PP30[hHsp90b]), have been described previously
[35]. A plasmid (pH90a) for human Hsp90a expression in
S. cerevisiae was constructed by PCR ampliﬁcation of the
Hsp90a ORF using the forward primer AAATAAGTCG
ACATGCCTGAGGAAACCCAG (SalI site underlined;
Hsp90a start codon in bold) and the reverse primer CTTC
ATCTGCAGTTAGTCTACTTCTTCCAT (PstI site under-
lined; stop codon position in bold). This PCR product was
cleaved with SalI and PstI, and then inserted into Sal
I–PstI-cleaved pHSCprom (an expression vector that
comprises the LEU2 vector YCplac111 with S. cerevisiae
HSC82 promoter and ADHI terminator inserts [45]),
thereby creating pH90a. Fusion of the HSC82 promoter to
the human Hsp90a sequence was conﬁrmed by sequence
analysis. Transformation of pH90a into S. cerevisiae
PP30[pHSC82] (MATa trp1-289, leu2-3,112, his3-200, ura3-
52, ade2-101oc, lys2-801am, hsc82::kanMX4, hsp82::kanMX4
[pHSC82]), and then curing of the pHSC82 URA3 vector
by restreaking onto plates containing 5-ﬂuoroorotic acid
(Melford Laboratories, Ipswich, UK), were as done as pre-
viously described [46], leading to a strain (PP30[hHsp90a])
that expresses human Hsp90a as its sole Hsp90.
Determination of client activations
Measurements of HSE2-LacZ expression, GR expression
and v-src expression were all done as previously described
[17,25,43,45]. Viability of v-src-expressing yeast strains was
determined on SGC-URA plates in dot spot experiments.
Plates were incubated for 3 days at 29 C.
To express human ERK5 MAP kinase in place of the
native Slt2p cell integrity MAP kinase in cells with either
Hsp90a or Hsp90b, slt2D mutant versions of PP30[hHsp90a]
and PP30[hHsp90b] were generated. First, strain PP30slt2D
was constructed by hphMX4 cassette [47] deletion of the
SLT2 gene in PP30[pHSC82]. The LEU2 vectors pH90a (this
study) and pH90b [35] were then inserted into this PP30slt2D,
and this was followed by 5-ﬂuoroorotic acid curing of the
pHSC82 URA3 vector, as previously described [46]. The
resultant strains (PP30[hHsp90a]slt2D; PP30[hHsp90b]slt2D)
were then transformed with the TRP1 plasmids pG1 and
pG1-ERK5 (control empty vector and vector for TDH1
promoter-driven ERK5 expression, respectively [18]) or
pHis-ERK5(1–407) (a vector forMET25 promoter-regulated
expression of a functional truncated ERK5 with a C-terminal
12xHis tag) [18].
Western blot analysis
Total protein extracts were prepared and western blots pre-
pared as described previously [46]. Antisera used at 1 : 2500
dilution were mouse monoclonal antibodies to Achlya ambi-
sexualis Hsp90 (Stressgen, Victoria, Canada) or tetra-His
(Qiagen, Crawley, UK).
Two-hybrid studies
Two-hybrid baits that consist of human Hsp90a and
Hsp90b fusions with a C-terminal BD extension (Hsp90a-
BD; Hsp90b-BD) were generated by homologous recombi-
nation within yeast, essentially as previously described
[34,48]. ORFs of these human Hsp90s were initially ampli-
ﬁed by two sequential PCR ampliﬁcations. The ﬁrst PCR
used primers that possess 3¢ sequence homologies to these
Hsp90s but 5¢ homologies to plasmid pBDC [34] (Hsp90a,
forward primer GCTTGAAGCAAGCCTCGATGCCT
GAGGAAACCCAGACCCAA, reverse primer CAGT
AGCTTCATCTTTTCGGTCTACTTCTTCCATGCGTGA;
Hsp90b, forward primer GCTTGAAGCAAGCCTCGAT
GCCTGAGGAAGTGCACCATGGA, reverse primer CA
GTAGCTTCATCTTTCGATCGACTTCTTCCATGCGA
GA). The second PCR used a universal pair of primers
[34,48]. PJ69-4a [48] was then transformed with the product
of this second PCR and NruI-digested pBDC, so as to gen-
erate, through homologous recombination within PJ694a
yeast, genes for Hsp90a-BD or Hsp90b-BD fusions. PJ694a
cells expressing the AD-Slt2p and AD-ERK5 fusions
(described previously [3,18]) were then mated to PJ694a
expressing Hsc82-BD, Hsp82-BD [34], Hsp90a-BD, or
Hsp90b-BD. The resultant PJ69-4 diploids (now expressing
both AD- and BD-fusions) were selected on DO lacking
histidine and tryptophan. Automated measurement of the
b-galactosidase activity due to basal and stress-induced
expression of the interaction-responsive, GAL7 promoter-
regulated LacZ gene of PJ69-4 was as previously described
[3,18,49]. The data shown (mean and SD of eight individual
assays) are expressed relative to the control diploid PJ69-4
cells containing pBDC lacking a gene insert and the plas-
mid for AD-fusion expression [as the low basal LacZ
expression levels in this system are generally due to the
AD-protein fusion, the even lower LacZ expression level in
cells containing an Hsp82-BD ‘bait’ and empty AD vector
(pOAD) are essentially unaffected by stress [49]].
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Drug sensitivity assays
Cells were inoculated into liquid DO containing the
indicated level of inhibitor, to a ﬁnal density of
6 · 105 cellsÆmL)1. Final cell density was monitored after
growth at either 30 C or 37 C, as indicated in the
legend to Fig. 6.
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Abstract
Chaperones and zinc are indispensable for proper immune function. All the zinc status, the immune function and the stress response
decline during aging. Here we studied the eﬀect of nutritional zinc and zinc homeostasis on the stress response in healthy old subjects
recruited during the ZincAge European Union project that either underwent or not a 48-day zinc supplementation. Inducible Hsp70 lev-
els were determined at basal conditions as well as after heat shock in the CD3+ and CD3 subset of lymphocytes by a two-color FACS
analysis. Short term zinc supplementation resulted in a marked increase in both basal as well as stress-induced Hsp70 levels in lympho-
cytes from healthy elderly donors with a higher impact on CD3+ cells. Heat inducibility showed a strong correlation with basal Hsp70
level, and both basal as well as stress-induced Hsp70 highly correlated with intracellular zinc availability. In conclusion, short term oral
supplementation with zinc safely and eﬃciently induces the stress response in lymphocytes of old donors. The stress response may be a
candidate pathway connecting zinc deﬁciency with aging and immunosenescence. Thus, proper dietary zinc intake may emerge as a chap-
erone inducer and an anti-aging mechanism in the immune system.
 2008 Elsevier Inc. All rights reserved.
Keywords: Stress response; Hsp70; Zinc; Zinc supplementation; Lymphocytes
1. Introduction
Zinc is one of the most important trace elements in the
body (Stefanidou et al., 2006). It has a catalytic/regulatory
role in many enzymes, maintains the structural integrity of
various proteins (such as superoxide dismutase and zinc-
ﬁnger transcription factors) and modulates protein–protein
interactions. At the cellular level zinc is essential for cell
proliferation and survival, contributes to genomic stability
and antioxidant defense, which highlights its crucial role in
aging and age-dependent degenerative diseases. Zinc is
indispensable for proper immune function. Zinc deﬁciency
increases susceptibility to infections, compromises both
innate immunity and the T-cell compartment (Shankar
and Prasad, 1998; Rink and Haase, 2007). It is well docu-
mented that zinc status and immune function declines with
aging, and zinc supplementation is beneﬁcial to immune
responses in the elderly (Haase et al., 2006b; Larbi et al.,
2006).
Molecular chaperones are conserved and abundant pro-
teins that guard the conformational homeostasis of pro-
teins (Hartl, 1996). They maintain signaling, regulate
proliferation, diﬀerentiation and apoptotic pathways (S}oti
et al., 2005b; Sreedhar and Csermely, 2004). Chaperones
(or stress proteins) confer cytoprotection and assure sur-
vival upon various stresses. The stress response is regulated
by the heat shock transcription factor 1 (HSF-1), named
after the archetype of proteotoxic stress. HSF-1 induces
0531-5565/$ - see front matter  2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.exger.2008.01.002
Abbreviations: HSF-1, heat shock transcription factor 1; Hsp70, 70 kDa
heat shock or stress protein; MFI, mean ﬂuorescence intensity; PBMC,
peripheral blood mononuclear cells.
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the transcription of various stress proteins. Inducibility of
the major chaperone, the 70 kDa heat shock protein
(Hsp70) reﬂects the robustness of the stress response, which
is indispensable for adaptation (Voellmy, 2004). Both a sin-
gle heat shock as well as transgenic Hsp70 induces longev-
ity (Tatar et al., 1997), HSF-1 overexpression induces a
twofold life-span extension, while HSF-1 knock-out mark-
edly shortens life-span (Hsu et al., 2003; Garigan et al,
2002), demonstrating the central importance of a robust
stress response in aging in invertebrate models. HSF-1
knock-out mice neither display heat shock response, nor
show premature aging in ‘sterile’ laboratory conditions.
However, they are hypersensitive to endotoxemia, which
reinforces the role of the stress response in immune func-
tion and inﬂammation (Xiao et al., 1999). Moreover, both
chaperone inducibility and chaperone function decrease
during aging and in chronic inﬂammation characteristic
to the elderly (Nardai et al., 2002; S}oti and Csermely,
2003; Arslan et al., 2006), therefore preserving their func-
tion is an attractive target in anti-aging therapies (S}oti
et al., 2005a; S}oti and Csermely, 2005).
Zinc and chaperones are connected in many ways (Larbi
et al., 2006; Arslan et al., 2006; S}oti and Csermely, 2005).
Zinc is a potent inducer of Hsp70 in cell culture (Hatayama
et al., 1993) including lymphoblasts form old, but not from
young donors (Ambra et al., 2004). Both zinc deﬁciency
and overdose inhibits the stress response in rodent thymus
(Moore et al., 2003). Thus, proper dietary zinc is critical for
mounting a robust stress response. The ZincAge project
funded by the 6th Framework Program of the European
Union aimed to study the role of nutritional zinc in healthy
aging and in immunosenescence. We were interested to
study the relationship of zinc homeostasis and aging with
the stress response, an essential adaptive and survival
mechanism in the immune system. Here we report on the
eﬀect of zinc status on the stress response of lymphocytes
obtained form healthy elderly donors.
2. Materials and methods
2.1. Subjects and zinc supplementation
Twenty healthy old subjects (between 64 and 85 years of
age) were enrolled according to the inclusion criteria
required by the ZincAge European speciﬁc targeted
research project (www.zincage.org) approved by the
respective National Ethical Committees. Brieﬂy, all sub-
jects were originated from Italy, lived an independent life,
were in a good general health conditions devoid of func-
tional impairment and serious acute or chronic disease,
without taking medical drugs or nutritional supplements.
All subjects gave informed consent and underwent medical
examination and clinical laboratory tests. Seven persons
from the twenty healthy old subjects underwent an oral
zinc supplementation which was performed with 10 mg
pure zinc/day (in the form of 50 mg zinc-aspartate Unizink
50, KO¨HLER PHARMA Corp., Alsbach-Ha¨hnlein, Ger-
many) for 48 ± 2 days. All subjects admitted to zinc sup-
plementation had values of plasma zinc below 11 lM at
least at one test out of two made within one year.
2.2. Blood withdrawal and PBMC preparation
Heparinized whole blood samples after an overnight fast
were withdrawn from each subject before and after zinc
supplementation. The whole blood was centrifuged at
450g for 10 min at 4 C to separate the plasma. Peripheral
blood mononuclear cells (PBMC) were prepared by Ficoll-
Hypaque (d = 1.077 g/ml) gradient centrifugation (450g for
30 min at 20 C), washed twice in PBS, and aliquots were
made in fetal bovine serum containing 10% DMSO and
were frozen in liquid nitrogen until further use.
2.3. Plasma zinc and intracellular zinc ion availability
determination
Plasma zinc levels were analyzed by induction plasma
coupled mass spectrometry (ICP-MS). All plasma samples
and standard were diluted 1:10 with a solution containing
the following reagents: 0.1% Triton X-100, to maintain a
stable emulsion with the diluted sample and 0.15%
HNO3, to ensure that trace elements are maintained in
solution and to aid washout of these elements between
samples. External calibration solutions containing zinc
(blank to 2000 ppb), were prepared by serial dilution of
parent 1000 ppm stock (VHG Labs, Manchester, NH,
USA), using the same solution used to dilute the samples.
Measurement of plasma zinc was performed with a
Thermo XII Series ICP-MS (Thermo Electron Corpora-
tion, Waltham, MA, USA), using an external calibration
curve containing zinc (blank to 2000 ppb). The instrument
was operated with a Peltier-cooled impact bead spray
chamber, single piece quartz torch (1.5 mm i.d. injector)
together with Xi interface cones and a Cetac-ASX 100
autosampler (CETAC Technologies, Omaha, Nebraska,
USA). A Burgener Trace nebuliser was used as this device
does not block during aspiration of clinical samples. The
instrument was operated in standard mode (non-CCT),
using 1400 W RF power, 1.10 L/min nebuliser gas ﬂow,
0.70 L/min auxiliary gas ﬂow, 13.0 L/min cool gas ﬂow,
70 ms dwell time, 30 s sample uptake and 35 s wash time
(two repeats per sample). Zinc ion availability of PBMC
was measured with zinpyr-1 (ZP1) (Neurobiotex, Galves-
ton, TX, USA) by ﬂow cytometry, as described (Malavolta
et al., 2006)). Brieﬂy, PBMCs (1  106) were stained with
20 lM Zinpyr-1 for 30 min at 37 C and 5% CO2 in
HEPES-buﬀered ‘‘zinc-free” RPMI Medium supplemented
with 1 mM EDTA. Following incubation, cells were ana-
lyzed with a ﬂow cytometer (Coulter Epics XL, Coulter,
Hialeah, FL, USA). The population of lymphocytes was
selected using FSC and SSC and the ZP1 derived ﬂuores-
cence was detected at 525 nm using 488 nm excitation
wavelength. Data for zinc ion availability are reported as
the mean ﬂuorescence intensity normalized to the mini-
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mum ﬂuorescence obtained after the addition of 50 lM
N,N,N0,N0-tetrakis (2-pyridylmethyl)ethylenediamine (TPEN)
(Sigma–Aldrich, MI, Italy).
2.4. Cell culture and heat shock treatment
PBMC were gently thawed in RPMI 1640 medium, sup-
plemented with 10 mM Hepes, 10% fetal bovine serum,
2 mM L-glutamine, 100 lg/ml streptomycin and 100 IU/
ml penicillin (all from Gibco–Invitrogen, Carlsbad, CA,
USA) and incubated for 16 h at 37 C in a 5% CO2 incuba-
tor at isobaric oxygen. Each PBMC sample was divided
into control and heat shock aliquot. Heat shock was per-
formed at 43 C for 1 h in an Eppendorf thermomixer at
a cell density of 106/ml. The induction of the heat shock
response was allowed to develop for 4 h at 37 C in a 5%
CO2 incubator. Control PBMCs of the same person were
treated identically except for exposing the cells to heat
shock. Then cells were harvested, washed with PBS supple-
mented with 2% fetal bovine serum, counted and the viabil-
ity was assessed using a CASY TT cell counter (Scharfe
Systems, Bielefeld, Germany). Viability was over 90%.
2.5. Intracellular staining and ﬂow cytometry
Cells were ﬁxed and permeabilized in 250 ll Cytoﬁx/
Cytoperm solution (BD Biosciences Pharmingen, San
Diego, CA, USA) at 4 C for 20 min. Cells were then
washed two times with Perm/Wash solution (BD Biosci-
ences Pharmingen, San Diego, CA, USA) and incubated
with ﬂourochrome-conjugated mouse monoclonal antibod-
ies [anti-CD3 allophycocyanin (APC) conjugated antibody
(345767, BD Biosciences, San Diego, CA, USA) and anti-
Hsp70 ﬂuorescein isothiocyanate (FITC) conjugated anti-
body (SPA-810FI, Stressgen, Alberta, Canada)] at 4 C
for 30 min. (CD3 immunostaining either in intact non-per-
meabilized or in permeabilized cells gave identical results.)
For compensation cells were stained either with anti-CD3-
APC conjugated antibody or with anti-CD3-FITC conju-
gated antibody (345763, BD Biosciences, San Diego, CA,
USA) as described above. After washing once with Perm/
Wash solution and once with PBS with 2% FBS cells were
ﬁxed with 2% paraformaldehyde in PBS and analyzed with
a FACSCalibur ﬂow cytometer using the CellQuest soft-
ware (BD Biosciences, San Diego, CA, USA). Approxi-
mately 5000 live lymphocytes from each sample were
electronically gated according to granularity and size in
the forward versus side scatter (Fig. 1A). Diﬀerentiation
between CD3+ and CD3 subpopulations was achieved
in the CD3-APC vs. forward scattergram (Fig. 1B).
Hsp70-related ﬂuorescence was obtained in a 530/30
(FITC) ﬁlter, and the relative Hsp70 protein level was
expressed as the mean ﬂuorescence intensity (MFI) of
FITC from logarithmic histograms. As a standard, two
parallel vials of lymphocytes isolated from the buﬀy coat
of a healthy subject (purchased from the Hungarian
National Blood Transfusion Service, approved by the
National Ethical Committee, and in accordance with the
Helsinki regulations) were used in each experiment includ-
ing heat shock treatment, staining and FACS analysis.
2.6. Statistical analysis
Data were statistically analyzed using Statistical Pack-
age for the Social Sciences software version 15.0 for Win-
dows (SPSS Inc., Chicago, IL, USA). Variables are
expressed as mean ± standard error of the mean (SEM).
Means were either compared by using the Student’s paired
samples or independent samples t-test. Correlation of con-
tinuous variables was analyzed by the Spearman algorithm.
A p value (two-tailed) <0.05 was considered statistically
signiﬁcant.
3. Results
3.1. Characteristics of the stress response in lymphocyte
populations
In order to gain insight into the stress response in spe-
ciﬁc subpopulations of lymphocytes, we set up a two-chan-
nel FACS analysis, using CD3 (Fig. 1A and B), a
T-lymphocyte marker, and Hsp70, the major cytosolic
stress protein. Initial experiments were performed on
pooled PBMCs from healthy donors. While basal Hsp70
level reﬂects steady-state chaperone capacity, stress-
induced Hsp70 level determines the robustness of adapta-
tion to a noxious insult. Heat shock, a model of fever
was selected not only as the archetype of stress but also
as an important physiopathological determinant of lym-
phocyte function. The optimal conditions of induction
were found to be 43 C for 1 h and 4 h of recovery time
to allow Hsp70 synthesis (data not shown) and used in sub-
sequent comparative studies.
Looking at the Hsp70 distributions, a high and a low
Hsp70-expressing population could be observed, and the
high population could respond more dynamically to heat
shock (Fig. 1C all, 37 vs. 43 C). Further examining the
relationship between baseline and heat-induced Hsp70 lev-
els, we investigated the stress response in PBMC obtained
from old donors. We found a signiﬁcant correlation
between these variables in the CD3+ lymphocyte popula-
tions, while no such strong association existed in CD3
lymphocytes (Fig. 2). Moreover, the strong correlation
persisted with respect to inducibility, indicating that it is
indeed a relationship between the basal level and the
mounting of the stress response. We did not observe any
gender-speciﬁc eﬀect.
3.2. Zinc supplementation boosts the stress response
Next, we tested the eﬀect of clinical zinc supplementa-
tion on the stress response. Seven healthy elderly subjects
received 10 mg zinc/day for 48 ± 2 days, and blood was
withdrawn before and after the supplementation. Zinc sup-
454 A´kos Putics et al. / Experimental Gerontology 43 (2008) 452–461
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plementation did not signiﬁcantly increase plasma zinc
concentration, however, it promoted a signiﬁcant improve-
ment of zinc availability, an intracellular measure of free
zinc ion available for cellular reactions, therefore a better
marker of zinc homeostasis (Table 1). Fig. 3 shows the indi-
vidual characteristics of the stress response in the total lym-
phocyte population before and after zinc supplementation.
All the basal (panel A) and heat-induced Hsp70 levels (B)
as well as the inducibility (C) were boosted by oral zinc
supplementation, as can be seen from the upward trend
of the individual subjects. However, heat induction of
Hsp70 showed a more uniform and stronger increase.
Statistical analysis showed a signiﬁcant increase of the
heat-induced Hsp70 as well as the stress-inducibility upon
zinc supplementation, while the basal Hsp70 level dis-
played a tendency to increase, probably due to the limited
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Fig. 1. Diﬀerential stress response in diﬀerent lymphocyte populations. (A) Scatterplot distribution of lymphocytes in the forward vs. side scattergram. (B)
Diﬀerentiation of CD3 (R3) and CD3+ (R2) lymphocyte populations using an anti-CD3-APC ﬂuorescence. (C) Histograms of basal (37 C) and heat-
induced (43 C) Hsp70 levels in total, CD3+ and CD3 populations by depicting the anti-Hsp70-FITC ﬂuorescence. The ﬁgure is a representative of three
independent experiments.
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number of subjects (Fig. 4). Zinc aﬀected the CD3 popu-
lation to a smaller extent. It should be also noted that
CD3 lymphocytes displayed a higher basal level but a less
intense heat induction of Hsp70 than CD3+ cells (Fig. 4).
Furthermore, the lymphocyte fraction that highly express
Hsp70 (gated at Hsp 70 MFI > 18) showed a sharp increase
both under basal as well as heat-induced conditions upon
zinc supplementation (basal: 9.6 ± 2.9% before zinc vs.
22.1 ± 6.3% after zinc, p = 0.026; heat-induced:
22.0 ± 16.7% before zinc vs. 57.8 ± 5.5% after zinc,
p = 0.004, respectively).
To further investigate the eﬀect of orally taken zinc on
the stress response, we compared the Hsp70 status of sub-
jects (Age: 76.6 ± 1.7, n = 10) after zinc supplementation
with that of subjects (Age: 72.2 ± 1.8, n = 10. p = 0.095
for age) not having taken zinc tablets. Fig. 5 demonstrates
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Fig. 2. Relationship between basal and heat-induced Hsp70 levels in
CD3+ and CD3 lymphocyte populations from old donors. PBMC were
obtained from healthy elderly patients (n = 20). Hsp70 levels were
expressed as the mean ﬂuorescence intensity (MFI). Observed heat-
induced (43 C) vs. basal (37 C) Hsp70 MFIs were plotted from CD3+
(A) and CD3 (B) lymphocyte populations of the same individual.
Bivariate linear correlations were calculated using the Pearson’s algorithm
and the parameters are indicated on the charts.
Table 1
Age of the subjects and zinc status before and after zinc supplementation
Age (years) Plasma Zn (lM) Zn availability
Before Zn suppl. 74.7 ± 2.0 12.1 ± 0.7 1.26 ± 0.03
After Zn suppl. — 13.5 ± 1.5 1.39 ± 0.02
P — 0.367 0.013
Data (n = 7) were obtained as described in Section 2 and shown as
mean ± SEM. p values were calculated using the Student’s paired samples
t-test.
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Fig. 3. Hsp70 status of lymphocytes from individual healthy old subjects
before and after clinical zinc supplementation. PBMC were obtained from
the same patients (n = 7) before and after a 48-day oral zinc supplemen-
tation (10 mg pure zinc/day) and the experiments were performed as
described in Section 2. Individual basal (37 C (A)) and heat-induced
(43 C (B)) Hsp70 levels are indicated as the mean ﬂuorescence intensity
(MFI), Hsp70 inducibility (C) is given as the 43 C/37 C ratio.
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that zinc-supplemented subjects had higher Hsp70 levels
and inducibility in all lymphocyte populations.
3.3. Robustness of the stress response correlates with
intracellular zinc availability
After having seen the eﬀect of clinical zinc supplementa-
tion, we were interested to analyze the relationship between
zinc status and Hsp70 levels/inducibility. We clustered the
subjects according to either plasma zinc or intracellular
zinc availability in low or high groups. Subjects with high
zinc availability displayed a higher steady state Hsp70 level
and a more robust stress response. Plasma zinc levels did
not signiﬁcantly diﬀer between groups (Table 2). Using
the same subjects, further calculation of bivariate linear
correlations of basal Hsp70 vs. zinc availability and heat-
induced Hsp70 vs. zinc availability showed that both the
basal as well as the heat-induced Hsp70 level correlated sig-
niﬁcantly with intracellular zinc availability in a concentra-
tion-dependent manner (basal Hsp70 vs. intracellular zinc
availability: R2 = 0.3260, p = 0.005; heat-induced Hsp70
vs. intracellular zinc ion availability: R2 = 0.4137,
p = 0.002). In contrast, plasma zinc level seemed to have
no signiﬁcant correlation with heat-induced Hsp70 levels
(R2 = 0.0048, p = 0.772). We observed no gender-speciﬁc
eﬀect.
4. Discussion
Loss of adaptation to stress is a hallmark of aging. A
major molecular mechanism behind is a decrease in heat
shock response, a fundamental cytoprotective and survival
mechanism in several models (S}oti and Csermely, 2003;
Arslan et al., 2006), including human blood cells and extra-
cellular chaperones of the elderly (Njemini et al., 2002; Rea
et al., 2001; Singh et al., 2006). Since molecular chaperones
are intimately involved in signaling and proliferation, a less
robust stress response may not only cause limited survival,
but may also contribute to the compromised reactivity of
old lymphocytes to various inﬂammatory stimuli, a phe-
nomenon called immune cell anergy (Pawelec, 2006).
Besides, looking at two lymphocyte subpopulations it
turned out that CD3 cells had a signiﬁcantly higher basal
and a lower heat-induced Hsp70 level then their CD3+
counterparts. Whether the CD3 B-cells (and NK-cells)
have almost no stress tolerance (in terms of heat shock
response) only in elderly subjects and if it relates to
immune function is an intriguing open question.
Stress tolerance, the adaptation to an environmental
noxa depends on the robustness of the stress response,
i.e. the inducibility of stress proteins by the heat shock
transcription factor (Voellmy, 2004). Preconditioning
(exposure to a mild stress, like hormesis [Verbeke et al.,
2001; Rattan, 2004]) results in elevations in Hsp70 and
other stress proteins, a more robust stress response and a
better adaptation with implications in longevity. However,
large elevation in Hsp70 is only transient and the remaining
protein level is insuﬃcient to meet the increased demand
during stress. To our knowledge, no molecular mechanism
has been associated with a better mounting of the stress
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Fig. 4. Hsp70 status of diﬀerent lymphocyte populations from healthy old
subjects before and after clinical zinc supplementation. PBMC were
obtained from the same patients (n = 7) before and after a 48-day oral zinc
supplementation (10 mg pure zinc/day) and the experiments were
performed as described in Section 2. Basal (37 C, (A)) and heat-induced
(43 C, (B)) Hsp70 levels were expressed as the mean ﬂuorescence intensity
(MFI), Hsp70 inducibility (C) is given as the 43 C/37 C ratio. Bars
represent the mean + SEM of the total (All), the CD3+ and the CD3
lymphocyte populations, respectively. p values were calculated using the
Student’s paired samples t-test and levels of signiﬁcance are as
follows: * denotes p < 0.05, ** denotes p < 0.005, *** denotes p < 0.001.
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response after a previous/chronic mild stress. We observed
that basal Hsp70 level in the CD3+ lymphocytes strongly
correlates (R2 = 0.6102) with its own inducibility
(Fig. 2A). Our results imply that Hsp70 may indeed oper-
ate a positive feedback loop chaperoning its own synthesis
upon a subsequent stress, providing a framework for stress
tolerance. Furthermore, one can predict that cells possess-
ing higher basal Hsp70 levels might have been primed by
hormetic means and have better chances to adapt to stress.
On the contrary, continuously very high level, such as
strong overexpression of Hsp70 would compromise cell
physiology (Seo et al., 1996), but this threshold either
may not be reached in physiological setting or in the old
cells analysed in the current study. Further studies are
needed to explore the molecular details and its applicability
as a biomarker of stress tolerance.
Zinc is indispensable for proper immune response. Zinc
deﬁciency is detrimental, while zinc supplementation is
beneﬁcial to T-lymphocyte function (Shankar and Prasad,
1998; Rink and Haase, 2007). Both zinc status and immune
function declines with aging (Haase et al., 2006b; Larbi
et al., 2006). Here we obtained evidence that nutritional
zinc intake modulates the stress response. Short term zinc
supplementation markedly improved all aspects of lympho-
cyte Hsp70 homeostasis involving also CD3 cells, in spite
of their less reactivity to heat shock (Fig. 4). This eﬀect was
highly signiﬁcant even in a relatively small study popula-
tion. The observations were extended and conﬁrmed
towards subjects that were or were not supplemented with
zinc (Fig. 5). Intriguingly, plasma zinc was mostly in the
normal range for the subjects studied (Tables 1 and 2)
and there was no signiﬁcant diﬀerence of Hsp70 response
between subjects having lower and higher than 11 lM
plasma zinc concentration, respectively (data not shown).
In contrast, intracellular zinc availability highly correlated
with basal and heat-induced Hsp70 levels, strongly suggest-
ing that low zinc availability exerts a negative eﬀect on the
stress response, and even without subclinical zinc deﬁciency
(plasma Zn < 11 lM) zinc supplemented subjects show a
more robust Hsp70 induction. Notably, plasma zinc con-
centration did not seem to aﬀect Hsp70 inducibility. This
may be in part attributed to the limited number of subjects
and in part to the fact that plasma is often discussed not to
be reliable to monitor zinc status in humans, because zinc
occurs in the body primarily intracellularly and there is
only a small portion of zinc in the plasma mainly bound
to plasma proteins. Furthermore, plasma zinc is highly
dynamic and is profoundly aﬀected by several factors such
as diurnal rhythm, stress, infection, starvation and plasma
protein levels (Wood, 2000). Alternatively, zinc status is
measured by erythrocyte membrane zinc (Bettger and Tay-
lor, 1986) or metallothioneins (Sullivan et al., 1998), pro-
teins which are responsible for the regulation of
intracellular free zinc ions. Similarly to our results, Thomas
et al. (1992) showed that metallothionein concentrations in
erythrocytes elevated signiﬁcantly while no changes in
plasma zinc could be observed after zinc supplementation.
Recent in vitro assessments (Malavolta et al., 2006; Haase
et al., 2006a) and preliminary ‘‘in vivo” ﬁndings (Mocchegi-
ani, 2007; Cipriano et al., 2006) suggest that intracellular
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Fig. 5. Hsp70 status of diﬀerent lymphocyte populations from healthy old
subjects undergoing or not clinical zinc supplementation. PBMCs were
obtained from patients not supplemented (Non-suppl., n = 10) or supple-
mented (Zn-suppl., n = 10) with zinc (10 mg pure zinc/day for 48 ± 2
days) and the experiments were performed as described in Section 2 . Basal
(37 C, (A)) and heat-induced (43 C, (B)) Hsp70 levels were expressed as
the mean ﬂuorescence intensity (MFI), Hsp70 inducibility (C) is given as
the 43 C/37 C ratio. Bars represent the mean + SEM of the total (All),
the CD3+ and the CD3 lymphocyte populations, respectively. p values
were calculated using the Student’s independent samples t-test and levels
of signiﬁcance are as follows: * denotes p < 0.05, ** denotes p < 0.01.
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zinc availability (or labile zinc) of leukocytes may be a
parameter that allows a good determination of zinc status.
The intracellular zinc that is available for zinc-dependent
enzymes is often called as the labile pool of zinc which is
modulated by the release of zinc from intracellular vesicu-
lar stores or from metallothioneins what is essential to reg-
ulate many cellular processes such as apoptosis, stress
response or cell cycle (Jacob et al., 1998; Malavolta et al.,
2006). Moreover, since stress signals mobilize zinc by oxi-
dation of protein sulfur ligands (Maret, 2006), the assess-
ment of labile zinc represents an optimal target for
establishing a link between stress response and zinc status.
In addition to these, this method allowed also the determi-
nation of zinc in the cells analyzed while plasma zinc is not
a cell speciﬁc indicator of zinc status. Our ﬁndings corrob-
orates in vitro experiments that reported a stress response
inducing property of zinc in various cell cultures and
peripheral cells of diﬀerent origin (Hatayama et al., 1993;
Ambra et al., 2004; Bauman et al., 1993; Odashima et al.,
2002; Qing et al., 2004 and reviewed in Arslan et al.,
2006). Similarly, zinc in our study also increased the basal
steady-state Hsp70 level in human lymphocytes, suggesting
that zinc per se exerts a mild stress on a variety of cell
types. This property of zinc might resembles an hormetic
action (Rattan, 2004). In fact, the zinc-induced increase
in Hsp70 elicited a more intense stress response (2- to 4-
fold increase of heat-induced Hsp70) with no apparent
damage. Moreover, PBMC from zinc-supplemented people
had much better morphology (data not shown), arguing for
a generally improved ability to cope with stress. Since
blood samples were obtained and frozen under controlled
conditions at diﬀerent times by the same personnel, the
eﬀect observed was not due to diﬀerential sample
preparation.
Chaperones and zinc may co-operate in other ways, as
well. Besides, zinc is also an important regulatory metal
in protein function and signaling. Both zinc and chaper-
ones promote lymphocyte proliferation (Csermely et al.,
1988; Huse et al., 1998; Schnaider et al., 2000). Lack of zinc
results in decreased cell proliferation, skin and mucous
membrane manifestations and decreased wound healing
(Prasad, 2003), while chaperone upregulation facilitates
wound healing and regeneration (Vı´gh et al., 1997). More-
over, zinc deprivation compromises the stress response in
ketratinocytes, and in the Jurkat T-cell line (Larbi et al.,
2006; Parat et al., 1998). An upregulation of HSF-1 was
observed in T-cell clones both upon zinc deprivation and
during in vitro aging, suggesting a compensatory mecha-
nism. As HSF-1 is a zinc ﬁnger protein, it may be directly
aﬀected by ﬂuctuations in intracellular free zinc ion avail-
ability. This is supported by the fact that free intracellular
zinc is in the femtomolar range, around the KD of various
zinc-binding proteins (Outten and O’Halloran, 2001) and
p53 and the apurinic/apyrimidinic endonuclease are all
inactivated by zinc deﬁciency (Ho and Ames, 2002; Ho
et al., 2003). According to a recent intriguing hypothesis
of Bruce Ames (Ames, 2006), shortage of micronutrients
may promote the re-allocation of scarce micronutrients
towards processes favoring short term survival at the
expense of longevity. According to this, the stress response
(a major adaptation mechanism) would either enjoy an
intermediate priority (after basic cellular processes like oxi-
dative metabolism, and before reproduction) and as such,
would be downregulated during modest nutrient depriva-
tion, as seen in the present study. It is very much in agree-
ment with the fundamental role of the stress response in
longevity (S}oti and Csermely, 2003). Therefore, beyond
genomic stability, the stress response is another candidate
mechanism to connect nutrient scarcity with aging and
degenerative diseases, at least in the cases of zinc. Eﬀect
of other micronutrients on the stress response remains to
be elucidated.
As a conclusion, we provided evidence that dietary zinc
is a chaperone inducer and a major determinant of the
stress response in human lymphocytes in the elderly. Since
the stress response is a conserved and universal phenome-
non, and the eﬀect of zinc in vitro is fairly general, these
ﬁndings may have wider implications in other bodily tis-
sues as a possible anti-aging mechanism. However, whether
this is a proof of principle or a special exception will be a
subject of future studies.
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Resveratrol Induces the Heat-Shock Response and Protects
Human Cells from Severe Heat Stress
ÁKOS PUTICS, ESZTER MÁRIA VÉGH, PÉTER CSERMELY, and CSABA SO˝ TI
ABSTRACT
Molecular chaperones play key roles in protein quality control, signal transduction, proliferation, and cell
death, and confer cytoprotection and assure survival after environmental stress. The heat-shock response is
implicated in a variety of conditions including ischemic diseases, infection and immunity, neurodegeneration,
and aging. Physiologic and pharmacologic chaperone inducers were shown to be an efficient therapeutic ap-
proach in different acute and chronic diseases. Here we characterize resveratrol, a polyphenol from red wine,
as an inducer of the heat-shock response. Resveratrol activated the heat-shock promoter and the expression
of the major chaperone Hsp70 in cell lines and in human peripheral lymphocytes, comparable to moderate
heat stress. This effect was not due to its antioxidant property, because 5 mM N-acetylcysteine was unable to
activate the heat-shock response. Moreover, resveratrol failed to upregulate Grp78, and tunicamycin was un-
able to induce Hsp70, suggesting that the resveratrol-induced heat-shock response was not mediated by canonic
endoplasmic reticulum stress. Resveratrol synergized with mild to moderate heat shock and conferred cyto-
protection against severe heat stress. Our results reveal resveratrol as a chaperone inducer that may con-
tribute to its pleiotropic effects in ameliorating stress and promoting longevity. Antioxid. Redox Signal. 10, 65–75.
65
INTRODUCTION
MOLECULAR CHAPERONES are conserved, abundant, and es-sential proteins that guard the conformational homeo-
stasis of proteins (15, 58). Chaperones in the everyday setting
maintain signal transduction and other molecular networks, reg-
ulate proliferation and differentiation, and they are important
modulators of the immune response and apoptotic pathways (9,
30, 44, 45). Besides, chaperone (or stress) protein levels are
subject to a sudden and transient increase with stress, a so-called
stress or heat-shock response, a basic cellular adaptation mech-
anism (27). Chaperone induction is mediated at the transcrip-
tional level by an autoregulatory feedback loop: an increase in
misfolded proteins results in the release of heat-shock tran-
scription factor 1 (HSF-1)1 from the repressing Hsp90/Hsp70/
Hsp40 complex, and a consequent transcriptional activation of
various heat-shock genes. Beyond chaperones, a variety of reg-
ulatory mechanisms are involved in the regulation of HSF-1 ac-
tivity, including phosphorylation, trimerization, nuclear import,
and termination of transcription (52).
The heat-shock response confers stress tolerance, cytopro-
tection, and assures short- and long-term survival during severe
environmental conditions. Both a single heat shock and trans-
genic Hsp70 induce longevity (47). HSF-1 overexpression in-
duces a twofold life-span extension, whereas HSF-1 knockout
markedly shortens the life span (13, 18) and compromises im-
mune responses in invertebrate and vertebrate model organisms,
respectively (13, 57). Moreover, proteotoxicity and cellular de-
generation increase, whereas chaperone inducibility and chap-
erone function decrease during aging (3, 28, 29). Modulation
of the chaperone levels has been shown to provide protection
in a variety of pathophysiologic states, such as ischemia/reper-
fusion, inflammation/sepsis, and conformational diseases (16,
41, 46, 49). Thus, preservation or enhancement of the heat-
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shock response is a subject of intense research. Chaperone in-
duction has been proven in preclinical studies to be an efficient
therapeutic approach in cardiovascular and age-related degen-
erative diseases involving cancer, diabetes, and neurodegener-
ation (11, 42, 43). Besides physiologic stressors (exercise,
sauna, calorie restriction), both synthetic and plant-derived
small molecules are among promising lead compounds (4, 19,
21, 23, 40, 50).
Resveratrol, a plant-derived polyphenolic compound, was
identified in 1992 as an ingredient of grape skin and red wine,
reducing the risk of coronary heart disease (40). Since then, it
has become clear that resveratrol displays an impressive thera-
peutic potential against cancer, ischemic injuries, cardiovascu-
lar and inflammatory diseases, as well as neurodegeneration (5,
20, 33). A potent antioxidant and antiinflammatory property is
an important determinant of its mechanism of action. Besides,
recent studies have shown that it induces stress resistance and
longevity in a variety of organisms, such as yeast, invertebrates,
and vertebrates (17, 48), and it may reprogram the bodily pro-
cesses similar to calorie restriction, probably by acting on the
sirtuin (SIR, silent information regulator) family of deacety-
lases (56). The puzzling similarity between the therapeutic ben-
efits of chaperone induction and resveratrol has led us to ex-
plore the effect of resveratrol on the heat-shock response of
mammalian cells. Here we provide evidence that resveratrol ac-
tivates the stress response, exerts a synergistic effect with mild
to moderate heat treatment, and confers cytoprotection against
a lethal heat shock. Our results reveal resveratrol as a chaper-
one inducer that may contribute to its pleiotropic effects in ame-
liorating stress and inducing longevity.
MATERIALS AND METHODS
Materials
Reagents for cell culture and Lipofectamine transfection
reagent were from Gibco-Invitrogen (Carlsbad, CA); solu-
tions and antibodies for flow cytometry were from BD Bio-
sciences (San Diego, CA); and Ficoll-Paque PLUS was from
GE Healthcare Bio-Sciences AB (Uppsala, Sweden). The
hsp70.1pr/luciferase plasmid was a kind gift of Richard Mo-
rimoto (Evanston, IL), the CMV/-galactosidase was from
BD Biosciences. The Bright-Glow luciferase and the -galac-
tosidase assay kits were from Promega (Madison, WI). Ma-
terials for protein determination, gel electrophoresis, and
Western blotting were from Bio-Rad (Hercules, CA). Trans-
resveratrol (RSV), N-acetyl-L-cysteine (NAC), hydrogen per-
oxide (H2O2), tunicamycin, the anti–-actin antibody and
propidium iodide were from Sigma (St. Louis, MO). The anti-
Hsp70 fluorescein isothiocyanate (FITC) conjugated anti-
body (recognizing inducible Hsp70) and the anti-Grp78
mouse monoclonal antibodies were from StressGen (Victo-
ria, BC, Canada). Peroxidase-conjugated secondary antibod-
ies were obtained from DAKO Cytomation (Glostrup, Den-
mark), and the ECL reagent was from New England Nuclear,
Perkin Elmer Life Sciences (Boston, MA). Complete tablets
were from Roche (Basel, Switzerland). All other reagents
were from either Sigma or Fluka (Buchs, Switzerland).
Preparation of lymphocytes
Human peripheral lymphocytes were isolated from a mixture
of buffy coats (purchased from the Hungarian National Blood
Transfusion Service, approved by the National Ethical Com-
mittee, and in accordance with the Helsinki regulations), which
were usually prepared from the venous blood of five young
healthy donors. To obtain leukocyte-rich plasma, the buffy coats
were first layered over 6% dextran in a ratio of 9:1 (vol/vol)
and sedimented for 1 h at room temperature. Lymphocytes were
then isolated by Ficoll-Paque PLUS (d  1.077 g/ml) gradient
centrifugation, according to the manufacturer’s instructions,
and washed twice in phosphate-buffered saline (PBS). Aliquots
were made in RPMI-1640 medium containing 40% fetal bovine
serum and 5% DMSO and were frozen in liquid nitrogen until
further use.
Cell culture and treatments
Peripheral lymphocytes were gently thawed and cultured in
RPMI 1640 medium, supplemented with 10 mM Hepes, 10%
fetal bovine serum, 2 mM L-glutamine, 100 g/ml streptomycin,
and 100 IU/ml penicillin at 37°C in a 5% CO2 incubator at iso-
baric oxygen. The African green monkey kidney fibroblast-like
cell line COS-7 was cultured in DMEM 4500, whereas the hu-
man cervical carcinoma cell line HeLa was cultured in mini-
mal essential medium supplemented with 10% fetal bovine
serum, 2 mM L-glutamine, 100 g/ml streptomycin, and 100
IU/ml penicillin. For each experiment, cells were treated first
with resveratrol (RSV) or with N-acetyl-L-cysteine (NAC) at
37°C in a 5% CO2 incubator for 10 h. Subsequent treatments
were performed with hydrogen peroxide (H2O2) for 2 h or with
tunicamycin for 16 h at 37°C in a 5% CO2 incubator. Heat shock
was carried out at 41–45°C for 20–60 min either in an Eppen-
dorf thermomixer (lymphocytes), or in a circulating water bath
(cultured adherent cells).
Transfection and HSF-1 reporter gene assay
COS-7 cells were plated in six-well plates at a density of
20% and transfected the next day with 1 and 0.5 g of
hsp70.1pr/luciferase and CMV/-galactosidase plasmids, re-
spectively, by Lipofectamin, according to the manufacturer’s
protocol. Treatments were made 24 h after transfection in com-
plete medium. Eighteen-hour posttreatment cells were lysed in
-galactosidase lysis buffer (Promega), and activities were de-
termined by Bright-Glow luciferase and -galactosidase com-
mercial assay kits and were expressed as a ratio.
Determination of Hsp70 levels by flow cytometry
The 106 lymphocytes or COS-7 cells were treated either with
resveratrol or NAC for 10 h and were or were not heat shocked,
as specified in the figure legends. The induction of the heat-
shock response was allowed to develop for 4 h at 37°C. Then
cells were fixed and permeabilized in 250 l Cytofix/Cytop-
erm solution at 4°C for 20 min. Cells were then washed twice
with Perm/Wash solution and incubated with an anti-Hsp70 flu-
orescein isothiocyanate (FITC)-conjugated mouse monoclonal
antibody and anti-CD3 Peridinin-chlorophyll-protein complex
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(PerCP) conjugated antibody at 4°C for 30 min in Perm/Wash
solution at a concentration recommended by the manufacturer.
For compensation, cells were stained either with anti-CD3-
PerCP–conjugated antibody or with anti-CD3 FITC–conjugated
antibody. After washing once with Perm/Wash solution and
once with PBS with 2% FBS, cells were fixed with 2% para-
formaldehyde in PBS and analyzed with a FACSCalibur flow
cytometer by using the CellQuest software (BD Biosciences).
Approximately 10,000 live lymphocytes from each sample were
electronically gated according to granularity and size in the for-
ward versus side scatter. Differentiation between CD3 and
CD3 subpopulations was achieved in the CD3-PerCP versus
side scattergram. Hsp70-related fluorescence was obtained in a
530/30 (FITC) filter, and the relative Hsp70 protein level was
expressed as the mean fluorescence intensity of FITC from log-
arithmic histograms.
Cell lysis and Western blotting
Cells were harvested, washed twice in PBS, then lysed in ly-
sis buffer (20 mM Hepes, 100 mM NaCl, 1 mM EDTA, 1%
NP40, pH 7.5, and 2 Complete protease inhibitor cocktail for
20 min at 4°C, vigorously vortexed, and centrifuged at 13,000
rpm for 10 min in a microcentrifuge. Protein content of the su-
pernatants was determined by the Bio-Rad Bradford-assay with
bovine serum albumin used as standard. Then 50 g protein
from detergent cell lysates was subjected to a 9% SDS-PAGE
and electroblotted by using a semidry transfer apparatus on ni-
trocellulose membranes. Blots were blocked in 5% milk pow-
der at room temperature, probed with the appropriate primary
antibodies (Abs) overnight at 4°C, washed and incubated with
peroxidase-conjugated secondary antibodies for an hour at room
temperature, and developed by using an ECL reagent.
Cell-survival assay
The 106 cells per sample were incubated in the presence or
absence of resveratrol for 10 h at 37°C, then treated with H2O2
or heat shocked, as indicated. Twenty-four hours later, cells
were harvested, washed twice with PBS with 2% FCS, and
stained with propidium iodide at a final concentration of 10
g/ml in PBS with 2% fetal bovine serum at room temperature
for 15 min. Flow-cytometric analysis was performed with a
FACSCalibur flow cytometer and the CellQuest software by
using 488 nm excitation and 630/22 emission filters, respec-
tively. Cell debris was eliminated by gating according to side-
scatter and forward-scatter detection, and 10,000 cells were
analyzed. The percentage of PI-negative (surviving) cells was
calculated by single-parameter analysis of the PI-related fluo-
rescence by using logarithmic histograms.
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FIG. 1. Resveratrol induces heat-shock promoter activation
and acts as a chaperone co-inducer. (A) Activation of the
hsp70.1 promoter reporter by resveratrol at 37°C. (B) Resvera-
trol potentiates the heat-shock response in a concentration-de-
pendent manner (the 37°C curve is displayed for comparison).
(C) Resveratrol lowers the threshold of the heat-shock response.
COS-7 cells were co-transfected with hsp70.1pr/luciferase and
CMV/-galactosidase and were incubated with the indicated
concentrations of (A, B) or 50 M (C) resveratrol for 3 h, and
then were heat stressed for 20 min at the indicated temperatures
(B, C) as described in Materials and Methods. After 18 h, en-
zyme activities were determined, and their ratio was expressed.
Data represent mean  SD of three experiments. * or **, sig-
nificant differences at p  0.05 or p  0.01, respectively.
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Statistical analysis
Data were statistically analyzed by using Statistical Package
for the Social Sciences software version 15.0 for Windows
(SPSS Inc., Chicago, IL). Variables are expressed as mean 
standard deviation (SD). Means were compared by using the
Student’s t test. A p value (two-tailed)  0.05 was considered
statistically significant.
RESULTS
Resveratrol activates heat-shock promoter–driven
transcription
To investigate the effect of resveratrol on the stress response,
we first asked whether it induced the activation of the heat-
shock promoter containing consensus binding motifs of HSF-1.
We transiently transfected COS-7 cells with a luciferase con-
struct fused to the promoter of the major stress protein, the in-
ducible isoform of Hsp70 (53) and observed a dose-dependent
induction of the reporter activity at both 37°C and at 42°C (Fig.
1A and B). The EC50 values calculated from double reciprocal
plots were 8.6 and 15.2 M, respectively. A cytotoxic effect
was already observed at 200 M and became predominant at
400 M, where the stress-response induction was compromised,
as well (data not shown). Resveratrol potently induced heat-
shock promoter–driven transcription in HeLa cells, as well (data
not shown).
Because resveratrol potentiated the heat-shock response at
42°C (Fig. 1B), we tested whether they cooperate in a syner-
gistic manner. To this end, cells were pretreated with resvera-
trol and subjected to heat stress at different temperatures. Fig-
ure 1C shows that resveratrol exerted an effect comparable to
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FIG. 2. Resveratrol induces Hsp70 protein ex-
pression in different cell types. COS-7 cells
(A) or human peripheral lymphocytes (B) were in-
cubated with the indicated concentrations of
resveratrol for 15 h; then cells were harvested,
stained with an anti-Hsp70 antibody FITC-conju-
gate, subjected to flow cytometry, and the mean
fluorescence intensities were determined, as de-
scribed in Materials and Methods. Solid diamonds,
A 20-min (A) or a 60-min (B) heat stress at 43°C
4 h before analysis. Data represent mean  SD of
three (A) or two (B) experiments, respectively.
*Significant difference at p  0.05.
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a 41°C heat shock, and a combination treatment at 41°C re-
sulted in a higher heat-shock response than that at 42°C. Sim-
ilarly, the combination of resveratrol with a 42°C treatment was
highly synergistic, suggesting that resveratrol increases the ro-
bustness of adaptation to a harmful stimulus. HeLa cells simi-
larly displayed a very pronounced synergy between resveratrol
and heat shock (data not shown).
Resveratrol induces Hsp70 protein expression
To see whether the activating property of resveratrol would
be translated into the expression of intrinsic chaperone proteins,
COS-7 cells were treated with resveratrol, and the amount of
the inducible Hsp70 protein was analyzed with flow cytometry
(Fig. 2A). Resveratrol induced a fivefold accumulation of
Hsp70 protein, close but not similar to the protein level after a
43°C heat stress. Maximal induction could not be properly de-
termined because above 200 M, resveratrol became cytotoxic
(data not shown). After establishing resveratrol as a chaperone
inducer in cell lines, we were seeking a more physiologic cel-
lular model to characterize. Because the stress response is of
central importance in the immune system, lymphocytes are gov-
ernors of immune activity, show a weak stress response, and
heat stress in the form of fever potentiates their function (30,
31, 38), we investigated human peripheral lymphocytes as a
possible target of the action of resveratrol. Indeed, resveratrol
treatment recapitulated the earlier findings on cell lines, al-
though with different kinetics (Fig. 2B). Hsp70 induction
seemed to start at the higher dose of 40 M and reached a
plateau at 80 M, resembling to a sigmoid cooperative response
curve. Even though none of the values, including the heat stress,
reached statistical significance, the maximal Hsp70 induction
of resveratrol tended to be higher than that of the 43°C treat-
ment, suggesting a physiologically relevant stress response–in-
ducing property.
Resveratrol’s mechanism of action is mediated
neither by its antioxidant property nor by a
canonic ER stress response
A potent direct antioxidant property is a reminiscent feature
of polyphenols and contributes to the beneficial effects of
resveratrol. However, an increasing body of evidence argues
for an indirect effect and implicates the upregulation of anti-
oxidant enzymes and inhibition of redox-active signaling by
resveratrol (35). It was also reported that the thiol antioxidant
1,2-dithiole-3-thione stimulated Hsp70 expression in dopamin-
ergic neuronal cells (2). To mimic the presumed antioxidant
property of resveratrol, we examined the possibility that a well-
known thiol antioxidant, N-acetylcysteine (NAC) (14) would
interfere with the stress response. But 5 mM NAC was unable
to activate or coactivate the heat-shock promoter with heat
stress in COS-7 and HeLa cells, respectively (Fig. 3A and data
not shown). In contrast, it inhibited the heat-induced reporter
activity, suggesting the role of reactive oxygen species in pro-
moter activation. However, when H2O2 was tested at various
concentrations, it did not induce the stress response at the HSF-
1, the mRNA, or the protein level (E.M.V, Á.P., C.S., unpub-
lished observations). Moreover, the inhibitory effect of NAC
could not be observed in HeLa cells, arguing against a general
mechanism (data not shown). Besides the results shown here,
NAC had no influence on Hsp70 protein expression either in
COS-7 cells or in peripheral lymphocytes (Fig. 3B and data not
shown), which further argues against a general antioxidant
property of resveratrol in its heat-shock–related effects.
It was recently reported that resveratrol induces longevity in
Caenorhabditis elegans via the induction of a subset of ER-
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FIG. 3. The antioxidant N-acetylcysteine does not induce
the heat shock response. (A) N-acetylcysteine (NAC) does
not activate the hsp70.1-promoter reporter. COS-7 cells were
co-transfected with hsp70.1pr/luciferase and CMV/-galactosi-
dase and were incubated with or without 5 mM NAC for 3 h,
and then were heat stressed at 42°C or were kept at 37°C for
20 min, as described in Materials and Methods. After 18 h, en-
zyme activities were determined, and their ratio was expressed.
(B) NAC does not induce Hsp70 protein expression. COS-7
cells were incubated with or without 5 mM NAC for 10 h, were
heat stressed at 42°C, or were kept at 37°C for 20 min, as de-
scribed in Materials and Methods. Four hours later, cells were
harvested, stained with an anti-Hsp70 antibody FITC-conju-
gate, subjected to flow cytometry, and the mean fluorescence
intensities were determined. Data represent mean  SD of two
experiments. *Significant difference at p  0.05.
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resident protein genes (51). Therefore, we analyzed possible
crosstalk between the unfolded protein response/ER-stress path-
way and the cytosolic heat-shock response. We found that tu-
nicamycin, an inhibitor of core glycosylation, did not activate
the heat-shock reporter. Furthermore, tunicamycin potently in-
hibited the heat-induced activation of the heat-shock promoter
in both COS-7 and HeLa cells (Fig. 4A and data not shown).
Notably, Hsp70 protein levels did not reflect the inhibition of
the heat-shock promoter on tunicamycin treatment (Fig. 4B),
raising the possibility that in these circumstances, transcrip-
tional and posttranscriptional regulation of Hsp70 became un-
coupled, which resulted in the preservation of adaptation to heat
stress.
To acquire an insight into the effect of resveratrol on ER
stress, Grp78, the major chaperone of the ER and a marker of
the unfolded protein response, was analyzed with Western
blotting. Figure 4C shows that neither resveratrol nor NAC in-
duced Grp78 protein. Furthermore, neither agent interfered with
Grp78 induction on tunicamycin treatment. Our results confirm
earlier findings on C. elegans, in which resveratrol did not in-
duce a canonic unfolded protein response, including the Grp78
orthologue (51). Neither they nor we found a general derange-
ment in protein homeostasis in the models studied on resvera-
trol treatment (51, and data not shown). These observations sug-
gest neither an overwhelming stress nor an imbalance in protein
homeostasis, but a specific signaling event may mediate a se-
lective induction of the cytosolic stress response by resveratrol.
Resveratrol protects cells from severe heat stress
Resveratrol has a well-documented chemopreventive and cy-
toprotective property because of its prominent action on free
radicals and on the redox homeostasis (5, 35). Resveratrol pre-
treatment potently inhibited cell death under circumstances of
oxidative stress in human peripheral lymphocytes (Fig. 5A).
However, its ability to induce apoptosis may mask its benefi-
cial effects under other stresses (12). We observed an aug-
mented cell death in resveratrol-treated lymphocytes compared
with control cells (data not shown).
Because molecular chaperones and the heat-shock response
antagonize proteotoxic noxae, we tested whether resveratrol
conferred cytoprotection against heat stress. Cells precondi-
tioned with resveratrol displayed an increasing survival at in-
creasing temperatures, even at the lethal 45°C heat shock (Fig.
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FIG. 4. Resveratrol does not use a canonic ER-stress path-
way to induce the heat-shock response. (A) Tunicamycin
does not activate the hsp70.1–promoter reporter and inhibits its
heat-induced activation. COS-7 cells were co-transfected with
hsp70.1pr/luciferase and CMV/-galactosidase, and were incu-
bated with or without 2 g/ml tunicamycin for 3 h, and then
were heat stressed at 42°C or were kept at 37°C for 20 min, as
described in Materials and Methods. Eighteen hours later, en-
zyme activities were determined, and their ratio was expressed.
(B) Tunicamycin does not induce Hsp70 protein expression.
COS-7 cells were incubated with or without 2 g/ml tuni-
camycin for 10 h, were heat stressed at 42°C, or were kept at
37°C for 20 min. Four hours later, cells were harvested, stained
with an anti-Hsp70 antibody FITC-conjugate, subjected to flow
cytometry, and the mean fluorescence intensities were deter-
mined. (C) Resveratrol does not induce Grp78 protein expres-
sion. COS-7 cells were incubated with or without NAC and
resveratrol (RSV) at the indicated concentrations for 3 h, and
then samples were supplemented with 1 g/ml tunicamycin,
and incubation was continued for 15 h. Cells were harvested,
lysed, and subjected to immunoblotting for Grp78 and -actin.
Data represent mean  SD, and the blot is a representative of
two experiments. *Significant difference at p  0.05.
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5B). These results suggest that resveratrol may ameliorate the
consequences of proteotoxicity, probably via induction of the
heat-shock response.
DISCUSSION
Resveratrol is a member of the polyphenol family of phyto-
chemicals, plant-derived small molecules with potent and wide
range of biological effects. Polyphenols, including resveratrol,
possess antimicrobial, antitumor, antiinflammatory, antiisch-
emic, and neuroprotective properties (12, 35, 36). Resveratrol
is the first compound that has been recognized to promote
longevity in several organisms (17, 48, 56), including mice kept
on a high-calorie diet (6), predicting a tremendous benefit for
human health. It has also been suggested that resveratrol acts
via the sirtuin family of the NAD-dependent deacetylase fam-
ily that connects metabolic stress and aging (17).
Our study identified resveratrol as an inducer of the heat-
shock response. Resveratrol treatment of various mammalian,
including human, peripheral cells activated HSF-1–dependent
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FIG. 5. Resveratrol confers cytoprotection
against oxidative and heat stress. (A) Resver-
atrol protects the cells from hydrogen peroxide.
(B) Resveratrol protects the cells from heat stress.
Lymphocytes were incubated in the presence or
absence of 100 M resveratrol for 10 h at 37°C
then treated with H2O2 for 2 h or heat shocked at
the indicated temperatures for 30 min. After 24 h,
cells were incubated with propidium-iodide and
analyzed in a flow cytometer. The fraction of the
propidium-iodide–negative (surviving) cells was
expressed relative to the absolute and resveratrol-
treated controls. Data represent mean  SD of
three experiments. *, **Significant differences at
p  0.05 or p  0.01, respectively.
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transcription and accumulation of Hsp70 protein at a level com-
parable to the effect of a moderate heat stress. The EC50 value
was in the low micromolar range (10 M), comparable to that
of the activating effect on sirtuins (56). However, it is still much
higher than the peak serum concentration after two glasses of
red wine [2.4 nM unmodified and 180 nM derivatized resvera-
trol, respectively (5)]. These data recall a major obstacle of
resveratrol research (i.e., a gap between bioavailability and the
effective concentration). In support of a physiologically rele-
vant stress-inducing effect is the fact that use of a 100-mg/kg
pharmacologic dose resulted in 9 M unmodified and 680 M
derivatized resveratrol concentration, respectively (5). Further-
more, various organs can accumulate resveratrol 30-fold over
the serum concentration; other polyphenols synergize with and
inhibit the conjugation of resveratrol, and altogether they may
put the red-wine consumption in the effective range.
The observed synergy of resveratrol with heat shock suggests
that small or transient increases in resveratrol concentration may
cooperate with other small stresses and promote the mounting
of a more robust stress response. This is reminiscent of a chap-
erone co-inducer property (42, 50) and is highly beneficial, be-
cause reprogramming the cellular thermometer increases the
stress tolerance and the fitness of the cell or organism.
By what mechanism does resveratrol induce the stress re-
sponse? Studies with NAC strongly suggest that an antioxi-
dant activity did not mediate this action. Moreover, our ob-
servations on protein aggregation and on the cytoprotective
effect in case of simultaneous resveratrol and heat treatment
argue against the possibility that resveratrol compromised
global protein homeostasis (data not shown). In some cir-
cumstances, ER stress may induce cytosolic chaperones (32).
In our model, the canonic unfolded protein response was un-
likely to be involved in the resveratrol-induced stress re-
sponse, because neither did tunicamycin activate the heat-
shock response, nor did resveratrol induce the ER Hsp70
homologue UPR marker, Grp78. In other studies, resveratrol
treatment seemed to upregulate the apoptosis-inducing tran-
scription factor CHOP in colon carcinoma cells (54) and in-
duced life-span extension through induction of a subset of
nonclassic UPR genes (51), suggesting that resveratrol may
interfere with and provide protection against stressful events
in the ER. Thus, crosstalk between a noncanonic UPR and
the cytosolic heat-shock response cannot be excluded.
Chaperone inducers may work along the heat-shock pathway:
through direct binding and activation of HSF-1, inhibition of
chaperones suppressing HSF-1, inhibition of the proteasome,
or by other hitherto unknown mechanisms (4, 19, 21, 23, 42,
43, 50, 53). Alternatively, an interference with the phosphory-
lation of HSF-1 may also modulate the stress response, because
protein kinase C, c-jun N-terminal kinase, and glycogen syn-
thase kinase 3 all repress HSF-1 activation (52), and, in turn, a
resveratrol-mediated inhibition of these kinases has been re-
ported (34, 54). Interestingly, another phenolic acid derivate
from cinnamon has recently been shown to activate the PI3-ki-
nase Akt pathway (24) that exerts an inhibition on glycogen
synthase kinase 3, suggesting a possible pathway for polyphe-
nol-dependent HSF-1 activation.
Resveratrol belongs to the group of agents/stimuli that ex-
hibit a reciprocal effect on HSF-1 activation (stress resis-
tance) and NF-B activation (inflammation). These processes
have an opposite effect on longevity (5, 35, 53) and may be
coordinately regulated branches of a survival program. This
program is regulated by the level of environmental stress and
operates with multiple sensors that transmit signals from the
internal and external environment and use robust and redun-
dant pathways that switch from costly reproduction to self-
maintenance. One master regulator is the sirtuin family,
which responds to food availability and may mediate the ef-
fects of calorie restriction (8, 22). It is tempting to speculate
whether SIR2 is an upstream regulator of HSF-1. Evidence
has suggested that SIR-2.1 may activate HSF-1 through the
forkhead transcription factor Daf-16 in C. elegans (8). How-
ever, a direct inhibitory effect via chromatin structure was
also described in yeast (39). In this context, resveratrol ei-
ther may induce an SIR2-dependent activation or may inhibit
a repression on the heat-shock response, or both (17, 51, 56).
Whether resveratrol exclusively uses any of the pathways
listed or promiscuously affects many of them simultaneously
remains to be seen. Another exciting question is whether
HSF-1 is needed for resveratrol to induce longevity, as was
the case in daf-2 mutants (18).
Resveratrol exerted a cytotoxic effect both on lymphocytes
and on cultured cell lines over 50 M, accompanied by the
downregulation of the stress response above 200 M, in agree-
ment of its proapoptotic activity (12, 54). Many chaperones ex-
ert a potent antiapoptotic effect, a possible escape and survival
mechanism for tumor and normal cells, respectively (42, 43,
45). In this regard, the resveratrol-induced heat-shock response
may be an aspecific compensatory mechanism in cytotoxicity.
One study found a correlation between resveratrol treatment,
apoptosis, and Hsp70 level in prostate cancer cells (7) that sup-
ports this hypothesis. In addition, the mechanistic insights pre-
sented in this study argue for a more specific mechanism of 
action.
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TABLE 1. EFFECT OF RESVERATROL ON THE STRESS RESPONSE AND
THERMOTOLERANCE IN VARIOUS MAMMALIAN CELLS
Lymphocyte COS-7 HeLa
Heat-shock response
Heat-shock promoter activation N.D. Yes Yes
Synergy with heat shock N.D. Yes Yes
Hsp70 protein induction Yes Yes Yes
Thermotolerance Yes Yes N.D.
N.D., not determined.
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An important finding of the present work is that resveratrol
protects cells from severe heat stress. It corroborates earlier re-
sults in which resveratrol rescued neuronal cells from mutant
huntingtin proteotoxicity (33). In that study, polyglutamine tox-
icity was prevented by either SIR-2.1 overexpression or resver-
atrol treatment in C. elegans, suggesting that resveratrol may act
via activation of SIR-2.1. Because HSF-1 is critical to combat
aggregation (18, 28), we propose that resveratrol exerts its ben-
eficial activity via the induction of the heat-shock response, a
central protein quality-control mechanism. The conservation of
this pathway in human cells is reasonable. Although HSF-1
maybe only one player in the signaling network that is regulated
by the metabolic state, downregulation of the stress response may
result in degenerative diseases (ischemic diseases, neurodegen-
eration, inflammation) as a consequence of overnutrition, all be-
ing major threats of Western civilization. Direct evidence indi-
cates that hyperlipidemia blunts the stress response in the rat (10).
Resveratrol, in contrast, lowers the temperature threshold of the
heat-shock response, so cells become preconditioned to cope with
a more severe, lethal stress, exactly what we have seen in the cy-
toprotection experiments. These effects were observed in various
mammalian cell lines and peripheral cells, reflecting a conserved
phenomenon (see Table 1).
Our data showed a biphasic effect of resveratrol on both heat
shock–promoter activation and Hsp70 protein expression. This,
as well as the cytotoxicity observed at higher doses, is a char-
acteristic hormetic property (37). Hormesis is a dose–response
phenomenon characterized by low-dose stimulation, high-dose
inhibition. Similarly, a number of other phytochemicals, called
hormetins, have been shown to evoke hormetic responses. The
stress-response inducers curcumin and celastrol have both been
demonstrated to induce the heat-shock response in a hormetic
manner (1, 53).
The hormetic property of resveratrol also supports the
“xenohormesis hypothesis,” which postulates that small but
harmful changes in the environment (famine, dryness, heat,
cold, infection) induce the production of phytoalexins in
plants (25). Most of these compounds are potent toxins, es-
pecially for insects (26), but their amount does not reach a
critical threshold in bigger animals and promotes a hormetic
response. Alternatively, phytoalexins seem to be danger sig-
nals and represent an altruistic courtesy of stressed plants to-
ward ingesting animals, alerting them to prepare for and to
survive during unfavorable environmental conditions. This
principle was intuitively used for centuries in the form of
herbal remedies by the ancient wisdom of folk therapy and
of traditional oriental medicine. Indeed, xenohormetic com-
pounds including resveratrol feature overlapping properties:
they induce self-maintenance and protective mechanisms,
such as improving energy metabolism (increasing insulin sen-
sitivity), upregulation of phase II detoxification, antioxidant
enzymes, and suppression of inflammatory pathways (26, 35),
a key to a healthy life.
In conclusion, we propose that among other desired physio-
logic effects, resveratrol activates the stress response, a molec-
ular pathway to combat stress, prevent disease, and induce
longevity. Deeper understanding of the mechanism of action as
well as the intricate interplay of resveratrol with various targets
may lead to a better understanding of aging, stress, and
longevity.
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ABBREVIATIONS
ER, endoplasmic reticulum; FITC, fluorescein isothio-
cyanate; Grp78, 78-kDa glucose-regulated protein; HSF-1,
heat-shock transcription factor 1; Hsp, heat-shock or stress pro-
tein, the number thereafter denotes molecular weight in kilo-
daltons; NAC, N-acetyl-L-cysteine; PBMC, peripheral blood
mononuclear cells, RSV, resveratrol (3,4,5-Trihydroxy-trans-
stilbene); SIR, silent information regulator; UPR, unfolded pro-
tein response.
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The Heat Shock Connection of Metabolic Stress and Dietary Restriction 
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Abstract: Molecular chaperones and the heat shock response guard and modulate protein conformation, protect proteins 
from misfolding and aggregation, and maintain signalling and organellar networks. Overnutrition and the metabolic syn-
drome represent a pro-aging condition, and dietary restriction is the most robust environmental intervention that induces 
longevity from yeast to mammals. In recent years a considerable effort has been made to elucidate the signaling pathways 
involved in metabolic signaling. Here we review the current understanding on the connection between metabolic stress, 
dietary restriction and the heat shock response and highlight results showing chaperone induction as a promising therapeu-
tic strategy to promote healthy aging and to prevent metabolic disorders. 
Keywords: Aging, caloric restriction, diabetes, heat shock response, resveratrol, sirtuin. 
INTRODUCTION: STRESS, AGING AND THE HEAT 
SHOCK RESPONSE 
 Stress can be defined as an environmental change that 
induces damage at all the molecular, cellular and organismal 
level, respectively [1,2]. In the organisms several adaptive 
(stress) responses have evolved to promote survival via the 
acquisition of stress tolerance. If these responses can not 
eliminate damage, it results in a functional decline, a so-
called distress, while hormesis is the induction of benefical 
effects by exposure to low doses of chemical or physical 
agents that are harmful at higher doses [3,4]. As aging can be 
considered as a chronic stress state [5], robust adaptive 
mechanisms are needed not only for instant survival but also 
to attain longevity.  
 An important target of stress at the cellular level is the 
proteome: during proteotoxic stress and in aging the dysbal-
ance of protein homeostasis and the loss of both protein sta-
bility and function occur [6]; besides, protein conformational 
disorders such as Parkinson’s, Alzheimer’s, and 
Huntington’s disease, respectively, may mimic the degenera-
tive distress state of aging [7]. The maintenance of proteome 
integrity is regulated by a network of genes that link stress 
responses and lifespan. A key player in this regard is the 
chaperone network [7-10] which is responsibe to maintain 
and modulate protein conformation, to protect proteins from 
misfolding and aggregation, to promote translocation and 
assembly and disassembly of macromolecular complexes 
[11-14]. The induction of heat shock response is mediated by 
the heat shock transcription factor 1 (HSF1) [15]. Under 
normal conditions HSF1 is kept in an inactive, monomeric 
form by an inhibitory complex of Hsp-s. Upon proteotoxic 
insults, like heat shock, heavy metals and proteasome inhibi-
tors, Hsp-s interact with denaturated and partially unfolded  
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proteins, thus HSF1 is titrated out of the inhibitory complex. 
HSF1 trimerizes, becomes phosphorylated and is translo-
cated into the nucleus, where it binds to consensus sequences 
of the promoter of heat shock genes (heat shock elements, 
HSEs). Recent evidence suggests that beyond this feedback 
loop translational elongation factor eEF1A and a thermome-
ter non-coding RNA (HSR1) together participate in HSF1 
activation [16,17]. According to this model, the heat shock 
derived translational shutdown and cytoskeletal collapse 
make eEF1A capable to bind the concomitantly formed 
HSR1. Thus the eEF1A-HSR1 complex is able to capture 
HSF1 released from the aforementioned chaperone complex 
and promotes trimerization and further activation steps, link-
ing general translation and RNA metabolism to the heat 
shock response. After activation and nuclear translocation 
HSF1 is located within 30s in so-called stress granules [18-
20]. These discrete subnuclear granules contain a plethora of 
proteins with unknown functions, including splicing factors 
suggesting a special micro-compartment for fine-tuning tran-
scriptional responses during stress [18,21,22]. 
 Mapping out the connection between the heat shock re-
sponse and longevity has already begun with ambiguous 
results. The nematodal HSF1 ortholog HSF-1 overexpression 
induces longevity, while HSF-1 knock out shortens life-span 
in C. elegans [23,24], while mice lacking HSF1 do not dis-
play shorter lifespan [25]. Furthermore, studies in worms 
expressing GFP under the hsp16.2 promoter demonstrated 
that the robustness of the heat shock response may predict 
lifespan [26]. However, a recent study using hsp22 and 
hsp70 reporter Drosophila strains reported a negative corre-
lation between reporter expression and lifespan warranting 
further research in this direction [27]. 
OBESITY AND DIABETES AS A METABOLIC 
DISTRESS: THE PROTECTIVE ROLE OF MOLE-
CULAR CHAPERONES 
 Overnutrition is one of the leading medical problems in 
the developed world. It is a result of an imbalanced diet, 
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where the energy consumption is higher than the energy ex-
penditure, and it leads to the development of the metabolic 
syndrome, characterized by obesity, type 2 diabetes, insulin 
resistance, dyslipidaemia and hypertension [28,29]. Meta-
bolic syndrome is also a risk factor of atherosclerosis, stroke, 
cancer, arthritis and diabetes. Thus, the metabolic syndrome 
and diabetes may be perceived as a chronic metabolic dis-
tress which induces diseases and limits life expectancy. 
 Metabolic disturbances in diabetes induce a number of 
alterations in protein homeostasis. Glycation of the small 
chaperone ?-crystallin of the lens compromises its chaperone 
activity and contributes to cataract formation [30]. High glu-
cose-induced oxidative stress in the obese Zucker rat led to 
protein misfolding and aggregate formation could be cleared 
by autophagy, but not by the proteasome [31]. Elevated lev-
els of HSF1, Hsp70 and Hsp90 that were found in the pan-
creas of diabetic monkeys may compensate for the altered 
protein homeostasis [32]. Intriguingly, decreased level of 
Hsp70 was found in the muscle of diabetic patients, as well 
as in the blood and in the liver of diabetic monkeys, where 
the level of HSF1 and Hsp70 and Hsp90 declined signifi-
cantly [32,33] Indeed, impaired insulin signaling reduces 
HSF1 transactivation via the activation of glycogen synthase 
kinase-3 (GSK-3) and extra-cellular regulated kinase-1 
(ERK-1) and c-jun N-terminal kinase (JNK) [34,35]. De-
creased Hsp70 may not be able to inhibit JNK-induced in-
flammatory signaling, giving rise to a vicious cycle [35,36]. 
High glucose alters the interaction of the specific chaperone 
Hsp90 with two prominent clients endothelial nitric oxide 
synthase (eNOS) and inhibitor of kappaB kinase (IKK) pro-
viding a mechanistic basis for endothelial dysfunction 
[37,38]. How altered chaperone levels and function may con-
tribute in other ways to peripheral insulin resistance, in-
flammation and to an altered extracellular stress signaling 
remains to be seen. 
 There are a number of experiments demonstrating the 
connection between diabetes and the heat shock response. 
Physical exercise is able to both raise chaperone levels and 
reverse diabetic alterations [34,35]. Besides, both the an-
tidiabetic drug, metformin and the alkaloid, berberin promote 
the association of eNOS with Hsp90 and augment NO pro-
duction and preserve endothelial function [39,40]. More im-
portantly, a 41°C heat treatment once a week for 12 weeks 
improved glucose tolerance and reduced stress-activated 
signaling in rats fed by a high-fat diet suggesting a crosstalk 
between the development of HSF1 dependent thermotoler-
ance and metabolic stress tolerance [41]. The chaperone co-
inducer bimoclomol derivative, BRX-220 was also able to 
improve insulin sensitivity of both Zucker fatty diabetic rats, 
and streptozotocin-treated diabetic rats [42]. Finally, a recent 
study demonstrated that besides heat shock either overex-
pression or pharmacologic induction of Hsp70 by a novel 
chaperone co-inducer BGP-15 was sufficient to prevent the 
development of obesity-induced insulin resistance in fat-fed 
mice [43]. Strikingly, a 1-month treatment with BGP-15 sig-
nificantly improved insulin sensitivity in insulin-resistant, 
nondiabetic human patients [44]. These protective effects 
may be related to an improved protein homeostasis, a more 
efficient modulation of signaling networks and to a better 
connectivity of subcellular organellar networks, such as the 
ER and the cytosol [8,45]. All these experiments highlight a 
vast therapeutic and preventive potential of chaperone induc-
tion in metabolic disorders. 
DIETARY RESTRICTION IS AN INDUCER OF 
LONGEVITY AND OF THE HEAT SHOCK RES-
PONSE 
 Dietary (caloric) restriction, a moderate (30-40%) reduc-
tion of caloric intake with maintained nutrient supply is the 
most robust intervention that induces longevity from yeast to 
mammals. Dietary restriction also decreases the incidence of 
age-related diseases, such as cancer, diabetes, cardiovascular 
and neurodegenerative diseases by inducing changes in me-
tabolism, protein biogenesis and turnover as well as by evok-
ing resistance to a variety of stresses [46,47]. Thus, dietary 
restriction may emerge as a hormetic metabolic stress that 
activates various defense mechanisms to promote longevity. 
 Early studies showed that dietary restriction was able to 
restore the age-induced loss of Hsp70 transcription via the 
preservation of HSF1 activation in rat hepatocytes [48,49]. 
As a functional consequence, dietary restriction highly im-
proved thermotolerance and was able to rescue 100% vs 50% 
of old rats subjected to hyperthermia [50]. These findings 
have been recapitulated in rat intestine, neural tissue, skeletal 
muscle and in heart myocardium, suggesting that a more 
efficient heat shock response induced by dietary restriction 
may improve muscle and neuronal function, protect from 
muscle cell loss and importantly may exert cytoprotection 
against ischemic episodes [51-55]. A small, but significant 
cytoprotection from heat stress could be transferred with 
blood serum to HepG2 cells by culturing them in serum ob-
tained from human subjects undergoing caloric restriction, 
however, this study found no difference in basal Hsp70 lev-
els [56]. Using transcriptional profiling, independent studies 
demonstrated a better maintenance of stress responses in-
cluding chaperones both in liver and in muscle, respectively, 
of caloric restricted primates [57,58]. This effect was re-
flected in an efficient protection in both nematode and mouse 
models of misfolding models of neurodegenerative disorders 
[59,60]. Similarly to food restriction, the mimetic 2-
deoxyglucose was shown to induce chaperones and protect 
neuronal cells from excitotoxic, oxidative and proteotoxic 
injury [61,62]. Intriguingly, 2-deoxyglucose blunted the 
Hsp70 induction and thermotolerance of prostate cancer cells 
suggesting that an otherwise hormetic intervention may in-
duce a distress in the already stressed tumor cells and provid-
ing one plausible mechanism for the potent antitumor effect 
of dietary restriction and fasting [63]. Since an increased 
protein turnover is implicated in the ‘cleansing’ effects of 
dietary restriction, and chaperones are known to play an im-
portant role both in proteasomal degradation and in chaper-
one-mediated autophagy, it would be worth studying their 
crosstalk to gain a better understanding on the interplay be-
tween these processes [52,55,64-67]. 
THE HEAT-SHOCK RESPONSE IN THE DIETARY 
RESTRICTION-RELATED SIGNALING NETWORK 
 In recent years evidence has been accumulated that die-
tary restriction is not only a simple consequence of restric-
tion of fuel and metabolism but initiates a highly regulated 
and orchestrated process that drives energy allocation from 
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reproduction to self maintenance during low food availabil-
ity. Due to its versatility, short lifespan and ease of genetic 
manipulations much of the understanding has been obtained 
in the nematode C. elegans. Here we will mainly rely on data 
from worms and supplement it with findings from higher 
organisms. 
 A major endocrine sensor of food supply is insulin sig-
naling. Reduction in insulin signaling extends life span in 
various organisms [68,69]. The essential role of HSF-1 and 
the chaperone-network in this pathway has been proven in 
the nematode Caenorhabditis elegans, acting in concert with 
the forkhead transcription factor FoxO/daf-16 [24,70]. Con-
sequently, insulin-signaling mutations delay the onset of 
polyglutamine toxicity in worms [71]. 
 To address the mechanism of dietary restriction a number 
procedures have been developed in C. elegans. All of them 
induce a further life extension of already long-lived insulin 
signaling mutants suggesting that the effects of dietary re-
striction involve different mechanism apart form insulin-like 
signaling. A dilution of the food source bacteria from 1011 to 
108 E. coli/ml on solid agar extended lifespan of worms by 
20-30%. Despite an increased stress resistance, the C. ele-
gans HSF1 ortholog hsf-1 was dispensable, however, it fully 
depended on the AMP-dependent protein kinase AMPK/aak-
2 and on FoxO/daf-16 [72,73]. A similar longevity by the 
dilution of the bacterial food peptone was also mediated by 
daf-16, however, the contribution of hsf-1 is, as yet, un-
known [74]. The reduction of pharynx pumping rate by a 
genetic mutation (eat-2) depends on the mitochondrial gene 
clk-1 while daf-16- and hsf-1 are indispensable, moreover, 
the necessity of clk-1 has been shown in the bacterial dilu-
tion protocol, too [24,73,75]. Yet, bacterial dilution com-
bined with eat-2 mutation produced a synergistic longevity 
[73]. Separate studies from two labs employed liquid me-
dium, where diluting bacteria extended lifespan which was 
also largely daf-16-independent, however, depended on neu-
roendocrine signals by either the transcription factors 
FoxA/pha-4 or Nrf2/skn-1, respectively [76,77]. Notably, 
pha-4 also seemed to mediate the longevity of eat-2 mutants 
[76]. The involvement of the heat shock response in these 
models has not been addressed. Dietary restriction in Droso-
phila appeared to be FoxO-independent [78]. The results 
highlighted above argue that a partial reduction of food 
source in invertebrates is heterogeneous intervention target-
ing various nodes of a highly connected signaling network 
and draws attention to the careful design and interpretation 
of research in mammalian models. 
 After reaching the adult stage, C. elegans displays a ro-
bust 50% increase in lifespan either in axenic medium almost 
devoid of calories or even in the total absence of the food 
source E. coli [79-81]. The life extending mechanism of 
these interventions is totally different from a partial food 
reduction, since (i) serial dilution of bacteria on the plates 
below a threshold (cca. 107 E. coli/ml) killed worms within 
two days [73], (ii) the longevity by bacterial deprivation was 
independent on FoxO/daf-16 and AMPK/aak-2 [80], (iii) the 
presence of metabolically active live bacteria, or their prod-
uct prevented the food deprivation-induced longevity 
[79,82]. Indeed, both the longevity induced as well as a po-
tent protection in several proteotoxic models by bacterial 
deprivation required hsf-1 [60]. It may be hypothesized that 
beyond the optimum food supply that finely tunes metabo-
lism a signal produced by live microorganism exerts a con-
stitutive inhibition on stress responses and HSF-1. Further 
research is necessary to reveal the nature and the pathway of 
the inhibition. For a summary of genes involved in dietary 
restriction-induced longevity please refer to Table 1. 
 Another important nutrient sensor is the target of ra-
pamycin (TOR) kinase which is activated by both nutrient 
supply and insulin. Inhibition of TOR in wild type and in 
eat-2 mutant worms induces longevity by activating transla-
tion and inhibiting autophagy [66,83]. Reduction of transla-
tional output per se induces thermotolerance and longevity, 
the latter being additive to that of both insulin-like and eat-2 
mutants [83,84]. Similarly, both insulin-like and eat-2 mu-
tants require autophagy for their longevity, however, activa-
tion of autophagy is not sufficient to extend lifespan [66,67]. 
Though there is no direct evidence on the role of the protea-
Table 1. Requirement of Genes for Longevity in Various Dietary Restriction (Mimetic) Interventions C. elegans. See the text for 
details and for references. * B. Dancsó and C. S?ti, unpublished results, ** Tóth ML, Dancsó B, Csermely P and S?ti C, submit-
ted manuscript 
Genes (human ortholog) 
Intervention 
daf-16 
(FoxO) 
aak-2 
(AMPK) 
hsf-1 
(HSF1) 
clk-1 
(CLK1) 
skn-1 
(Nrf2) 
pha-4 
(FoxA) 
sir-2.1 
(SirT1) 
Bacterial dilution yes yes no Yes no no no 
Peptone dilution yes yes ? ? ? ? ? 
Pharynx pumping (eat-2) no no no Yes ? yes yes/no 
Liquid DR #1 no ? ? ? yes ? ? 
Liquid DR #2 partial partial ? ? ? yes ? 
Bacterial deprivation no *no yes ? ? ? *no 
Resveratrol yes/no yes **yes ? ? ? yes 
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somal system in dietary restriction, a close relationship can 
be suspected. A proper protein homeostasis seems to be a 
critical determinant in longevity and closely connected to the 
mechanism of dietary restriction. Namely, translation modu-
lates protein output, molecular chaperones guard protein 
conformation and protein disposal clears the damaged and 
unnecessary proteins and provides fuel from intrinsic stores 
to build new proteins, elements of an adaptive response. 
 HSF1 and chaperones are involved in several physiologi-
cal and housekeeping processes like signaling and immunity, 
however, the exact contribution of their significance related 
or unrelated to protein homeostasis has not been addressed. 
Taking use of the poikilothermic nature of C. elegans we 
investigated the effect of dietary deprivation on the lifespan 
of wild type and hsf-1 loss-of function animals at tempera-
tures below and above the ambient 20ºC. Fig. (1) shows that 
decreasing temperature progressively lengthens the lifespan 
of both the wild type and hsf-1 worms to a similar extent (to 
280% mean lifespan at 15ºC) suggesting that at the tempera-
tures tested there is a uniform need of hsf-1 for survival. Be-
sides, dietary deprivation progressively extends the lifespan 
of wild type worms with increasing temperature. However, 
this effect is completely abolished in hsf-1 mutants. These 
data indicate that either the effect of dietary deprivation is 
independent of the protein homeostatic burden or HSF-1 
mediates the longevity effect via both protein-maintenance 
and independent means. Indeed, it has been shown that HSF1 
regulates 3% of the genome in yeast and supports such core 
cellular functions as cell size, translation and ribosome bio-
genesis as well as glucose metabolism in mammalian tumor 
cell lines [85,86]. It may well be, that HSF1 orchestrates a 
network that optimizes fuel utilization and overall cellular 
and organismal functions in the postmitotic worm to attain 
efficient self maintenance and longevity. However, the 
mechanisms and the gene network involved remains to be 
identified. 
RESVERATROL AND SIR2 ARE ACTIVATORS OF 
HSF1 
 The plant polyphenol resveratrol recapitulates the dietary 
restriction-induced longevity of yeast, invertebrates and mice 
on a high-fat diet (but not on a normal diet) [87-91]. Other 
studies, nevertheless, could not show an increased longevity 
upon resveratrol treatment in invertebrate and normal fed 
mouse trials [92,93]. Resveratrol has been shown to act via 
the Sir2 (silent information regulator) sirtuin family of 
NAD+-dependent protein deacetylases in a FoxO/daf-16-
independent manner [88,94]. Sir2 deacetylates a number of 
key regulatory proteins including FoxO, PPAR?, and its ac-
tivator PGC-1? and, responsible for survival under stress and 
the metabolic change [95-97]. Genetic activation of Sir2/sir-
2.1 induces a lifespan extension in worms and mice overex-
pressing the major mammalian ortholog SirT1 show reduced 
energy expenditure, improved metabolism and protection 
from diabetes [98-100]. Sir2/sir-2.1 seems to mediate some 
forms of dietary restriction including the eat-2 mutation in C. 
elegans and SirT1 is required for dietary restriction-induced 
physical activity in mice [101-103]. However, in other stud-
ies dietary restriction by eat-2 by bacterial dilution or by 
bacterial deprivation did not depend on Sir2 [73,80,83]. 
A) 
 
 
 
 
 
 
 
 
B) 
 
 
 
 
 
 
 
 
C) 
 
 
 
 
 
 
 
 
Fig. (1). HSF-1 mediates dietary deprivation-induced life-span 
extension at various temperatures. Survival curves of wild type 
(N2) and hsf-1(sy441) loss of function nematodes at 25ºC (A), 20ºC 
(B) or 15ºC (C) in the presence (closed symbols) or absence (die-
tary deprivation, DD, open symbols) of the food source, E. coli. 
Synchronized strains were grown on NGM plates containing 50 ?M 
FudR (5-fluoro-2’-deoxyuridine). DD was initiated at day 4 of 
adulthood. Animals that crawled off the plate, exploded, bagged, or 
became contaminated were removed from the evaluation process. 
The figure shows representative curves of 3 independent experi-
ments. 
 
 Both resveratrol and Sir2/SirT1 were protective in mis-
folding neurodegenerative models suggesting an improved 
protein homeostasis [104,105]. As a potential mechanism, 
we have shown that resveratrol specifically induces the heat 
shock response and protects various mammalian cells against 
heat stress and proposed a Sir2-dependent modulation of 
HSF1 [106]. Recently this has been experimentally demon-
strated by showing that SirT1 deacetylates HSF1 and pro-
longs its binding to the heat shock promoter [107]. However, 
the exact contribution of the heat-shock response to resvera-
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trol-induced longevity remained unknown. Recent results 
from our lab show that HSF-1 mediates resveratrol-induced 
longevity in a manner dependent on Sir-2.1 in C. elegans 
(Tóth ML, Dancsó B, Csermely P and S?ti C, submitted 
manuscript, Table 1). These findings link the metabolic and 
proteotoxic stress responses in longevity regulation in inver-
tebrates. How this interaction modulates aging in mammals 
remains to be determined. 
SUMMARY AND PERSPECTIVES 
 The observations presented in this review demonstrate an 
intimate connection between metabolic disturbances, dietary 
restriction and protein homeostasis with a special emphasis 
on the HSF1-orchestrated heat shock response. Most ex-
periments elucidating the dietary restriction-induced longev-
ity regulation have been performed in invertebrates and ana-
lyzing one or two components of the signaling pathways. 
Future studies employing systems biology and mammalian 
models will reveal the topology of the signaling network and 
the place of HSF1 in response of dietary restriction. This 
may lead to the development of novel strategies to attain the 
final goal of healthy aging and to prevent or heal civilization 
diseases. 
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Absence of effects of Sir2 overexpression on lifespan
in C. elegans and Drosophila
Camilla Burnett1*, Sara Valentini1*, Filipe Cabreiro1*, Martin Goss1, Mila´n Somogyva´ri2, Matthew D. Piper1, Matthew Hoddinott1,
George L. Sutphin3,4, Vid Leko5, Joshua J. McElwee1, Rafael P. Vazquez-Manrique6,7, Anne-Marie Orfila6,7, Daniel Ackerman1,
Catherine Au1, Giovanna Vinti1, Miche`le Riesen1, Ken Howard8, Christian Neri6,7, Antonio Bedalov5, Matt Kaeberlein3,4,
Csaba So˝ti2, Linda Partridge1,9 & David Gems1
Overexpressionofsirtuins(NAD1-dependentproteindeacetylases)has
been reported to increase lifespan in budding yeast (Saccharomyces
cerevisiae), Caenorhabditis elegans and Drosophila melanogaster1–3.
Studies of the effects of genes on ageing are vulnerable to confound-
ing effects of genetic background4.Herewere-examined the reported
effects of sirtuin overexpression on ageing and found that standard-
ization of genetic background and the use of appropriate controls
abolished the apparent effects in both C. elegans and Drosophila. In
C. elegans, outcrossing of a line with high-level sir-2.1 overexpres-
sion1 abrogated the longevity increase, but did not abrogate sir-2.1
overexpression. Instead, longevity co-segregated with a second-site
mutation affecting sensory neurons. Outcrossing of a line with low-
copy-number sir-2.1 overexpression2 also abrogated longevity. A
Drosophila strain with ubiquitous overexpression of dSir2 using
the UAS-GAL4 system was long-lived relative to wild-type controls,
as previously reported3, but was not long-lived relative to the appro-
priate transgenic controls, and nor was a new line with stronger
overexpression of dSir2. These findings underscore the importance
of controlling for genetic background and for the mutagenic effects
of transgene insertions in studies of genetic effects on lifespan. The
life-extending effect of dietary restriction on ageing in Drosophila
has also been reported to be dSir2 dependent3.We found that dietary
restriction increased fly lifespan independently of dSir2. Our find-
ings do not rule out a role for sirtuins in determination ofmetazoan
lifespan, but they do cast doubt on the robustness of the previously
reported effects of sirtuins on lifespan in C. elegans and Drosophila.
The role of sirtuins in ageingwas discovered in budding yeast, where
overexpression of SIR2 increases replicative lifespan5. It was then
reported that elevated sirtuin levels increase lifespan in the nematode
C. elegans1,2,6 and the fruitfly Drosophila3, indicating an evolutionarily
ancient role of sirtuins in longevity assurance7. Dietary restriction
(reduced food intake short of starvation) extends lifespan in organisms
ranging from yeast to mammals8, and initial studies indicated that
dietary restriction increases lifespan by activating sirtuins in yeast9,
C. elegans10 and Drosophila3. Pharmacological activation of sirtuins
has therefore been widely promulgated as a potential means to mimic
dietary restriction and slow ageing in humans11. However, several
aspects of the role of sirtuins in ageing have proved controversial12.
Subsequent studies have indicated that sirtuins do not mediate the
effects of dietary restriction on ageing, at least in budding yeast and
C. elegans13,14. The plant-derived polyphenol resveratrol and other
compounds have been reported to activate sirtuins and extend life-
span15,16, but more recent findings have challenged both effects17–20.
We therefore re-examined the effects of sirtuin overexpression on
lifespan in C. elegans and Drosophila. In particular, we wished to
exclude the possibility that the increased longevity observed in strains
with overexpression of sirtuin genes is caused by differences in genetic
background, or by the mutagenic effects of transgene insertion, which
frequently confound studies of the genetics of ageing4.
We first examined a high-copy-number sir-2.1 transgenicC. elegans
strain (LG100) carrying the integrated transgene array geIn3 [sir-2.1
rol-6(su1006)] (ref. 1). As expected, this strain was long-lived (Fig. 1a
and Supplementary Table 1). However, outcrossing (35) of geIn3 to
wild type (N2) abrogated the increase in longevity (Fig. 1a and
Supplementary Table 1) without affecting SIR-2.1 protein levels
(Fig. 1b). This loss of longevity upon outcrossing was verified by an
independent research team (Supplementary Table 2).
LG100 showed a neuronal dye-filling (Dyf) defect21 that did not
segregate with the transgene upon outcrossing (Supplementary Fig. 2a).
Dyfmutants often show extended lifespan22. To determinewhether the
longevity of LG100might be attributable to a dyfmutation, we derived
from this strain threeDyf, non-Rol lines (lacking geIn3) and three non-
Dyf, Rol lines (carrying geIn3). Dyf, non-Rol lines were long-lived and
showed wild-type SIR-2.1 protein levels (Fig. 1c, d and Supplementary
Table 3).Non-Dyf, Rol lines showed elevated SIR-2.1 protein levels but
had wild-type lifespans. Dyf mutant longevity seemed to be partially
dependent on daf-16 (Supplementary Fig. 2b), as seen previously for
other Dyf mutants22. The co-segregation of longevity with this dyf
mutation, but notwith geIn3, was previously noted by another research
team (S. S. Lee, personal communication). Furthermore, knockdown
of sir-2.1 expression in LG100 using RNA-mediated interference did
not suppress longevity, despite lowering SIR-2.1 protein to wild-type
levels (Fig. 1e, f and Supplementary Table 4). Taken together, these
results indicate that the longevity of LG100 is attributable to an un-
identified dyfmutation (or possibly another mutation closely linked to
the dyf locus), and that high-level overexpression of sir-2.1 is not suf-
ficient to increase lifespan in these strains.
A low-copy-number transgenic strain (NL3909)overexpressing sir-2.1
(ref. 7) is also long-lived2.Weconfirmed the increased lifespanofNL3909
(pkIs1642 [sir-2.1 unc-119] unc-119(ed3)) relative to the control strain
NL3908 (pkIs1641 [unc-119] unc-119(ed3)) (Fig. 1g and Supplementary
Table 5).We also observed an apparent increase in SIR-2.1 protein levels
in NL3909 relative to NL3908 (Fig. 1h). Outcrossing (36) of NL3909
once again abrogated longevity (Fig. 1g and Supplementary Table 5)
without affecting SIR-2.1 protein levels (Fig. 1h and Supplementary
Fig. 1c). This effect of outcrossing was independently verified (Sup-
plementary Table 6). Thus, the longevity of NL3909 also seems to be
attributable to effects of genetic background rather than to pkIs1642.
The duplication mDp4 includes the sir-2.1 locus, and the mDp4-
containing strain DR1786 is long-lived1. We found that DR1786 is
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indeed long-lived, and also shows elevated sir-2.1 expression.
However, longevity was not suppressed by sir-2.1 RNA interference
(RNAi) (Supplementary Fig. 3 and Supplementary Table 7) indicating
causation by factors other than sir-2.1, either onmDp4 or elsewhere in
the genome.
InDrosophila, overexpression of dSir2 reportedly increases lifespan
relative to wild-type controls3. Overexpression was achieved using the
GAL4-UAS binary system23, with the largest increases in lifespan being
produced by the combination of EP-UAS–dSir2 (dSir2EP2300) with a
ubiquitously expressed tubulin–GAL4 driver. We outcrossed these
two transgenes (36) into the control white Dahomey (wDah) back-
ground.When assayed on amedium similar to that used in the original
study, EP-UAS–dSir2/tubulin–GAL4 flies were longer-lived thanwild-
type controls, as previously reported3 (Fig. 2a). However, they did not
live longer than the tubulin–GAL4/1 control flies (Fig. 2a). This
implies that lifespan extension is due to transgene-linked genetic
effects other than the overexpression of dSir2. Lifespan was assayed
on a range of food media (see Methods for details) to test for nutrient
dependence of any effect. However, in no case were EP-UAS–dSir2/
tubulin–GAL4 flies longer-lived than one or both transgenic controls
(Supplementary Fig. 4).
The lack of an observable effect on lifespan could reflect the relatively
modest increase in dSir2 expression in EP-UAS–dSir2/tubulin–GAL4
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represent s.e.m. *, 0.01,P, 0.05; **, 0.001,P, 0.01; ***, P, 0.001; NS,
not significant; Student’s t-test (two-tailed). One remaining possibility is that
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flies, both in terms of messenger RNA levels (Supplementary Fig. 5)
and protein levels (increased by 35% relative to wild type; Sup-
plementary Fig. 6). We therefore created lines with a higher level of
overexpression of dSir2 (UAS–dSir2–Myc9/tubulin–GAL4). Here,
dSir2mRNAand protein levels were robustly increased relative towild
type (an increase of 318% relative to wild-type protein levels; Sup-
plementary Figs 5 and 6). We examined recombinant protein raised
in Escherichia coli to check that the presence of the Myc tag did not
interfere with dSir2 histone deacetylase activity, as measured by
deacetylation of the fluorophore-containing p53 substrate (Fluor de
Lys) or of native acetylated histone H4 substrates, and it did not
(Supplementary Fig. 7). We also found that dSir2 histone deacetylase
activity was unaffected by addition of resveratrol in either assay
(Supplementary Fig. 7). We saw no increase in lifespan in UAS–
dSir2–Myc/tubulin–GAL4 flies relative to tubulin–GAL4/1 controls,
either on a food medium similar to that used in the original study
(Fig. 2b), or relative to either control on a range of other media
(Supplementary Fig. 4b, c, f). An independent research team also
saw no increase in lifespan in UAS–dSir2–Myc9/tubulin–GAL4 flies
(Supplementary Fig. 8). These results indicate that the previously
observed longevity of EP-UAS–dSir2/tubulin–GAL4 flies was not attri-
butable to elevated expression of dSir2, and that stronger, ubiquitous
overexpression of dSir2 also does not extend fly lifespan.
The role of sirtuins in the extension of lifespan by dietary restriction
in yeast and C. elegans is controversial, with several groups reporting
that sirtuins are not required for lifespan extension via dietary restric-
tion in both organisms8. In Drosophila, it was reported that dietary
restriction does not increase lifespan in dSir2 deletion-mutant flies3.
We tested this too, using the deletion alleles dSir24.5 (tested previ-
ously3) and dSir217. We first outcrossed these alleles (Supplementary
Fig. 9a) into the Canton S wild type (see Methods), which was used in
the previous dietary-restriction study3. We then checked the effect of
each allele on dSir2 gene expression. The allele dSir217 abrogated dSir2
mRNA, indicating that this is a null allele. By contrast, dSir24.5, which
contains a relatively small deletion at the 59 end of the gene, did not
reduce dSir2 mRNA levels (Supplementary Fig. 9b, c).
To reassess the role of dSir2 in dietary restriction in Drosophila, we
compared lifespans of wild-type (Canton S), dSir24.5 and dSir217
homozygotes.All genotypes responded similarly andnormally todietary
restriction in trials conducted by two independent research teams
(Fig. 2c andSupplementaryFig. 10), hence the effect of dietary restriction
on lifespan did not require dSir2.
In this study, we were unable to verify the effect of sirtuin over-
expression on lifespan in either C. elegans or Drosophila. Increased
lifespanwas seen in twoC. elegans lineswith elevated sir-2.1 expression,
derived from independent studies, as previously reported, but in each
case this was abrogated by outcrossing. Overexpression of sir-2.1 does
exert effects on traits other than lifespan. For example, geIn3 is neuro-
protective in a worm model of neuron dysfunction in Huntington’s
disease24 and, notably, this effect is not attributable to the dyfmutation
(Supplementary Fig. 11). Moreover, both NL3909 and its outcrossed
derivative are thermotolerant (M. Somogyva´ri andC. So˝ti, unpublished
data). InDrosophila, lines overexpressing dSir2 were longer-lived than
wild-type controls, as previously reported, but they were not longer-
lived than lines containing the appropriate transgenic controls. The fact
that all transgenic lines were longer-lived than the Dahomey wild type
into which they had been outcrossed could reflect heterosis in the
vicinity of the transgene inserts, or a mutagenic effect of the GAL4
insert.
Lifespan was not increased either by overexpression of sir-2.1 from
its own promoter in C. elegans, or by ubiquitous overexpression of
dSir2 from a heterologous promoter in Drosophila. Our findings call
into question the robustness of earlier reports of a role for sirtuins in
longevity assurance on the basis of overexpression in C. elegans and
Drosophila, and also the role of dSir2 in the response to dietary restric-
tion in Drosophila. However, sirtuins can affect lifespan in animals
under certain conditions: C. elegans daf-2(e1370) mutants are hyper-
sensitive to genetic effects on lifespan25, and in these mutants, deletion
of sir-2.1 reproducibly increases lifespan6 (Supplementary Fig. 12).
Our finding that resveratrol does not activate the histone deacety-
lase activity of dSir2 using a native histone H4 peptide is consistent
with earlier findings using yeast SIR2 and mammalian SirT1 (refs 17,
18). Resveratrol increasedDrosophila lifespan in one study26 but not in
another27. In principle, this could reflect sensitivity of resveratrol
effects to subtle differences in culture conditions. If this were the case,
our findings would indicate that such effects are not attributable to
direct activation of dSir2 by resveratrol.
METHODS SUMMARY
Nematode strains andmaintenance.Nematodesweremaintained on nematode-
growth-medium agar at 20 uC, with E. coli OP50 bacteria as a food source.
Nematode strains used included: wild type (N2), GA707 wuEx166 [rol-
6(su1006)] (rol-6 control), LG100 geIn3 [sir-2.1 rol-6(su1006)] dyf-?(wu250),
NL3909 pkIs1642 [sir-2.1 unc-119] unc-119(ed3) and the control strain NL3908
pkIs1641 [unc-119] unc-119(ed3).
Nematode lifespan measurements. These were performed as previously
described28, at 20 uC. To prevent progeny production, 5-fluoro-29-deoxyuridine
(FUdR) was added to seeded plates, to a final concentration of 10, 40 or 50mM.
Before testing the effects of RNAi on lifespan, wormswere kept for two generations
on the RNAi bacteria. The statistical significance of effects on lifespan was esti-
mated using the log-rank test, performed using JMP, Version 7 (SAS Institute).
Drosophila stocks and maintenance. Tubulin–GAL4 and dSir2EP2300 were
obtained from the Bloomington Stock Center. The dSir2–Myc2 and dSir2–Myc9
lines were generated by germline transformation into strain w04. The dSir24.5/
SM6B, dSir217/Cyo and Canton S lines were gifts from S. Pletcher, J. Rine and S.
Helfand. All lines were outcrossed at least six times into the relevant controls.
Experiments were performed at 25 uC on a 12h:12 h light:dark cycle at constant
humidity.
Drosophila lifespan assays. Flies were bred at standard density, allowed to mate
for 48 h after emerging, then sorted into ten females per vial. Vials were changed
every 48 h, and deaths per vial were scored until all flies were dead. In overexpres-
sion studies, n5 200. In dSir2-mutant studies, n5 100. For statistical methodo-
logy, see earlier.
dSir2 deacetylation assays.We used both the SirT1 Fluorimetric Drug Discovery
Kit (Enzo Life Sciences) and an HPLC-based acetyl-histone-H4 deacetylation
assay29. dSir2 and dSir2–Myc were cloned into pET SUMO (Invitrogen) and
proteins were purified on HisPur cobalt spin columns (Thermo Scientific).
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Nematode strains andmaintenance.Caenorhabditis eleganswere cultured under
standard monoxenic conditions31,32. Strains used included N2 (wild type), GA707
wuEx166 [rol-6(su1006)], HT1593 unc-119(ed3), LG100 geIn3 [sir-2.1 rol-
6(su1006)] dyf-?(wu250), NL3908 pkIs1641 [unc-119] unc-119(ed3) and NL3909
pkIs1642 [sir-2.1 unc-119] unc-119(ed3).
Outcrossing of nematode strains. LG100 was outcrossed with N2 and the Rol
trait was used to detect the presence of gIn3. NL3908 andNL3909were outcrossed
using HT1593 unc-119(ed3). Rescue of Unc (uncoordinated movement) was used
to detect the presence of the transgene array.
Isolation of Dyf, non-Rol and non-Dyf, Rol lines. LG100 was crossed with N2
and lines were established from individual F2 animals with Dyf, non-Rol or non-
Dyf, Rol phenotypes. The Dyf phenotype was identified by staining with the dye
1,19-dioctadecyl-3,3,3939-tetramethylindocarbocyanine perchlorate (DiI) and
looking for absence of dye uptake into the amphid and phasmid neurons. Non-
Dyf, Rol F2 animals that were heterozygous for the geIn3 transgene array (the rol-6
marker is dominant) were identified by the presence of non-Rol animals in the F3,
and were excluded.
RNAi in C. elegans.Animals were fed E. coli containing the HT115 vector, either
with or without a portion of the sir-2.1 gene cloned into it. The sir-2.1 feeding
strainwas obtained from theAhringer RNAi library33.Wormsweremaintained on
RNAi feeding strains for two generations before lifespan measurements. One day
before starting measurements, FUdR was applied to seeded plates at 10mM to
prevent progeny production.
Analysis of SIR-2.1 protein levels in C. elegans. Protein was prepared from
synchronous nematode cultures (L4 larvae and young adults) raised on E. coli
OP50 or RNAi bacteria for two generations. Western blots were performed with
anti-actinmonoclonal antibodies (Santa-CruzBiotechnology) and an anti-SIR-2.1
polyclonal antibody (provided by A. Gartner34). For all assays, 3–5 replicate worm
cultures were used.
Neuroprotection assays in C. elegans. To test for sirtuin-mediated protection
from expanded polyglutamines (polyQs), we crossed GA919 (geIn3 dissociated
from dyf-?(wu250)) to strains carrying integrated polyQ arrays. These polyQ
strains co-express the first 57 amino acids of human huntingtin with either 19
or 128 Gln residues fused to cyan fluorescent protein and expressed from the
mec-3 promoter, and YFP expressed from the mec-7 promoter in touch-receptor
neurons24. The response to touch at the tail was tested as previously described24.
Three trials were performed and 150–200 animals were tested per genotype.
Lifespan analysis in C. elegans. Lifespans of synchronized population cohorts
were measured as previously described28. FUdR was applied to the plates at 10, 40
or 50mM (see Supplementary Tables). Lifespan experiments were performed at
20 uC.A small proportionof animalswere censored, usuallydue to uterine rupture,
which mainly occurred at mid-adulthood (,day 9–11).
Statistical analysis of C. elegans data. The statistical significance of effects on
lifespan was estimated using the log-rank test, performed using JMP, Version 7
(SAS Institute).
Drosophila stocks and maintenance. Tubulin–GAL4 and dSir2EP2300 lines were
obtained from the Bloomington Stock Center. dSir2–Myc2 and dSir2–Myc9 lines
were generated by germline transformation. These were outcrossed into white
Dahomey (wDah). The strains dSir24.5/SM6B (ref. 35) and dSir217/Cyo (ref. 36),
provided by S. Pletcher and J. Rine, were outcrossed into Canton S. All lines were
outcrossed at least six times. The presence of the deletion was detected by PCR
using the following primers: 149F (59-AGATATGACATAAGGCAGTGGC-39),
1427R (59-TCCCGTTAGCACAATGATCTTC-39) and 3909R (59-GAAGGCGG
TAGCAATGGTGACAA-39). Flies were maintained at 25 uC on a 12 h:12 h light:
dark cycle at constant humidity.
Myc-tagged dSir2. The Myc tag was added to RE27621 (Riken) using standard
techniques and cloned into pUASP. The construct wasmicroinjected intow04 and
the transformant lines dSir2–Myc2 and dSir2–Myc9were recovered. Primerswere:
Sir59R2(59-CAAGAATTCCAACGAGAATTTTACACAGGTCGTGTG-39), Sir39Xba
(59-ATC GAGTCTAGACACTGCTGCTAACTGTCCTGGAGG-39) and MYC39Xba
(59-GAGCTATCTAGAGGATCCGAGGAGCAGAAGCTGATC-39).
Lifespan assays inDrosophila. Flieswere bred at standard density (,300 flies per
200-ml bottle), allowed to mate for 48 h after emerging (once mated) and then
sorted into ten females per vial (experiments performed at University College
London) or 35 per vial on 15% SYA (experiments performed at University of
Michigan). Vials were changed every 48 h and deaths per vial were scored until
all flies were dead. The numbers of flies used in lifespan assays were: overexpres-
sion studies, n< 200 (UCL) or n< 350 (U.Michigan); dietary-restriction studies,
n5 100. For the overexpression studies, the fly-food recipes were as follows: SYA
(100 g yeast, 50 g sugar, 15 g agar, 30ml nipagin and, inmost trials, 3ml propionic
acid per litre of food); ASG (20 g yeast, 85 g sugar, 10 g agar and 60 gmaize per litre
of food); ASG1 (31 g yeast, 124 g sugar, 9 g agar, 53 g cornmeal and 25ml nipagin
per litre of food); 15% SYA (150 g yeast, 150 g sugar, 21 g agar and 15ml tegosept).
For the dietary-restriction trials, the food dilutions used were as follows: 15 g agar,
30ml nipagin, 3ml propionic acid, with yeast and sugar both altered to final
concentrations of 10 g, 50 g, 100 g, 150 g or 200 g per litre of food. All food was
prepared as previously described27.
Genetic crosses in Drosophila. Tubulin–GAL4/TM3 males were crossed to
dSir2EP2300, dSir2–Myc2 or dSir2–Myc9 virgin females, and dSir2EP2300/1;
tubulin–GAL4/1, dSir2–Myc2/1; tubulin–GAL4/1 or dSir2–Myc9/1; and
tubulin–GAL4/1 females were selected from the progeny. For the controls,
tubulin–GAL4/TM3 males or dSir2EP2300, dSir2–Myc2 or dSir2–Myc9 virgin
females were crossed to wDah and dSir2EP2300/1, tubulin–GAL4/1, dSir2–Myc2/
1 or dSir2–Myc9/1 females were selected from the progeny.
Quantitative reverse transcriptase PCR inDrosophila.RNAwas extracted from
ten females at 10 days of age using standard techniques and transcribed into
cDNA. Four biological replicates were run per genotype, each in triplicate.
Samples were normalized to either actin5C or ribosomal protein 49 (RP49).
Primers used were: Sir2-4 59-GCTCTCCACCGTTGTCTGAGGGCC-39 (ref. 3),
Sir2-5 59-GGCGGCAGCTGTGCTGCGATGAG-39 (ref. 3), Actin5CF 59-CAC
ACCAAATCTTACAAAATGTGTGA-39, ActinCR 59-AATCCGGCCTTGCAC
ATG-39, RP49F 59-ATGACCATCCGCCCAGCATCAGG-39 and RP49R
59-ATCTCGCCGCAGTAAACG-39.
Analysis of dSir2 protein levels. Protein was extracted from 30 females at 7 days
of age. Western blots were performed using antibodies c-myc 9E10 (Santa Cruz
Biotechnology), p2E2 (Developmental Studies Hybridoma Bank) and tubulin
(Sigma).
dSir2 deacetylation assays. Sequences encoding dSir2 (RE27621) and dSir2–Myc
were cloned into pET SUMO (Invitrogen) and proteins were purified on HisPur
cobalt spin columns (Thermo Scientific). For the Fluor de Lys assay, using the
SirT1 Fluorimetric Drug Discovery Kit (Enzo Life Sciences), results presented are
the mean6 s.e.m. of three biological replicates. In each biological replicate, sam-
ples were run in triplicate. Final concentrations were: resveratrol and suramin,
0.2mM; NAD1 0.1mM. Deacetylation of native acetyl-histone-H4 peptide was
monitored by HPLC29. Deacetylation of histone H4 amino-terminal peptide
(SGRGKGGKGLGKGGA(acetyl-K)RHRC) (Biomatik) was carried out using
500mMNAD1, 100mMTris-HCl (pH 8.0), 150mMNaCl, 0.5mMdithiothreitol
and 0.05% Triton X-100, and monitored by HPLC (Agilent 1100) with an ACE
C8-300 1503 3.0mm column. The elution profiles were analysed using
Chemstation for LC 3D software.
Statistical analysis of Drosophila data. Survivorships and the response to dietary
restriction were compared using the log-rank test and analyses were performed
using JMP, Version 7 (SAS Institute).
31. Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71–94 (1974).
32. Sulston, J. & Hodgkin, J. in The Nematode Caenorhabditis elegans (ed. Wood, W. B.)
587–606 (Cold Spring Harbor, 1988).
33. Kamath, R. et al. Systematic functional analysis of the Caenorhabditis elegans
genome using RNAi. Nature 421, 231–237 (2003).
34. Greiss, S., Hall, J., Ahmed, S. & Gartner, A. C. elegans SIR-2.1 translocation is linked
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apoptosis. Genes Dev. 22, 2831–2842 (2008).
35. Newman, B. L., Lundblad, J. R., Chen, Y. & Smolik, S. M. A Drosophila homologue of
Sir2 modifies position-effect variegation but does not affect life span. Genetics
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Misfolded proteins inhibit proliferation and promote
stress-induced death in SV40-transformed
mammalian cells
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ABSTRACT Protein misfolding is implicated in neu-
rodegenerative diseases and occurs in aging. However,
the contribution of the misfolded ensembles to toxicity
remains largely unknown. Here we introduce 2 primate
cell models of destabilized proteins devoid of specific
cellular functions and interactors, as bona fide mis-
folded proteins, allowing us to isolate the gain-of-
function of non-native structures. Both GFP-degron
and a mutant chloramphenicol-acetyltransferase fused
to GFP (GFP-!9CAT) form perinuclear aggregates, are
degraded by the proteasome, and colocalize with and
induce the chaperone Hsp70 (HSPA1A/B) in COS-7
cells. We find that misfolded proteins neither signifi-
cantly compromise chaperone-mediated folding capac-
ity nor induce cell death. However, they do induce
growth arrest in cells that are unable to degrade them
and promote stress-induced death upon proteasome
inhibition by MG-132 and heat shock. Finally, we show
that overexpression of all heat-shock factor-1 (HSF1)
and Hsp70 proteins, as well as wild-type and deacety-
lase-deficient (H363Y) SIRT1, rescue survival upon
stress, implying a noncatalytic action of SIRT1 in
response to protein misfolding. Our study establishes a
novel model and extends our knowledge on the mech-
anism of the function-independent proteotoxicity of
misfolded proteins in dividing cells.—Arslan, M. A.,
Chikina, M., Csermely, P., So˝ti, C. Misfolded proteins
inhibit proliferation and promote stress-induced death
in SV40-transformed mammalian cells. FASEB J. 26,
766–777 (2012). www.fasebj.org
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Protein misfolding has been implicated in the etiol-
ogy of neurodegenerative diseases and aging, although
the molecular mechanisms remain elusive (1). Proteins
may misfold due to inherent mutations (1), mistransla-
tion (2), in response to denaturing stress, or from
post-translational modifications (3–4) resulting in di-
verse non-native conformations. However, misfolding-
induced exposure of hydrophobic surfaces generally
results in incorrect protein-protein interactions, by
which misfolded oligomeric species gain a cytotoxic
function (5–6). These mechanisms are supported by
studies using both repeat-expansion mutants linked to
neurodegeneration and observations on non-disease-
associated proteins (7–9). In these models, however,
the loss of physiological function and misfolding-in-
duced alterations in specific protein-protein interac-
tions could not be ruled out. Hence, the exact contri-
bution of misfolded ensembles, per se, to cytotoxicity is
largely unclear.
Protein maintenance is achieved by a complex pro-
teostasis network including molecular chaperones (10).
Many chaperones are heat-shock proteins induced by
proteotoxic stress via heat-shock factor-1 (HSF1; ref.
11). The heat-shock response is considered the prime
sensor of misfolded proteins in the cytosol (12), sug-
gesting that a common structural determinant of non-
native ensembles mediates both their recognition and
cytotoxicity. Indeed, chaperones confer protection by
preventing misfolding, as well as by promoting clear-
ance and sequestration of misfolded proteins into
aggregates (13). The heat-shock response declines dur-
ing aging, with a concomitant accumulation of protein
aggregates, especially in postmitotic tissues (14–15).
Moreover, both aging and chronic expression of polyQ
expansions disrupt proteostasis in Caenorhabditis elegans
(16–17). However, it is unknown how short-term ex-
pression of a single misfolded protein affects proteos-
tasis in replicating cells.
Green fluorescent protein (GFP) and chloramphen-
icol-acetyltransferase (CAT) are widely used reporters
in mammalian cells. A C-terminal fusion of a degron
peptide to GFP has been reported to aggregate and
induce cytotoxicity in C. elegans and in mammalian
neurons (18), and a C-terminally truncated form of
CAT (!9CAT) has been shown to form inclusion
bodies in Escherichia coli (19). Both variants are almost
identical to their wild-type counterparts in sequence,
meaning no major difference in costs of their expres-
sion and degradation. They lack disease-associated se-
1 Current address: Department of Neurology, Mt. Sinai
School of Medicine, New York, NY, USA.
2 Correspondence: Semmelweis University, Department of
Medical Chemistry, Tu¨zolto´ u. 37–47. Budapest, H-1094,
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quences, high-affinity interactors, and cellular func-
tion, which eliminates mechanisms originating from
sequence-specific interactions and from losing func-
tional benefits upon misfolding. Hence, we introduce
both mutants as bona fide misfolded proteins in COS-7
cells, allowing the isolation of the gains of function of
misfolded ensembles. In this report, we analyze their
turnover, effect on the heat-shock response, chaper-
one-mediated protein folding, cell proliferation, and
survival under basal and stress conditions. Finally, we
address how genetic up-regulation of major stress-
inducible defense mechanisms combat the challenge
induced by protein misfolding.
MATERIALS AND METHODS
Constructs
pEGFP-C1 was obtained from Clontech Laboratories (BD
Biosciences, San Jose, CA, USA). GFP-degron was a kind gift
of Christopher Link (University of Colorado, Boulder, CO,
USA). GFP-wtCAT was generated by cloning the PCR-ampli-
fied full-length CAT (pCAT3-Control vector; Promega, Mad-
ison, WI, USA) region into the BglII/PstI sites of pEGFP-C1,
using forward primer 5"-AAAGATCTATGGAGAAAAAAAT-
CAC-3" and reverse primer 5"-AACTGCAGTTACGCCCCGC-
3". For GFP-!9CAT cloning, the reverse primer was designed
to omit sequences corresponding to the last 9 C-terminal
amino acids (5"-AACTGCAGTTACTGTTGTAATTC-3"). Ex-
pression plasmids were kind gifts of the following colleagues:
His-cBSA, Richard Voellmy (University of Miami, Miami, FL,
USA); GFP170*, Elizabeth Sztul (University of Alabama,
Birmingham, AL, USA); Hsp70.1pr-luc, Rick Morimoto
(Northwestern University, Evanston, IL, USA); HSF1-myc-His,
Lea Sistonen (Åbo Akademi University, Turku, Finland);
Hsp70-myc, Kerstin Bellmann (Heinrich-Heine University,
Du¨sseldorf, Germany); SIRT6-Flag, Haim Cohen (Bar-Ilan
University, Ramat-Gan, Israel). Wild-type and deacetylase-
deficient (H363Y) SIRT1 were obtained from Addgene (Cam-
bridge, MA, USA). CMV-#-galactosidase was purchased from
Promega, and pTK-luc was provided by La´szlo´ Hunyady
(Semmelweis University, Budapest, Hungary). All constructs
were verified by DNA sequencing.
Cell culture and transfection
COS-7 cells (SV40-transformed African green monkey kidney
fibroblast-like cell line; CRL-1651; American Type Culture
Collection, Manassas, VA, USA) were cultured in Dulbecco’s
modified Eagle medium (with 4.5 mg/ml glucose; Life Tech-
nologies–Invitrogen, Carlsbad, CA, USA), supplemented with
10% fetal bovine serum, 100 U/ml penicillin and 100 $g/ml
streptomycin, and 2 mM l-glutamine in a humidified incuba-
tor at 37°C with 5% CO2. Cells were plated at a density of
2.8–3 % 104 cells/cm2, 1 d before transfection. Transient
transfections were performed by Lipofectamine LTX reagent
(Invitrogen) with the indicated plasmids according to the
manufacturer’s guidelines at a total DNA ($g) to Lipo-
fectamine ($l) ratio of 1:3. Cells were processed for analyses
at 24 or 48 h post-transfection.
Purification of aggregates and Western blotting
Cells were lysed in 1% Triton X-100 in PBS with protease
inhibitors (Complete; Roche, Mannheim, Germany) for 30
min at 4°C. After sonication on ice for 3 % 10 s, the lysates
were cold-centrifuged (4°C) at 12,500 g for 15 min, and
supernatants (S) containing soluble proteins were transferred
to new tubes. Detergent-insoluble pellets (P), containing
aggregated proteins, were solubilized in urea buffer (2% SDS,
6 M urea, 30 mM TrisHCl, pH 7.6) in the same volume, by
shaking at 600 rpm for 10 min at 50°C. Equal volumes of
protein extracts from each fraction (S, P) were resolved by
SDS-PAGE. Western blotting was performed by transfer to
nitrocellulose membrane (Bio-Rad, Hercules, CA) and by
blocking in 5% (w/v) skim milk powder (Fluka, Buchs,
Switzerland). Blots were probed with antibodies against GFP
(20) and Hsp70 (HSPA1A/B; SPA-810; Stressgen, San Diego,
CA), HSF1 (Cell Signaling, Danvers, MA, USA), SIRT1 (Cell
Signaling), and SIRT6 (Sigma-Aldrich, St. Louis, MO, USA).
Immunodetection was performed by ECL (PerkinElmer,
Wellesley, MA, USA).
Estimation of misfolded protein expression levels
Cells were trypsinized and split, and the ratio of GFP& cells
was determined by flow cytometry (FACSCalibur; BD Biosci-
ences, Heidelberg, Germany) using the FL1 (530/30 BP)
channel. The rest of the cells were lysed in urea buffer, and
protein concentration was determined by detergent-compat-
ible BCA protein assay (Pierce, Rockford, IL, USA). Protein
extracts (10 $g) were loaded on SDS-PAGE along with known
quantities of recombinant GFP (Roche). GFP expression
levels (% of total protein) were determined by densitometric
analysis of the GFP Western blots using Image J (U.S. Na-
tional Institutes of Health, Bethesda, MD, USA), normalized
to the corresponding GFP& cell ratio.
Immunofluorescence microscopy
Cells were grown on poly-l-lysine-coated (0.1 mg/ml; Sigma)
glass coverslips. At 2 d after transfection, cells were fixed and
permeabilized in prechilled ('20°C) absolute methanol for 5
min. After being washed twice in PBS, cells were blocked in
1% BSA, then incubated in an anti-Hsp70 mouse monoclonal
antibody solution (BD Biosciences) recognizing both induc-
ible (HSPA1A/B) and constitutive (HSPA8) Hsp70 for 1 h at
room temperature. Following washing, cells were stained by
Cy3-conjugated goat anti-mouse secondary antibody (Jackson
ImmunoResearch Labs, West Grove, PA, USA) for 30 min at
room temperature. After washing, cells were counterstained
with DAPI (Molecular Probes, Eugene, OR, USA). Coverslips
were mounted using Vectashield (Vector Laboratories, Bur-
lingame, CA, USA) and visualized by epifluorescence micro-
scope (Nikon Eclipse E400; Nikon, Tokyo, Japan), employing
%10 % 100 (oil immersion) power with the appropriate filter
sets.
HSF1 transactivation and luciferase folding assays
Cells were cotransfected with a reporter plasmid harboring
the hsp70 promoter region upstream of the firefly luciferase
gene (hsp70.1pr-luc) and a #-galactosidase plasmid driven by
the cytomegalovirus promoter (#-gal) for an internal control.
For luciferase folding, a firefly luciferase plasmid harboring
the thymidine kinase minimal promoter (TK-luc) was used.
Cotransfections were done at a ratio of 4:1:1. Cells were lysed
in 1X Reporter Lysis Buffer (Promega) for 20 min at room
temperature with occasional rocking. For luciferase folding
assay, cells were immediately cooled on ice to prevent rena-
turation of luciferase, and cell lysis was performed on an ice
bed for 40 min. Then cells were centrifuged (4°C) at 12,500
g for 3 min. Cell lysates were processed for #-galactosidase
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and luciferase (Bright-Glo; Promega) assays according to the
manufacturer’s protocols. Absorbances and luminescence
were measured by a plate reader (Thermo Varioskan Flash;
Thermo Scientific, Wiesbaden, Germany). Data were ex-
pressed by dividing luminescence values by #-gal activities
(luc/#-gal).
BrdU incorporation
Cells grown on poly-l-lysine-coated coverslips were pulse-
labeled with bromodeoxyuridine (BrdU; Molecular Probes)
at 100 $M for 3 h. After being washed once in PBS, cells were
fixed in 4% paraformaldehyde (Sigma) at 4°C for 30 min.
Following washing in PBS containing 0.5% (w/v) BSA (wash
buffer), cells were permeabilized in 1% Triton-X in PBS for
20 min at room temperature, then stained with FITC-conju-
gated anti-GFP antibody (Abcam, Cambridge, MA, USA) for
40 min at room temperature. Following washing, genomic
DNA was denatured in 2 M HCl containing 0.5% Tween-20
for 30 min at 37°C. Cells were stained with Alexa Fluor
546-conjugated anti-BrdU antibody (Molecular Probes) for
40 min at room temperature. Following multiple washes, cells
were counterstained with DAPI for 5 min and analyzed by an
epifluorescence microscope (DMI6000B; Leica Microsystems,
Wetzlar, Germany), employing %10 % 10 power with the
appropriate filter sets (DAPI: A4, FITC: L5, Alexa Fluor 546:
TX2). Image analysis was performed by counting 600–700
cells/ area for 6 different areas randomly selected from each
sample.
Annexin assay
Cells were treated with the proteasome inhibitor MG-132 (2
$M; Calbiochem, San Diego, CA, USA) on the same day of
transfection, for a total duration of 42 h. Cells were
trypsinized and cold-centrifuged (4°C) at 2000 rpm for 5 min.
Following washing in ice-cold PBS, cells were resuspended in
100 $l annexin buffer (10 mMHEPES, 140 mM NaCl, and 2.5
mM CaCl2) and stained with 5 $l annexin V-Alexa Fluor 647
conjugate (Molecular Probes–Invitrogen) for 20 min at room
temperature. After the addition of 900 $l annexin buffer,
cells were mixed gently and immediately analyzed by flow
cytometry. Cells were counted (10,000) and gated in an
FSC/SSC dot plot to eliminate cell debris. Acquisition and
analysis were done by BD CellQuest Pro software (BD Biosci-
ences). Native GFP and annexin signals were measured in a
dual-parameter dot plot by FL1 (530/30 BP) vs. FL4 (661/16
BP) channels, respectively. The percentage of annexin& cells
out of the GFP& subpopulation was calculated by the formula
UR/(UR&LR)%100, as obtained from quadrant statistics.
Analysis of cellular DNA content
Cells were treated with 2 $M MG-132 1 day after transfection
for 20 h. For concomitant heat-stress experiments, cells were
heat-shocked at 43°C or kept 37°C at for 30 min in a
circulating water bath. Cells were collected and cold-centri-
fuged (4°C) at 1800 rpm for 3 min. The resulting cell pellet
was resuspended in 1 ml prechilled (at '20°C) 70% ethanol
at room temperature for 30 min, then stored at '20°C
overnight. Fixed cells were pelleted at 2200 rpm for 5 min at
4°C and resuspended in 1 ml extraction buffer (200 mM
Na2HPO4, pH 7.8, adjusted with 200 mM citric acid) contain-
ing 10 $g/ml final concentration of RNase A (Sigma).
Following incubation at room temperature for 30 min, the
remaining nuclear DNA was stained by propidium iodide (10
$g/ml) for 10 min at room temperature. Gated total cell
population was immediately analyzed by a flow cytometer
(FACSCalibur; BD Biosciences) in a 2-parameter dot plot with
FL1 (530/30 BP) vs. FL3 (650 LP) channels, measuring the
native GFP and PI fluorescence, respectively. For data analysis
(BD CellQuest Pro), only the percentage of GFP& cells with
an intact cell cycle (i.e., combination of G1-S-G2/M peaks) out
of the gated total population (i.e., UR values obtained from
the quadrant statistics) was taken into consideration.
Statistical analysis
Data were analyzed using SPSS 15.0 software (SPSS, Chicago,
IL, USA) and compared by Student’s t test. All data are
presented as means ( se of indicated numbers of indepen-
dent experiments. Values of P ) 0.05 were considered
significant.
RESULTS
GFP-degron and GFP-!9CAT display characteristics
of misfolding
First, we generated GFP-fusions of wild-type (wtCAT) and
!9CAT and used GFP and GFP-degron and CAT variants
to transiently transfect COS-7 cells and investigated their
solubility by sequential extraction into detergent-soluble
and insoluble fractions. While GFP and GFP-wtCAT
showed an equal distribution, GFP-degron and GFP-
!9CAT sedimented predominantly in detergent-insoluble
pellet fractions, respectively (Fig. 1A). This sedimentation
was not due to higher-level overexpression, since both
mutants were detected at a level 2- to 5-fold less than their
wild-type counterparts (see the sum of S&P fractions in
Figs. 1A and 2A). Moreover, we observed GFP-reactive
bands at higher molecular weight in the pellet fractions
of GFP-degron and GFP-!9CAT, indicating the pres-
ence of insoluble oligomeric and/or ubiquitinylated
species, both of which indicate the exposure of buried
regions in misfolded ensembles. Spectrophotometric
CAT assays (21) revealed that deletion of the 9 C-ter-
minal amino acids also caused total loss of CAT enzy-
matic activity (Supplemental Fig. S1). Thus, destabilizing
modifications induced the loss of native conformation and
converted both GFP and GFP-wtCAT into a less soluble
state.
Next, we examined the subcellular distribution of
GFP-degron and GFP-!9CAT by fluorescence micros-
copy. Both GFP-degron and GFP-!9CAT prevailed pre-
dominantly as deposits of perinuclear aggregates re-
sembling aggresomes, while GFP and GFP-wtCAT
distributed diffusely (Fig. 1B). These observations have
been confirmed in live cells (data not shown) and
demonstrated that the decreased solubility was not an
artifact caused by cell lysis, but was due to the formation
of aggregated ensembles inside living cells, a hallmark
of protein misfolding (3). Our findings on the perinu-
clear deposition of GFP-degron are consistent with
those of Link et al. (18).
Expression of both GFP-degron and GFP-!9CAT
increased the level of inducible Hsp70 (HSPA1A/B;
Fig. 1A, bottom panel). Equally increased Hsp70 levels
were observed in the soluble and pellet fractions,
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respectively, of both mutants, indicating that Hsp70 did
not show a strong preference toward insoluble species
after cell lysis. Moreover, immunofluorescence analyses
showed that GFP-degron and GFP-!9CAT led to a
robust constitutive and inducible Hsp70 (HSPA8 and
HSPA1A/B, respectively) accumulation only in cells
where they were expressed, in contrast to the soluble
controls GFP and GFP-wtCAT (Fig. 1B). Remarkably,
Hsp70 was strongly enriched in both GFP-degron and
GFP-!9CAT aggregates. The Western blot and immu-
nofluorescence data together suggest a transient asso-
ciation of Hsp70 with the misfolded/aggregated species
of GFP-degron and GFP-!9CAT and are consistent with
a previous report showing a dynamic interaction of
Hsp70 with polyglutamine proteins (22). These results
demonstrate that both GFP-degron and GFP-!9CAT
exhibit decreased solubility and aggregation, induce
and transiently associate with the chaperone Hsp70,
and establish GFP-degron and GFP-!9CAT as bona fide
misfolded proteins.
Misfolded proteins undergo proteasomal degradation
Both Link et al. (18) and our group observed GFP-
degron as perinuclear aggregates (Fig. 1), though
GFP-degron& cells were always only a modest fraction
(5–15%) of the total cell population. Hence, we tested
whether a proteolytic degradation of misfolded pro-
teins occurred. Using the proteasome inhibitor MG-
132, we detected an increased level of both GFP-degron
and GFP-!9CAT by flow cytometry. MG-132, at a con-
centration as low as 2 $M (a concentration without
severe cytotoxicity), induced a significant increase in
GFP-degron& and GFP-!9CAT& cells, approaching the
ratio of GFP& and GFP-wtCAT& cells (Fig. 2A). It is
important to note that neither GFP-degron nor GFP-
!9CAT was detected in soluble forms, and proteasome
inhibition did not significantly change the appearance
and topology of aggregates examined by fluorescent
microscopy, which suggests that aggregation is a direct
consequence of the presence of misfolded, undegrad-
able ensembles. We found that 3-methyladenine, a
specific inhibitor of autophagy, did not increase GFP-
fluorescence (data not shown), suggesting that the
stabilization observed with MG-132 was not due to an
unspecific inhibition of the cellular proteolytic capac-
ity. Altogether, these results define the proteasome
responsible for the degradation of these misfolded
proteins.
Flow cytometric histograms of MG-132-treated cell
populations show that proteasome inhibition stabilizes
GFP-degron and GFP-!9CAT at fluorescence intensi-
ties exceeding 102 and 3 % 102, respectively, suggesting
that misfolded species are tolerated below these tresh-
olds (Fig. 2B). We determined the corresponding ex-
pression levels by densitometry of anti-GFP Western
blots of total cell lysates (Fig. 2C, D). While traces of
misfolded proteins were detected using these settings,
inhibition of their turnover increased the average ex-
pression of GFP-degron and GFP-!9CAT to 2.2 vs. 0.9%
of total cellular protein, respectively. These results are
consistent with the higher peak of GFP-degron ob-
served in flow cytometry (Fig. 2B). Considering the
logarithmic scale of fluorescence and the abovemen-
tioned thresholds, we assume that maximal expression
levels cannot exceed 1–2% of total cellular proteins,
and that misfolded proteins in the range of *0.02–
0.04% of total cellular proteins are efficiently sensed
and disposed.
Figure 1. GFP-degron and GFP-!9CAT display characteristics of misfolding. A) Misfolding GFP-degron and GFP-!9CAT
proteins sediment in detergent-insoluble aggregates and increase Hsp70 (HSPA1A/B) protein level. After transient transfec-
tions with the indicated constructs (GFP, GFP-degron, GFP-wtCAT, GFP-!9CAT), COS-7 cells were lysed, and cell lysates were
separated into soluble (S) and detergent-insoluble pellet (P) fractions by centrifugation and analyzed by Western blotting for
GFP and Hsp70, respectively. B) Misfolding proteins form perinuclear aggregates and accumulate total Hsp70 protein in vivo.
Transfected cells grown on coverslips were fixed in methanol; stained by an antibody recognizing both inducible (HSPA1A/B)
and constitutive (HSPA8) Hsp70, followed by a Cy3-conjugated secondary antibody, and DAPI for nuclear DNA; and were
visualized under a fluorescence microscope. Images are representatives of 5 independent experiments.
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Misfolded proteins activate the hsp70 promoter
Since we could see an accumulation of Hsp70 protein
with both misfolded proteins, we were interested
whether they would induce transactivation of heat-
shock factor 1 (HSF1), responsible for the induction of
hsp genes. To accomplish this, we used a reporter
construct harboring the hsp70 promoter fused to firefly
luciferase (23). GFP-degron expression resulted in a
moderate induction of the reporter at 37°C by up to
4-fold compared to that of GFP (Fig. 3A). GFP-!9CAT
was able to induce the reporter gene at a smaller,
comparable extent (3-fold increase compared to the
induction by GFP-wtCAT). Induction of the reporter by
misfolded proteins was completely blunted by cotrans-
fection with HSF1 siRNA, confirming that the induc-
tion was entirely HSF1-dependent, consistent with pre-
vious results (data not shown; ref. 24). GFP-degron and
GFP-!9CAT did not activate the endoplasmic reticulum
chaperone, grp78 promoter (data not shown), suggest-
ing that misfolding of cytosolic proteins does not result
in the activation of the endoplasmic reticulum un-
folded protein response, consistent with recent studies
in yeast (25–26).
We next addressed how misfolded proteins would
interfere with the induction of the heat-shock response
by a moderate proteotoxic heat stress (43°C). The
presence of GFP-degron and GFP-!9CAT, neither
Figure 2. Misfolded proteins undergo proteasomal
degradation. A) Cells were treated with increasing
concentrations of the proteasome inhibitor MG-
132 for 20 h before they were harvested and
analyzed by flow cytometry. Chart shows percent-
age of GFP& cells in total cell population. Data
represent means ( se of 3 independent experi-
ments and were compared to their own untreated
control samples in the absence of MG-132. B)
Cells, treated with or without MG-132 (5 $M,
20 h), were harvested and analyzed by flow cytom-
etry. Histogram overlays show MG-132-treated
(thick line) and untreated (thin line) cell popula-
tions for each protein model as a function of GFP
fluorescence intensity. Images are representatives
of 2 independent experiments. C) Western blot
analysis for GFP of total protein extracts (10 $g) of
cells from B, using a recombinant GFP (rGFP)
calibration. Images are representatives of 2 independent experiments. D) GFP expression levels. Densitometric analysis of
Western blots from C, normalized to their corresponding GFP positivities. Data represent means ( se of 2 independent
experiments and were compared to untreated GFP and GFP-wtCAT controls (asterisks on columns) and to GFP-degron/
GFP-!9CAT in the absence or presence of MG-132, respectively (linked bars). n.s., not significant. *P ) 0.05; **P ) 0.01;
***P ) 0.001.
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failed to synergize with nor compromised the heat-
induced activity of the reporter gene construct, respec-
tively, suggesting that the induction of the heat-shock
response was not significantly changed by a transient
expression of a single misfolded protein (Fig. 3B).
However, misfolded proteins led to a higher basal level as
well as a reduced reserve capacity of the heat-shock
response, suggesting that the induction of heat-shock
proteins was under a constant strain at basal conditions
(Fig. 3C). We observed the same phenomenon with
bovine serum albumin misdirected to the cytosol (GFP-
cBSA) and with the coiled-coil region of the Golgi com-
plex protein 170 fused to GFP (GFP170*), a nonpolyQ
protein reported to form nuclear aggregates and colocal-
ize with Hsp70, consistent with a previous reports (refs. 9,
24 and data not shown). Hence, we conclude that a
transient expression of a single misfolded protein induces
HSF1-dependent transactivation without a severe compro-
mise of heat inducibility along with a reduced reserve
capacity of the heat-shock response.
Opposing effects by GFP-degron and GFP-!9CAT on
chaperone-mediated folding
Chronic expression of polyQ proteins was previously
shown to interfere with protein folding in C. elegans
(17). To test this possibility in replicative cells, we asked
how acute expression misfolded proteins would affect
the activity of firefly luciferase, a metastable multido-
main protein commonly used as a model substrate to
monitor chaperone activity/function (27). Overexpres-
sion of GFP-degron caused a 25% decrease of luciferase
activity compared to that of wild-type GFP-cotransfected
cells at 37°C (Fig. 4A). Surprisingly, GFP-!9CAT en-
hanced luciferase activity by 20% compared to that of
GFP-wtCAT at 37°C (Fig. 4B). With increasing periods
of time at 42°C heat shock, the difference between
luciferase activities of both GFP vs. GFP-degron and
GFP-wtCAT vs. GFP-!9CAT pairs disappeared. Similar
phenomena were observed with MG-132, consistent with
the proteasomal clearance of an extensive amount of
mistranslated-misfolded proteins already at nonstress con-
ditions (28). Hsp70 overexpression promoted luciferase
folding by*25% for all constructs even in the presence of
MG-132 (data not shown), establishing that global manip-
ulations of the proteostatic buffer were efficiently moni-
tored by firefly luciferase. None of the interventions
affected the activity of #-galactosidase (data not shown).
We conclude that in contrast to global proteotoxic stresses
(heat shock and MG-132), short-term expression of single
misfolded proteins exerts a modest effect on chaperone-
mediated protein folding.
Misfolded proteins inhibit cell proliferation
We next investigated the consequences of protein
misfolding on cell growth. Incorporation of the thymi-
dine analog bromodeoxyuridine (BrdU) into genomic
DNA is an indicator of cell division. To analyze rates of
BrdU uptake in transfected and untransfected sub-
populations we immunostained the cells with both
anti-GFP and anti-BrdU antibodies. Image analyses of
dual immunofluorescence data revealed that both GFP-
degron& and GFP-!9CAT& cells incorporated less
BrdU than their wild-type counterparts (Fig. 5). Induc-
tion of cell proliferation arrest was more pronounced
with GFP-degron, suggesting a stronger effect of GFP-
degron on cell growth. MG-132 (2 $M, 20 h) treatment
completely blocked BrdU uptake (data not shown).
Thus, similarly to proteasome inhibition, misfolded
proteins arrest cell proliferation.
Misfolded proteins promote stress-induced cell death
Although misfolded proteins inhibited cell prolifera-
tion (Fig. 5B), we detected neither any necrosis by
propidium iodide exclusion nor apoptosis by sub-G1
peak of DNA (data not shown). However, treatment of
transfected cells with MG-132 resulted in an altered
histogram with a distorted sub-G1 peak containing cell
Figure 3. Misfolded proteins activate the hsp70 promoter. HSF1-transactivation at 37°C (A), heat-induced HSF1-transactivation
(B), and the ratio of induced and basal outputs (C). A, B) Along with the indicated constructs, cells were cotransfected with
hsp70.1pr-luc and #-galactosidase (#-gal) plasmids. A second set (B) was given a heat shock at 43°C for 30 min. Luciferase and
#-gal assays were performed 18 h later, and their ratios were expressed as percentages of the value obtained in the GFP sample.
C) Alternatively, fold inductions in the heat-shock response were calculated by dividing the normalized (luc/#-gal) heat-shocked
(43°C) values by their corresponding basal (37°C) values and are displayed in the chart as a percentage of the value obtained
in the GFP sample. Data represent means ( se of 7 independent experiments for GFP and GFP-degron and 3 independent
experiments for GFP-wtCAT and GFP-!9CAT, respectively. Values were compared to the respective wild-type controls. n.s., not
significant. **P ) 0.01; ***P ) 0.001.
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debris along with a marked decrease in the number of
intact cells (Fig. 6A). Therefore, as a more appropriate
marker of the number of intact (live) cells, a joint
measure of cell proliferation and death, we calculated the
area below the G1-S-G2/M peaks of GFP
& cells (labeled by
peaks in Fig. 6A). GFP-degron and GFP-!9CAT transfec-
tion combined with MG-132 treatment resulted in a lesser
amount of intact GFP& cells compared to their wild-type
controls already at 37°C (Fig. 6B). Notably, there was a
further sharp decrease in the number of GFP-degron- or
GFP-!9CAT-transfected intact cells when they were given
a moderate heat shock (43°C, 30 min) that did not affect
GFP and GFP-wtCAT controls.
To obtain an independent measure of cell death, we
performed annexin staining, detecting cell death from
early apoptosis through late necrosis. GFP& cells dis-
played enhanced annexin staining compared with GFP-
negative population and MG-132 treatment resulted in
Figure 4. Opposing effects by GFP-degron and GFP-!9CAT on chaperone-mediated folding. GFP-degron compromises (A),
while GFP-!9CAT enhances (B) firefly luciferase folding at 37°C. Along with the indicated protein models, cells were
cotransfected with TK-luc and #-gal plasmids. After treatment with or without MG-132 (2 $M, 20 h), cells were either incubated
at 37°C or given a heat shock at 42°C for the indicated periods of time. Immediately after the heat shock, cells were cooled on
ice, lysed, and analyzed, as described in Materials and Methods. Charts show normalized luciferase (luc/#-gal) activities as a
percentage of the value obtained in the respective wild-type controls at 37°C without MG-132 treatment. Data represent means(
se of 3 independent experiments and were compared to the respective wild-type controls subjected to the same treatment. *P)
0.05; **P ) 0.01; ***P ) 0.001.
Figure 5. Misfolded proteins induce cell proliferation
arrest. Transfected cells were pulse-labeled with BrdU
(100 $M) for 3 h, fixed, and immunostained with
anti-GFP and anti-BrdU antibodies, followed by a nu-
clear staining (DAPI). A) Fluorescence microscopy
pictures show merged images of GFP (green), BrdU
(red), and nuclei (blue) stainings. Arrows indicate cells
that are positively stained for both GFP and BrdU.
Image for each construct is representative of 12 differ-
ent regions from 2 independent experiments. B) Quantification of dual immunofluorescence data. Six different areas
randomly selected from each protein model with an average of 600–700 cells/area were first counted for single DAPI, GFP,
and BrdU signals. Double positives for both GFP and BrdU signals were then counted, and calculations were done
accordingly to determine percentages of BrdU positivity in GFP& (dark bars) and GFP-negative (light bars) subpopulations.
Data represent means ( se of 2 independent experiments and were compared to the respective wild-type controls. n.s., not
significant. *P ) 0.05; **P ) 0.01.
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an increase in annexin-positivity from 10 to 25%,
consistent with a general proteotoxicity induced by
proteasome inhibition (Fig. 6C). Similarly to the previ-
ous propidium iodide data, there was no significant
difference between annexin staining of GFP-degron-
and GFP-!9CAT-transfected cells compared to that of
their wild-type counterparts. However, MG-132 treat-
ment of cells expressing GFP-degron, but not GFP-
!9CAT, yielded a significantly higher annexin positivity
compared to controls (Fig. 6C). These results confirm
the GFP-degron-related findings presented in Fig. 6B
and suggest that some form of GFP-!9CAT-induced cell
death may escape detection by annexin in our experi-
mental conditions. Nevertheless, when GFP-!9CAT
cells underwent a moderate heat shock, they also
displayed an increased annexin positivity comparable
to that of GFP-degron (data not shown). Moreover, we
obtained similar results with 2 other misfolded protein
models, GFP-cBSA and GFP170*, upon MG-132 treat-
ment (Supplemental Fig. S2). Thus, diverse misfolded
proteins sensitize cells to manifest enhanced cytotoxic-
ity in response to stress.
HSF1, Hsp70, and SIRT1 protect from GFP-degron-
induced cytotoxicity
We next addressed how genetic activation of stress-
responsive mechanisms would combat the cytotoxicity
induced by GFP-degron. HSF1 and Hsp70 are impor-
tant determinants of the heat-shock response, amelio-
rating toxicity of neurodegenerative models (10, 29–
30). SIRT1 is an NAD&-dependent protein deacetylase,
which was reported to control HSF1 activity by prolong-
ing its DNA binding through deacetylation (31). It was
also shown to be protective in initial studies against
polyglutamine-induced cytotoxicity in both C. elegans
and mammalian neurons (32), though its general role
in invertebrate longevity has been questioned (33).
SIRT6 is a nuclear sirtuin paralog implicated in dietary
restriction and the metabolic syndrome; however, there
are no data on its role in proteostasis (34).
All the HSF1, Hsp70, SIRT1, and SIRT6 constructs
were strongly overexpressed upon transfection
(Fig. 7A). None of the constructs caused any significant
difference in the number of GFP-degron& cells (i.e.,
Figure 6. Misfolded proteins promote stress-
induced cell death. A) Cell cycle alterations ob-
served during flow cytometric analyses of our
protein models after treatment with MG-132.
Combination of G1-S-G2/M peaks (representing
intact cells) was chosen as the parameter for
analysis of the following assay. B) Misfolded pro-
teins diminish survival of proteasome-inhibited
cells upon a concomitant heat stress. Cells treated
with MG-132 (2 $M, 20 h) were either incubated
at 37°C (dark bars) or at 43°C for 30 min (light
bars). The next day, cells were harvested and
fixed overnight in ethanol at'20°C. After extrac-
tion of fragmented DNA, cells were stained with
propidium iodide, and the remaining DNA con-
tent was analyzed by flow cytometry. Chart dis-
plays percentage of GFP& cells with an intact cell
cycle out of the total cell population. Data repre-
sent means ( se of 3 independent experiments
and were compared with the respective wild-type controls for 37°C data and with their own 37°C controls for 43°C data.
C) Misfolded GFP-degron, but not GFP-!9CAT, induces annexin positivity upon proteasome inhibition. Cells treated with
or without MG-132 (2 $M, 42 h) were stained with annexin V, and analyzed by flow cytometry. The chart shows the
percentage of annexin positivity in GFP& (dark bars) and GFP-negative (light bars) subpopulations for each protein model.
Data represent means ( se of 3 independent experiments, and GFP& values were compared to GFP and GFP-wtCAT
controls (asterisks on columns) and GFP-degron/GFP-!9CAT to their respective MG-132-treated wild-type control (linked
bars). n.s., not significant. **P ) 0.01; ***P ) 0.001.
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cells expressing and not degrading GFP-degron) in the
absence or presence of MG-132 (data not shown), sug-
gesting they did not alter the turnover of GFP-degron.
HSF1, Hsp70, and SIRT1 constructs were all found to
prevent cell death inMG-132-treated GFP-degron-express-
ing cells (Fig. 7B). Interestingly, SIRT1-mediated recovery
from GFP-degron-induced cytotoxicity was independent
of the deacetylase activity of SIRT1, as both wild-type
(wtSIRT1) and the deacetylase-deficient H363Y mutant
(ddSIRT1) were protective. In contrast, SIRT6 did not
exert a protective effect, giving an independent evi-
dence for the specific action of SIRT1. This finding is in
line with a recent study where SIRT1-induced neuro-
protection was found to be independent of its deacety-
lase activity (35), suggesting a novel, noncatalytic mech-
anism of cytoprotection for SIRT1.
DISCUSSION
Conformational diseases share common features: the
accumulation of non-native protein species and a con-
sequent cytotoxicity. Here we have isolated the general
effects elicited by single misfolded polypeptides by
expressing 2 bona fide misfolded proteins not occurring
in the mammalian cytosol. Both GFP-fused degron and
C-terminally truncated chloramphenicol acetyltrans-
ferase lost solubility and exhibited aggregation, tran-
siently associated with and induced the expression of
the chaperone Hsp70, underwent a proteasomal deg-
radation in the majority of cells, induced growth arrest,
and caused cytotoxicity in response to stress, which was
ameliorated by stress-responsive mechanisms (Fig. 8).
These features obtained with diverse misfolded pro-
teins are consistent with an inherent toxicity of the
misfolded ensembles per se.
Loss of a stabilizing interaction mediated by a C-ter-
minal residue in !9CAT disrupts its stability and results
in inclusion body formation in E. coli (19, 36). Our
results indicate that GFP-!9CAT instability also induces
its misfolding in mammalian cells (Figs. 1 and 2, and
Supplemental Fig. S1). The 16-residue degron peptide
supplements proteins with a C-terminal amphipathic +
helix conferring destabilization to the extended proteins
(18, 37). GFP-degron appears to be a Janus-faced mole-
cule, i.e., both an in vivo ubiquitin-proteasome system
(UPS) reporter (6, 38) and a misfolded protein (Fig. 1
and ref. 18). This dual behavior can be explained by
considering a primary misfolding of GFP-degron and its
chaperone-mediated disposal by the UPS (Fig. 8 and ref.
18), a pathway identical to that of global protein misfold-
ing (13). This model is supported by the similar pheno-
type (exhibiting aggregation, chaperone induction,
growth inhibition) of GFP-degron to several misfolded
proteins: YFP point mutants in yeast (26), GFP170* (pres-
ent study and ref. 9), and GFP-!9CAT (present study),
respectively. In addition, yeast Ura3p fused to degron
requires the Hsp70/Hsp40 orthologs Ssa1p/Ydj1p for
both its proteasomal degradation and solubility (39), in
agreement with a degron-induced misfolding of Ura3p.
Figure 7. HSF1, Hsp70, and SIRT1 protect from
GFP-degron-induced cytotoxicity. A) HSF1, Hsp70,
SIRT1s, and SIRT6 are strongly overexpressed on
transfection. Cells were transfected with mock (ctr),
HSF1,Hsp70, wtSIRT1, deacetylase-deficientH363Y
mutant SIRT1 (ddSIRT1), and SIRT6 constructs,
respectively, for 24h, lysed, and analyzed byWestern
blotting for the respective proteins. Images are rep-
resentatives of 2 independent experiments. B) Cell
death ofMG-132-treated (2$M, 42h) cells. Cotrans-
fections of the constructs were done at a ratio of 1:1
(misfolded protein construct:modulator). Annexin
assay was performed as described in Materials and
Methods. Chart shows the percentage of annexin
positivity in GFP& (dark bars) and GFP-negative
(light bars) subpopulations for each cotransfection. Renilla luciferase plasmid served asmock. Data representmeans( se of 3 independent
experiments. Statistical comparisons were made between the respective GFP& samples compared to mock-cotransfected sample. n.s., not
significant. *P ) 0.05; **P ) 0.01.
Figure 8. Misfolded proteins in mammalian cells. Misfolded
proteins induce the heat-shock response and are turned over by
the UPS in the majority of cells. In cells that are incompetent to
degrade them, they form aggregates and cause growth arrest.
Upon various stresses, such as the inhibition of UPS or heat
shock, misfolded proteins promote cell death. The genetic
up-regulation of the heat-shock response (HSF1 or Hsp70) and
the sirtuin SIRT1, independently of its deacetylase activity (dd-
SIRT1), protects from stress-induced cytotoxicity.
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Our findings suggest that aggregate formation prevails
if the level of misfolded proteins exceeds the proteostatic
capacity of the cell. Upon transient transfection in our
study (Fig. 1B) and in that of Link et al. (18) misfolded
proteins were efficiently cleared from the majority of cell
population and formed aggregates in GFP& cells. These
effects were augmented by proteasome inhibition (Fig. 2).
Overexpression of Hsp70 or HSF1 did not decrease the
number of GFP-degron& cells (i.e., did not increase the
turnover of the protein), which, along with the yeast study
on Ura3p-degron (39), suggests that chaperones are
required for but do not limit GFP-degron degradation.
These findings suggest that the UPS is a rate-limiting step
in the chaperone-mediated disposal of misfolded proteins
and offer a rationale for GFP-degron as an in vivomarker
measuring UPS capacity.
The roles of Hsp70 and HSF1 in cells expressing
misfolded proteins (Fig. 7) corroborate the well-docu-
mented role of the heat-shock response in the recogni-
tion and defense against proteotoxicity (22, 40). The
decreasing order of intensity of Hsp70 induction by
GFP-degron , GFP-!9CAT , GFP-cBSA - GFP170*
indicates a proportional release of HSF1 from its re-
pressing chaperone complex in response to misfolding.
This effect is consistent with the previously reported,
dose-dependent effect of cytosolic BSA on HSF1 activa-
tion (24). Considering the *1–2% maximal level of
misfolded proteins induced by proteasome inhibition
and an induction of Hsp70 in the heat-shock range, we
speculate that misfolded ensembles at the 0.02–0.04%
threshold level may elicit a signal potent enough to
provoke a significant threat, namely, cell cycle arrest.
This threat, however, appears to be compensated in our
experimental conditions by a highly efficient recogni-
tion/disposal (demonstrated by the negligible effects
of misfolded protein expression on thermotolerance
and on cytotoxicity). Recent studies demonstrate a
specific, HSF1-mediated cytosolic unfolded protein re-
sponse within the wider heat-shock response/proteo-
static network in yeast and plants (25–26, 41–42). Our
results, by showing a selective activation of hsp70 vs. the
ER stress marker grp78 promoter (Fig. 3A and data not
shown), extend the existence of this specific cytosolic
response to mammalian cells. The misfolded proteins
used in this study provide a tractable model to identify
the cytosolic unfolded protein response at the systems
level in mammalian cells.
We observed a differential, but modest, effect of
GFP-degron and GFP-!9CAT on firefly luciferase fold-
ing (Fig. 4). The reason for this difference is unknown.
It may be that GFP-degron and GFP-!9CAT differen-
tially affect protein transcription/translation. Though
we did not test luciferase mRNA and protein levels, the
similar #-galactosidase activities and the equal residual
activities after heat shock or MG-132 treatment exclude
such a possibility. The GFP-!9CAT-induced luciferase
activation may be explained by its less pronounced
effects (i.e., higher ratio of GFP& cells, slower turnover,
smaller hsp70-promoter induction, and decreased inhi-
bition of cell proliferation), suggesting less toxic mis-
folded species formed by GFP-!9CAT, which in turn
may activate chaperone-mediated folding. Though
these data do not allow a clear conclusion, the modest
effects and the clear dissection from toxicity (Figs. 5
and 6) suggest chaperone-mediated folding is not the
major determinant of short-term action of individual
misfolded proteins.
Our results in COS-7 cells recapitulate the proliferation
arrest obtained with single misfolded mutants, including
polyQ103-GFP in HEK-293 cells (6), GFP170* in COS-7
cells (9), YFP mutants (26), and azetidine-carboxylate in
yeast (43), which suggests a conserved, general effect of
protein misfolding. This occurs in GFP& cells (i.e., cells
that are unable to degrade themisfolded proteins; Fig. 8).
The almost complete loss of BrdU incorporation may be
consistent with a G1 arrest. As in COS-7 cells, the SV40
large T-antigen inactivates both Rb and p53; it is tempting
to speculate that mechanisms distinct from these check-
point responses may inhibit proliferation. Indeed, such
mechanisms arising from the inherent toxicity of misfold-
ing have been demonstrated, such as sequestration of the
growth-promoting CBP into aggregates (5, 9). Alterna-
tively, growth inhibition may be due to the adaptive
response, e.g., HSF1 mediating reversible cell cycle arrest
in yeast (43) or increased Hsp70 inhibiting growth (44–
45). Though the molecular pathways induced by mis-
folded proteins remain to be analyzed, our findings on
transformed cells might have a potential effect in non-
transformed mitotic cells or stem cells.
A number of studies demonstrated extensive apoptosis
using disease-associated mutants in cell (mostly neuronal)
culture and in animal models (1, 7). However, we have
not been able to detect death of immortalized COS-7 cells
expressing misfolded proteins in nonstress conditions
during the time scale of our experiments. Whether the
long-term expression of a single misfolded protein leads
to cell loss requires further studies. We also consider the
possibility that misfolded proteins may induce cytotoxicity
in neurons, where proteostatic defenses, such as the
heat-shock response, are inherently weaker (46–47).
Moreover, paralysis in the absence of apoptosis in C.
elegans muscle expressing GFP-degron (18) and prolifer-
ation arrest (our study) suggest that severe dysfunctional-
ity does not necessarily need cell death. The augmenta-
tion of death observed upon proteasome inhibition or
heat shock by 4 misfolded mutants (Fig. 6 and Supple-
mental Fig. S2) indicates that already a short-term expres-
sion of misfolded ensembles compromise cells to mount
an efficient adaptive response to proteotoxic stress. De-
fective stress tolerance seems to be a deleterious conse-
quence of misfolding, as up-regulation of 2 stress-respon-
sive mechanisms, the heat-shock response (HSF1 and
Hsp70), as well as the sirtuin SIRT1, conferred protection
(Fig. 7). Our findings extend earlier studies on the
beneficial role of chaperones in various models (18, 40).
The cytoprotective effect by chaperones may either lie in
the restoration of protein homeostasis and/or the nega-
tive regulation by Hsp70 of death signals via p38 and JNK
(48–49).
Our findings on the SIRT1 overexpression protecting
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from GFP-degron-induced proteotoxicity confirm previ-
ous results involving neurodegenerative models (32, 50–
51). Moreover, the lack of effect of SIRT6 overexpression
indicates divergent roles for sirtuin paralogs in mammals.
SIRT1-dependent deacetylation of key signaling mole-
cules includingHSF1 and consequent cellular events have
been extensively reported (31, 52). However, our study
did not demonstrate a requirement of deacetylase activity,
suggesting the SIRT1-mediated response did not demand
an increased deacetylation/activation of HSF1 in our
model (Fig. 7B). Recently, growing body of evidence
shows deacetylase-independent functions of SIRT1 (53–
55) including neuroprotection (35); however, the molec-
ular mechanism of SIRT1 remains enigmatic. Our results
extend these functions to protein misfolding and recall
tests on the involvement of SIRT1 deacetylase activity in
protection from neurodegenerative disease models (32,
50–51). Finding the proper role for SIRT1 is espe-
cially important in the light of our recent demonstra-
tion of the inability of SIRT1 orthologs to extend life
span in invertebrates (33), which has implications on
the development and use of SIRT1 activators as
potential drug candidates (56).
Our results show that the action of misfolded proteins
depends on the proteostatic balance and cellular hetero-
geneity. Protein misfolding is not limited to single genes/
proteins, but it rather involves a significant fraction of the
proteome probably due to destabilizing SNPs (57), mis-
translation (2, 28, 58), and post-translational modifica-
tions. We note that the level of misfolded proteins in our
study is comparable to protein carbonyls in aged tissues
(3–4). Lack of dilution of damage as well as the age-
associated collapse and/or intrinsic weakness of proteos-
tasis precipitate symptoms particularly in postmitotic neu-
rons during aging (16, 46–47). Our findings raise a
question whether protein misfolding would induce dam-
age to the replicative compartment in situ, which may
have implications for aging of regenerating tissues. In-
deed, dystrophy of hair follicles has been reported in a
mistranslation mouse model (2). Detrimental outcome of
misfolding may also shape the evolution of tumors, where
intensive growth (translation) and high stress are associ-
ated with the absolute reliance on HSF1 (59). These
hypotheses, as well as the long-term effects of misfolded
proteins on cellular fitness, are subjects of future studies.
As a conclusion, our study provides a mammalian cellular
model of misfolded proteins and reveals that short-term
expression of single misfolded proteins independently of
sequence and function inhibit proliferation and stress
adaptation in replicating cells.
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RNA Interference Links Oxidative Stress
to the Inhibition of Heat Stress Adaptation
Zolta´n Spiro´,1,* Mehmet Alper Arslan,1 Mila´n Somogyva´ri,1 Minh Tu Nguyen,1 Arne Smolders,2
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Abstract
Increased oxidative stress is associated with various diseases and aging, while adaptation to heat stress is an
important determinant of survival and contributes to longevity. However, the impact of oxidative stress on heat
resistance remains largely unclear. Aim: In this study we investigated how oxidative stress impinges on heat
stress responses. Results: We report that hydrogen-peroxide (H2O2) pretreatment inhibits both acquired ther-
motolerance and heat-induced Hsp70 expression in mammalian cells, as well as acquired thermotolerance in the
nematode Caenorhabditis elegans, via RNA interference. Moreover, we demonstrate that elimination of RNA
interference by silencing key enzymes in microRNA biogenesis, dcr-1 or pash-1, restores the diminished intrinsic
thermotolerance of aged and H2O2-elimination compromised (catalase-2 and peroxiredoxin-2 deficient) worms.
Innovation and Conclusion: These results uncover a novel post-transcriptional element in the regulation of heat
stress adaptation under oxidative conditions that may have implications in disease susceptibility and aging.
Antioxid. Redox Signal. 17, 890–901.
Introduction
Basic physiological processes such as metabolism, cel-lular signaling, and immunity are associated with the
production of reactive oxygen species (ROS) (16). An accu-
mulation of ROS, called oxidative stress, plays a critical role in
various diseases and in aging (13, 16, 34). Although an excess
of ROS generates diverse molecular and cellular damages and
evokes a plethora of signaling events, how it is involved in the
induction or aggravation of these pathological states is not
entirely understood.
Increased resistance to heat stress protects against degener-
ative diseases in mammals (9, 32) and associates with longevity
in Caenorhabditis elegans (10, 26). Intrinsic thermotolerance is
maintained by multiple mechanisms. A preconditioning (i.e.,
heat) stress induces acquired thermotolerance, mediated by the
heat shock response via heat shock factor (HSF1)-dependent
induction of heat shock proteins (Hsp-s) (30, 47). Previous
studies reported contrasting results of oxidative stress on HSF1
activation (2, 28) and Hsp70 levels (14, 22, 43). However, the
effect of oxidative stress on thermotolerance remains largely
unexplored.
RNA interference is a powerful post-transcriptional regu-
lator of gene expression that operates via*22 nt microRNAs
(miRNAs) (27). Genomic miRNA precursors are processed by
highly specific RNases: the nuclear Drosha/PASH-1 produces
hairpin pre-miRNAs, which are transported to the cytoplasm
and cleaved to mature miRNAs by Dicer/DCR-1 (capital
names indicate the respective nematode orthologs). Hence,
Dicer/Drosha knockout is a reliable tool to investigate the
general role of miRNAs (5, 41, 44). miRNAs bind to the
mRNA 3¢ untranslated region (3¢UTR), repress translation, or
promote mRNA degradation (27). miRNAs modulate diverse
Innovation
Oxidative stress is a serious cause of cell and tissue
damage associated with many human diseases. Our ob-
servations beyond demonstrating a novel crosstalk be-
tween various types of stresses via RNA interference
extend our understanding on how oxidative stress may
debilitate physiological function. As RNA interference
exhibits a significant functional conservation from nema-
todes to humans, we anticipate that the mechanism iden-
tified herein may be involved in human diseases and
aging.
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biological processes. Their connection with stress is exempli-
fied by imparting robustness to gene expression networks
in response to environmental change (24) and by the pro-
found alterations of miRNA expression upon heat and oxi-
dative stresses (25, 42, 49) [reviewed in (23)]. Heat and
ischemic preconditioning-induced miRNAs induce Hsp70
and are cardioprotective during ischemia-reperfusion in
mice (48, 49). Moreover, miRNAs modulate the life span
and stress resistance of C. elegans involving DAF-16 and HSF1
(6, 11), underscoring a vital role of RNA interference in stress
responses.
In this study we focused on the impact of oxidative stress
on heat stress adaptation and found that hydrogen-peroxide
(H2O2) pretreatment inhibited acquired thermotolerance in
both COS-7 mammalian cells and in C. elegans. As an under-
lying mechanism, H2O2 inhibited the heat-induction of Hsp70
in cells, consistent with a recent study (1). Moreover, H2O2
prevented the heat-induction of an Hsp70 3¢UTR reporter.
H2O2-induced effects required Dicer, a key enzyme inmiRNA
biogenesis, in both cells and worms. We further found that
RNAi against Dicer and Drosha orthologs restored the com-
promised thermotolerance of two worm strains deficient in
H2O2 disposal. Finally, Dicer silencing delayed the decline of
thermotolerance in aging worms and phenocopied the effect
of the antioxidant N-acetyl-l-cysteine (NAC). Our results re-
veal RNA interference as a mediator of oxidative stress-in-
duced inhibition of heat stress responses.
Results
H2O2 inhibits acquired thermotolerance and Hsp70
induction at the post-transcriptional level
in COS-7 cells
The effect of a transient H2O2 exposure on thermotolerance
of COS-7 cells was determined by subjecting cells to a lethal
heat stress 24 h after H2O2 and/or preconditioning heat
treatments. Heat preconditioning elicited a large increase in
survival (acquired thermotolerance, Fig. 1A). A prior H2O2
treatment slightly increased intrinsic thermotolerance. Im-
portantly, it potently inhibited acquired thermotolerance in a
concentration-dependent manner (Fig. 1A).
To examine whether the decrease in acquired thermo-
tolerance is due to the inhibition of the heat shock response, we
pretreated COS-7 cells with a series of H2O2 concentrations and
monitored the heat induction of Hsp70 by flow cytometry (Fig.
1B). Cells, exposed to heat shock, exhibited an *10-fold in-
duction of Hsp70, concordant with the induction of thermo-
tolerance (cf. Fig. 1A). H2O2 treatment did not affect basal
FIG. 1. Hydrogen-peroxide (H2O2) impairs heat-preconditioned thermotolerance and Hsp70 heat-induction in COS-7
cells. (A) Effect of H2O2 on thermotolerance. Cells were treated by the indicated concentrations of H2O2 for 2 h, then kept at
37!C (control) or at 43!C for 30min (heat shock). About 24 h later cells were subjected to a lethal heat stress (45!C, 60min).
Cell survival was analyzed 24 h later by Trypan blue exclusion. Values are means – standard deviations (SDs) of three
experiments. (B, C) Effect of H2O2 on Hsp70 and Hsp90 protein levels. Cells were treated by H2O2 and heat shock as in panel
A. Five hours later Hsp70 levels were analyzed by flow cytometry using a monoclonal antibody (B) or by Western blot using
a polyclonal anti-Hsp70 and monoclonal anti-Hsp90 and anti-actin antibodies, respectively (C). Values are means – SDs
of five experiments compared to their respective controls, and image is a representative of three experiments. (D) Densito-
metric analysis of relative Hsp70 and Hsp90 levels from (C). (E) H2O2 titration curve of cytosolic HyPer-C in COS-7 cells. The
490/420-nm fluorescence excitation ratio of HyPer was calculated after background fluorescence subtraction from two
experiments. *p< 0.05, **p< 0.01, ***p< 0.001.
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Hsp70 level, but inhibited Hsp70 heat induction in a concen-
tration-dependent manner (Fig. 1B). Western blots using a
polyclonal anti-Hsp70 antibody showed a similar inhibition of
Hsp70, but not of the specific chaperone Hsp90 (Fig. 1C, D).
These results exclude an H2O2-induced modification or deg-
radation of Hsp70 as well as a general, stress-induced tran-
scriptional or translational block. The efficacy of H2O2 was
verified by cells expressing the H2O2-sensor Hyper-C (Fig. 1E)
(12). Thus, H2O2 pretreatment compromises both acquired
thermotolerance and Hsp70 heat-induction in COS-7 cells.
Next, we investigated the site of action of H2O2 along the
heat shock regulon. Upon heat, misfolded proteins activate
HSF1, which binds to heat shock promoter elements and in-
duces hsp gene transcription (32). To assess the level of HSF1-
dependent transactivation, we transfected COS-7 cells with a
hsp70pr/luciferase vector and performed reporter gene assays
after cells had either been oxidatively stressed and/or heat-
shocked. Heat shock markedly induced reporter activity,
while H2O2 treatment significantly affected neither basal nor
heat-induced transactivation (Fig. 2A). Likewise, H2O2 treat-
ment did not decrease hsp70 mRNA level (Fig. 2B). Thus, a
transcriptional inhibition does not seem to underlie the H2O2-
induced decrease in Hsp70 protein expression.
To assess, if H2O2 could down-regulate Hsp70 post-
translationally, we changed the order of stresses (i.e., em-
ployedH2O2 after heat shock) and followed theHsp70 protein
level by flow cytometry (Fig. 2C). H2O2 did not change the
heat shock-induced sustained elevation of Hsp70, which ex-
cluded the possibility of an accelerated Hsp70 turnover.
The 3¢UTR is intimately connected with the post-
transcriptional regulation of mRNAs. To investigate the mo-
lecular events at the Hsp70 3¢UTR, we took use of a reporter
harboring the mouse hsp70.1 3¢UTR fused to Firefly luciferase
(18). Monitoring luciferase activity provided an estimate of
the impact of the hsp70 3¢UTR on the translation of luciferase
mRNA following H2O2 and/or heat shock treatments. 3¢UTR
reporter activity displayed a time-dependent increase after
heat-shock peaking at 6 h (Fig. 2C). This finding is consistent
with early reports in Drosophila and mammalian cells on the
role of the 3¢UTR in the regulation of Hsp70 protein synthesis
during heat shock (33, 38). Neither H2O2 nor the combination
of H2O2 and heat shock increased luciferase activity above the
FIG. 2. H2O2 inhibition of Hsp70 involves a potential post-transcriptional regulation. (A) H2O2 does not affect hsp70
promoter activation. Cells transfected with the hsp70.1pr/luc and control plasmids were treated as in Figure 1. Enzyme
activities were measured 18 h later, and their ratios were expressed. (B) H2O2 does not diminish hsp70 (HSPA1A) mRNA
expression. Cells were treated as in Figure 1. mRNA levels were determined 1-h after treatments by quantitative reverse
transcriptase–polymerase chain reaction and expressed relative to b-actin. (C) H2O2 does not affect Hsp70 protein turnover.
Cells were heat shocked as above, after 2 h at 37!C cells were incubated in the absence (control), or presence of 800lM of H2O2
for 2h, and then harvested at the indicated timepoints, and analyzed by flow cytometry. (D) H2O2 inhibits the heat-induced
luciferase reporter translation mediated by the Hsp70 3¢ untranslated region (3¢UTR). Cells transfected with a pGL3/luc/hsp70.1
3¢-UTR and control plasmids were treated by 650lM H2O2 for 2 h, and then kept at 37!C or heat shocked. At the indicated
timepoints enzyme activities were determined, and expressed as a ratio. Values are means–SDs of three experiments. n.s., non-
significant, *p< 0.05, **p< 0.01, ***p< 0.001.
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baseline demonstrating that H2O2 entirely prevented the heat-
induced activation by the hsp70 3¢UTR (Fig. 2C).
RNA interference mediates H2O2-induced inhibition
of Hsp70 induction and acquired thermotolerance
in COS-7 cells
RNA interference is a powerful modulator of stress re-
sponses (23). To address whether RNA interference may
mediate the events involving the Hsp70 3¢UTR, we blocked
miRNA maturation by anti-Dicer siRNA transfection. Only
the siRNA, but not H2O2 led to a knock-down of Dicer (Fig.
3A). Intriguingly, anti-Dicer siRNA led to a large decrease in
heat-induced 3¢UTR reporter activity, suggesting that Dicer
was necessary for the 3¢UTR-mediated translational activa-
tion of the luciferase mRNA upon heat shock. This inhibition
was comparable to that induced by H2O2, and a combination
of anti-Dicer siRNA and H2O2 was not additive (Fig. 3B).
Thus, H2O2 prevents the heat-induced Hsp70 3¢UTR activa-
tion primarily via RNA interference.
To investigate how the inhibition of the 3¢UTR by RNA
interference is reflected in Hsp70 translation, we determined
Hsp70 protein levels in anti-Dicer siRNA-transfected cells
undergoing H2O2 and heat shock treatments. Dicer silencing
inhibited Hsp70 heat-induction to approximately two-thirds
of the control siRNA transfected value, comparable to the
effect of Dicer silencing (Fig. 3C). Remarkably, H2O2 could
not further reduce Hsp70 expression in Dicer-silenced cells,
suggesting that the effect of H2O2 required an intact RNA
interference.
These results suggested that RNA interferencemight play a
role in the H2O2-induced inhibition of acquired thermo-
tolerance. Indeed, we found that Dicer siRNA reduced ac-
quired thermotolerance in heat-preconditioned cells, which
was similar to the effect of H2O2 (Fig. 3D). Moreover, H2O2
did not further diminish thermotolerance in Dicer-silenced
cells, in agreement with our observations on Hsp70 induction
(cf. Fig. 3C). Hence, we conclude that RNA interference me-
diates theH2O2-induced inhibition of heat stress adaptation in
COS-7 cells.
H2O2 inhibits aquired thermotolerance through DCR-1
in C. elegans
To address if the effect of H2O2 on heat stress adap-
tation was conserved during evolution, we used C. elegans, a
FIG. 3. RNA interference mediates H2O2-induced inhibition of Hsp70 induction and acquired thermotolerance in COS-
7 cells. (A) Effect of H2O2 treatment and anti-Dicer siRNA on Dicer protein level. Two days after transfecton by anti-Dicer or
control siRNA, respectively, cells were treated with 800 lMH2O2 for 2 h. Protein levels were analyzed by Western blot. Image
is a representative of three experiments. (B) Effect of Dicer siRNA and H2O2 on the Hsp70 3¢UTR activation. Cells undergoing
a 2-day co-transfection with a control/Dicer siRNA and the 3¢UTR reporter plasmids were treated by 650 lM H2O2 for 2 h,
and then heat shocked. About 6 h later enzyme activities were determined and expressed as a ratio. (C) Effect of Dicer siRNA
and H2O2 on Hsp70 protein expression. Cells transfected with a control/Dicer siRNA were treated by 800 lM H2O2 for 2 h,
and then kept at 37!C or heat shocked. Five hours later Hsp70 levels were analyzed by flow cytometry. (D) Effect of Dicer
siRNA and H2O2 on heat preconditioned thermotolerance. Cells transfected with a control/Dicer siRNA were treated by
800 lM H2O2 for 2 h, and then kept at 37!C or heat shocked. Lethal heat stress and survival assay was performed as in Figure
1A. Values are means – SDs of three experiments. n.s., non-significant, *p< 0.05, **p < 0.01, ***p < 0.001.
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powerful model system exhibiting an organismal complexity.
In search of an H2O2-exposure that did not cause significant
damage in nematodes, we found that a treatment by 100lM
for 1 h was below the threshold to induce oxidative tolerance
to a lethal H2O2 challenge (Fig. 4A). This concentration in-
duced a rapid signal elevation in the pharynx and intestine of
worms ubiquitously expressing HyPer (Fig. 4B) (3). We used
the 100-lM pretreatment to investigate its effect on nematodal
thermotolerance. A preconditioning heat shock at 30!C
for 2 h resulted in a 20%–40% increase in thermotolerance
(Fig. 4C). A prior H2O2 treatment did not affect intrinsic
thermotolerance of worms; however, it entirely abolished
acquisition of thermotolerance by the preconditioning heat
shock.
To address whether H2O2would affect anHSF1-dependent
process, we employed the hsf-1(sy441) point mutant strain
FIG. 4. A prior H2O2 treatment inhibits aquired thermotolerance in an HSF1-dependent manner in Caenorhabditis
elegans. (A) Effect of preconditioning H2O2 treatments on oxidative tolerance. Oxidative stress was applied in the liquid
nematode growth medium (NGM) for 1 h at 20!C, 12–14 h before a lethal oxidative challenge. Data are means – SDs of two
separate experiments. (B) Intensity-normalized ratio image demonstrating a rapid rise of oxidized/reduced HyPer ratio in
jrIs[Prpl-17::HyPer] worms in response to a 1-min challenge by 100 lM H2O2 in liquid NGM. Representative image from five
independent experiments. (C) Effect of H2O2 (100 lM for 1 h) on intrinsic and acquired thermotolerance induced by a
preconditioning heat shock (heat shock, 30! for 2 h). Lethal heat stress was employed 12 h later. Only heat shock induces a
significant difference in survival ( p < 0.0001). (D) No change in thermotolerance by a preconditioning heat shock and/or an
H2O2 treatment in hsf-1(sy441) mutant worms ( p> 0.1). (E) H2O2 employed after the preconditioning heat shock does not
abrogate acquired thermotolerance ( p> 0.1 compared to heat shock). (To see this illustration in color the reader is referred to
the web version of this article at www.liebertonline.com/ars).
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harboring a truncated transactivation domain that prevented
the heat-induction of HSF1-target genes (15). In line with re-
cently published data of McColl and colleagues (29), HSF1
was required for aquired, but not for intrinsic thermotolerance
(Fig. 4D). H2O2 treatment was not additive to the hsf-1(sy441)
background; it affected neither basal nor heat-preconditioned
survival. Moreover, in wild-type worms, H2O2, if applied
after the preconditioning heat shock, was unable to inhibit
acquired thermotolerance (Fig. 4E), suggesting that H2O2
needs to precede heat preconditioning. Thus, H2O2 specifically
inhibits the acquisition of HSF1-dependent thermotolerance in
C. elegans.
If, similarly to mammalian cells, H2O2 inhibited the heat
shock response via RNA interference in C. elegans, then
worms deficient in miRNA synthesis would escape from
the H2O2-dependent inhibition of thermotolerance. In-
vestigating this hypothesis we found that silencing the
Dicer ortholog by dcr-1(RNAi) restored the acquired ther-
motolerance of H2O2-treated worms to levels comparable
to heat shock alone (Fig. 5A, B). dcr-1(RNAi) per se did not
affect thermotolerance (Fig. 5B). We obtained similar re-
sults using loss-of-function dcr-1 mutant nematodes (Fig.
5C). The efficiency of dcr-1 silencing and the lack of a
general disruption of RNA interference by H2O2, respec-
tively, were demonstrated by an RNA interference reporter
strain (20) (Fig. 5D). We made attempts to investigate
an analogous involvement of Hsp70 regulation. Un-
fortunately, a number of antibodies were unable to detect
nematode Hsp70. Quantitative polymerase chain reac-
tion (PCR) measurements revealed a tendency of H2O2
preconditioning to augment heat-induced hsp-70 mRNA
expression. However, dcr-1(RNAi) significantly altered
neither heat-induced mRNA level nor the H2O2-induced
elevation (Supplementary Fig. S1; Supplementary Data are
available online at www.liebertonline.com/ars). Despite
the unclear involvement of Hsp70, RNA interference is
required for H2O2 to inhibit acquired thermotolerance in
worms.
Inhibition of RNA interference restores
thermotolerance in endogenous models
of oxidative stress
Next we asked how thermotolerance might be affected by
chronic genetic disturbances in antioxidant defense. Anti-
oxidant enzymes provide protection against oxidative stress
FIG. 5. DCR-1 mediates the H2O2-induced inhibition of thermotolerance in C. elegans. Effect of H2O2 on intrinsic and
acquired thermotolerance in worms fed by empty (EV, A) or dcr-1(RNAi) (B) vectors, respectively. Treatments were as in
Figure 4. Note that the activatory effect of preconditioning heat shock was less pronounced on RNAi plates. In EV-fed worms
(A) only heat shock, while in dcr-1(RNAi)-fed worms (B) both heat shock as well as H2O2+heat shock induced a significantly
higher survival compared with controls ( p< 0.001). (C) Both heat shock and H2O2 +heat shock induces a significant increase
in thermotolerance in dcr-1(ok247);unc-32(e189) nematodes ( p < 0.0001 vs. control). Survival curves are representatives of three
experiments yielding similar results. (D) H2O2 does not compromise RNA interference. Epifluorescence image demonstrating
increased expression of pajm::GFP (harboring an anti-GFP hairpin siRNA in addition to the GFP sequence) in the GR1401
RNA interference reporter strain fed by dcr-1(RNAi). Arrows point to specific dots localized to epithelial seam cells. In
contrast, H2O2 (100 lM for 1 h) treatment followed by a 12- or 24-h recovery did not inhibit GFP silencing. Please note the
autoflurescence of oxidatively stressed worms. Representative image from three independent experiments. (To see this
illustration in color the reader is referred to the web version of this article at www.liebertonline.com/ars).
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by removing ROS. Catalase-2 is a peroxisomal enzyme in-
volved in H2O2 elimination accounting for *80% of total
catalase activity in the worm (39). ctl-2 loss of function ele-
vates endogenous H2O2 levels (3), decreases oxidative toler-
ance and shortens lifespan (39).We observed that ctl-2(ok1137)
animals exhibited impaired intrinsic thermotolerance com-
pared to wild type, which was completely restored by dcr-
1(RNAi) (Fig. 6A). Silencing the Drosha ortholog PASH-1, the
other key enzyme in miRNA biogenesis, phenocopied the ef-
fect of dcr-1(RNAi) in the ctl-2(ok1137) strain (Fig. 6B) without
affecting wild-type thermotolerance (Fig. 6C). Neither the
survival decrease in ctl-2(ok1137) nor the amelioration by pash-
1(RNAi) was prevented by hsf-1(RNAi) (Fig. 6D). Hence, ctl-2
loss of function modulates intrinsic thermotolerance, not in-
volving the HSF1-Hsp axis.
To test whether the observed phenomena might be attrib-
uted to the general impairment of H2O2 elimination, we ex-
amined the lack of peroxiredoxin-2, involved in H2O2
reduction in the cytosol. prdx-2(gk169)worms, similarly to the
ctl-2(ok1137) strain, are susceptible to H2O2 injury, and dis-
play a shortened lifespan (37). We found that prdx-2 knockout
also markedly decreased C. elegans thermotolerance (Fig. 6E).
Importantly, dcr-1(RNAi) prevented thermotolerance inhibi-
tion in prdx-2(gk169)worms. Together these data suggest that
genetic defects in H2O2 elimination compromise heat stress
adaptation via RNA interference.
FIG. 6. Loss of RNA interference rescues thermotolerance in nematodes with genetic defects of H2O2 disposal. (A) Effect
of dcr-1(RNAi) on thermotolerance of N2 and ctl-2(ok1137)worms. ctl-2(ok1137)worms exhibited significantly shorter survival
( p< 0.001), while other survivals were not significantly different ( p> 0.2), compared to N2 control. (B) pash-1(RNAi) phe-
nocopies dcr-1(RNAi) by inducing a significant increase in thermotolerance of ctl-2(ok1137) ( p< 0.0001) compared to that of
the EV control. (C) pash-1(RNAi) does not change thermotolerance of wild-type worms ( p > 0.1) compared to that of the EV
control. (D) pash-1(RNAi) extends thermotolerance independently of hsf-1 in ctl-2(ok1137) worms [p< 0.01 vs. pash-1/hsf-
1(RNAi)]. (E) Effect of dcr-1(RNAi) on thermotolerance of N2 and prdx-2(gk169) worms. prdx-2(gk169) worms fed by EV
exhibited significantly shorter ( p < 0.0001), while those fed by dcr-1(RNAi) exhibited slightly longer survival ( p < 0.05) com-
pared to N2 control. Survival curves are representatives of three independent experiments giving similar results.
896 SPIRO´ ET AL.
               dc_625_12
Inhibition of RNA interference delays age-dependent
decline of thermotolerance
Aging is characterized by a collapse of proteostasis and an
impairment of the heat shock response in C. elegans (4). Con-
sistent with this, we observed a decline in C. elegans thermo-
tolerance during aging (Fig. 7A–C). Oxidative stress andH2O2
increases during aging and ROS are considered a major cause
of aging (3, 34). To address if oxidative stress affected ther-
motolerance during aging, we treated worms with the small
molecular antioxidant, NAC. Intriguingly, NAC was able to
reduce the decline of thermotolerance during aging resulting
in a milder slope and a significant difference at the old worms
at day 10 of age (Fig. 7A–C).
Then we asked, whether RNA interference was involved in
the age-associated decline of thermotolerance of worms. dcr-
1(RNAi) did not significantly influence the thermotolerance of
young animals at day 1 (Fig. 5), but efficiently suppressed the
age-induced decline of thermotolerance similarly to NAC
treatment (Fig. 7A–C). Moreover, the combination of dcr-
1(RNAi) with NAC was not significantly different from the
effect of dcr-1(RNAi) at any time points tested. These findings
indicate that RNA interference is involved in the oxidative
stress-induced age-dependent decline of heat stress adapta-
tion in C. elegans.
Discussion
In this study, we have presented evidence that oxidative
stress inhibits the adaptive responses to heat stress in both
mammalian cells and C. elegans. Silencing Dicer and Drosha
orthologs, key enzymes specific tomiRNAmaturation reveals
a conserved role for RNA interference. In mammalian cells
H2O2 abolishes a positive action of RNA interference on ac-
quired thermotolerance. Inhibition of RNA interference does
not alter thermotolerance in young nematodes, suggesting
thatH2O2may inducemiRNA(s) that inhibit the acquisition of
thermotolerance. Intrinsic thermotolerance decrease of prdx-2
and ctl-2 knockouts and aged worms might require accumu-
lation of miRNA(s) inhibiting HSF1-independent processes.
Despite species-specific and context-dependent mechanisms,
our results provide support to the modulation of stress re-
sponses by RNA interference (Fig. 8) (23).
Our findings on the post-transcriptional inhibition of
Hsp70 expression offer a potential molecular mechanism
underlying the H2O2-induced compromise of acquired ther-
motolerance. Early reports demonstrating a heat-induced
stabilization of hsp70 mRNA by its 3¢UTR (33, 38) and the
decrease in heat-induced hsp70 mRNA by H2O2 in glioma
cells (1) suggested that H2O2 may prevent mRNA stabiliza-
tion. However, our results showing no impact of H2O2 on
FIG. 7. Loss of RNA interference and the antioxidant N-acetyl-l-cysteine ameliorate age-associated decline of ther-
motolerance in C. elegans. Thermotolerance of 2-day (A) and 10-day (B) old nematodes treated by dcr-1(RNAi) and/or 5mM
N-acetyl-l-cysteine (NAC; from day 1 of adulthood). There was no significant difference in survival between treatments at
day 2 ( p> 0.1). The 10-day old control (EV) exhibited a significantly shorter survival ( p< 0.001 vs. 2-day EV). All dcr-1(RNAi)
and/or 5mM NAC induced a significant increase in survival ( p< 0.001 vs. 10-day old EV), which approached ( p= 0.028 10-
day EV +NAC vs. 2-day EV), and became non-significant ( p> 0.05 10-day dcr-1(RNAi) and dcr-1(RNAi) +NAC vs. 2-day EV)
compared with the survival of the 2-day old EV control. Survivals of 10-day dcr-1(RNAi) and dcr-1(RNAi) +NAC strains were
not significantly different ( p> 0.4). (C) Mean thermotolerance of nematodes treated by dcr-1(RNAi) and/or 5mM NAC as a
function of age. Panels are representatives of two independent experiments yielding similar results. **p< 0.01, ***p < 0.001.
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hsp70 mRNA and inhibition of 3¢UTR reporter, respectively,
are consistent with a compromised translation by H2O2. In-
terestingly, inflammatory cytokines inhibit colonic Hsp70
translation by recruiting its mRNA to stress granules (17, 18).
Although it may be one plausible mechanism, our results
using Dicer knockdown suggest the involvement of miR-
NA(s). Possible scenarios include an H2O2-induced decrease
of activatorymiRNA(s), or displacement/domination of heat-
induced activatory miRNA(s) by H2O2-induced inhibitory/
neutral miRNA(s) from the hsp70 mRNA. Both mechanisms
are generally employed by RNA interference (23, 27). More-
over, recent articles provide evidence on miRNAs either in-
hibiting (miR-378*, miR-711, miR-146a, miR-146b-5b) (35, 46),
or ischemic preconditioning-induced miRNAs (miR-1, miR-
21, miR-24 or others) (48, 49) activating Hsp70 expression.
Identification of the exact mechanism(s) and miRNA(s),
as well as an analogous Hsp70 regulation in nematodes re-
quires further studies. Nevertheless, our study raises the idea
that pathophysiological oxidative conditions (inflammation,
wound healing, aging) might employ RNA interference to post-
transcriptionally regulate Hsp70 in various tissues (7, 18, 36).
Our use of mutants deficient in H2O2 elimination demon-
strates that a chronic disturbance in ROS metabolism impairs
intrinsic thermotolerance, independently of HSF1 (Fig. 6).
This defect can entirely be reversed by blocking miRNA
maturation, suggesting a profound post-transcriptional re-
modeling of heat stress adaptation by RNA interference in
response to oxidative stress. McColl et al. elegantly showed
that increased intrinsic thermotolerance in daf-2 mutant
worms is mediated by a daf-16-dependent translational re-
sponse (29). A common motif in the two studies is that RNA
interference or translation do not limit survival in young
worms; however, they differentially condition heat resistance in
both long-lived insulin-like signaling mutants and short-lived
oxidative defense-deficient mutants and aged worms, respec-
tively [(29) and our study]. It is tempting to speculate that the
daf-16-regulated response of insulin signaling mutants might
involve miRNAs. The clarification of a possible interaction of
the translational response and RNA interference in the regula-
tion of stress resistance remains the task of future studies.
Aging in the worm is characterized by an increased accu-
mulation of ROS as well as a collapse of protein homeostasis
(4). Our results on the age-induced decline of intrinsic ther-
motolerance support these observations, and use of the anti-
oxidant NAC demonstrates a progressive causal role for
ROS in decline of stress resistance during aging (Fig. 7).
Importantly, both the comparable pattern of NAC and
dcr-1(RNAi) protection and the lack of significant synergism
imply a substantially overlapping mode of action. Moreover,
increased protection by dcr-1(RNAi) suggests that RNA in-
terference adversely affects heat resistance with aging. Single
miRNAs do not seem to play an essential role in C. elegans
development and growth, but both RNA interference and
single miRNAs are indispensable to ensure proper develop-
ment during environmental stress (20, 24, 31). Likewise, there
is an extensive change in miRNA expression during C. elegans
aging (11, 19) and several individual miRNAs similarly
modulate longevity and stress resistance in C. elegans (11).
Inhibition of the entire RNA interference in adulthood pro-
vides strong evidence to the general dysregulation ofmiRNAs
in aging and in oxidative stress with a negative impact on
stress resistance (Figs. 6 and 7). It remains to be seen whether
RNA interference would pose a trade-off between fine-tuning
developmental programs and growth during stress in ex-
change for a self-maintenance later in life. Our results imply
that beyond well-characterized stress-responsive HSF1 and
DAF-16 pathways, RNA interference may offer a novel target
to alleviate decline of stress responses during aging.
Materials and Methods
Materials
Reagents for cell culture were from Invitrogen. Solutions
for flow cytometry were from BD Biosciences. Electrophoresis
and blotting reagents were from Bio-Rad. N-acetyl-l-cysteine
and H2O2 were from Sigma. All other reagents were from
either from Sigma or Fluka.
Cell culture and survival
COS-7 cells were obtained from the ATCC. Cells were
cultured as described (40). Cell survival was analyzed by
Trypan Blue exclusion 24 h after challenge.
Determination of protein levels
Flow cytometry using a fluorescein-isothiocyanate-conju-
gated monoclonal anti-Hsp70 antibody (StressGen), cell lysis,
and Western blotting using a polyclonal anti-Hsp70 antibody
(21), or antibodies against Hsp90 (Stressgen), Dicer (CST),
actin (Sigma) was carried out as previously described (40).
Transfection and reporter gene assays
Cells were transfected at a density of 40% using Lipo-
fectamine (Invitrogen). Control/anti-Dicer siRNA (Quiagen)
FIG. 8. Model for the role of RNA interference in the
modulation of heat stress responses by oxidative stress.
Oxidative stress may be induced by various sources, such as
increased production/extrinsic factor (H2O2), decreased
elimination (impaired defense, endogenous mutants), or a
combination of the two (aging). RNA interference mediates
an inhibitory action of oxidative stress and reduces heat re-
sistance.
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was introduced at 100 nM. Further treatments were applied at
48 h post-transfection. For the hsp70-promoter reporter gene
assay, cells were transfected with 0.35 lg hsp70.1pr/Firefly
luciferase plasmid (RickMorimoto, Northwestern University)
and cytomegalovirus/b-galactosidase plasmids, while for
the 3¢UTR reporter assay 0.35 lg pGL3 basic or pGL3/hsp70.1
3¢-UTR plasmid (Eugene Chang, University of Chicago) and
thymidine kinase/Renilla luciferase plasmids were em-
ployed, respectively. Treatments were performed 24h post-
transfection. About 18 h post-treatment reporter activities
were measured using commercial assay kits (Promega) and
expressed.
C. elegans strains and RNA interference
Strains were obtained from the CGC, if not otherwise
specified. The following strains were used in this study:
wild type (N2), jrIs[Prpl-17::HyPer], PS3551 hsf-1(sy441),
BB1 dcr-1(ok247);unc-32(e189) III, VC289 prdx-2(gk169) II,
VC574 ctl-2(ok1137) II, and the GFP RNAi-reporter GR1401
(Gary Ruvkun, Harvard University). Strains were back-
crossed to the wild type at east three times to clear po-
tential background mutations, and were maintained as
described (8). RNAi was performed as described by feed-
ing worms with HT115(DE3) bacteria transformed with
empty vector, dcr-1(RNAi) Gary Ruvkun (Harvard Uni-
versity) or pash-1(RNAi) (Source BioScience) vectors, repec-
tively (45). Experiments were carried out in the second
generation. Experiments were performed in the second gen-
eration with synchronized young 1-day-old adults, except for
age-related thermotolerance.
Thermotolerance assay
Thermotolerance was performed on nematode growth
medium plates at 35!C till complete extinction of the popu-
lation using 25 animals per condition in at least two inde-
pendent trials. Viability was determined hourly by assaying
for movement in response to gentle prodding.
mRNA expression analysis
mRNAwas prepared using the GeneJET RNAPurification
Kit (Fermentas). mRNA was reverse transcribed using the
RevertAidTM cDNA Synthesis Kit (Fermentas). Quantitative
PCR was performed in an ABI 7300 System by Taqman
Gene Expression Assays: HSPA1A:Hs_00359147_s1; b-actin:
Hs_99999903_m1 (Applied Biosystems). Relative amounts
of hsp70 mRNA were determined using the Comparative
Cycle Treshold Method for quantitation and normalized to
actin mRNA levels. Please see Supplementary Materials and
Methods for the analysis of hsp70 mRNA expression in ne-
matodes.
Analysis of H2O2 levels and fluorescence microscopy
Fluorescence measurements in COS-7 cells transfected by
HyPer-C (Miklo´s Geiszt, Semmelweis University) were per-
formed as described (12). HyPer titration was achieved by
sequential addition of increasing concentrations of H2O2.
Mean fluorescence intensities over individual cells were cal-
culated from 3-min recordings. H2O2 in worms was moni-
tored using the jrIs[Prpl-17::HyPer] strain, ubiquitously
expressing the H2O2-biosensor HyPer, was used. Worms
were immobilized and imaged as described (3).
Statistical analysis
Data were analyzed using SPSS software 15.0 (SPSS, Inc.).
Survival curves were compared by the log-rank test. If not
stated otherwise, all experiments were repeated at least three
times. Variables were expressed as mean– standard devia-
tion. Statistical significance was indicated as follows: *p< 0.05,
**p< 0.01, ***p < 0.001.
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A Role for SKN-1/Nrf in Pathogen Resistance and
Immunosenescence in Caenorhabditis elegans
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Abstract
A proper immune response ensures survival in a hostile environment and promotes longevity. Recent evidence indicates
that innate immunity, beyond antimicrobial effectors, also relies on host-defensive mechanisms. The Caenorhabditis elegans
transcription factor SKN-1 regulates xenobiotic and oxidative stress responses and contributes to longevity, however, its role
in immune defense is unknown. Here we show that SKN-1 is required for C. elegans pathogen resistance against both Gram-
negative Pseudomonas aeruginosa and Gram-positive Enterococcus faecalis bacteria. Exposure to P. aeruginosa leads to SKN-
1 accumulation in intestinal nuclei and transcriptional activation of two SKN-1 target genes, gcs-1 and gst-4. Both the Toll/IL-
1 Receptor domain protein TIR-1 and the p38 MAPK PMK-1 are required for SKN-1 activation by PA14 exposure. We
demonstrate an early onset of immunosenescence with a concomitant age-dependent decline in SKN-1-dependent target
gene activation, and a requirement of SKN-1 to enhance pathogen resistance in response to longevity-promoting
interventions, such as reduced insulin/IGF-like signaling and preconditioning H2O2 treatment. Finally, we find that wdr-
23(RNAi)-mediated constitutive SKN-1 activation results in excessive transcription of target genes, confers oxidative stress
tolerance, but impairs pathogen resistance. Our findings identify SKN-1 as a novel regulator of innate immunity, suggests its
involvement in immunosenescence and provide an important crosstalk between pathogenic stress signaling and the
xenobiotic/oxidative stress response.
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Introduction
A proper immune response ensures survival in a hostile
environment and contributes to longevity. The nematode
Caenorhabditis elegans provides a valuable genetic tool for studying
innate immunity and various aspects of host-pathogen interac-
tions. During infection, both bacterial virulence factors and host
antimicrobial defense mechanisms present oxidative and proteo-
toxic noxae inducing tissue-damage, especially in the intestine [1–
5]. Accordingly, several self-protective stress-response regulators
including the forkhead transcription factor DAF-16/FOXO [6],
the heat shock transcription factor HSF-1 [7] and the X-box
binding protein 1 (XBP-1) [8] are required for robust immunity.
Moreover, the DAF-16-regulated antioxidant enzymes SOD-3
and CTL-2 contribute to immunity by protecting intestinal cells
from reactive oxygen species during exposure to Enterococcus faecalis
[9]. Strikingly, hyper-activation of DAF-16 enhances susceptibility
to bacterial infection [10].
These data illustrate a critical role of stress response in innate
immunity, and raise questions about the co-ordination of
antimicrobial and host-defense mechanisms. Antimicrobial re-
sponses are mediated by a canonical p38 mitogen-activated
protein kinase (MAPK) pathway, which is conserved from
nematodes to humans [11,12]. Besides, the insulin/IGF-like
signaling (IIS) and TGF-b pathways are also involved in the
regulation of the pathogen-specific immune response in C. elegans
[13,14]. Both p38 MAPK and IIS pathways regulate the Nrf1/2/3
ortholog SKN-1, a transcription factor that orchestrates both
oxidative and xenobiotic stress responses in C. elegans [15,16].
However, the involvement of SKN-1 in the regulation of pathogen
stress response is unknown.
In nematodes, three SKN-1 isoforms exist. While the function of
SKN-1A has not been elucidated yet, SKN-1B and C provide
distinct biological functions. SKN-1B is expressed in the ASI
neurons, and mediates lifespan extension in response to dietary
restriction [17]. In contrast, intestinal SKN-1C is required for
oxidative stress resistance and contributes to longevity by reduced
IIS [15]. SKN-1 activity is regulated by phosphorylation and
degradation. Under normal conditions, inhibitory phosphoryla-
tions by GSK-3 and IIS kinases, AKT-1/2 and SGK-1, retain
SKN-1 in the cytosol [15,18], where it is rapidly targeted to
proteasomal degradation by the WD40 repeat protein WDR-23
[19,20]. In response to oxidative stress, the p38 MAPK ortholog
PMK-1 phosphorylates SKN-1, which then translocates to the
nuclei of intestinal cells and induces transcription of phase 2
detoxification genes [16].
Here we report that SKN-1 is required for pathogen resistance
against both Gram-negative P. aeruginosa and Gram-positive E.
faecalis bacteria, consistently with an independent study [21]
published after submission of this paper. We further demonstrate a
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Toll and Interleukin-1 Receptor domain protein (TIR-1)/PMK-1-
dependent SKN-1 activation upon P. aeruginosa infection. More-
over, we show a gradual decrease of pathogen resistance and of the
activation of SKN-1-dependent targets during aging, and a
requirement of SKN-1 to boost immunity in response to
longevity-promoting manipulations, such as reduced IIS and
preconditioning H2O2 treatment. Finally, we find that hyper-
activation of SKN-1 impairs pathogen resistance. Our results
indicate an intricate regulation of innate immunity by SKN-1 and
links pathogenic stress signaling to the xenobiotic stress response.
Results
SKN-1 is required for bacterial pathogen resistance in C.
elegans
To study the role of SKN-1 in C. elegans immunity, we examined
the pathogen resistance of animals in the absence of SKN-1. skn-
1(zu135) allele is considered to be a genetic null mutation as it
creates a premature stop codon that affects all SKN-1 isoforms
[15]. skn-1(zu135) mutant worms were first exposed to the Gram-
negative Pseudomonas aeruginosa (PA14) strain. As skn-1(zu135)
mutants are sterile, we eliminated the difference between them
and wild-type N2 strain arising from the ‘bag of worms’
phenotype, a major contributor to killing. To this end, germline
development was inhibited by silencing cdc-25.1, required for
embryonic mitosis and meiosis. cdc-25.1(RNAi) animals exhibit
extended survival on pathogenic bacteria, as reported previously
[21,22]. In these conditions, we observed an increased suscepti-
bility of skn-1(zu135) mutants to PA14 (Figures 1A and S1A,
Tables S1A and S1E). This result was confirmed by using skn-
1(RNAi) (Figures 1B and S1B, Table S1A and S1E). Furthermore,
when animals were exposed to the Gram-positive Enterococcus
faecalis SdB262 strain, both skn-1(zu135) and skn-1(RNAi) exhibited
significantly decreased survival, though in this case the absence of
SKN-1 exerted a more modest effect (Figures S1C and S1D, Table
S1E). These results suggest a requirement of SKN-1 for the
efficient immune response against two distinct bacterial pathogens.
In subsequent experiments, we focused on further defining the role
of SKN-1 in the antibacterial response against P. aeruginosa.
P. aeruginosa infection triggers SKN-1 activation
To investigate if SKN-1 nuclear translocation occurs upon
PA14 exposure, we incubated skn-1::gfp L3 larvae on P. aeruginosa
lawn for 5 hours. We found a massive accumulation of SKN-
1::GFP in intestinal nuclei of infected larvae, compared to control
animals fed by the non-pathogenic OP50 Escherichia coli strain
(Figures 2A and 2B). The specificity of this response was
demonstrated by a complete inhibition using a skn-1-specific
double-stranded RNA. To reveal a SKN-1-dependent transcrip-
Author Summary
Innate immunity promotes survival by combating patho-
genic threat. During infection, tissue damage is induced
both by invading pathogens and immune effectors such as
toxins and free radicals. Therefore, it is important to
elucidate by what self-protective mechanisms the host
defends itself against pathogenic stress. The conserved
SKN-1 protein of the roundworm Caenorhabditis elegans
directs a detoxification response neutralizing harmful
compounds as well as confers tolerance to oxidative
stress. Here we identify SKN-1 as a novel regulator of C.
elegans innate immunity. We show that SKN-1 contributes
to resistance against infection caused by two bacterial
pathogens. Components of a pathogen-responsive signal-
ing pathway are required to activate SKN-1 in intestinal
cells at the site of infection. Moreover, the SKN-1-
dependent response to pathogen exposure declines
during aging, whereas mild metabolic and oxidative
stresses, known to extend lifespan, evoke a SKN-1-
dependent boosting of immunity. Finally, we find that
elimination of an inhibitory protein leads to an excessive
activation of SKN-1 and impairs pathogen resistance. Thus,
SKN-1 integrates various chemical, metabolic and micro-
bial signals to elicit a self-protective detoxification
response, which promotes innate immunity and may be
relevant to diseases and aging of the human immune
system.
Figure 1. SKN-1 is required for bacterial pathogen resistance. (A, B) Increased susceptibility to Pseudomonas aeruginosa PA14 occurs in both
skn-1(zu135) mutant (p,0.0001) and skn-1(RNAi) nematodes (p,0.0001). Killing assays were performed with at least 90 young adult animals in each
condition. EV: empty vector RNAi.
doi:10.1371/journal.ppat.1002673.g001
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tional activation upon PA14 infection, we examined the Pgcs-1::gfp
and gst-4::gfp reporter strains. While gcs-1 is regulated exclusively
by SKN-1, gst-4 is under the mutual control of both DAF-16 and
SKN-1 [15]. We observed an effective intestinal induction of
fluorescence to comparable extent in both strains in response to a
24 h-exposure of PA14 (Figures 2C and 2D). Both the gcs-1
promoter activation and the GST-4 expression were significantly
suppressed by feeding worms with skn-1(RNAi), indicating the
specific requirement of SKN-1 to elicit these responses. Thus,
PA14 infection induces nuclear translocation of SKN-1 and
transcriptional activation of its targets.
The TIR-1/PMK-1 pathway controls SKN-1 activation upon
P. aeruginosa infection
The p38 MAPK ortholog PMK-1 has a fundamental role in C.
elegans innate immunity [11]. To investigate whether PMK-1
regulates SKN-1 in response to bacterial exposure, we monitored
the activity of a Pgcs-1::GFP reporter in a wild-type and a pmk-
1(km25) mutant genetic background (Figures 3A and 3B). We
found that silencing pmk-1 entirely prevented the SKN-1-
dependent activation of gcs-1 in response to PA14 infection. In
physiological settings, PMK-1 is inactivated by the dual specificity
MAPK phosphatase VHP-1 [23]. Suppression of VHP-1 resulted
Figure 2. P. aeruginosa infection activates SKN-1. (A) Representative epifluorescence image demonstrating the translocation of SKN-1::GFP in
the Is007[SKN-1::GFP] strain to intestinal nuclei in L3 larvae, fed by the empty vector or skn-1 dsRNA, upon a 5-hour exposure to P. aeruginosa PA14.
Note that the intestinal tissue displays autofluorescence, and in the ASI neurons SKN-1::GFP is not silenced by skn-1 RNAi treatment. (B) Quantification
of SKN-1 nuclear translocation from data shown on panel (A). SKN-1::GFP-positive nuclei were counted in the intestine of 78 animals. ‘‘Low’’ refers to
animals in which SKN-1::GFP was detected in less than 5 intestinal nuclei, while ‘‘high’’ indicates that SKN-1::GFP signal was present in more than 15
intestinal nuclei. (C) Representative epifluorescence microscopic image showing intestinal expression of Pgcs-1::GFP and GST-4::GFP in L3 larvae upon
a 24-hour PA14 exposure. Images of control animals incubated on OP50 bacteria are shown in Figure S2. (D) Quantification of reporter expression
demonstrating the SKN-1-dependence of the response. Data were obtained from panel (C) completed with the data of skn-1(RNAi) animals.
Microscopic images are representatives of 3 independent experiments. EV: empty vector RNAi.
doi:10.1371/journal.ppat.1002673.g002
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in increased PMK-1 phosphorylation and resistance to PA14 [23].
However, vhp-1(RNAi) significantly increased Pgcs-1::GFP activa-
tion upon PA14, but not upon OP50 exposure, suggesting that
PMK-1 is an indispensable permissive factor for SKN-1 activation
by infection.
TIR-1 is a conserved Toll/IL-1 resistance (TIR) domain protein
known to activate p38 MAPK signaling independently of the Toll-
like receptor ortholog tol-1 during PA14 infection [24,25].
Depletion of TIR-1 by RNAi prevented Pgcs-1::GFP fluorescence
upon PA14 infection (Figures 3A and 3B). A similar inhibition in
Figure 3. The pathogen response-specific TIR-1 and p38 MAPK PMK-1 are required for SKN-1 activation upon P. aeruginosa
infection. (A) Representative epifluorescence microscopic images showing the expression of Pgcs-1::GFP in pmk-1(km25) mutants as well as in the
p38 MAPK phosphatase vhp-1(RNAi), and the Toll/IL-1 resistance (TIR) domain protein tir-1(RNAi) animals in response to P. aeruginosa infection. L3
larvae were exposed to PA14 for 24 hours. Microscopic images are representatives from 3 independent experiments. (B) Quantification of reporter
expression from data shown on panel (A) completed with data of control animals fed by OP50 for 24 h. (C) Quantification of SKN-1 nuclear
translocation in tir-1(RNAi) L3 larvae upon 5 h PA14 exposure. Representative epifluorescence images of tir(RNAi) L3 larvae are shown in Figure S3.
Please note that data in Figure 2B and 3C were derived from the same set of experiments. (D) Suggested model of SKN-1 activation during P.
aeruginosa infection. Upon exposure to PA14, the TIR-1/PMK-1 pathway is indispensable but insufficient to elicit SKN-1 transactivation. We propose a
second, unknown factor/pathway that is required to activate SKN-1. Whether the two pathways act in parallel or consecutively is unclear. Solid arrows
indicate a direct, while dashed arrows indicate an indirect/unknown connection. EV: empty vector RNAi.
doi:10.1371/journal.ppat.1002673.g003
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Pgcs-1::GFP expression was also observed in tir-1(qd4) mutant
animals (data not shown). Moreover, silencing tir-1 prevented the
nuclear translocation of SKN-1 induced by PA14 infection, but
did not affect its baseline expression levels (Figures 3C and S3.).
Altogether, these results suggest that the TIR-1/PMK-1 pathway
is necessary to attain activation of SKN-1 by PA14 exposure
(Figure 3D).
Involvement of SKN-1 in immunosenescence
Immune function declines with age, leading to compromised
immune responses to infections in the elderly. Accordingly, aged
nematodes exhibit increased susceptibility to infection by various
pathogens, including P. aeruginosa [26–28]. As SKN-1 is required
for both longevity and for pathogen resistance, we asked if
chronological aging affected SKN-1-dependent target gene
expression in nematodes exposed to pathogenic stress. To this
end we examined the promoter induction of gcs-1 by PA14 in L3
stage larvae, 4-day and in 9-day old adult worms, respectively
(Figures 4A and 4B). We observed a massive age-dependent
decrease in the expression of Pgcs-1::GFP reporter after 24 h of
PA14 infection. To investigate, how SKN-1 activity is involved in
immunosenescence, we examined the survival of 1, 4 and 9 day-
old adult N2 and skn-1(zu135) mutant nematodes exposed to
PA14. We observed that pathogen resistance in wild-type animals
already declined at day 4 as previously described by Laws et al.
[26]. Consistent with a premature decline of self defense in the
absence of SKN-1 activity, 4 d adult N2 worms showed similar
survival on PA14 to 1 d adult skn-1(zu135) animals (p = 0.1429).
Furthermore, we found that skn-1(zu135) mutant animals
exhibited increased susceptibility to PA14, compared to N2 at
all ages (p.0.0001) (Figure 4C and Table S1B), indicating that
SKN-1 function is also required to survive infection beyond day 9.
To address the potential involvement of SKN-1-dependent gene
expression in immunosenescence, we performed a bioinformatics
analysis using the microarray data of Youngman et al. [27]. From
the 379 genes exhibiting the most significant down-regulation
during aging (.10 fold down-regulation at d15 vs. d6) we
identified 46 SKN-1-regulated genes (based on skn-1(RNAi) screens
[29,30]) (Figure 4D, Table S2). Next, we examined the regulation
of these genes with respect to oxidative stress, PA14 and PMK-1
dependent regulation using Wormbase expression data [31].
Strikingly, SKN-1-regulated genes subject to PA14-dependent
regulation were over-represented compared to those regulated by
either oxidative stress or PMK-1, respectively. These results
confirm a progressive age-dependent compromise in pathogen
resistance and imply that a decline in SKN-1 function contributes
to immunosenescence.
Reduced IIS and oxidative preconditioning require SKN-1
for enhanced pathogen resistance
Loss-of-function mutations in the insulin/IGF-1 receptor gene,
daf-2 enhance stress resistance and extend lifespan, and both
processes require DAF-16 and SKN-1 activity [15]. As reduced
IIS increases pathogen resistance [6], we investigated the
contribution of SKN-1 to pathogen resistance in daf-2(e1370)
mutant animals. In accordance with previously published data [6],
daf-2(e1370) mutants exhibited robustly increased pathogen
resistance against PA14 (Figure 5A and Table S1C). However
silencing skn-1 by RNAi largely increased their susceptibility to
PA14. These data suggest that SKN-1 is required for reduced IIS
to bring about enhanced pathogen resistance against P. aeruginosa.
Exposure to mild oxidative stress induces tolerance to a lethal
challenge, cross-tolerance to other stresses and extends lifespan
[32]. To address the impact of oxidative preconditioning on
pathogen resistance, nematodes were pretreated with various
concentrations of H2O2, and then exposed to PA14 infection.
H2O2 preconditioning induced resistance against PA14 in a
concentration-dependent manner, reaching a 2-fold increase in
survival by 2 mM H2O2, compared to untreated controls
(Figure 5B and Table S1D). Intriguingly, the same treatment on
skn-1(zu135) mutant nematodes not only exhibited a decreased
pathogen resistance, but had a strongly suppressed reaction to
H2O2 (Figure 5C and Table S1D). We also found that the
mutation of another major oxidative stress response regulator,
DAF-16 (daf-16(mu86)), shows an even shorter basal survival,
compared to skn-1(zu135), and poorly responded to H2O2
(Figure 5C and Table S1D). Thus, oxidative preconditioning
requires both SKN-1 and DAF-16 for enhanced pathogen
resistance against P. aeruginosa.
Excessive activation of SKN-1 by wdr-23(RNAi) impairs
pathogen resistance
Finally, we investigated whether increased activation of SKN-1
was able to promote pathogen resistance. Stabilization of SKN-1
by RNAi against wdr-23 has been shown to induce constitutive
SKN-1 activation, resistance to oxidative stress and longevity [19].
Feeding worms with wdr-23(RNAi) indeed resulted in an
unexpectedly robust increase in the expression of Pgcs-1::GFP
and GST-4::GFP (Figure 6A) compared to the PA14-induced
expression (Figure 2C). To our surprise, wdr-23(RNAi), compared
to empty vector feeding greatly reduced pathogen resistance to
PA14 (Figure 6B and Table S1A). wdr-23(RNAi) did not impair
survival in a skn-1(zu135) mutant background excluding a SKN-1-
independent impact of WDR-23 on pathogen resistance. Inter-
estingly, the compromised reactivity of worms to wdr-23(RNAi) was
confined to pathogenic stress. Determination of oxidative
tolerance revealed that wdr-23(RNAi) animals exhibited increased
survival, whereas skn-1(RNAi) nematodes displayed decreased
survival, compared to control worms, when exposed to 3 mM or
5 mM H2O2, respectively (Figure 6C). Our results suggest that an
excessive post-translational stabilization of SKN-1 induces oxida-
tive stress resistance but impairs resistance to bacterial infection.
Discussion
Our present study identified SKN-1 as a novel regulator of
pathogen resistance against both Gram-negative P. aeruginosa and
Gram-positive E. faecalis bacteria (Figures 1 and S1). We
demonstrated a TIR-1/PMK-1-dependent SKN-1 activation
upon P. aeruginosa infection (Figures 2 and 3). Moreover, we
showed an early onset of immunosenescence with a parallel
decline in SKN-1-dependent transcriptional activation (Figure 4)
and a requirement of SKN-1 to efficient immunity in response to
reduced IIS or preconditioning H2O2 treatment (Figure 5).
Finally, we found that excessive activation of SKN-1 by blocking
its turnover impaired pathogen resistance (Figure 6).
The xenobiotic stress response provides a conserved defense
mechanism against oxidative and electrophilic stress via the
induction of phase 2 detoxification enzymes [33]. Nrf2 and its
nematode ortholog, SKN-1, are transcription factors important in
oxidative and xenobiotic stress response [34,35]. Previously,
several studies demonstrated the importance of Nrf2 in innate
immunity in mammals [36–38]. For example, Nrf22/2 mice
exhibit increased susceptibility to bacterial infection and bacterial
lipopolysaccharide (LPS)-induced inflammation [39]. Similarly,
our present study demonstrates that SKN-1 deficiency in C. elegans
impairs resistance to infection (Figures 1 and S1). During the
revision of our manuscript an independent paper from the Garsin
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lab appeared, which obtained similar results [21]. A previous study
found no significant impairment of pathogen resistance by skn-
1(zu135) and skn-1(zu67) mutations in the wildtype background
[40]. A possible reason of this discrepancy might be the use of cdc-
25.1(RNAi) by the Garsin lab and our study, suggesting that
selective bagging in wild-type vs. sterile skn-1 mutants might have
masked the pathogen resistance decrease induced by loss of skn-1
in the previous investigation. Consistently with this note, the use of
skn-1(RNAi) from the L1 stage, which did not induce sterility [21],
confirmed the decrease in pathogen resistance. A similar finding
was also reported as an earlier unpublished result of Evans et al.
[41].
We observed a nuclear translocation and transcriptional
activation of SKN-1 in the intestine, consistent with the primary
site of infection (Figures 2 and 3). Furthermore, we could not
detect any apparent change in SKN-1 intensity or nuclear
localization in ASI neurons upon PA14 exposure (Figure 2). This
finding is in agreement with previous reports on constitutive SKN-
Figure 4. Involvement of SKN-1 in immunosenescence. (A) Representative epifluorescence images showing the decreased induction of the
gcs-1 promoter. L3 larvae, 4 d/9 d adult Pgcs-1::gfp worms were exposed to PA14 for 24 h. (B) Quantification of the epifluorescence images of panel
(A). Epifluorescence images are representatives of two independent experiments. EV: empty vector RNAi. (C) Pathogen resistance of young adult (1
day-old), 4 day-old and 9 day-old adult N2 and skn-1(zu135) mutant animals. skn-1(zu135) mutant worms exhibited significantly increased
susceptibility to PA14 compared to N2 wild-type animals at all ages (p,0.0001). 1 day-old adult skn-1(zu135) worms show similar pathogen resistance
to 4 day-old N2 worms (p = 0.1429) (middle graph). Killing assays were performed with 3 parallel plates in each condition in 2 independent trials. (D)
Venn diagram showing the distribution of age-regulated SKN-1 target genes. Data were analyzed by finding the overlaps between micro-array
databases containing the genes down-regulated at least 10-fold in 15 d adult compared to 6 d adult wild-type animals [27] and SKN-1 dependent
genes under non-stress [29] or oxidative stress conditions [30] using expression data from Wormbase [31]. Please note that the majority of genes
belong to those regulated by PA14 infection. 10 of 46 genes could be assigned to none of the groups. For the detailed gene list please refer to Table
S2.
doi:10.1371/journal.ppat.1002673.g004
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1B activity and a lack of interaction between SKN-1B and WDR-
23 in ASI neurons, respectively [19,34]. Together, our data imply
an active role of the intestinal SKN-1C isoform and does not allow
a conclusion regarding the involvement of the ASI neuronal SKN-
1B in the inducible antibacterial response. However, a continuous
transcriptional output of SKN-1B and/or a different mode of
regulation of SKN-1B in response to infection cannot be excluded.
Hence, a tissue-specific analysis of SKN-1 function may give a clue
whether SKN-1 isoforms co-operate in immunity.
Our findings confirm those of van der Hoeven et al. [21] on the
critical role of the p38 MAPK pathway in SKN-1 activation
(Figure 3). However, the inability of vhp-1(RNAi) to activate SKN-1
on OP50 suggests that there should be additional, unidentified
signals that govern SKN-1 activation in response to PA14
infection, which will certainly prompt additional studies. We
showed an absolute requirement of TIR-1 for SKN-1 nuclear
translocation and for gcs-1 promoter induction upon PA14
exposure, while the Garsin lab reported no to minimal
involvement of TIR-1 in gst-4 and gcs-1 induction in response to
E. faecalis [21]. Whether the difference between our observations
beyond differences in assays and dosage/treatment by tir-1(RNAi)
may be due to a differential pathogen sensing of P. aeruginosa and
E. faecalis is an exciting possibility to explore. TIR-1 and PMK-1
are related to the mammalian SARM and p38 MAPK proteins,
respectively [42,43]. Although the existence of an orthologous
pathway in mammals remains elusive, these findings indicate that
the SKN-1-mediated response is an ancient component of innate
immunity.
Immunosenescence, the age-dependent decline of immune
response, is a critical problem impeding healthy ageing [44]. C.
elegans provides a useful tool to investigate elements of innate
immunity contributing to immunosenescence [45]. A recent
systematic study reported an age-dependent progressive increase
in susceptibility to PA14, detectable at day 6 of adulthood [27].
Our data on a similar age-related decline in survival, with a 45%
decrease in pathogen resistance at day 4 (Figure 4C) establishes an
earlier, dramatic onset of immunosenescence. Moreover, the loss
of SKN-1 function phenocopies the decreased resistance of d4
worms already at day 1, and continues to negatively affect survival
at day 9 (Figure 4C). A parallel strong decline in gcs-1
transactivation on day 4 and the widespread down-regulation of
SKN-1 targets, including PA14-regulated genes, between day 6
and 15 of adulthood (Figure 4D, Table S2) are consistent with this
observation and indicate SKN-1 as a key player in immunosenes-
cence.
Youngman and colleagues found an involvement of PMK-1 in a
decline of the innate immune response, and hypothesized
intestinal deterioration as a primary event in immunosenescence
[27]. Of note, the dependence of SKN-1 activation on PMK-1
([21] and our study), the high number of age-dependent SKN-1
targets among PMK-1 targets (13 of 26; Figure 4D, Table S2 and
[27]) and the impact of SKN-1 on intestinal homeostasis [30]
suggest a dynamic, probably mutual interaction between SKN-1
and PMK-1 in immunosenescence. We propose that SKN-1-
dependent stress responses collapse early in adulthood, which
manifest in a vicious circle of decreasing intestinal homeostasis,
progressive immunosenescence and increasing pathogenic load in
C. elegans. This hypothesis is consistent both with the short lifespan
of worms in natural conditions and with the allocation of resources
to maintain the soma until the production of fit progeny (the
‘‘disposable soma theory’’ [46]).
Genetic or environmental interventions that operate via stress-
responsive mechanisms extend both lifespan and pathogen
resistance [6,15,32,47,48]. Our results on H2O2-induced pathogen
resistance (Figure 5B), together with previous analogous heat-
shock experiments [7] suggest that mild stresses acting early in
adulthood confer resistance against pathogenic stress. Further-
more, the demonstration of the requirement of SKN-1 and DAF-
16 in the enhanced pathogen resistance of both H2O2-precondi-
tioned and daf-2(e1370) mutant nematodes suggests a dynamic
Figure 5. Reduced IIS and oxidative preconditioning require
SKN-1 for enhanced pathogen resistance. (A) daf-2(e1370) mutant
nematodes exhibited increased resistance to P. aeruginosa, compared
to that of wild-type N2 worms (p,0.0001). skn-1(RNAi) treatment of daf-
2(e1370) animals increased the susceptibility to P. aeruginosa infection
(p,0.0001). Killing assays were performed with at least 90 young 1-day
old adult animals in each condition. (B) H2O2 pretreatment increased
survival on PA14 in a concentration-dependent manner. Survival curves
of N2 wild-type worms treated with various concentrations of H2O2 in
liquid NGM: 1 mM (p = 0.425), 1.5 mM (p,0.0001) and 2 mM
(p,0.0001) 12 h prior to the killing assay are shown. Killing assay was
performed with 90 3-day old adult animals in each condition. (C)
Oxidative preconditioning-induced pathogen resistance was impaired
in the absence of SKN-1 or DAF-16. Increase in survival was less
pronounced in either skn-1(zu135) (p = 0.0156) or daf-16(mu86) mutant
(p = 0.0304), than in wild-type animals (p,0.0001). Survival curves of
the same genetic background were compared in the absence and
presence of H2O2. Data were combined from at least two experiments
with 89 animals in average for each group. EV: empty vector RNAi.
doi:10.1371/journal.ppat.1002673.g005
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cross-talk of these stress-responsive transcription networks tipping
the balance between responses to nutrient availability, oxidative
and pathogen stress. Though our data do not allow a clear
conclusion, the recent prediction of a DAF-16-dependent
regulation of SKN-1 [49] is in line with the proposed functional
interaction between SKN-1 and DAF-16 and is a subject of future
interesting studies.
Evidence on mammals indicates a defensive role of Nrf2 against
inflammation-induced tissue damage [36–39]. An analogous
nematode model raises the question, whether SKN-1 affects
immunity independently of its impact on aging. Indeed, longevity,
stress resistance and pathogen resistance are intimately linked in
short-lived C. elegans. However, a greater reduction of survival in
skn-1(zu135) mutants on PA14 than on non-pathogenic OP50
(51% vs. 19% compared to N2, Figures 1 and S4, Tables S1 and
S3) suggests a stronger impact of SKN-1 on pathogen resistance
than on longevity. The pathogen-induced activation of SKN-1 and
the large number of PA14-regulated SKN-1-targets including
immune-related CUB-like domain proteins (Figure 4D, Table S2)
[29] support SKN-1’s active involvement in the pathogen
response. Finally, it has previously been shown that knock-down
of skn-1 in the daf-2(e1370) mutant selectively suppresses stress
resistance but not lifespan [15]. Thus, our findings demonstrating
a SKN-1-dependent increase of pathogen resistance by this allele
(Figure 5A), suggest an immune-specific effect of SKN-1. Studies
investigating SKN-1-dependent responses on OP50 vs. pathogens
Figure 6. Excessive activation of SKN-1 by wdr-23(RNAi) impairs pathogen resistance. (A) Robust up-regulation of Pgcs-1::GFP and GST-
4::GFP in 1 d adult wdr-23(RNAi) worms. (B) Pathogen resistance of wdr-23(RNAi)-fed N2 and skn-1(zu135) mutant worms. N2;wdr-23(RNAi) exhibited
increased susceptibility to P. aeruginosa infection (p,0.0001). skn-1(zu135) mutant nematodes fed by wdr-23(RNAi) showed no significant difference
in survival on PA14 (p = 0.1992). Killing assay was performed with at least 90 1-day old adult animals in each condition. Please note that data in
Figures 1A and 6B were derived from the same set of experiments. (C) wdr-23(RNAi) treatment increased (p,0.0001, both at 3 mM and 5 mM H2O2,
respectively), while skn-1 RNAi treatment decreased oxidative tolerance to H2O2 (p,0.0001 at 3 mM H2O, p,0.05 at 5 mM H2O2). Worms were
treated with 3 mM or 5 mM H2O2 for 1 hour, and 24 h after challenge survival was scored. Data were combined from three experiments with 120
animals in average for each group. EV: empty vector RNAi.
doi:10.1371/journal.ppat.1002673.g006
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would help reveal the downstream mediators of SKN-1 and to
determine the immune-specific and other branches of SKN-1
action.
SKN-1 activation by wdr-23(RNAi) impairs pathogen resistance,
a result in contrast with those of the Garsin lab [21]. The reason
may lie in the use of cdc-25.1(RNAi) by us, or in the different
dosage/duration of RNAi treatment in the two experimental
protocols. Nevertheless, our findings on the adverse effects of
excessive SKN-1 activity are consistent with those reporting that
loss of WDR-23 activity slows growth via SKN-1 [19], expression
of SKN-1 from high-copy arrays is toxic [15], and that SKN-1
mediates increased susceptibility to PA14 in the absence of BLI-3
[21]. Combining the two wdr-23(RNAi) results ([21] and our study)
clearly shows that this type of activation can dissociate immunity
from oxidative stress resistance. As a potential mechanism,
excessive SKN-1 activation may remodel the transcriptional
response in favor of anti-oxidative defense and/or may repress
pathogen-specific defenses. Indeed, differential SKN-1 transcrip-
tional outputs were demonstrated [29]. It is logical to assume that
negative and positive inputs regulating SKN-1 allow fine-tuning of
stress resistance, growth and immunity. An analogous deteriora-
tion of pathogen resistance by the excessive activation of DAF-16
[10] underscores the necessity of tight control of stress responses to
avoid deleterious consequences during infection.
Taken together, we propose that an optimal enhancement of
SKN-1 activity in proper time-frame may enhance immune
responses and delay immunosenescence without compromising
longevity. In recent years, C. elegans has become a versatile model
not only for studying innate immunity, host-pathogen interactions,
but for testing pharmacological interventions in drug discovery
[50]. The results presented herein may prompt studies on drugs
targeting SKN-1/Nrf2 to modulate the innate immune response.
In conclusion, our findings indicate an intricate regulation of
innate immunity by SKN-1, and link pathogenic stress signaling to
xenobiotic and oxidative stress responses.
Materials and Methods
C. elegans strains and maintenance
Nematodes were maintained and propagated on E. coli OP50 as
described by Brenner [51] at 20uC. The following C. elegans strains
were obtained from the Caenorhabditis Genetics Center and were
used in this study: N2, EU31 skn-1(zu67)IV/nT1[unc-?(n754) let-
?](IV;V), KU25 pmk-1(km25)IV., ZD101 tir-1(qd4)III. Further
strains were used: LD001 Is007 [skn-1::gfp], CF1038 daf-
16(mu86)I., CB1370 daf-2(e1370)III. (Tibor Vellai, Eo¨tvo¨s Lora´nd
University, Budapest, Hungary), LD1171 Is003 [Pgcs-1::gfp] (T.
Keith Blackwell, Harvard Medical School, Boston MA, USA) and
MJCU017 kIs17[gst-4::gfp, pDP#MM016B]X. (Johji Miwa, Chubu
University, Kasugai, Japan). Nematodes were treated with cdc-
25.1(RNAi) to avoid the bacterial infection induced ‘bag of worms’
phenotype in all experiment.
Crossing and genotyping by PCR
Pgcs-1::gfp;pmk-1(km25) and Pgcs-1::gfp;tir-1(qd4) strains were
created by mating male pmk-1(km25) or tir-1(qd4), respectively,
with LD1171 Is003 [Pgcs-1::gfp] hermaphrodites. Transgenic rol
progeny was isolated with the correct genotype as scored by PCR.
PCR primers were obtained from Sigma. The primers pmk-1-OF
(59-GGATACGGAAGAAGAGCCAATG-39) and pmk-1-OR (59-
CAACAGTCTGCGTGTAATGC-39) were used to detect the
pmk-1(km25) deletion allele. The wild-type pmk-1 allele amplified a
1195-bp fragment compared to a 882-bp fragment from pmk-
1(km25) allele. Homozygous pmk-1(km25) mutants were identified
by PCR using primers pmk-1-IF (59-TCCTATAAGTTGCCAT-
GACCTCAG-39) and pmk-1-IR (59-CCCGAGCGAGTACATT-
CAGC-39) from inside the deletion region. Wild-type animals
generated a 469-bp fragment, while the homozygous pmk-1(km25)
allele did not produce any fragment. The primers tir-1-OF (59-
TGGGTAAATGAGGAAGAGAGAGAG-39) and tir-1-OR (59-
TCGGTTGACGAGTCGAATTTGG-39) were used to detect the
tir-1(qd4) deletion allele. The wild-type tir-1 allele amplified a
1368-bp fragment compared to a 228-bp fragment from tir-1(qd4)
allele. Homozygous tir-1(qd4) mutants were identified by PCR
using primers tir-1-OF and tir-1-IR (59-CACAAGAACGTGCAA-
CATCG-39) from inside the deletion region. Wild-type animals
generated a 327-bp fragment, while the homozygous tir-1(qd4)
allele did not produce any fragment.
RNA interference (RNAi)
The HT115(DE3) E. coli bacteria producing dsRNA against cdc-
25.1 (Andy Golden NIDDK/NIH, Bethesda MD, USA), skn-1 (T.
Keith Blackwell, Harvard Medical School, Boston MA, USA),
wdr-23 (Keith P. Choe, University of Florida, Gainesville FL,
USA), vhp-1 and tir-1 (Source BioScience Geneservice, Cambridge,
United Kingdom) were used in our study. RNAi feeding E. coli
clones were grown overnight in LB medium containing 100 mg/ml
ampicillin. RNAi treatment was performed as described by
Shapira et al. [22]. Worms were grown on RNAi bacteria from
hatching till young adult stage. If several RNAi constructs were
used in one condition, ON cultures of the feeding bacteria strains
were mixed equally. Empty vector containing HT115(DE3)
bacteria (EV) was used as a control in all cases.
Preparation of pathogenic bacteria
Different human opportunistic bacteria, such as Pseudomonas
aeruginosa and Enterococcus faecalis [28,52] are ubiquitously used as
pathogen models. Gram-negative Pseudomonas aeruginosa PA14
(David W. Wareham, Queen Mary University of London,
London, UK) and Gram-positive Enterococcus faecalis SdB262
(Jonathan J. Ewbank, Centre d’Immunologie de Marseille-
Luminy, Marseille, France) bacteria were maintained and
prepared for experiments as described by Powell and Ausubel
[53]. BHI agar was supplemented with 100 mg/ml rifampicin for
E. faecalis killing assay.
Killing assay
Killing assays were performed with young adult animals at
25uC on slow killing plates (P. aeruginosa) or rifampicin BHI plates
(E. faecalis), or otherwise as it was noted in the figure legend.
Dead worms were scored every 12 hours till complete extinction
of the population. Viability was determined by assaying for
movement in response to gentle prodding. Worms died on the
wall of the Petri dish or crawled into the gel were censored. 30
animals per condition were tested with 3 parallel plates in at least
two independent trials, except that an H2O2-concentration
dependence of preconditioned pathogen resistance was estab-
lished in one trial. For studying pathogen resistance of daf-2
mutants, nematodes were grown at 15uC. For oxidative
preconditioning 2-day old adult animals were treated with 0
(control), 1 mM, 1.5 mM and 2 mM H2O2 (Sigma) in liquid
NGM for 2 hours at 20uC. Before the killing assay worms were
transferred to OP50 seeded NGM plates for a 12-hour recovery
period. To test the effect of aging on pathogen resistance, worms
were maintained on OP50-seeded NGM plates before the
challenge. To avoid ‘bag of worms’ phenotype, animals were
fed by cdc-25.1(RNAi).
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Fluorescence microscopy
Nematodes were treated as indicated in the figure legends
(Figures 2, 3, 4 and 6). After treatments at least 40 worms per
condition were placed on a 2% agarose pad, and immobilized by
adding 40 mM levamisole in M9 buffer. Images were taken by a
Leica DMI6000B epifluorescence microscope with a DFC480
camera. Epifluorescent microscopic images are representatives of
at least 3 experiments. To analyze Pgcs-1::GFP and GST-4::GFP
expression upon PA14 infection, two groups of animals were
determined depending on the detected GFP level in the intestine:
GFP positive and GFP negative animals. To study the nuclear
localization of SKN-1 in response to PA14 infection minimum 15
skn-1::gfp worms per condition were analyzed in at least 3
independent trials. Images were captured by a Zeiss LSM510
confocal laser scanning microscope equipped with a 406/1.3 oil
immersion objective (Plan-Neofluar, Zeiss).
Analysis of SKN-1 dependent targets amongst genes
down-regulated by aging
A list of 379 genes exhibiting the most significant age-dependent
decline in their expression (.10-fold at d6 vs. d15) was acquired
from [27]. Data were analyzed by finding the overlaps between
genes subject to SKN-1 dependent genes under non-stress [29] or
oxidative stress conditions [30]. Then the expression of the
identified genes was analyzed based on Wormbase data, focusing
on PA14-, oxidative stress- or PMK-1-dependent regulation [31].
Oxidative stress tolerance
Young, 1-day old adult worms were incubated in liquid NGM
for 1 hour at 20uC with 3 mM and 5 mM H2O2 (Sigma). After
oxidative challenge animals were transferred to OP50 seeded
NGM plates and viability was tested 24 hours later. 35 animals per
plate were examined in each condition with 3 parallel plates in 3
independent trials.
Statistical analysis
Data were analyzed by using the SPSS software 15.0 (SPSS Inc.,
Chicago, IL, USA). Survival curves were compared by Kaplan-
Meyer log-rank test. To compare the means of survival (oxidative
tolerance assay) or the GFP expression of the Pgcs-1::gfp, gst-4::gfp,
skn-1::gfp strains variables were analyzed by one-way ANOVA test.
Results are expressed as mean 6 standard deviation (SD).
Statistical significance was indicated as follows: * p,0.05,
** p,0.001, *** p,0.0001.
Accession numbers
C. elegans proteins/genes: Q17941, Q9XTG7, Q2MGF0,
Q17450, O61213, P54145, Q9U3Q6, O02215, G5EC10,
Q18198, Q9XUH3, Q9XUF9, O44552, Q27487, Q18938,
O17725, O16849, Q968Y9, Q9XVB4, Q9XVA9, Q19223,
O62146, G5EGH6, Q8MNR8, Q19774, O02357, Q09321,
Q9UAQ9, P91316, Q20770, Q20840, G5EC22, P90893,
Q20968, Q21009, Q20117, Q9U2Q9, Q21355, Q9XW45,
Q21381, Q09991, Q94269, Q94271, P34528, Q17446, Q2PJ68,
P34707, P41977, O02364, Q9XUC0, Q86DA5, Q10038,
P90794, Q8WRF1, Q9U309, G5EFR9, Q9GR66, G5ECJ8,
Q86S61, O76725, Q9N4X8, Q9NAB1, Q23498, Q23564
Human proteins/genes: Q12778, Q16656, Q16236, Q9Y4A8
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